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Short Tandem Repeats (STRs) have been the standard DNA marker employed in 
forensic laboratories for more than two decades. Due to the advances in the kit 
chemistries and separation technologies (capillary electrophoresis (CE) systems), the 
number of STRs that can be simultaneously typed has grown to 21-26; this provides 
sufficient confidence in the conclusions of most kinship cases. However, more complex 
cases (e.g. testing distant relatives, potential mutations, deficient cases or incest cases) 
or when the target population shows an increased level of consanguinity, the genetic 
evidence may prove inconclusive. This necessitates testing additional STRs included in 
supplementary STR kits. Another option is by using Massively Parallel Sequencing (MPS) 
systems that allow simultaneous sequencing of additional DNA markers.  
A total 500 samples from the population of Saudi Arabia were collected. Two CE-
based STR kits were used: Globalfiler™ PCR amplification kit (AB, USA) and SureID® 23 
comp Human Identification kit (Health Gene Technologies, China) that together allowed 
38 aSTRs to be analysed.  
In addition, as the SureID® 23 comp kit has not been validated either by an 
independent laboratory or by the manufacturer, the kit was validated following the 
minimum criteria of the European Network of Forensic Science Institutes (ENFSI) and 
the Scientific Working Group on DNA Analysis Methods (SWGDAM).  
Moreover, the ForenSeq™ DNA Signature Prep Kit (Verogen) was used to sequence 
87 samples and to generate sequence-based data for 122 autosomal markers included 
in the kit. The project allowed, in total, obtaining size-based data for 136 autosomal 
markers (42 aSTRs and 94 iiSNPs) and sequence-based data for 122 autosomal markers 
iii 
 
(28 aSTRs including SE33 and 94 iiSNPs). The data were evaluated for human 
identification and kinship testing in Saudi Arabia  
Although Globalfiler™ kit provided combined match probability (CMP) of 1.42E-26 
that is much higher than the kit currently used in Saudi Arabia that has a CMP of 2.23E-
18 (Identifiler plus kit), the availability of data for 42 aSTRs allowed other commercially 
available kits to be evaluated (based on the loci they contain). The study suggests 
adopting VeriFilerTM Plus (AB) or PowerPlex Fusion 6C system (Promega Corporation, 
USA) as a standard STR kit that would provide the lowest CMPs (9.26E-29 and 1.03E-29, 
respectively). Adopting any of the three kits would provide sufficient confidence in most 
parent-child cases (trio or duo). 
The validation of the SureID® 23 comp has shown that the kit met the criteria 
commonly used in forensic genetics laboratories. In addition, the kit can benefit from 
some developments that were identified by the validation, in particular the addition of 
extra alleles in the allelic ladder and also to increase the amount of input DNA that can 
be added to an amplification. The kit can be used if any kinship cases showed 
inconclusive results with GlobalFilerTM, VeriFilerTM Plus or PowerPlex Fusion 6C allowing 
38-40 aSTRs to be analysed. 
The ForenSeq™ DNA Signature Prep Kit provided CMP of 1.97E-68 and 3.65E-77 for 
the size and sequence-based data respectively, where 1.24E-37 (size-based data) and 
5.6E-41 (sequence-based data) were provided from the iiSNPs alone. The kit can be used 




The study highlighted 220 syntenic pairs, 46 of which would have significant impact 
on LR estimation due to lower RFs (< 0.12). The case-specific impact of linkage should 
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Asian) generated by the 1000 Genomes Project (Phase 3) using LDlink v3.7.2. (Machiela 
and Chanock 2015). (A) is for pairs rs6955448- rs6950322, (B) rs430046-rs409820, (C) 
rs409820-rs430044, (D) rs430046-rs430044, (E) rs4606077-rs1869434, (F) rs445251-
rs369438, (G) rs279844-rs279845 (all populations) and (H) is for rs279844-rs279845 
(Africans). Each table shows the haplotypes frequencies across 5008 samples per all 
population (A-G)/African population (H), D' (an indicator of allelic segregation for two 
genetic variants. A D' value of 0 presents no linkage of alleles and a D' value of 1 
indicates at least one expected haplotype combination is not observed), R2 value, Chi-
sq. and p-value (High chi-square statistics and low p-values are evidence that haplotype 
counts deviate from expected values and suggest linkage disequilibrium may be 
present). Each table shows a statement for the correlation between the variants of 
interest and if (R2 > 0.1), the variants are correlated. 
184 
Table 7.1. LR medians for eight scenarios simulated using seven different markers sets 
for related and unrelated simulations. The table shows the improvement on LRs when 
more markers were used for the tested relationships. It also shows the case pedigrees 
(hypothesis 1) as in (Table 2.5) where orange colour represents simulated members 
(i.e. genotyped members) and crossed member were assumed as not available for 
testing. As expected, LRs improved when more loci were added. The improvement 
varied and was impacted by the type relationship tested and by the number of relatives 
included in the simulation. 
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Table 7.2. The results of the LD test for 14 syntenic STR-STR pairs (at the same arm) 
resulted from using SureID 23 kit in conjunction with GlobalFiler (12 syntenic pairs, P 
value = 0.004) or with Fusion 6C (14 syntenic pairs, P value = 0.0035) and their RF values. 
The RFs were calculated using Kosambi mapping function using genetic map distance 
in cM estimated using cumulative genetic map distance in cM which were reviewed 
from (Phillips 2017). None of the syntenic pairs showed LD after Bonferroni correction. 
The Bonferroni correction was performed by dividing 0.05 by the number of tested 
pairs (the number of tests being performed), i.e. 0.05/12 STRs = 0.004 and 0.05/14 = 
0.0035. Shaded rows show all syntenic pairs with RFs < 0.12. Cautions should be 
considered when including D18S51-D18S1364 and PentaD-D21S2055 pairs in the 
calculation of LRs due to low RFs. The pair vWA-D12S391 will not have significant 





Table 7.3. The results of the LD test for 166 syntenic (STR-STR, STR-SNP and SNP-SNP) 
pairs (at the same arm) resulted from using ForenSeq DNA Signature Prep kit alone and 
the RF values. The RFs were calculated using Kosambi mapping function using genetic 
map distance in cM estimated using high-density multi-point SNP data of HapMap as 
described by Phillips et al. (2012). The cumulative genetic map distance in cM of 27 
aSTRs were reviewed from (Phillips 2017) and of the 94 iiSNPs were estimated as 
described by Phillips et al. (2012) (Appendix 6, Section 10.6.2). None of the syntenic 
pairs showed LD after Bonferroni correction (P value = 0.0003). The Bonferroni 
correction was performed by dividing 0.05 by the number of tested pairs (the number 
of tests being performed), i.e. 0.05/166 pairs = 0.0003. Shaded rows present pairs with 
RFs < 0.12 (43 pairs). This table assumed that SE33 was typed as shown in Chapter 6.  
The data of the 87 samples were used in the test of LD. 
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Table 7.4. The results of the LD test for additional 50 syntenic (STR-STR and STR-SNP) 
pairs (at the same arm) resulted from combining GlobalFiler, SureID23 and ForenSeq 
DNA Signature Prep kits. The cumulative genetic map distance in cM of 12 STRs were 
reviewed from (Phillips 2017) and of D16S539 with the 94 iiSNPs were estimated as 
described by Phillips et al. (2012) (Appendix 6, Section 10.6.2). The RFs were calculated 
by Kosambi mapping function using genetic map distance in cM that was estimated 
using high-density multi-point SNP data of HapMap as described by Phillips et al. (2012). 
None of the syntenic pairs showed LD after Bonferroni correction (P value = 0.00023). 
The Bonferroni correction was performed by dividing 0.05 by the number of tested 
pairs (the number of tests being performed), i.e. 0.05/216 pairs (166 pairs from Table 
7.3 and 50 from this table) = 0.00023. Shaded rows present pairs with RFs < 0.12) (49 
pairs in total when using the 136 loci). 
232 
Table 8.1. The order of 42 aSTRs studied in this project based on their MP. The table 
also shoes the CMP that can be obtained when using any of the latest four developed 
CE-based aSTR kits. 
241 
Table 10.1. Scenarios specific equations that used for calculating the RI. The table shows 
the equations that are used in calculating RI based on the genotypes of the tested 
individuals. The numerator (X) represents the probability of that the alleged father has 
passed the common allele with the disputed child. The denominator (Y) represent the 
probability of that random male from the same population is the source of shared 
allele. The RI equations are the result of numerator (X)/denominator (Y). The last five 
rows, show specific scenarios’ equations that used for calculating the RI when the 
mother’s genotype is not available (Stephenson 2010). 
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Table 10.2. Scenarios specific equations that used for calculating the RI when the child 
is missing, and the genotypes of the parent are is available (AABB 2010b) 
271 
Table 10.3. Scenarios specific equations that used for calculating the Sibling Index (SI) 
and the Half-Sibling Index (HSI) (AABB 2010b) 
272 
Table 10.4. Sequence-based data for 27 aSTRs generated from Chapter 6. 288 
Table 10.5. HWE test for aSTRs for the data generated from Chapter 6. None of the 
analysed markers showed significant deviation from HWE after Bonferroni correction 
(P value>0.0004). The Bonferroni correction was performed by dividing 0.05 by the 






Table 10.6. SE33 data Generated from Chapter 6. 306 
Table 10.7. iiSNPs sequence-based data generated from Chapter 6. 308 
Table 10.8. HWE test for iiSNPs data generated from Chapter 6. None of the analysed 
markers showed significant deviation from HWE after Bonferroni correction (P 
value>0.0004). The Bonferroni correction was performed by dividing 0.05 by the 
number of tested markers (the number of tests being performed), i.e. 0.05/121 loci = 
0.0004. 
323 
Table 10.9. LD test for 122 autosomal markers. A total of 292 pairs (STR-STR, STR-SNP 
and SNP-SNP) of syntenic markers (q-q, p-p, and p-q) were tested and no LD was 
detected after Bonferroni correction (P value> Bonferroni-corrected P value 0.0001). 
The Bonferroni correction was performed by dividing 0.05 by the number of tested 
markers (the number of tests being performed), i.e. 0.05/292 pairs = 0.0001. 
325 
Table 10.10. The cumulative genetic map distances of 95 SNPs estimated in this study. 
The 95 SNPs includes 94 iiSNPs and (rs925658351) for D16S539 STR (shaded row). The 
cumulative genetic map distances were estimated as described by (Phillips et al. 2012). 
The SNP position (bp) on 1000 Genome Browser was used to find the approximate HAP 
MAP Position (bp) and then to give the cumulative genetic map distance estimation 





IV. List of figures 
Figure 1.1. Number of individual's DNA profiles on the UK's NDNAD. This figure is 
showing the number of individuals’ DNA profiles stored on the NDNAD of the UK starting 
from 2008 to 2016 (National Police Chief's Council 2017, 2015). 
5 
Figure 1.2. Match percentage when loading a DNA profile from a crime scene. This figure 
is showing the efficiency of the UK's NDNAD when adding a DNA profile from a crime 
scene (National Police Chief's Council 2017). 
6 
Figure 1.3. The efficiency of the NDNAD before and after applying the Protection of 
Freedoms Act (May 2012). This figure is showing that the efficiency of the NDNAD was 
not affected after applying the PoFA (May 2012) (National Police Chief's Council 2015, 
2017). 
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Figure 1.4. Number of individual's DNA profiles on the NDIS. This figure is showing the 
total number of individual's DNA profiles (offenders and arrestee) on the NDIS in the 
period of 2000-2017. It can be noticed that starting from 2004, the increase trend in the 
individual's DNA profiles, was higher than before, which was in response to new 
regulations that allow NDIS to collect samples even from arrestees (James 2012), 2017 
data (Federal Bureau of Investigation 2017). 
8 
Figure 1.5. This figure is showing the percentage of crime scene samples that match to 
a sample on the database in the period of 2000 -2016 (James 2012) , 2017 data (Federal 
Bureau of Investigation 2017). 
8 
Figure 1.6. An example of discordance in allele calling between two kits. The figure 
shows the genotype of the same sample at the SE33 locus using genRES MPX-2 (A) and 
genRES MPX-2sp (B) (Lederer et al. 2008). 
10 
Figure 1.7. An explanation of one of the possible reasons of discordance between 
different kits. This figure explains the cause of the discordance of the same sample when 
using genRES MPX-2 and genRES MPX-2sp (Serac, Bad Homburg). The annealing region 
of the 5′ primer of the genRES MPX-2 includes the 60 bp deletion present in one allele. 
The 5′ primer of the genRES MPX-2sp is closer to the repeat region and the 60 bp 






Figure 1.8. Inheritance pattern of alleles through generations. The pedigree shows 
three generations of a family and the portion of DNA shared between the family 
members. In the parent-child relationships, each of the offspring No. 4,6,9 and 11 has 
four expected genotypes (A,C),(A,D),(B,C),(B,D) each of which has 100% chance to have 
one shared allele with the father (No. 2) and 100% chance to have another shared allele 
with the mother (No. 1). In full sibling relationships (e.g. 4,6,9 and 11) there is 25% 
chance of having zero shared allele, 50% chance of having one shared allele and 25% 
chance of having two shared alleles. In half-sibling relationships (No. 12 and 13), there 
is 50% chance of having one shared allele, and 50% chance to have zero shared allele 
between them. There is 50% chance of having one shared allele and 50% of having zero 
shared allele between uncles (No. 4,6,9 and 11) and nephews (No. 12-17). There is 50% 
chance of having one shared allele and 50% of having zero shared allele between 
grandchild (NO. 12-17) with any of their grand grandparent (No. 1 and 2). Finally, there 
is a 25% (4/16) chance of having one shared allele and 75% (12/16) of having zero 
shared allele between the first cousins 13, (14 or 15),16 and 17. The shared alleles are 
termed as identical by descent (IBD) as they have originated from common ancestors. 
An original figure, and the table was adopted from (Butler 2015). 
15 
Figure 1.9. Inheritance pattern of the maternal and the paternal DNA component to 
offspring. 1) shows the maternal alleles (A, B), paternal (C, D), and the possible alleles 
combinations of the offspring. Each of the maternal and the paternal allele has 50% 
chance to be passed to the offspring. 2) shows a typical case of that the alleged father 
cannot be excluded from being the true father of the male offspring. 3) shows a typical 
exclusion case where the alleged father did not share any of his alleles with the disputed 
offspring with the assumption of no mutation event is suspected (an original figure). 
16 
Figure 1.10. HW frequencies resulted from two alleles A and a and their frequencies p 
and q respectively, where p + q = 1. When a population is within the expectations of 
HWE, the equations of homozygous and heterozygous genotypes can be used to 
estimate the genotypes frequencies. Adopted from (Brooker 2012). 
20 
Figure 1.11. The expected genotype frequencies based on the alleles frequencies in a 
population that met the HWE expectations. It can be seen that the highest percentage 
of heterozygosity can be obtained when the two alleles (assuming only two alleles can 
be seen at a marker) have a frequency of 0.5 (Figure from (Butler 2015). 
21 
Figure 1.12. The steps of PCR1 and PCR2 during the library preparation using the 
ForenSeqTM DNA Signature Prep kit. PCR1 is for amplifying the target regions with 
tagged primers (green colours). In PCR2, the tags on the amplicons are used to attach 
adapters and to attach sequencing primer in the sequencing stage. The adapters 
contain a part used as a unique index for each library (light red and light yellow) and a 
part complimentary to primers attached to the flow cell (dark red and dark yellow) (An 
original figure based on information from (Verogen 2018a)). 
33 
Figure 1.13. Cluster generation of the ForenSeqTM DNA Signature Prep kit. The figure 
is showing a detailed process for cluster generation. By the end of this stage, millions 
of the forward strands are ready for sequencing (An original figure based on 






Figure 1.14. Reversible termination strategy used by Illumina systems. The figure shows 
two types of termination strategies (Irreversible and reversible). The Irreversible 
strategy blocks the 3′ by hydrogen atom. The reversible strategy caps the hydroxy group 
at the 3′ position by a removable cap (O-azidomethyl) (an original figure adopted from 
(Chen et al. 2013). 
36 
Figure 1.15. Sequencing by synthesis used by the illumina systems. Once the sequencing 
primer is annealed to the forward strand, four labelled nucleotides A, G, C, T with 
reversible terminating groups are added simultaneously and are competing to be 
incorporated to the target base. The complimentary nucleotide is annealed and the 
TCEP is added to remove the dye, the reversible terminating groups, and to generate 
hydroxy group at the 3′ position simultaneously. This allows second base annealing in 
the second read. The fluorescent of the cleaved dye is imaged and recorded (an original 
figure adopted from (Chen et al. 2013)). 
37 
Figure 1.16. The minimum requirements for STR nomenclature system. This figure 
showing an example of the minimum requirements for STR nomenclature when using 
MPS systems that were recommended by the ISFG (Parson et al. 2016). 
41 
Figure 1.17. Saudi Arabia administrative divisions. This map is showing the 13 
administrative provinces: Makkah, Al-Madinah, Riyadh, Eastern Province, Al-Qassim, 
Asir, Hail, Tabuk, Northern Borders, Jizan, Al-Baha, Al-Jouf, and Najran. It also shows the 
eight Arab countries (image from https://www.123rf.com/). 
43 
Figure 2.1. This map is showing distribution of collection sites. Collection started from 
Riyadh to Dammam, Riyadh, Abha, Makkah (Mecca), Al-Madinah, Tabuk, and then back 
to Riyadh. 
51 
Figure 2.2. A hypothetical pedigree created by an in-house Excel sheet. The hypothetical 
pedigree comprised of three generations and 13 members. Circles represent female 
members and squares represent male members. The profiles of the members were 
generated by the in-house Excel sheet based on the allele frequencies of the 136 loci. 
67 
Figure 2.3. Mutation rate settings in Familias3 software. For aSTRs, extended stepwise 
model was used by applying the mutation rate in Table 2.4 in the rate box, 0.1 in the 
range box, 0.000001 in the rate 2 box for microvariants alleles. For iiSNPs, equal 
probability was used by applying 2.5E-8 in the rate box. 
69 
Figure 2.4. An example of how the genetic distance (cM) between syntenic pairs was 
calculated. This figure shows how the genetic distance (cM) between syntenic pairs was 
calculated as described by Phillips et al. (2012). 
74 
Figure 3.1. An example of an FTA card used for sample collection. Each card contained 
the sample number and the donor sex (F/M). The same number was printed in the 
consent form. A series of 2 mm punches can be seen in the upper blood spot. 
78 
Figure 3.2. Extracted DNA run on agarose gels (1%) (A, B, and C). A) Shows results of the 
5 samples following manufacturer’s protocol. B) Shows results of the same samples 
after applying the 6 hours/overnight incubation in the ATL buffer before starting the 
manufacturer’s protocol. C) Shows results of the 5 samples when using a volume of 100 






Figure 3.3. The average concentration of each DNA samples extracted. The average of 
the samples concentrations was 1.5 ng/µl that ranged from 0.07 - 13.5 ng/µl. Each dot 
represents the average of the two reading/sample. 
81 
Figure 3.4. Internal validation of half volume reaction and 50 cm capillary/ POP6. The 
figure shows one of the replicates of two Globalfiler™ profiles for the positive control 
using the manufacturer’s protocol (A) and the half volume reaction (B). Due to the use 
of 50 cm capillary, the run time was increased to 3800 s which was sufficient to cover 
the designated area of the largest locus SE33 that allowed the local Southern method 
to be used. 
82 
Figure 3.5. Allele variants of 7 and 8 at D1S1656. The figure shows allele 7 (A) and 8 (B) 
at the D1S1656 locus and the allelic ladder (C). Allele 7 is located outside the designated 
area of the locus. Both alleles are not represented in the allelic ladder of the 
Globalfiler™ PCR amplification kit. The alleles were reported in STRBase (Ruitberg et al. 
2001) but no sequence data was available (Alsafiah et al. 2017). 
83 
Figure 3.6. Non-reported Allele variants at SE33. The figure shows alleles 14.3 (A), 20.3 
(B), and 38 (C) at SE33 and the allelic ladder (D). The alleles have not been reported 
before in the STRBase (Ruitberg et al. 2001) and are not represented in the allelic ladder 
of the Globalfiler™ PCR amplification kit (Alsafiah et al. 2017). 
84 
Figure 3.7. Two electropherograms (A & B) for the same sample using two different STR 
kits. (A) shows the genotype of D7S820 locus (9, 12, OL) using the GlobalFiler® PCR 
amplification kit. (B) shows the genotype of the same locus (9,12) using PowerPlex® 21 
System. This confirmed that the OL allele belonged to SE33 and the OL allele appeared 
within the allelic window of D7S820 because of the adjacent locations of the D7S820 
and SE33 in the GlobalFiler® PCR amplification kit (Alsafiah et al. 2017). 
85 
Figure 3.8. The OL allele at the SE33 and the allelic ladder of the GlobalFiler® PCR 
amplification kit. The figure shows the size of the OL allele comparing to the allelic 
ladder. As it had been confirmed that the OL allele belonged to the SE33 locus, it was 
possible to calculate the repeat numbers based on the sizes of the OL allele and the 
nearest allele in the allelic ladder (4.2); the OL was called as allele 2 (size-based call). 
The black arrow points to stutter artefact of the OL allele (Alsafiah et al. 2017). 
86 
Figure 3.9. A multi-dimensional scale (MDS) for the average FST values of 13 common 
loci. Fourteen populations were included in the comparison: Saudi Arabian (this study), 
Saudi Arabian (Khubrani et al. 2019a), Saudi Arabian population in Riyadh (Osman et al. 
2015), Saudi Arabian in Dubai (Alshamali et al. 2005), Saudi Arabian in Kuwait (Al-Enizi 
et al. 2013), Qatari (Perez-Miranda et al. 2006), UAE population (Jones et al. 2017), 
Kuwaiti (Al-Enizi et al. 2013), Omani-Dubai (Alshamali et al. 2005), Yemeni-Dubai 
(Alshamali et al. 2005), Iraqi-Kuwait (Al-Enizi et al. 2013), Egyptians-Kuwait (Al-Enizi et 
al. 2013), Iranian-Kuwait (Al-Enizi et al. 2013), and Indian-Kuwait (Al-Enizi et al. 2013). 
Note: the data of Saudi population in (Sinha et al. 1999) was not included in the FST test 
due to the limited number of common loci included in the study (four loci). SA: Saudi 
Arabian and UAE: United Arab Emirates. The cmdscale function was used in R software 
to generate a multi-dimensional scale (MDS). 
98 
Figure 4.1. A 20-cm-long 3% agarose gel for the novel SE33 alleles; from the left side, 
alleles 20.3, 14.3, 38, 2 and a 100 bp ladder. It shows the separation of alleles 20.3 and 





Figure 4.2. An example of the quality of sequencing results. This figure shows an 
electropherogram for the forward strand of allele 2 at the SE33 locus. 
106 
Figure 4.3. Sequencing data of the reverse strand of the alleles 7 and 8 at the D1S1656 
locus. This data was generated using ForenSeq™ DNA Signature Prep (Primer Mix B) and 
MiSeq FGx System (Verogen). (A) Shows the sequence data of allele 7; (B) Shows the 
sequence data of allele 8. Due to the presence of the A variant of rs78443572 SNP 
(TAGG, G: 73%, A: 27%) in the alleles 8 and 13, these alleles ended with TAGA rather 
than TAGG (Alsafiah et al. 2018). 
109 
Figure 4.4. An estimation of the biogeographical ancestry. The figure shows the result 
of the biogeographical ancestry estimation of the two samples using the piSNPs and 
aiSNPs included in the Primer Mix B of the ForenSeq™ DNA Signature Prep kit. Both 
samples were classified as ad-Mixed Americans, one of which was more like the 
European main population. 
110 
Figure 5.1. Allelic ladder of the SureID® 23comp kit. This figure shows the allelic ladder 
provided with the SureID® 23 comp kit. It represents 232 alleles that are supported by 
53 additional bins for variant alleles (pink bins). It also shows the successful calibration 
and optimisation of the ABI 3500 DNA Genetic Analyser (Alsafiah et al. 2019a). 
120 
Figure 5.2. The genotype of the 9947A control DNA at the D5 locus included in the 
SureID® 23 comp kit. The locus had 14, 23, which is the genotype of D5S2800, 
confirming the correct name. The locus name is now updated by the manufacturer from 
D5S2500 (as shown in the locus name) to D5S2800. 
121 
Figure 5.3. Sensitivity and stochastic tests for the SureID® 23comp kit. Serial dilutions 
(500, 250, 125, 62, and 31) pg were prepared from the 2800M control DNA (Promega 
Corporation). Each test was done in five replicates and the highest number of detected 
alleles are shown. Each cell represents an allele and merged cells represent homozygote 
loci in 2800M. Green cells identify detected alleles with ≥ 60% peak balance ratios. 
Yellow cells identify detected alleles with < 60% peak balance ratios. Red cells represent 
non-detected alleles with threshold of 50 RFU/150 RFU for heterozygotes/homozygotes 
(Alsafiah et al. 2019a). 
123 
Figure 5.4. Testing of the SureID® 23comp kit with tannic acid. Three different 
concentrations of 100 ng/µl, 120 ng/µl and 150 ng/µl were tested. This figure shows 
the results of the control sample (no inhibition) and of the 100 ng/µl (tannic acid) 
sample. Figure 5.5 shows the results of 120 and 150 ng/µl of tannic acid. 
125 
Figure 5.5. Testing of the SureID® 23comp kit with tannic acid. Three different 
concentrations of 100 ng/µl, 120 ng/µl and 150 ng/µl were tested. This figure shows 
the results of the 120 ng/µl (tannic acid) sample and of the 150 ng/µl (tannic acid) 
sample. Full profiles were achieved with ≤ 120 ng/µl of tannic acid. 
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Figure 5.6. Testing of SureID® 23comp kit with humic acid. Three different 
concentrations of 50 ng/µl, 75 ng/µl and 100 ng/µl were tested. This figure shows the 
results of the control sample (no inhibition) and of the 50 ng/µl (humic acid) sample. 






Figure 5.7. Testing of SureID® 23comp kit with humic acid. Three different 
concentrations of 50 ng/µl, 75 ng/µl and 100 ng/µl were tested. This figure shows the 
results of the 75 ng/µl (humic acid) sample and of the 100 ng/µl (humic acid) sample. 
Full profiles were achieved with ≤75 ng/µl of humic acid. 
128 
Figure 5.8. SureID® 23comp kit performance with two common PCR inhibitors. Full 
profiles were generated in the presence of 75 ng/µl of humic Acid and 120 ng/µl of 
tannic acid. These figures are similar to those reported for the SureID®PanGlobal (Liu et 
al. 2017). However, the kit was not as robust with inhibitors as PowerPlex® Fusion 6C, 
GlobalFiler™, and Investigator® 24plex (Lin et al. 2017) (Figure from (Alsafiah et al. 
2019a). 
129 
Figure 5.9. Peak balance ratios study for the D21S2055 locus. This figure shows a study 
of the correlation between the size difference between heterozygous alleles and the 
peak balance ratio for the D21S2055 locus using data of 500 samples. The peak ratios 
of all genotypes that have the same size difference (nt) (e.g. the genotypes 13, 17; 14, 
18; and 15, 19 have the same size difference of 4 nt) were averaged and are represented 
by the black dots. The blue line shows the smoothed mean of the peak ratios. 
Heterozygote alleles with >50 nucleotides deference showed peak ratios <45% (Alsafiah 
et al. 2019a). 
134 
Figure 5.10. Stutter ratios study for the SureID 23comp Kit. The figure shows the 
average of - 4 stutter ratios for STRs included in the SureID 23comp kit. Each box 
represents the stutter ratios of an STR. The x-axis represents alleles and the y-axis 
represents the stutter ratios. The line was drawn based on the average ratios of 
observed stutters. Alleles of x.1, x.2 and x.3 are plotted at x.25, x.5, and x.75 
respectively. The average of stutter ratios ranged from 3.8% for D2S441 to 16.15% for 
D12S391 (Alsafiah et al. 2019a). 
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Figure 5.11. Precision study of the SureID 23comp Kit. The figure shows standard 
deviation (s.d) values of the fragment sizes of 22,981 alleles generated from 500 
samples tested by the SureID 23comp. The highest s.d. was observed in allele 21 at 
D7S3048 (0.1048 nt) (Alsafiah et al. 2019a). In the box plots, the lower whisker 
represents 25% of the lowest data, the upper whisker represents 25% of the highest 
data. The rectangle shows that 75% of the data are below the upper line, 25% of the 
data are below the lower line, and the centre bar represents the median of the data 
(50% of the data above this bar and 50% of the data below the bar). 
137 
Figure 5.12. Accuracy study of the SureID 23comp Kit. The average of the size values of 
each allele in the data of the 500 samples and in 21 allelic ladders were compared to 
the actual sizes of the corresponding allele (actual sizes provided by the manufacturer). 
The size differences per nucleotides were calculated and are represented by the 
coloured dots. All alleles fell within the range of ±0.41 nt of the allelic window; the 
largest differences were seen at D6S474 allele 17 (0.4096 nt) and D7S3048 allele 26 (-






Figure 5.13. Alleles outside the windows of the allelic ladder of the SureID® 23comp kit. 
This figure shows ten alleles observed in the population of Saudi Arabia that are not 
represented and were situated outside the designated widow of their loci. a) Alleles 7 
and 8 at D1S1656. B) Alleles 26.3 and 27.3 at D13S325. c) Allele 30 at D7S3048. d) Allele 
16 at D4S2366. e) Allele 12 at D3S1744. f) Allele 10 at D6S474. g) Alleles 6 and 7 at 
D15S659. Allele 7 at D1S1656 (a) was situated under the designated area of D18S1364 
(Alsafiah et al. 2019a). 
141 
Figure 5.14. Multi-dimensional scaling for the average FST values. Five populations were 
included in the comparison and each number represent a population, Saudi Arabia (this 
study), European (Iyavoo et al. 2019), African (Iyavoo et al. 2019), South Asian (Iyavoo 
et al. 2019) and Ningbo population (data provided by the Health Gene Technologies). 
The European and South Asian populations were more similar to Saudi population than 
the African and Ningbo populations. The cmdscale function was used in R software to 
generate a multi-dimensional scale (MDS). 
148 
Figure 6.1. Run metric indicators of the sequencing results. The indicators of the 
sequencing showed that the average quality of the generated reads is within the 
optimal ranges. 
156 
Figure 6.2. Depth of coverage for 27 aSTRs analysed in this study. The average reads 
count was 673 for all aSTRs that ranged from 173 reads for D5S818 to 2936 reads for 
TH01. In the box plots, the lower whisker represents 25% of the lowest data, the upper 
whisker represents 25% of the highest data. The rectangle shows that 75% of the data 
are below the upper line, 25% of the data are below the lower line, and the centre bar 
represents the median of the data (50% of the data above this bar and 50% of the data 
below the bar). 
158 
Figure 6.3. Depth of coverage for 94 iiSNPs analysed in this study. The average was 120 
reads for all iiSNPs that ranged from 36 for rs1736442 to 1320 reads for rs1109037. In 
the box plots, the lower whisker represents 25% of the lowest data, the upper whisker 
represents 25% of the highest data. The rectangle shows that 75% of the data are below 
the upper line, 25% of the data are below the lower line, and the centre bar represents 
the median of the data (50% of the data above this bar and 50% of the data below the 
bar). 
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Figure 6.4. Average ACRs of 27 aSTRs. The ACRs of all aSTRs were >60% and ranged from 
92.5% for D17S1301 to 65.5% for D22S1045. 
161 
Figure 6.5.  Average ACRs of 94 iiSNPs. All iiSNPs showed >60% ACRs except rs6955448 
SNPs that showed an average of 40% ACR. 
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Figure 6.6. Averages of stutter ratios for the 27 aSTRs. Each STR is represented by a plot 
and the x-axis represents alleles and the y-axis represent stutter ratios. Stutter ratios 
ranged from 0.6% for allele 6 in TPOX to 31.4% for allele 30 in FGA. Allele variants of 
x.1, x.2 and x.3 were plotted as x.25, x.50 and x.75. 
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Figure 6.7. The number of observed alleles by sequencing. Nineteen aSTRs presented a 
greater number of observed alleles, 13 of which had more alleles based on the repeat 
region sequences (green), 8 aSTRs had more alleles based on the flanking region 
sequences (red) (two aSTRs had variants in both regions), and 8 aSTRs did not show 





Figure 6.8. Improvements in the discrimination power of the 27 aSTRs. 170 
Figure 6.9. Improvements in the discrimination power of the 94 iiSNPs. 171 
Figure 6.10. Allele of interest at D19S433. A) shows the genotype of the sample using 
the GlobalFiler™ kit, the sequencing results using the ForenSeqTM kit, and typical 
sequences of the alleles 14 and 14.2 comparing to the allele of interest. B) shows the 
repeat region (blue) and the location of AG deletion (green) and the 5'and the 3' 
anchors used by the SR (yellow). 
175 
Figure 6.11. The number of observed size and sequence-based SE33 alleles. 176 
Figure 6.12. The number of SE33 sequence variants observed per allele. 177 
Figure 6.13. Sanger sequencing results for the discordance event. (A) the reference 
sequence of nucleotides 88277350 – 88277381 (GRCh38) at the 3' flanking region of 
the SE33 locus. (B) the sequence of the sample showed the discordance event. It shows 
a TTTT deletion at 88277355_88277358 (GRCh38) that explains the discordance 
between sequence and CE data. 
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Figure 7.1. A hypothetical pedigree created by an in-house Excel sheet. The hypothetical 
pedigree comprised of three generations and 13 members. Circles represent female 
members and squares represent male members (This figure is a copy of Figure 2.2). 
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Figure 7.2. A confirmation of the parent-child relationship assumed between the 
pedigree’s members. The figure shows a screen shot from the Familias3 software for 
the results of the blind search (parent-child). Each parent-child relationship was 
validated for the 136 loci before starting the simulation tests. 
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Figure 7.3. The impact of adding more DNA markers to the simulation tests on the LR. 
The figure shows how testing more DNA markers improves the LR and thus reduces 
uncertainty. The blue line represents LR distribution for related simulations, the red line 
represents LR distribution for unrelated simulations, the light blue area represents the 
true positive (TP), the light red area represents the true negative (TN), the yellow area 
represents the false positive (FP), and the green area represents false negative (FN). 
The marker sets A, B and C are examples of different marker sets where the number of 
markers in set A lower than in set B, which is lower than in set C. The green and yellow 
areas are the uncertainty areas. When more markers are used (e.g. set B) LR distribution 
of related moves to the right (LR increased) and LR distribution of unrelated moves left 
(LR decreased). The uncertainty areas are decreased when more markers are added 
(e.g. set C) (log10 of LR 1 = 0) (an original figure). 
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Figure 7.4. LR distributions of the simulation study for parents-child relationship (trio 
pedigree) using 15 aSTRs included in the Identifiler kit, which was plotted based on data 
generated by Familias3 software. The green histogram represents LR distributions for 
the true positive simulations (parents-child relationship), the orange histogram 
represents the LR distributions of true negative simulations (unrelated). The 15 aSTRs 






Figure 7.5. LR improvements (increment) for different relationships using the seven 
marker sets for related simulations. The figure shows LR improvements when more loci 
used and shows the impact of type of the relationship simulated and impact of including 
relatives in the simulation tests, on the LRs. In the box plots, the lower whisker 
represents 25% of the lowest data, the upper whisker represents 25% of the highest 
data. The rectangle shows that 75% of the data are below the upper line, 25% of the 
data are below the lower line, and the centre bar represents the median of the data 
(50% of the data above this bar and 50% of the data below the bar). 
200 
Figure 7.6. LR improvements (decrease) for different relationships using the seven 
marker sets for unrelated simulations. The figure shows LR improvements when more 
loci were used and shows the impact of type of the relationship simulated and impact 
of including relatives in the simulation tests, on the LRs. Higher impact of the 94 iiSNPs 
on parent-child relationship (when used alone or when they were included in the 121 
or the 136 loci) can be seen in the bottom right (will be discussed at the end of this 
study). In the box plots, the lower whisker represents 25% of the lowest data, the upper 
whisker represents 25% of the highest data. The rectangle shows that 75% of the data 
are below the upper line, 25% of the data are below the lower line, and the centre bar 
represents the median of the data (50% of the data above this bar and 50% of the data 
below the bar).. 
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Figure 7.7. LR distributions of the simulation study for parent-child relationship (duo 
pedigree) using different marker combinations. The figure also shows the case pedigree 
(hypothesis 1) as in (Table 2.5) where orange colour represents simulated members and 
crossed member was not available for testing. 
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Figure 7.8. The TP and FP at different LR thresholds generated from the simulation study 
for parent-child relationship (duo pedigree) using different marker combinations. Each 
marker set is represented by a unique colour. True positive (TP) and false positive (FP). 
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Figure 7.9. LR distributions of the simulation study for full-siblings/unrelated (Scenario 
1) using different marker combinations. The figure also shows the case pedigree 
(hypothesis 1) as in (Table 2.5) where orange colour represents simulated members and 
crossed members were not available for testing. 
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Figure 7.10. The TP and FP at different LR limits generated from the simulation study 
for full-siblings/unrelated (Scenario 1) using different marker combinations. Each 
marker set represented by a unique colour. True positive (TP) and false positive (FP). 
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Figure 7.11. LR distributions of the simulation study for full-siblings/unrelated (Scenario 
2) using different marker combinations. The figure also shows the case pedigree 
(hypothesis 1) as in (Table 2.5) where orange colour represents simulated members and 
crossed members were not available for testing. 
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Figure 7.12. The TP and FP at different LR limits generated from the simulation study 
for full-siblings/unrelated (Scenario 2) using different marker combinations. Each 
marker set represented by a unique colour. True positive (TP) and false positive (FP). 
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Figure 7.13. LR distributions of the simulation study for full-siblings/unrelated (Scenario 
3) using different marker combinations. The figure also shows the case pedigree 
(hypothesis 1) as in (Table 2.5) where orange colour represents simulated members and 





Figure 7.14. The TP and FP at different LR limits generated from the simulation study 
for full-siblings/unrelated (Scenario 3) using different marker combinations. Each 
marker set represented by a unique colour. True positive (TP) and false positive (FP). 
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Figure 7.15. LR distributions of the simulation study for first-cousin/unrelated (Scenario 
1) using different marker combinations. The figure also shows the case pedigree 
(hypothesis 1) as in (Table 2.5) where orange colour represents simulated members and 
crossed members were not available for testing. 
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Figure 7.16. The TP and FP at different LR limits generated from the simulation study 
for first-cousin/unrelated (Scenario 1) using different marker combinations. Each 
marker set represented by a unique colour. True positive (TP) and false positive (FP). 
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Figure 7.17. LR distributions of the simulation study for first-cousin/unrelated (Scenario 
2) using different marker combinations. The figure also shows the case pedigree 
(hypothesis 1) as in (Table 2.5) where orange colour represents simulated members and 
crossed members were not available for testing. 
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Figure 7.18. The TP and FP at different LR limits generated from the simulation study 
for first-cousin/unrelated (Scenario 2) using different marker combinations. Each 
marker set represented by a unique colour. True positive (TP) and false positive (FP). 
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Figure 7.19. LR distributions of the simulation study for half-siblings/unrelated using 
different marker combinations. The figure also shows the case pedigree (hypothesis 1) 
as in (Table 2.5) where orange colour represents simulated members. 
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Figure 7.20. The TP and FP at different LR limits generated from the simulation study 
for half-siblings/unrelated different marker combinations. Each marker set represented 
by a unique colour. True positive (TP) and false positive (FP). 
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Figure 7.21. LR distributions of the simulation study for grand-parent or child/unrelated 
using different marker combinations. The figure also shows the case pedigree 
(hypothesis 1) as in (Table 2.5) where orange colour represents simulated members and 
crossed members were not available for testing.. 
218 
Figure 7.22. The TP and FP at different LR limits generated from the simulation study 
for grand-parent or child/unrelated using different marker combinations. Each marker 
set represented by a unique colour. True positive (TP) and false positive (FP). 
219 
Figure 10.1. Incorporating the allele-specific mutation rates in the calculation of the RI-
LR. This Figure explains the third way of incorporating the allele-specific mutation rates 
in the calculation of the RI-LR. The allele-specific mutation (paternal and maternal) rates 
for are provided in (AABB 2008). µ 𝐵→𝐸: is the mutation rate of allele B to allele E, µ 𝐴 
→𝐸: is the mutation rate of allele A to allele E, and 𝑝𝐸: the frequency of the allele E (An 
original figure). 
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Figure 10.2. Incorporating the mutation event into the calculation of the RI-LR. This 
figure describes a way of including the mutation event into the calculation of the RI-LR 
using a fixed probability for each type of mutation that was suggested by Brenner (2018) 






Figure 10.3. An example of calculating the PI, paternity probability, RMNE and PE. This 
figure shows a typical parentage case and shows how the strength of evidence can be 
estimated. In this example, the specific equation was adopted from Table 10.1. based 
on the genotypes of the tested individuals and the frequencies of the D1S1656 alleles 
were adopted from (Alsafiah et al. 2017). By only one locus, the PI shows that there is 
1/9.6 chance random unrelated man from the same population is the biological father. 
The paternity probability shows that 90.6% (posterior probability) is the chance that the 
AF is the source of the shared allele comparing to 50% (prior probability). Based on the 
RMNE, the PE is 80.3% that means 80.3% of the population is excluded from being the 
biological father of the disputed child (an original figure). 
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Figure 10.4. An example of calculating the PI, paternity probability, RMNE and PE in a 
mother-less case. This figure shows a typical parentage mother-less case and shows 
how the strength of evidence can be quantified and estimated. In this example, the 
specific equation was adopted from Table 10.1. (an original figure). 
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Figure 10.5. Exceedance probability for Parent-child relationship when using seven 
different marker combinations. 
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Figure 10.6. Exceedance probability for full-siblings (Scenario 1) relationship when using 
seven different marker combinations. 
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Figure 10.7. Exceedance probability for full-siblings (Scenario 2) relationship when using 
seven different marker combinations. 
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Figure 10.8. Exceedance probability for full-siblings (Scenario 3) relationship when using 
seven different marker combinations. 
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Figure 10.9. Exceedance probability for first-cousin (Scenario 1) relationship when using 
seven different marker combinations. 
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Figure 10.10. Exceedance probability for first-cousin (Scenario 2) relationship when 
using seven different marker combinations. 
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Figure 10.11. Exceedance probability for grand parent/child relationship when using 
seven different marker combinations. 
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Figure 10.12. Exceedance probability for half-sibling relationship when using seven 
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1 Chapter One: Literature Review 
1.1 History of using STRs for human identification 
Following the discovery and characterization of short tandem repeat (STR) 
polymorphisms they were rapidly applied in forensic genetics (Goodwin 2015). For over 
20 years, STR markers have been the standard system for forensic genetics worldwide.  
Automated DNA sequencers, modified Taq polymerases and fluorescently labelled 
primers, enabled multiplexing several STRs in a single reaction. The first multiplex used 
by a national forensic service provider, which included four tetranucleotide-STR loci 
(VWA, TH01, F13A1, and FES), was developed by the UK’s Forensic Science Services (FSS) 
(Kimpton et al. 1994). This was improved with a Second Generation Multiplex (SGM) 
that included a sex-chromosome marker (amelogenin) and six STR loci (vWA, TH01, FGA, 
D8S1179, D18S51, and D21S11) (Sparkes et al. 1996); both the quadraplex and SGM 
assays were produced in-house. 
In response to the demand for commercial kits, Applied Biosystems (AB, USA) 
developed AmpFlSTR Blue (D3S1358, vWA, and FGA) as the first commercial STR kit, 
which was followed by AmpFlSTR Green (TH01, TPOX, and CSF1PO). Then, loci in both 
kits were combined with D13S317, D7S820, and D5S818 in developing the AmpFlSTR 
Profiler PCR Amplification Kit (Applied Biosystems 2004). Promega Corporation (USA) 
have been the other commercial company pivotal in developing commercial kits and, in 
2000, Promega developed the PowerPlex 1.1 that included CSF1PO, TPOX, TH01, vWA, 
D16S539, D7S820, D13S317, and D5S818 (Greenspoon et al. 2000). 
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The loci first selected by the FSS in the UK, Combined DNA Index System (CODIS) of 
the USA and the European Standard Set (ESS) have influenced the selection and the 
number of STR loci included in commercial STR kits.  
In 1997, the Federal Bureau of Investigation (FBI) laboratory started to evaluate the 
data available for a number of STRs and selected 13 to make up the CODIS (Budowle et 
al. 1998). The CODIS loci are CSF1PO, FGA, TH01, TPOX, vWA, D3S1358, D5S818, D7S820, 
D8S1179, D13S317, D16S539, D18S51, and D21S11. The CODIS loci could initially be 
genotyped in two reactions by using AmpFlSTR Profiler Plus (FGA, vWA, D3S1358, 
D5S818, D7S820, D8S1179, D13S317, D18S51, and D21S11) and AmpFlSTR COfiler 
(CSF1PO, FGA, TH01, TPOX, D3S1358, D7S820, D16S539) developed by AB. Promega 
Corporation developed PowerPlex 2.1 (FGA, TH01, TPOX, vWA, D3S1358, D8S1179, 
D18S51, and D21S11) (Levedakou et al. 2002), in addition to the PowerPlex 1.1, which 
together covered the CODIS loci. Common loci between AmpFlSTR Profiler Plus and 
AmpFlSTR COfiler (FGA, D3S1358, and D7S820), and between PowerPlex 1.1 and 
PowerPlex 2.1 (TH01, TPOX and vWA) were used for quality control purposes, to 
minimize the potential for generating chimeric profiles. However, using two reactions 
for the CODIS loci was not ideal for crime scene samples. Therefore, Promega 
Corporation and AB developed PowerPlex 16 system (Krenke et al. 2002) and AmpFLSTR 
Identifiler Kit (Collins et al. 2004) respectively, each of which include all of the CODIS in 
one reaction. 
The European Network of Forensic Science Institutes (ENFSI) also evaluated number 
of STR loci to establish their own set of markers (European Standard Set (ESS)), which 
would facilitate data sharing between European countries. In 1999, the ENFSI defined 
the ESS as VWA, TH01, FGA, D8S1179, D18S51, and D21S11 (Schneider 2009), which 
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were already included in the SGM, PowerPlex 2.1, PowerPlex 16 system and AmpFLSTR 
Identifiler Kits. In 2009, the ESS was expanded by adding six loci (Schneider 2009), three 
of which were characterized as mini-STRs with maximum amplicon size 123 bp 
(D10S1248, D22S1045, and D2S441) and three others: D12S391, D1S1656, and TPOX. In 
2015, seven loci were added to the CODIS loci, these were D1S1656, D2S441, D2S1338, 
D10S1248, D12S391, D19S433 and D22S1045 (Hares 2015). Based on the latest 
expansions in the CODIS and the ESS, the GlobalFiler kit (AB), Investigator 24plex QS 
(Qiagen, Germany) and PowerPlex Fusion 6C (Promega Corporation) were developed.  
In the UK, AmpFlSTR SGM Plus (AB) was the first commercial used kit, which targets 
ten STR-markers (SGM’s markers plus D3S1358, D19S433, D16S539 and D2S1338) 
(Cotton et al. 2000). In 2014, this panel was expanded by adding six loci (D10S1248, 
D22S1045, D2S441, D1S1656, D12S391, and SE33) (Home office 2013), which can be 
genotyped using AmpFlSTR NGM SElect Kit (AB) (Applied Biosystems 2015), PowerPlex 
ESI 17 Pro System (Promega Corporation) (Promega Corporation 2017), or Investigator 
ESSplex SE Plus (Qiagen) (Qiagen 2012b). Table 1.1 reviews the currently available STR 
kits provided by AB, Promega Corporation and Qiagen.  
Little known about the STR loci used in China; however, AB has designed AmpFlSTR 
Sinofiler kit (Applied Biosystems 2012) that is only available in China (Zhang et al. 2015). 
The kit includes the Chinese population specific locus of D6S1043 and other 14 STRs 
(D8S1179, D21S11, D7S820, CSF1PO, D3S1358, D5S818, D13S317, D16S539, D2S1338, 
D19S433, vWA, D12S391, D18S51 and FGA).  
Although the selection of a certain set of STR loci was based on population evaluation 
studies, it is also influenced by millions of DNA profiles that already exist in National DNA 
Databases (NDNADs).   
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Table 1.1. Currently available autosomal STR kit that provided by AB, Promega Corporation and Qiagen. Data 
from https://www.thermofisher.com, https://www.promega.co.uk/, and https://www.qiagen.com. (RM) 
rapidly mutating Y-STR. 
Autosomal STR 
Applied BioSystems Promega Qiagen 




























































































































































1 CSF1PO                    
2 D5S818                    
3 D7S820                    
4 D13S317                    
5 TPOX                    
6 D3S1358                    
7 D8S1179                    
8 D16S539                    
9 D18S51                    
10 D21S11                    
11 FGA                    
12 TH01                    
13 vWA                    
14 D2S1338                    
15 D19S433                    
16 D1S1656                    
17 D2S441                    
18 D10S1248                    
19 D12S391                    
20 D22S1045                    
21 SE33                    
22 D6S1043                    
23 PentaD                    












Amelogenin                    
Y-indel                    
DYS391                    
DYS570 (RM)                    
DYS576 (RM)                    
Internal Quality Control                    
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1.2 National DNA Databases (NDNADs) 
The rationale for offender DNA databases is that criminals tend to be repeat-
offenders and therefore having records of DNA profiles may help to solve future crimes 
rapidly. By the end of 2016, the number of the Interpol member countries with a 
national DNA database reached to 69 countries (Interpol 2016). 
The effectiveness of DNA databases depends on the legislation that governs the 
collection and storage of profiles along with the coverage of the population. As of 2016, 
for example, the number of individual’s DNA profiles in the NDNAD of the UK reached 
5.86 million profiles and the probability of finding a match between a sample from a 
crime scene and a known person in the NDNAD, was 63.3% (National Police Chief's 
Council 2017) (Figure 1.1 and Figure 1.2).  
 
Figure 1.1. Number of individual's DNA profiles on the UK's NDNAD. This figure is showing the number of 
individuals’ DNA profiles stored on the NDNAD of the UK starting from 2008 to 2016 (National Police 
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Figure 1.2. Match percentage when loading a DNA profile from a crime scene. This figure is showing the 
efficiency of the UK's NDNAD when adding a DNA profile from a crime scene (National Police Chief's 
Council 2017). 
in response to the Protection of Freedoms Act (PoFA) (May 2012) (National Police 
Chief's Council 2017), more than 592,000 DNA profiles for innocent people have been 
deleted, between March 2012 to September 2013, (Figure 1.3), the efficiency of the 
NDNAD was not affected that illustrates that the PoFA is balanced in establishing the 































Figure 1.3. The efficiency of the NDNAD before and after applying the Protection of Freedoms Act (May 
2012). This figure is showing that the efficiency of the NDNAD was not affected after applying the PoFA 
(May 2012) (National Police Chief's Council 2015, 2017). 
Another example is the National DNA Index System (NDIS) of the USA that used CODIS 
loci to profile samples for the database (James 2012). Three types of samples were 
included in the NDIS that are 1) individuals convicted of crimes, 2) unknown human 
remains, and 3) samples collected from crime scenes (James 2015). Later, the NDIS was 
permitted to collect and to analyse samples from arrestees based on amended 
legislations issued in 2004, and in 2005 (James 2015). Between 2000 and up to July 2017, 
the total number of individual’s profiles was 15,760,528; this included 2,794,862 for 
arrestees, and the number of matches reached 385,590 (2.44%) (Federal Bureau of 














































The efficiency of the NDNAD before and after applying the Protection of Freedoms 
Act (May 2012) 




Figure 1.4. Number of individual's DNA profiles on the NDIS. This figure is showing the total number of 
individual's DNA profiles (offenders and arrestee) on the NDIS in the period of 2000-2017. It can be noticed 
that starting from 2004, the increase trend in the individual's DNA profiles, was higher than before, which 
was in response to new regulations that allow NDIS to collect samples even from arrestees (James 2012), 
2017 data (Federal Bureau of Investigation 2017). 
 
Figure 1.5. This figure is showing the percentage of crime scene samples that match to a sample on the 
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The Chinese DNA database is considered as the largest and the most rapidly growing 
DNA database. In 2013, the database included 20 million profiles that has led to more 
than 410,000 matches between known and unknown samples (Ge et al. 2014), and by 
2017 the number had grown to 68 million DNA profiles (DNA Resources-Forensic and 
Policy 2019).  
1.3 Capillary electrophoresis (CE) and labelled primers 
The CE system is the most widely adopted system in forensic genetics laboratories. 
This system is based on using a primer pair for each locus, one of which is fluorescently 
labelled with a dye (e.g. 6‑FAM, VIC, NED, TAZ, or SID). The movement of labelled 
amplicons through the polymer (e.g. POP4) in the capillary is based on their size (smaller 
size moves faster). During the movement, a CCD camera detects the florescence signal 
of the dye when it is excited by a laser and translates it to a peak on the 
electropherogram. When the expected sizes of two STRs amplicons overlap, they can be 
labelled with two different dyes to allow discrimination. Regardless of the repeat 
sequence, the repeat number can be determined by subtracting the flanking regions 
from the size of amplicons (total number of bases). 
Although microvariants alleles (x.1, x.2, and x.3) can be detected by CE system, it is 
not possible to know the structure of the variants, for example, whether they are formed 
due to a deletion/insertion in the repeat region, or whether this happened in the 
flanking region. In addition, discordance in allele calling, between commercial kits may 
be observed, as they do not necessarily use the same primer pairs. For example, at SE33, 
a sample showed two alleles (heterozygote) using genRES MPX-2 kit (Serac, Bad 
Homburg, Germany) (Figure 1.6 A) while it showed one allele (homozygote) genRES 
MPX-2sp (Serac, Bad Homburg) (Lederer et al. 2008) (Figure 1.6 B). Both alleles had 23.2 
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repeats by sequencing; however, one of them had 60 bp deletion in the 5′ flanking 
region, which is included by the primer pair of the genRES MPX-2 (Figure 1.7). 
 
Figure 1.6. An example of discordance in allele calling between two kits. The figure shows the genotype 




Figure 1.7. An explanation of one of the possible reasons of discordance between different kits. This figure 
explains the cause of the discordance of the same sample when using genRES MPX-2 and genRES MPX-
2sp (Serac, Bad Homburg). The annealing region of the 5′ primer of the genRES MPX-2 includes the 60 bp 
deletion present in one allele. The 5′ primer of the genRES MPX-2sp is closer to the repeat region and the 
60 bp deletion will not be reflected in the allele size (An original figure). 
1.4 Internal validation of new multiplex kits  
The ENFSI and the Scientific Working Group on DNA Analysis Methods (SWGDAM) 
have developed guidelines for validation and verification of new kits for forensic 





repeatability, reproducibility, sensitivity and stochastic effect, heterozygote peak 
balances, stutter/corresponding allele ratios, concordance with other kits for the same 
STRs, performance when PCR inhibitors are present. 
The repeatability and reproducibility assess the performance of a new multiplex kit 
when used by the same operator/instrument and by different operator/instrument, 
which maximises the likelihood of an identical result (DNA profile) at any time, by any 
operator, and using any instrument. The ENFSI guidelines have determined 5 replicates, 
as the minimum number, of the same sample that will be used for the repeatability and 
for reproducibility tests (ENFSI 2010). 
The sensitivity test measures the limits of the detection of a multiplex kit using 
concentrations below the range defined by the manufacturer. A series of five dilutions 
(e.g. 500, 250, 125, 62, and 31 pg) each concentration replicated three times, was 
defined by the ENFSI to assess the sensitivity of a kit (ENFSI 2010).  The sensitivity study 
can also assess the stochastic effect (allele imbalances or allele drop out) that result 
from low quantity/quality DNA (SWGDAM 2016). In addition, it can also measure the 
ideal concentration of DNA/reaction that achieves higher peak balances of heterozygous 
genotypes.    
The peak balances are expressed within three categories: intra-locus balances, intra-
dye balances, and inter-dye balances. Low intra-locus balances (peak balance ratios 
within a locus) would increase the possibility of not detecting the second allele of 
heterozygote genotypes that may lead to mis-characterisation mixture samples. The 
intra-dye balances (peak balances ratios within one dye) is important to assess the 
quality of the samples and in the interpretation of mixture samples. As the performance 
of some loci differ from others and the level of fluorescence of dyes are not the same, 
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selection of a dye attached to markers combination is important that is expressed by the 
inter-dye balances. ENFSI has defined 60% as the minimum ratio of the peak balance 
between heterozygote genotypes (intra-locus) (ENFSI 2010). 
PCRs are in vitro reactions that may lead to the creation of mis-copies observed in 
DNA profiles called stutter. While the most common type of stutter is a peak with one 
repeat smaller than the true allele, a stutter with one repeat larger can also be observed 
(Krenke et al. 2005). Studying the peak ratios of stutter height to true allele height is 
important in the interpretation of DNA profiles especially when multiple contributions 
are suspected.  It was found that the number of repeat (allele size), structure complexity, 
and A - T content of the repeats are positively correlated to the height of the stutter 
peak (Brookes et al. 2012). The stutter ratios measured by the validation study have to 
be lower than ratios estimated by the manufacturer and will be ignored during the 
interpretation of DNA profiles (ENFSI 2010).  
As mentioned above, STR multiplexes can use different primer pairs for the same loci 
and it is possible to observe discordance between kits at the same locus (Figure 1.6 and 
Figure 1.7). Therefore, previously genotyped samples can be tested to study loci 
concordance between different kits. 
The performance of the kit when any of the common PCR inhibitors are present 
(stability), can also be tested. The inhibitors, which generally are either derived from the 
cell components or from the environment, interfere with amplification and may 
decrease the efficiency of amplifying the targeted DNA markers (Wilson 1997). Different 
concentrations of common inhibitors, like humic acid, tannic acid and collagen, are used 
to study the performance of kits (Lin et al. 2017).   
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The SWGDAM guidelines demand studying the precision and accuracy of the kit. The 
precision of a kit can be measured by identifying the size variations through all 
observations of each individual allele, which can be computed as a standard deviation 
(s.d). As the mobility of DNA fragments is affected by the attached dye, the accuracy 
study ensures that alleles will fit within the designated space (±0.5 bp of the actual size) 
that can be carried out by measuring the differences between the size of genotyped 
alleles and their actual sizes (SWGDAM 2016). In general, the precision and accuracy 
tests show the reliability of a kit in identifying heterozygote genotypes that have a single 
base difference between the two alleles and show to what extent an allele can be sized 
outside the designated widow. 
For kits that include Y-specific loci (e.g. the DYS391 STR and the Yq11.221 indel in the 
GlobalFiler™ PCR Amplification Kit), the detection of male/female contents in artificially 
mixed samples with known male and female samples also needs to be evaluated if the 
kit is to be used for analysis of material recovered from a crime scene.  
1.5 Applications of STR-based systems 
1.5.1 Criminal investigation 
Samples recovered from a crime scene are typed and are compared to the DNA 
database or to the suspect’s profile. A full match links a suspect to the crime scene or 
links different crime scenes.  However, would someone else, from the same population, 
have the same DNA profile? or would two unrelated individuals, from the same 
population, have the same DNA profile?. Although this could be answered if the whole 
population was tested, the option would involve some ethical and privacy implications 
and would also be expensive (Williamson and Duncan 2002, Jeffreys 2005). 
Alternatively, the match event can be statistically evaluated or quantified by estimating 
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the match probability (MP), that shows to what extent another unrelated individual 
could have the same DNA profile. The MP is calculated for independently inherited loci 
(see Section 1.7) by multiplying the genotype frequency generated from the allele 
frequencies (p2 for homozygous and 2pq for heterozygous genotypes where p and q are 
the allele frequencies) and is based on population being in Hardy Weinberg equilibrium 
(HWE) (see Section 1.6) 
While the MP decreases with the increased number of tested STRs and with the 
number of heterozygous genotypes, it increases in case of partial DNA profile (e.g. due 
to DNA degradation) and when the tested individual is related to the perpetrator or from 
the same sub-population (Jobling and Gill 2004). 
1.5.2 Kinship testing 
The number of relationship (kinship) tests reported by American Association of Blood 
Banks (AABB) has risen from 77,000 in 1988 to 371,719 in 2013. In 2013, almost 900,000 
samples were tested by 19 AABB accredited laboratories to identify the father of a 
disputed child (AABB 2013, AABB 2010a). Unlike the criminal investigation of crime 
scene samples, kinship testing looks at inherited alleles within tested individuals where 
the inheritance pattern of the alleles, within relatives, varies based on the type of 
relationship (Figure 1.8). 
The level of uncertainty is higher in kinship testing compared to the matching of crime 
scene samples due to the variations in the inheritance pattern between relationships 
and due to the possibility of the presence of the shared allele in an unrelated individual 
(Butler 2015). When kinship testing suggests an individual cannot be excluded from a 
claimed relationship due to allele sharing, the event can then be quantified to assess the 
strength of the evidence by calculating the relationship index likelihood ratio (RI-LR). 
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This can be done by using the equation: RI-LR = X/Y, where X is the probability of the 
genotypes when tested individuals are related as claimed and Y is the probability of the 
genotypes when a random individual from the same population has the shared allele 
(Allen 2013). 
 
Figure 1.8. Inheritance pattern of alleles through generations. The pedigree shows three generations of a 
family and the portion of DNA shared between the family members. In the parent-child relationships, 
each of the offspring No. 4,6,9 and 11 has four expected genotypes (A,C),(A,D),(B,C),(B,D) each of which 
has 100% chance to have one shared allele with the father (No. 2) and 100% chance to have another 
shared allele with the mother (No. 1). In full sibling relationships (e.g. 4,6,9 and 11) there is 25% chance 
of having zero shared allele, 50% chance of having one shared allele and 25% chance of having two shared 
alleles. In half-sibling relationships (No. 12 and 13), there is 50% chance of having one shared allele, and 
50% chance to have zero shared allele between them. There is 50% chance of having one shared allele 
and 50% of having zero shared allele between uncles (No. 4,6,9 and 11) and nephews (No. 12-17). There 
is 50% chance of having one shared allele and 50% of having zero shared allele between grandchild (NO. 
12-17) with any of their grand grandparent (No. 1 and 2). Finally, there is a 25% (4/16) chance of having 
one shared allele and 75% (12/16) of having zero shared allele between the first cousins 13, (14 or 15),16 
and 17. The shared alleles are termed as identical by descent (IBD) as they have originated from common 




The simplest type of kinship testing is parentage testing that typically aims to identify 
the true father (paternal testing) by looking for shared alleles between the alleged father 
and the disputed child (Figure 1.9). 
  
Figure 1.9. Inheritance pattern of the maternal and the paternal DNA component to offspring. 1) shows 
the maternal alleles (A, B), paternal (C, D), and the possible alleles combinations of the offspring. Each of 
the maternal and the paternal allele has 50% chance to be passed to the offspring. 2) shows a typical case 
of that the alleged father cannot be excluded from being the true father of the male offspring. 3) shows 
a typical exclusion case where the alleged father did not share any of his alleles with the disputed offspring 
with the assumption of no mutation event is suspected (an original figure). 
In parentage testing, the calculation of paternity index (PI)/maternity index (MI) 
depends on the genotypes of the tested individuals (homozygote or heterozygote) by 
which specific equations are applied to calculate each of the probabilities (i.e. X and Y) 
(Stephenson 2010) (Appendix 1, Section 10.1.1, Table 10.1). When the child is missing 
(e.g. disaster victim identification (DVI)) or is needed to be identified (e.g. immigration 
cases), the case may involve reverse parentage analysis using the genotypes of the 
parent. In such cases, the PI-LR or MI-LR can be calculated using specific equations based 
on the genotypes of tested individuals too (homozygote or heterozygote) that are 
shown in (Appendix 1, Section 10.1.2, Table 10.2).  
Kinship testing may also involve identifying distant relatives like sibling, half-sibling, 
grandparent/grandchildren, uncle/nephew, aunt /niece or first cousin. Table 10.3 
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(Appendix 1, Section 10.1.3) shows the scenarios specific equations that are used to 
calculate the sibling index-LR (SI-LR) and the half-sibling index (HSI-LR) based on the 
genotypes of tested individuals. Due to the complication of calculating the LR for 
grandparent/grandchildren, uncle/nephew, aunt/niece or first cousin relationships, the 
AABB  recommends using validated kinship software to do these complex calculations 
(AABB 2010b). 
STRs have shown relatively higher mutation rates (an average of 1.001E-
3/locus/generation) for tetra-nucleotides STRs and the paternal origin of the mutations 
were estimated to be 3.3 times more those originated from the maternal side (Sun et al. 
2012). This is a problematic in kinship testing as it is believed that it is possible to observe 
two inconsistencies with the true father and to observe same number of inconsistencies 
with a random man (not the true father) when using ~ 12 STRs in parentage testing 
(Brenner 2018). Therefore, the AABB emphasizes incorporating the mutational event in 
calculation of the LR (AABB 2008). Several ways are used to integrate the mutation event 
to the calculation that are described in detail in (Appendix 1, Section 10.1.4). 
Once the RI-LR (i. e. PI, MI, SI or HSI) is calculated for each individual locus, the 
combined relationship index (CRI) can then be calculated by multiplying the RI-LRs for 
all independent loci. Although the RI-LR takes in account the probability of allele sharing 
showed in Figure 1.8, allele frequency and possible mutation events, it does not include 
non-genetic evidence (i.e., the prior probability). The prior probability (Pr) assesses the 
strength of non-genetic evidence before incorporating the DNA test data. In general, the 
prior probability of 0.5 is used for most kinship cases unless the court has assigned a 
different probability (Allen 2013). In case of missing person, the AABB (AABB 2010b) 
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emphasises the use of 1/N prior probability, where N is the number of missing people 
taking in account the number of males and female (e.g. mass graves).  
Sections 10.1.5 and 10.1.6 (Appendix 1) show how the prior probability (Pr) and the 
genetic evidence are included in the calculation of the posterior probability (Po) (i. e. 
relationship probability) and how The RMNE (random man not excluded) is calculated, 
respectively. 
In general, the accreditation standards of the AABB for kinship testing (9th edition) 
defined 100 as a threshold of combined paternity index (CPI) by which the evidence 
achieves acceptable level of certainty (Allen 2013).  The 100 CPI means that there is 99 
to 1 chance that the alleged father is the true father and it generates paternity 
probabilities of 91.7% at (Pr = 0.10) and of 99.89% at (Pr = 0.90). In Germany, new 
guidelines have defined 15 STRs as the minimum number of tested STRs and 99.999% as 
a threshold for exclusion probability (i. e. CPI ≥ 100,000) to be accepted in the court 
(Poetsch et al. 2013). In addition, the guidelines necessitate testing additional STRs (16-
20 STRs) in case of deficient pedigrees to allow the exclusion probability threshold 
(Poetsch et al. 2013). 
In complex kinship cases, however, testing around 20 STRs may lead to inconclusive 
results especially when identifying distant relatives (Carboni et al. 2014). It has been 
demonstrated that additional STRs can increase the certainty of genetic testing in 
determining the true relation among parent-child, sibling, half sibling (O’Connor et al. 
2010), and distant relatives (Carboni et al. 2014). 
1.5.3 Ancestry testing 
The adopted STRs for human identification (idSTRs) are not expected to be suitable 
for ancestry inference (Phillips et al. 2013), as they have been selected that are similarly 
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diverse in different populations. Therefore, attempts have been carried out to select 
ancestry informative STRs (aiSTRs) and to use them to infer the ancestry of a DNA profile 
(Rosenberg et al. 2002, Londin et al. 2010, Phillips et al. 2013, Rosenberg et al. 2003).  
Rosenberg et al. (2002) have used 377 STRs and were successful in differentiating 
more than 1000 individuals from 52 populations to six major groups (Africans, Eurasians, 
East-Asians, Oceanians and Americans). However, the large number of STRs here is not 
suitable for forensic applications. Another attempt by using a set of 36 aiSTRs (33 di-
nucleotides, 2 tetra-nucleotides and 1 tri-nucleotides) was successfully able to 
distinguish Africans, East-Asians, Oceanians, Americans and Caucasians (Londin et al. 
2010). Although di-nucleotide STRs are more informative than tetra-nucleotides STRs 
for ancestry inference (Rosenberg et al. 2003), the high stutter products make them less 
suitable for forensic applications, especially when analysing mixed samples (Phillips et 
al. 2013). As recent as 2013, a set of 12 aiSTRs were selected to be a complementary set 
for the idSTRs (Phillips et al. 2013), by which this set alone, the success rate (correct 
assignment) ranged from 51.86% for Africans to 96.82 for Europeans. When combining 
this set with 20 idSTRs (32 STRs in total), the success rate has improved that ranged from 
81.73% for Africans to 100% for Oceanians. Despite that STRs are multi-allelic markers 
and are more informative than binary markers (single nucleotides polymorphisms 
(SNPs)), the 32 STRs performance was still less efficient in comparison to 34 aiSNPs 
developed by Phillips et al. (2007). When analysing the same samples using the 34 
aiSNPs, the success rates was higher and ranged from 92% (Oceanians) to 100% 
(Europeans). 
Unlike SNPs, STR markers appear to be of limited use for ancestry prediction due to 
the rarity of finding population-specific alleles (Phillips et al. 2014), which might be a 
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consequence of having higher mutation rate comparing to SNPs (  ̴2.5E-8 (Nachman and 
Crowell 2000)). 
1.6 Hardy Weinberg equilibrium (HWE)    
The HWE law states that when a population is within the expectation of HW, the allele 
and genotypes frequencies are constant through generations. Thus, HW equation can 
be used to calculate the genotypes frequencies based on allele frequencies (Brooker 
2012) (Figure 1.10).  
  Maternal gametes  























 p is the frequency of alleles A  
q is the frequency of alleles a 
 
 The frequency of the genotype AA = p X p = p2 (homozygous) 
 The frequency of the genotype aa = q X q = q2 (homozygous) 
 The frequency of the genotype Aa = (pq + pq) = 2pq (heterozygous) 
Figure 1.10. HW frequencies resulted from two alleles A and a and their frequencies p and q respectively, 
where p + q = 1. When a population is within the expectations of HWE, the equations of homozygous and 
heterozygous genotypes can be used to estimate the genotypes frequencies. Figure from (Brooker 2012).  
 
There are five possible factors that may disturb HWE in a population:  
1- Mutations that may introduce new alleles leading to a change in the allele 
frequencies. 
2- Non-random mating that means that population members are mating based on 
specific genotypes or phenotypes. 




4- Migration that introduces new alleles from different population. 
5- Genetic drift: the population is small that changes allele frequencies due sampling 
effect. 
The HWE law predicts the genotypes frequencies based on the allele frequencies if 
none of the five factors disrupted HWE (Figure 1.11).  
 
 
Figure 1.11. The expected genotype frequencies based on the alleles frequencies in a population that met 
the HWE expectations. It can be seen that the highest percentage of heterozygosity can be obtained when 
the two alleles (assuming only two alleles can be seen at a marker) have a frequency of 0.5. Figure from 
(Butler 2015).  
Deviation from HWE in a data set can be tested by comparing the observed 
heterozygosity (Ho, the number of heterozygous genotypes divided by the total number 
of genotypes) to the expected heterozygosity (He, the expected number of 




1.7 Linkage disequilibrium (LD) 
LD represents a non-random association of alleles at two or more markers within a 
population leading to that certain genotypes are more likely to be observed than others 
(genotypes show higher frequency more than expected based on their alleles 
frequencies) (Edge et al. 2017), which can even be observed between different types of 
markers (i. e. between STRs and SNPs) (Payseur et al. 2008). 
LD can be caused by the genetic linkage between two closely located markers or as a 
result of other population genetic effects like genetic drift, neutral selection or 
population subdivision.  
The genetic linkage between two closely located markers (syntenic loci) may 
influence the inheritance pattern of their alleles, by which having one allele from a 
marker influence the second allele from the other marker. Here, this association can be 
disturbed by the presence of recombinational hot spot between any two linked but not 
associated markers or by several mutational events through generations (Carothers and 
Wright 1992). Syntenic markers are regarded as independent (unlinked) if they are 50 
centimorgans (cM) or more apart (at which point the probability of recombination 
between them is 0.5) (Lobo and Shaw 2008). 
It is believed that unlinked markers (markers in different chromosomes or those are 
50 cM or more apart), which showed LD, return to equilibrium faster (in fewer 
generations) than in those that are linked (Bright et al. 2014). 
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1.8 Common forensic statistical parameters 
1.8.1  Match probability (MP) and power of discrimination (PoD) 
MP is a measure that indicates the weight of a match (e.g. between a DNA profile 
from a crime scene and a DNA profile for a suspect). It shows the probability of that an 
unrelated person from the same population who could have the same genotype at a 
locus (National Research Council 1996). On the other hand, PoD presents the probability 
that two unrelated individuals from the same population would have different DNA 
genotype at a locus, which can be calculated by 1 – MP.  
1.8.2 Power of exclusion (PoE) 
PE of a locus is defined by the probability of that an individual has a different 
genotype from a randomly selected individual in a paternity case, which can be 
calculated by PE = h2(1−2hH2), where h is the heterozygosity and H is the homozygosity 
of the locus (Huston 1998).  
1.8.3 Polymorphic information content (PIC) 
PIC is described by Serrote et al. (2020) as an indicator of the ability of a marker to 
detect polymorphisms among individuals in a population, that was found to be impacted 
by the number of observed alleles and their distribution (frequency). Loci with > 0.5 PIC 
are recommended to genetic studies while those below 0.25 are not recommended 
(Serrote et al. 2020). 
1.8.4 Analysis of molecular variance (AMOVA) 
The AMOVA analysis is a common method to estimate F-statistics that includes the 
inbreeding coefficient (FIS) and the total genetic variance (FST). The FIS is the probability 
that a person has two identical alleles received from one ancestor; a high FIS implies a 
higher level of inbreeding. The FST is the proportion of the total genetic variance 
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contained in a population. FST ranges from 0 to 1, where 1 demonstrates high level of 
differentiation between populations. The typical FST value among human populations 
was estimated to be <0.1 (Mathieson and McVean 2012). 
Multidimensional scaling (MDS) is a common way to visualise the distances or the 
similarity between populations. The FST values generated by AMOVA analysis, are used 
to map the location of each population among others, and that are more similar appear 
closer together on the graph than populations that are less similar.   
1.9 Limitations of STR-CE systems 
The majority of STRs adopted in forensic applications, are tetranucleotide markers 
and the target regions are relatively longer (e.g. the sizes in the Identifiler kit are from 
100 bp to 450 bp (Collins et al. 2004)). This increases the probability of degradation and 
can often lead to partial DNA profiles when processing material recovered from scenes 
of crimes. Some STRs were characterised as mini-STRs, where the primer can be 
designed to anneal close to the repeat region allowing shorter amplicons (50-150 bp) 
(Hill et al. 2008). The sensitivity was improved, when using this feature in the MiniFiler 
kit (amplicon sizes are 71-250 bp) (Mulero et al. 2008), by six-fold compared to the 
Identifiler kit; but a minimum quantity of 0.3 ng (300 pg) is still recommended to obtain 
a full profile (Luce et al. 2009). However, due to the limited number of labelling dyes (5-
6 dyes), this feature is limited when using CE systems as labelled primers must be 
designed in a way that prevents overlap between adjacent loci labelled with the same 
dye and thus limits the number of STRs that can be genotyped with shorter amplicons. 
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1.10 Single Nucleotide polymorphisms (SNPs) 
Building on earlier projects, such as the SNP Consortium, the 1000 Genome Project 
Consortium (GPC), has studied, in the final phase, 2500 individuals from 26 populations 
and has reported more than 88 million variants, almost half of which were newly 
reported by the project (Auton et al. 2015). This huge number of SNPs allows more 
selectivity on defining which SNPs suitable for forensic applications. 
SNPs are a powerful tool for individual identification (identity informative SNPs 
(iiSNPs)) and paternity testing for two main reasons: Firstly, SNPs have a lower mutation 
rate of  2̴.5E-8 (Nachman and Crowell 2000). Secondly, SNPs are a single-base 
substitutions, which enable PCR-primers to anneal close to the target polymorphic 
nucleotides in many cases, and therefore can be designed to generate very short 
amplicons (e.g. 65-115 bp) (Børsting et al. 2012).  
SNPs can also infer the bio-geographical ancestry by testing SNPs that show specific 
allele frequency variations (ancestry informative SNPs (aiSNPs)) for a population and by 
testing SNP variants related to specific appearance traits (hair, skin and eyes colours) 
(phenotypic informative SNPs (piSNPs)). 
Y-STRs and mitochondrial-DNA (mtDNA) haplotypes exhibit higher differentiation 
between ancestries because they are not disrupted by recombination and are preserved 
through generations (if no mutation has occurred). However, the limited database 
coverage of some populations has reduced the benefit of using these markers for 
ancestry inference and may lead to misinterpretation of DNA evidences (Phillips 2015). 
For example, the presence of an African-specific Y-haplotype has been reported in a 
native Northern-England branches (King et al. 2007), showing the risk of 
misinterpretation that may occur. In addition, uniparental markers need relatively larger 
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sample sets to establish adequate estimations of allele frequencies for a population in 
comparison to autosomal markers (Phillips 2015). Therefore, inferring the ancestry was 
focusing on autosomal SNPs and thus many panels have been developed as summarized 
in Table 1.2. 
Table 1.2. A list of the developed aiSNPs panels. This table summarizes a list of recently developed aiSNPs 
that have been adopted in forensic laboratories (an original table based on information from (Fondevila et 
al. 2013, Gettings et al. 2014, Rogalla et al. 2014). 
aiSNPs Number SBE Reaction Targeted Population Accuracy 
34 aiSNPs 
(Fondevila et al. 2013)* 
1 Reaction Europeans, Africans, 
Americans, East Asians, and 
Oceanians 
Europeans: 99.37%, Africans: 100%, 
Americans: 100%, East Asians: 94.71%, 
and Oceanians: 100% 
50 aiSNPs 
(Gettings et al. 2014) 
3 Reactions US populations: (Africans 
Americans, East Asians, 
European Americans, and 





 (Rogalla et al. 2014) 
2 Reactions Europeans, Africans, and 
East Asians. 
This panel could differentiate the three 
major populations with 100% accuracy, 
but it has categorised Middle Eastern as 
Europeans.   
*This panel is a revised panel of SNP panel published in (Phillips et al. 2007), the rs727811 was replaced with more informative 
SNP rs3827760 
 
In 2016, a new global assay tests 31 of the most informative aiSNPs in a single 
SNaPshot reaction was developed to differentiate between five populations (Europeans, 
Africans, Native Americans, East Asians, and Oceanians), which was examined by known-
ancestry control samples and could infer the population group correctly (De La Puente 
et al. 2016). 
In general, the procedure of selecting SNP markers was influenced by the number of 
the characterised SNP markers in the human genome, and the availability of population 
data. To select global iiSNP markers five conditions were applied: 1) high heterozygosity 
in each population tested (≥0.4 heterozygosity), 2) almost the same allele frequencies 
between populations (F󠅸st ≤ 0.06), 3) feasibility of multiplexing, 4) located in non-coding 
region, and 5) unlinked SNPs.  Having non-coding SNPs would help to avoid political and 
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legal considerations, and non-linked SNPs would allow higher discrimination even when 
relatives are suspected (Kidd et al. 2006, Sanchez et al. 2006, Pakstis et al. 2007, Pakstis 
et al. 2008, Pakstis et al. 2010, Wang et al. 2016, Lou et al. 2011) (Table 1.3). 
Table 1.3. iiSNPs panels developed for human identification. The table shows the iiSNPs panels developed 
for human identification and the progress in match probability (MP) from 2006 – 2016. This table 
summarizes effort by research groups to select informative iiSNPs that can be applied globally leading to the 





(Kidd et al. 2006) 19 SNPs 1E-6 to E-7 
− ≥0.4 heterozygosity. 
− low differences between all studied populations (F󠅸st ≤ 
0.06). 
− feasibility of multiplexing. 
− non-coding region. 
− unlinked SNPs. 
(Sanchez et al. 2006)  52 SNPs 5E-19 
(Pakstis et al. 2007)  40 SNPs 1E-14 to E-17 
(Lou et al. 2011) 44 SNPs 1E-19 
(Wang et al. 2016) 54 SNPs 1.3E-22 
 
On the other hand, nominating aiSNPs have only two conditions: 1) aiSNPs should 
express the differences between the target populations (higher allele frequency 
variations), 2) should be non-linked (De La Puente et al. 2016).  
However, most SNPs are binary markers and less informative than STRs and thus 
increases the number of SNPs that would meet the power of STRs. It was found that 44 
SNPs are required to meet the power of 15-16 STRs (~ 3 SNPs = 1 STR) (Amorim and 
Pereira 2005).  
Phillips et al.(2015) reported 41 newly characterised tetra-allelic SNPs which have 
four possible alleles, 24 SNPs were found to be useful as iiSNPs. Having four possible 
alleles rather than two alleles increases the informativeness for each SNP, and therefore 
lowers the number of SNPs required to meet the power of STRs. In addition, those tetra-
SNPs have been studied in three populations (Europeans, Africans, and East Asians), and 
the possibility of finding at least one heterozygote locus in a tetra-SNP-profile is 99.93% 
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in Europeans, 99.9% in Africans, and almost 93% in East Asians. This elevated 
heterozygosity allows better recognition of mixture samples that could not achieved by 
bi-allelic SNPS (Phillips et al. 2015) (Table 1.4). 
Table 1.4: the maximum possible heterozygosity calculation based on maximum allele frequencies of SNP 
types. 
SNPs type Maximum allele frequencies Maximum possible 
heterozygosity 
Bi- allelic SNPs 0.5 0.5 0.5 
Tri-allelic SNPs 0.33 0.33 0.34 0.67 
Tetra-allelic SNPs 0.25 0.25 0.25 0.25 0.75 
 
A set of 19 multi-allelic SNPs (11 tetra-allelic SNPs and 8 tri-allelic SNPs) has provided 
6.07E-11 MP for the Chinese Han population (Gao et al. 2018) while the same number 
of biallelic-SNPs provided an average of 1E-7 MP (Kidd et al. 2006). 
Two genotyping methods have been commonly used in the forensic field for 
characterising SNPs: TaqMan® Real-Time PCR assay (Pakstis et al. 2010), and SNaPshot 
assay (Wang et al. 2016). Both assays have the advantage of using infrastructure that 
already established in most forensic laboratories. The TaqMan® assay is a reliable 
method, utilizing the minor groove binder (MGB) at the 3’ terminal which increases the 
specificity of relatively shorter probes and increases the sensitivity of the probe even 
with 1 bp mismatch (Kutyavin et al. 2000). MGB reduces the effect of background noises 
comparing with probes with no-MGB (Kutyavin et al. 2000), allowing easier 
interpretation. However, only 1 di-allelic SNP (two possible alleles) can be genotyped in 
each reaction (Applied Biosystems 2014) (cannot be multiplexed) and two reactions for 
multi-allelic SNPs (a maximum of two alleles per reaction), that does not suit forensic 
applications especially with low quantities of DNA (Gao et al. 2018). 
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SNaPshot is a high throughput assay that can genotype, for example, 52 SNPs in only 
two reactions (29 SNPs and 23 SNPs) (Sanchez et al. 2006). Furthermore, SNaPshot assay 
has been applied in some laboratories which have been accredited the ISO 17025 
(Børsting et al. 2009). In addition, the 52 SNPs multiplex has been validated against low-
template DNA (Lt-DNA) and shows high sensitivity with only 50-100 pg of DNA (Børsting 
et al. 2013). However, some considerations have been raised regarding the allele calling 
as each labelled ddNTP for the same polymorphism is separated in a different channel 
(Phillips 2012). To illustrate, a person who has G as allele 1, and C as allele 2, and the 
ddGTP labelled with 6FAM dye, the ddCTP labelled with VIC dye, each allele will be in 
different channel and then it is difficult to be interpreted with another 23 SNPs. 
Although, guidelines have developed for electropherogram interpretation based on the 
ratio of peaks high for heterozygote alleles and the ratio of peak high to background 
noise for homozygote alleles, these guidelines fail when there are mixtures as most SNPs 
are binary polymorphism (Børsting et al. 2009).  
1.11 Massively Parallel Sequencing (MPS) 
MPS (also called Next Generation Sequencing (NGS)) systems have larger capabilities 
than conventional sequencing (Sanger sequencing). MPS systems can be used for 
sequencing the whole DNA “shotgun sequencing” where the DNA is fragmented to be 
as short as 50-500 bp prior the sequencing, or for sequencing specific regions on the 
DNA (targeted sequencing). Although the whole genome sequencing allows a huge 
amount of data to be gathered from a sample that may be useful, it does not suit 
forensic applications as micrograms of DNA are needed (Børsting and Morling 2015). In 
addition, the huge amount of data needs an extensive analysis and may eventually 
produce non-concordant DNA profiles for the same sample when using different MPS 
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platforms (Ratan et al. 2013). Therefore, all forensic kits that are commercially available, 
are based on targeted sequencing method, where the regions of interest are amplified, 
which reduces the amount of DNA template needed and avoids the problem of 
characterising coding regions.  
The developed systems simultaneous test many markers. In addition, MPS facilitates 
the combination of different types of markers with detailed sequences. Three STR-MPS 
kits are available: ForenSeqTM DNA Signature Prep (Verogen), PowerSeqTM Auto/Mito/Y 
system (Promega Corporation) and Precision ID GlobalFilerTM NGS STR (AB) (Table 1.5). 
Illumina provides the MiSeq FGx, a bench-top instrument, that includes a data analysis 
software (ForenSeqTM Universal Analysis Software (UAS)) for the ForenSeqTM and the 
PowerSeqTM kits.  
The rest of this section provides details of the ForenSeqTM DNA Signature Prep kit 
with the MiSeq FGx platform for forensic application, as they were used in this project. 
Verogen provides the ForenSeqTM DNA Signature Prep kit with two primer mixes A and 
B, and the purpose of the application defines which one will be used. The Primer Mix A 
targets 27 autosomal-STRs (aSTRs), 24 Y-STRs, 7 X-STRs, and 94 iiSNPs, while the Primer 
Mix B includes additional 78 SNPs (56 aiSNPs and 22 piSNPs) (Table 1.5).  
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Table 1.5. DNA markers included in three STR-MPS kits commercially available (Faith and Scheible 2016, 
Applied Biosystems 2017, Verogen 2018a).  
Locus 
Amplicon length range (bp) 










D1S1677 - - 151–191 
D1S1656 141–189 161–208 167–215 
D2S441 144–180 158–204 163–195 
TPOX 85–145 196–244 167–199 
D2S1776 - - 163–195 
D2S1338 114–182 197–269 133–197 
D3S4529 - - 167–195 
D3S1358 138–186 192–240 129–177 
D4S2408 93–117 - 167–191 
FGA 150–306 176–268 137–299 
D5S2800 - - 171–211 
D5S818 102–150 191–239 141–173 
CSF1PO 85–129 185–229 143–183 
D6S1043 163–227 - 163–227 
D6S474 - - 158–186 
D7S820 135–179 211–255 130–166 
D8S1179 86–138 203–255 151–199 
D9S1122 108–140 - - 
D10S1248 128–172 135–179 155–199 
TH01 100–148 220–264 129–173 
D12S391 237–281 202–254 149–193 
vWA 132–192 202–262 147–207 
D12ATA63 - - 126–146 
D13S317 138–186 209–257 149–181 
D14S1434 - - 163–195 
PentaE 362–467 179–284 168–273 
D16S539 132–180 198–253 139–179 
D17S1301 114–142 - - 
D18S51 140–227 190–277 156–232 
D19S433 154–212 193–253 155–195 
D20S482 125–165 - - 
D21S11 158–276 203–273 179–245 
PentaD 209–293 192–266 139–204 





DYS393 - 294–256 - 
DYS505 154–194 - - 
DYS456 - 141–165 - 
DYS570 162–214 157–217 - 
DYS576 183–235 155–203 - 
DYS522 294–334 - - 
DYS458 - 171–199 - 
DYS481 102–129 139–184 - 
DYS19 261–345 168–294 - 
DYS391 123–167 147–178 - 
DYS635 214–306 155–179 - 
DYS437 178–210 181–197 - 
DYS439 199–239 204–224 - 
DYS389I 231–275 258–294 - 
DYS389II 255–299 - - 
DYS438 144–169 202–242 - 
DYS390 242–286 204–248 - 
DYS643 115–215 150–210 - 
DYS533 198–258 242–284 - 
GATA-H4 151–203 231–251 - 
DYS612 215–248 - - 
DYS385 a 
316–354 202–303 - 
DYS385 b 
DYS460 356–380 - - 
DYS549 214–262 189–230 - 
DYS392 346–358 143–164 - 
DYS448 288–324 213–255 - 
DYF387S1a 






DXS10074 211-309 - - 
DXS10103 161-185 - - 
DXS10135 228-334 - - 
DXS7132 176-208 - - 
DXS7423 147-215 - - 
DXS8378 430-462 - - 
HPRTB 193-237 - - 
SN
P
s 94 iiSNPs 63-170 - - 
56 aiSNPs* 73-227 - - 







(cover the mitochondrial control region) 
- 




Processing samples using the ForenSeqTM DNA Signature Prep kit with the MiSeq FGx 
platform includes four main steps: library preparation, cluster generation, sequencing 
and data analysis. Here, the word “library” means a combination of DNA fragments for 
the target regions that were prepared for sequencing for an MPS system. 
1.11.1 Library preparation 
This stage contains two PCR steps, PCR1 is to amplify the target regions using a tagged 
primer pair for each locus; each strand is tagged with a different sequence (Figure 1.12). 
The tags have specific sequences of nucleotides that are used as complementary to 
adapters that are added in the PCR2 and to a sequencing primer (in sequencing stage).  
In PCR2, a combination of one i5 adapter (8 indexed adapters) and one i7 adapter (12 
indexed adapters) are added to the tagged fragments. The adapters comprised two 
parts: indices that are used as unique identifiers for samples and complementary 
sequences to those primers attached to the flow cell (Figure 1.12). As each sample will 
have a unique identifier (an index), this enables pooling up to 96 samples for sequencing 
in a single run.  
Then, libraries are purified by removing excess tagged primers, dNTPs, adapters and 
unamplified DNA using sample purification beads (SPB). The purified libraries are then 
normalised using library normalisation beads (LNB), to approximate all the sample’s 
concentration, that allows equal amounts of DNA be used in the downstream steps. 




Figure 1.12. The steps of PCR1 and PCR2 during the library preparation using the ForenSeqTM DNA Signature Prep kit. PCR1 is for amplifying the target regions with tagged primers 
(green colours). In PCR2, the tags on the amplicons are used to attach adapters and to attach sequencing primer in the sequencing stage. The adapters contain a part used as a 
unique index for each library (light red and light yellow) and a part complimentary to primers attached to the flow cell (dark red and dark yellow) (An original figure based on 
information from (Verogen 2018a)). 
34 
 
1.11.2 Cluster generation 
In this stage, the pooled libraries are denatured and applied into the flow cell that 
has two types of attached primers, where only one of them is enabled for hybridisation. 
When the fragments are hybridised, the DNA polymerase create a complimentary strand 
for each fragment and the original fragment is then removed by washing. The other 
primer (attached to the cell) is enabled allowing the other end of complimentary strands 
to anneal, which promotes bridge amplification. This process is repeated (cycles) to 
create millions of copies attached to the flow cell. At the end of this stage, all reverse 





Figure 1.13. Cluster generation of the ForenSeqTM DNA Signature Prep kit. The figure is showing a detailed process for cluster generation. By the end of this stage, millions of the 




Illumina systems utilises sequencing by synthesis (SBS) that uses reversible 
termination strategy (Bentley et al. 2008). The polymerase stops adding nucleotides if 
the 3′ is terminated (i. e. di-deoxynucleotides tri-phosphate (ddNTPs) that are being 
used in conventional sequencing and SBE) (Figure 1.14).   
 
Figure 1.14. Reversible termination strategy used by Illumina systems. The figure shows two types of 
termination strategies (Irreversible and reversible). The Irreversible strategy blocks the 3′ by hydrogen 
atom. The reversible strategy caps the hydroxy group at the 3′ position by a removable cap (O-
azidomethyl) (an original figure adopted from (Chen et al. 2013). 
The illumina systems employ the O-azidomethyl at the 3′ position as a reversible 
terminating group that can be cleaved to allow annealing the next base (Figure 1.14) 
(Bentley et al. 2008). In the flow cell, a universal sequencing primer is annealed to the 
37 
 
forward strands (attached to the flow cell) and the four labelled nucleotides (A, G, C, T 
with reversible terminating groups) are added simultaneously and are competing to be 
incorporated to the target base.  Once the first base is incorporated, tris-2-carboxyethyl 
phosphine (TCEP) is added to simultaneously remove the dye, the reversible terminating 
groups, and to generate hydroxy group at the 3′ position(Bentley et al. 2008).  The dye 
fluorescence is then imaged and the 3′ position allows the next base to be attached in 
the second cycle. The illumina systems perform multiple cycles of sequencing and real 
time imaging for each cluster and generate the data automatically (Chen et al. 2013) 
(Figure 1.15). 
 
Figure 1.15. Sequencing by synthesis used by the illumina systems. Once the sequencing primer is 
annealed to the forward strand, four labelled nucleotides A, G, C, T with reversible terminating groups are 
added simultaneously and are competing to be incorporated to the target base. The complimentary 
nucleotide is annealed and the TCEP is added to remove the dye, the reversible terminating groups, and 
to generate hydroxy group at the 3′ position simultaneously. This allows second base annealing in the 
second read. The fluorescent of the cleaved dye is imaged and recorded (an original figure adopted from 
(Chen et al. 2013)).  
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1.11.4 Data analysis 
Sequencing stage generates millions of reads for clusters that needs to extensive data 
analysis. The ForenSeqTM Universal Analysis Software (UAS) separates and aligns of all 
fragments based on the unique indices and provides all calls for DNA markers included 
in the kit. The software can also evaluate the sequencing process by measuring the 
depth of coverage and allele balance at each locus, which is useful for any manual editing 
of the results (Alonso et al. 2018). The software generates three reports as excel sheets: 
a sample’s report (a single file for each sample that contains detailed information of 
each locus including length-based calling and sequence-based calling for STRs (Alonso et 
al. 2018), a genotypes report for all samples and a Flanking Region Report for the 
sequencing run. In the Flanking Region Report, variants at the flanking regions are 
enlarged and in blue colour (highlighted in blue), while variants within the repeat region 
are enlarged and in black colour (highlighted in black) (Table 1.6). 
Table 1.6. An example of how the ForenSeqTM Universal Analysis Software (UAS) reports the sequences in 
the Flanking Region Report. Here, the sequences of the D5S818 STR and of the rs560681 SNP were used for 
illustration. For STRs, the Flanking Region Report highlights variants within the repeat region in black colour 
(enlarged) and highlights variants in flanking region in blue colour (enlarged). In SNPs, the Flanking Region 
Report highlights the target SNP in black colour (enlarged) and highlights variants in flanking region in blue 
colour (enlarged). All highlighted variants in the flanking region are predefined and variants that were not in 
the predefined list are not highlighted by the software, but still reported.  










All reports are generated based on the setting of the analytical and interpretation 
thresholds (AT and IT respectively) and the stutter filters. 
1.11.5 Advantages and disadvantages of MPS systems 
MPS systems reveal more information about variations in the repeat region of STRs 
and the flanking regions than STR-CE systems do. For example, allele 20 at D2S1338 
locus could have 6 different sequences that will be designated as allele 20 using the STR-
CE systems (Gettings et al. 2016) (Table 1.7). This has led to the fact that some 
individuals may show homozygous genotypes using the size-based systems while they 
have heterozygote genotypes when using sequence-based systems (Gelardi et al. 2014).  
Table 1.7. Different sequences of allele 20 at D2S1338 locus using MPS technologies. STR-CE systems 
distinguish alleles by their sizes (Gettings et al. 2016). 









Moreover, STR loci can be even more variable when SNPs in the flanking regions are 
associated in the statistics (Table 1.8).  
Table 1.8. Comparison of the power of discrimination of four loci by using STR-CE systems, MPS systems for 
variants in the repeat region and for variants in both repeat and flanking regions. This study was conducted 




Power of Discrimination (PoD) 
Size-based systems Include variations in 
repeat region 
Include variation in repeat and 
flanking regions 
D2S441 0.900 0.930 0.931 
D7S820 0.904 0.904 0.947 
D13S317 0.928 0.930 0.956 
D21S11 0.927 0.983 0.983 
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Although that by looking to the repeat region variants, some loci would gain more 
alleles, some do not gain any additional alleles. A study of sequence variants (within 
repeat region) of 22 autosomal STRs using MPS in 183 volunteers from the three most 
common populations in the USA, found that, for example, D2S1338 locus gained 233.3% 
more alleles by sequencing (Table 1.9). 
Table 1.9 : Comparison between the number of alleles obtained by size-based systems and by MPS systems. 
This table showing data that compares the number of alleles obtained by size-based systems and by MPS 
systems for 23 of the most common used autosomal STRs (Gettings et al. 2016), SE33 data (Gettings et al. 
2015).  
Locus Alleles obtained by length Alleles obtained by sequence Difference 
D2S1338 12 40 233.3% 
D12S391 17 53 211.8% 
SE33 50 152 204.0% 
D21S11 19 46 142.1% 
D3S1358 8 19 137.5% 
vWA 8 19 137.5% 
D8S1179 10 22 120.0% 
D1S1656 14 23 64.3% 
D2S441 9 14 55.6% 
CSF1PO 8 10 25.0% 
D5S818 9 11 22.2% 
PentaE 16 19 18.8% 
FGA 16 19 18.8% 
D18S51 18 21 16.7% 
D19S433 14 16 14.3% 
D10S1248 9 10 11.1% 
PentaD 14 14 0.0% 
D22S1045 11 11 0.0% 
D13S317 8 8 0.0% 
D7S820 7 7 0.0% 
D16S539 7 7 0.0% 
TPOX 7 7 0.0% 
TH01 6 6 0.0% 
 
In addition, the MPS systems allow the amplification of STRs with shorter amplicons 
as they are not separated based on their sizes. A study for the ForenSeqTM DNA Signature 
Prep kit has shown that 0.1 ng of DNA template was enough to profile more than 98% 
of DNA markers included in Primer Mix A (Xavier and Parson 2017). However, some STRs, 
where the flanking regions are highly repetitive, and the amplicon sizes cannot be 
constricted (e.g. SE33). 
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The deep information about the repeat structure and about variants in the flanking 
region encouraged the International Society of Forensic Genetics (ISFG) to increase the 
STR nomenclature minimum requirements for MPS systems. The ISFG recommended 
including a description of the reference of the genome assembly sequence, locus name 
and allele name for the CE, version of the human genome assembly, STR region, 
description of the repeat region, and the location of flanking region variants (Parson et 
al. 2016) (Figure 1.16). 
 
Figure 1.16. The minimum requirements for STR nomenclature system. This figure showing an example of 
the minimum requirements for STR nomenclature when using MPS systems that were recommended by 
the ISFG (Parson et al. 2016). 
However, MPS systems are not adopted in all forensic genetics laboratories. The cost 
of the instruments and the kits may delay adopting MPS in the routine work of forensic 
genetics laboratories. In addition, the huge amount of data generated by MPS systems 
increases the demands to establish a sophisticated software that capable to analyse this 
data (Børsting and Morling 2015). 
However, the benefits can be significant, for example the ForenSeq DNA Signature 
Prep Kit was used to test 62 samples from Native American tribe (Yavapai) and result in 
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a combined MP (STRs and iiSNPs) more than 3E-61, where 1 ng was enough to generate 
full DNA profiles (Wendt et al. 2016). A recent study found that the kit is a powerful tool 
in kinship testing especially in paternity and full sibling with zero error rate (Li, R. et al. 
2019). Interestingly, the true positive (TP) and the true negative (TN) of testing second 
generation relationships, including half-siblings, and uncle/aunt-nephew/niece, and 
grandparent-grandchild; were 93.6% and 92.4% respectively (Li, R. et al. 2019).  
1.12 Project Background  
Saudi Arabia, in the Southwest region of Asia, occupies the majority of the Arabian 
Peninsula. It shares borders with eight Arab countries: Bahrain, Qatar, and the United 
Arab Emirates (UAE) to the East; Oman and Yemen to the South; Jordan and Iraq to the 
North and Kuwait to the Northeast. Saudi Arabia is divided into 13 administrative 
provinces: Makkah, Al-Madinah, Riyadh, Eastern Province, Al-Qassim, Asir, Hail, Tabuk, 




Figure 1.17. Saudi Arabia administrative divisions. This map is showing the 13 administrative provinces: 
Makkah, Al-Madinah, Riyadh, Eastern Province, Al-Qassim, Asir, Hail, Tabuk, Northern Borders, Jizan, Al-
Baha, Al-Jouf, and Najran. It also shows the eight Arab countries (image from https://www.123rf.com/). 
 
As of the 2016 census, the Saudi population was 31,742,308 (20,064,970 were Saudis 
and 11,677,338 were non-Saudis). Half of the population resides in two administrative 
provinces of Riyadh and Makkah (General Authority for Statistics in Saudi Arabia 2016). 
Saudi Arabia is an Arab country where African and Asian surrounding populations have 
influenced the genetic structure of its population (Abu-Amero et al. 2007, 2009). The 
majority of Saudi Arabian Y-chromosome composition was estimated to be of Levantine 
origins (69%); with significant contributions from the east via Iran (17%), and Africa 
(14%) (Abu-Amero et al. 2009). The intermediate location between Africa and Asia, and 
the coastal borders of the Red Sea and the Persian Gulf, have facilitated migrations 
between Africa and Asia, and trading between neighbouring areas. In addition, the 
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Arabian Peninsula is connected to the Levant by a long landlocked area that has 
contained important routes for trading caravans and migration. The movement of 
people has increased over the last centuries through the presence of the holy Cities of 
Mecca and Al-Madinah, which have received millions of Muslims performing the Haj for 
more than 1,400 years, some of whom have remained for many generations (Alsafiah et 
al. 2017).  
The first forensic genetics laboratory in the Criminal Evidences Administration was 
established in 1991, in the capital city of Riyadh. Since then, another 12 forensic genetics 
laboratories have been established, ten of the 13 laboratories, are accredited to 
ISO17025:2005/2017 (Alsafiah et al. 2017). The main contribution of Saudi laboratories 
is toward fighting terrorism, solving crimes, and the identifications of human remains 
resulting from terrorist attacks or mass disasters (e.g. explosions in petro-chemical 
factories, or accidents during the Haj). Although paternity testing regulations are very 
strict due the tribal nature of the Saudi population, paternity cases are being addressed 
by DNA analysis, when directed by the courts. 
Laboratory Information Management Systems (LIMS) administrates the workflow in 
the Saudi forensic genetics laboratories. DNA IQ™ System (Promega Corporation) and 
biomek 2000 laboratory automation workstations (Beckman Coulter, USA) are used in 
the extraction laboratories. Extracted DNA from forensic samples is quantified by using 
Quantifiler Human DNA Quantification Kit and 7500 Real-Time PCR System (AB). 
AmpFlSTR Identifiler Plus kit is the standard STR kit in Saudi Arabia that provides a 
typical match probability of 2.2278E-18, D19S433 is the most informative locus, and 
TPOX is the least informative locus (Alsafiah et al. 2017). In some cases, AmpFLSTR™ 
Yfiler™ PCR Amplification Kit (AB) for Y-STR markers and Investigator Argus X-12 QS Kit 
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(Qiagen) for X-STR markers, are used. Capillary electrophoresis is performed using 3500 
Genetic Analysers (AB).  
The main laboratory, in the capital City of Riyadh, holds the Saudi DNA Data Bank 
(SDDB) and the other 12 laboratories deal with the SDDB as clients either for adding or 
for searching.  
At the time of the study, four studies have described the genetic diversity of forensic 
STRs in the Saudi population. The first was a study of 207 samples with eight STR loci 
(Sinha et al. 1999); another two studies investigated 13 STR loci in Saudi individuals 
residing in Dubai (94 samples) (Alshamali et al. 2005) and 15 STR loci in individuals 
residing in Kuwait (250 samples) (Al-Enizi et al. 2013). The most recent study was carried 
out in 2015, testing 190 individuals from the Riyadh province using the AmpFlSTR 
Identifiler PCR amplification kit (Osman et al. 2015).However, Saudi individuals residing 
in Dubai, Kuwait or even in the Riyadh province are not necessarily representative of the 
entire population of Saudi Arabia (Alsafiah et al. 2017).  
In addition, consanguineous marriage is a major factor in shaping the genetic 
structure of the Saudi population. Previous studies conducted by questionnaires on 
3212 families (El-Hazmi et al. 1995) and on 4498 pregnant women (Wong and Anokute 
1990) found that the percentages of consanguinity were 56.8% and 54.3% respectively. 
First cousin marriage prevalence was 25.8% and 31.4% while the prevalence of second 
cousin marriage was 31% and 22.9% of the Saudi population (El-Hazmi et al. 1995, Wong 
and Anokute 1990) respectively. El-Hazmi et al. (1995) studied five provinces and the 
highest rate (67.7%) was observed in the North Western province (Al-Madinah and 
Tabuk provinces based on the new division system) and the lowest (52.1%) was in the 
Northern Borders province with an overall inbreeding coefficient of 0.024. 
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Recently, three studies were published about the Saudi population (Khubrani et al. 
2018, Khubrani et al. 2019a, Khubrani et al. 2019b). Khubrani et al. (2018) studied 597 
male samples from five different regions, which are Central (Riyadh and Al-Qassim 
provinces), Northern (Northern borders,  Tabuk, Al-Jauf and Hail provinces), Southern 
(Asir, Jazan, Bahah and Najran provinces), Eastern (Eastern province) and Western 
(Makkah and Al-Madinah provinces). The study used the Yfiler®Plus PCR Amplification 
Kit (AB) to generate Y-chromosome haplotypes for 27 STRs. By comparing the predicted 
haplogroups, the Central and Northern regions showed low diversity, while high 
diversity was observed in the Eastern and the Western regions. In addition, high 
similarity was observed between samples from the Central and Northern regions and 
between samples from Eastern and Western. However, the Southern region was 
distinguished from all other regions (Khubrani et al. 2018). 
This confirms the heterogeneity of the Saudi population. It is more likely due to the 
geographical isolation of the Central and Northern regions and the costal borders of the 
Eastern and Western areas that allow historical immigrations between Africa and Asia. 
On the other hand, the Southern region is an agricultural region, where the lands are 
valuable, and inhabited by tribes who preserve the land within the families by 
consanguineous marriages.    
Khubrani et al. (2019a) studied 523 male samples from the population of Saudi Arabia 
using the GlobalFiler kit. The study highlighted excess of homozygosity in 20/21 aSTRs 
and the data set showed 0.0476 inbreeding coefficient (FIS), suggesting history of 
consanguineous marriages. 
The excess of homozygosity and the elevated FIS was also observed in the sequence-
based data when 89 male samples from the Saudi population were examined using 
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ForenSeq™ DNA Signature Prep Kit (Khubrani et al. (2019b). The study reported excess 
of homozygosity in 23/27 aSTRs and 63/91 tested with an overall FIS of 0.04131. 
The heterogeneity nature of the Saudi population and the elevated level of 
consanguinity increase the importance of studying the genetic diversity to evaluate to 
what extent new STR markers can be utilized for crime scene investigations and for 
expanded kinship testing (testing beyond just parent-child relationships). 
1.13 Project Aims 
To evaluate the GlobalFiler PCR amplification kit for use in Saudi Arabia for human 
identification and kinship testing. In addition, to evaluate SureID®23comp Human 
Identification kit as a supplementary STR kit for complex kinship testing. Finally, to 
evaluate ForenSeqTM DNA Signature Prep kit for human identification and kinship testing 
in Saudi Arabia. 
1.14 Objectives 
1- Gain an ethical approval for the PhD project. 
2- Collecting around 500 samples from the population of Saudi Arabia. 
3- Using the GlobalFiler PCR Amplification Kit to genotype 21 aSTRs included in the 
kit. 
4- Characterising microvariant alleles observed when using the GlobalFiler kit, which 
have not been characterised before. 
5- Examine 17 non-CODIS STR loci in a new kit specifically designed to complement 
the existing kits: the kit is SureID 23comp (Health Gene Technologies, China). This 
will generate data 38 STR loci which will be evaluated for human identification 
and kinship testing in Saudi Arabia. This will include concordance study for five 
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loci common with the GlobalFiler kit and an evaluation of the kit following the 
minimum criteria for validation recommended by the ENFSI and the SWGDAM. 
6- Using ForenSeqTM DNA Signature Prep kit to examine micro variation in the STR 
loci studied to date and to generate information on a selection of SNP markers. 
Concordance study for loci that are common with the GlobalFiler kit and the 
SureID 23comp will also be carried out. This includes generating information 
about SE33 sequence‐based data for the Saudi population.  
7- Using the data generated from Objectives 3, 5 and 6 (42 aSTRs and 94 iiSNPs) to 




2 Chapter Two: Materials and Methods 
2.1 Background 
This chapter describes the materials and methods used throughout the experimental 
work. Table 2.1 shows all reagents used in the experimental work of the project. 
Table 2.1. The reagents and suppliers used in the experimental work. 
  
Item supplier 
Whatman® FTA® card Whatman, UK 
Unistik® 3 Normal (single use safety lancets) Owen Mumford, USA 
QIAamp DNA Mini Kit Qiagen, Germany 
DNA Ladder Plus NBS-biologicals, UK 
SafeView 
GelRed® Biotium, USA 
Qubit® assay tubes Invitrogen, USA 
Qubit® dsDNA HS Kit 
Qubit® Fluorometer 3.0 
Control DNA (G147A) Promega, USA 
 GlobalFiler PCR kit Applied Biosystems (AB), USA 
POP-6™ polymer 
50 cm capillary array 
Hi-Di™ Formamide 
600 LIZ™ v2 
2X ReddyMix PCR Master Mix 
SE33-1 and SE33-2 primers 
PureLink™ Quick Gel Extraction Kit 
BigDye™ Terminator v3.1 Cycle Sequencing Kit 
Shrimp Alkaline Phosphatase (SAP) 
PrepFiler™ BTA Forensic DNA Extraction Kit 
Quantifiler™ Trio DNA Quantification Kit 
MicroAmp™ optical 96-well reaction plates 
MicroAmp™ Optical adhesive films 
Agarose gel  
SureID®23comp kit Health Gene Technologies, China 
HGT 5-Dye Matrix Standard 
Size-500-Plus 
2800M control DNA Promega, USA 
G147A control DNA 
Humic acid Sigma-Aldrich, USA 
Tannic acid 
The ForenSeq DNA Signature Prep Kit Verogen, USA 
MiSeq FGx ForenSeq Reagent Kit 
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2.2 Samples collection and preparation 
2.2.1 Ethical approval 
Before collecting samples, a communication started with the Security Forces 
Hospitals Programme (SFHP, Saudi Arabia) to allow sample collection in the facilities of 
six branches in Saudi Arabia. In addition, the proposed application with the title 
‘Forensically Relevant Polymorphisms (STRs/SNPs) in the population of Saudi Arabia’, 
Participant Information Sheet (Appendix 2, Section 10.2.1) and consent form (Appendix 
2, Section 10.2.2) were sent to the ethics committee to be studied and approved.  
2.2.2 Samples collection 
Blood samples were collected by utilizing the facilities of the SFHP in Saudi Arabia. 
There are six branches of Security Forces Hospitals in different cities (different 
administrative provinces) Makkah, Al-Madinah, Riyadh, Dammam, Tabuk and Abha. In 
the Riyadh and Dammam branches, the project had been presented in their lecture halls 
that allowed participants to gain a better understanding of the project and the consent 
process.  
Although dealing with volunteers who already have medical or scientific backgrounds 
(staff and trainees in the hospitals) was easier, collecting 500 samples from six cities, in 
different provinces, within three weeks (15 working days) was the main challenge. 






Figure 2.1. This map is showing distribution of collection sites. Collection started from Riyadh to Dammam, 
Riyadh, Abha, Makkah (Mecca), Al-Madinah, Tabuk, and then back to Riyadh. 
In each branch, the collection event was announced by sending an e-mail to the staff 
and the trainees. The e-mail included the Participant Information Sheet and instructed 
people who are willing to participate to respond to the e-mail. Responders were given a 
specific date and an approximate time for collection. The collection was from 8 am to 6 
pm over the five working days. To ensure that samples are from unrelated 
representative, every volunteer was asked if she/he has a related person in the same or 
in any of the other branches. Volunteers had signed consent forms before sample were 
collected. 
Around 200 µl of liquid blood was spotted onto FTA card (Whatman, UK). Cards were 
left in a clean ventilated fume hood to dry the blood spots before placing the card in an 
envelope. Each card and its envelope were identically numbered by a unique number 
and has the sex of the volunteer. 
52 
 
2.2.3 DNA extraction 
DNA was extracted using the QIAamp DNA Mini Kit (Qiagen) following the 
manufacturer’s guidelines (Qiagen 2016) with two modifications. First: samples were 
incubated in the ATL buffer for at least 6 h/overnight at 56 °C (additional step) before 
proceeding with the manufacturer’s procedure. Second, a volume of 100 µl of the AE 
buffer was used for the elution stage rather than 150 µl (amended step). Before applying 
these modifications, the impact of each modification was evaluated by running the 
extracted DNA of five samples on a 1% agarose gel (Section 2.8.1).  
After optimising the extraction procedure, collected samples were extracted in 
batches, each batch contained 20 samples. For quality control purpose, one blank tube 
(no DNA) was processed with every extraction batch. Five (2 mm diameter) punches per 
sample were placed in a 1.5 ml tube. Then, 180 μl of ATL were added and samples were 
incubated at 56 °C for 6 h/overnight. The manufacturer’s procedure started from this 
point where the temperature of the incubation was raised to 85 °C for 10 min. This was 
followed by adding 20 μl proteinase K (PK) and an incubation at 56 °C for 1 h. Then, 200 
μl of AL buffer were added and samples were incubated at 70 °C for 10 min. 
Subsequently, 200 μl of absolute ethanol were added. It is important to note that every 
tube was briefly centrifuged to remove drops from the lid before any addition and was 
vortexed thoroughly after any addition.  
The 600 μl mixture was moved to a QIAamp Mini spin column inserted in a 2 ml 
collection tube. Then, the tube was centrifuged at 8000 rpm for 1 min. Subsequently, 
the collection tube was emptied, 500 µl of AW1 buffer was added and the samples were 
centrifuged at 8000 rpm for 1 min. The final washing step included adding 500 µl of AW2 
buffer, and centrifuge at 14000 rpm for 3 min. To collect the extracted DNA, the spin 
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column was placed in a labelled cross-linked 1.5 ml tube, 100 µl of the AE buffer was 
added, and samples were incubated at the room temperature for 1 min. Finally, the 1.5 
ml tube (with the spin column) was centrifuged at 8000 rpm for 1 min and tubes with 
the eluted DNA were placed in a -20 °C freezer. 
To monitor the performance of the extraction stage, five random samples from each 
batch (5/20 samples) were run on a 1% agarose gel (Section 2.8.1). If any of the five 
samples did not show an obvious band, all samples from the same batch were run on a 
gel to identify samples that need re-extraction.      
2.2.4 Quantification of the extracted DNA 
The concentrations of the extracted DNA were estimated using Qubit® dsDNA HS Kit 
and Qubit® Fluorometer 3.0 (Invitrogen, USA). The samples were processed in ten 
batches, each batch contained 50 DNA samples. 
Qubit® assay tubes (0.5 ml) were used for the quantification reaction. Based on the 
manufacturer’s protocol, 10 µl of extracted DNA or of the Qubit® standards (Qubit® 
dsDNA HS Standard #1 and #2) was added to 190 µl Qubit® working solution. However, 
the workflow of the assay was reversed by adding the extracted DNA or the standards 
first, followed by adding Qubit® working solution to all the tubes. The Qubit® working 
solution was prepared by 1 µl of Qubit® dsDNA HS Reagent and 189 µl of Qubit® dsDNA 
HS Buffer. 
The workflow reversal was to reduce the effect of variations in the incubation time 
between the tested samples. In addition to the standard tubes, an addition tube that 
contained a known concentration DNA (G147A control DNA, Promega) was analysed 
with each batch. The G147A control was diluted to 1.92 ng/µl (original concentration 
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192 ng/µl) to place it within the detection range of the kit (0.001 ng/µl to 100 ng/µl). In 
total, 53 tubes were proceeded in every batch. 
After adding the Qubit® working solution, the tubes were vortexed for 2-3 s and then 
incubated for 2-3 min at room temperature.  Each of tested sample was read twice and 
the average of the two reads was defined as the sample’s concentration. 
2.3 GlobalFiler™ PCR kit. 
2.3.1 DNA amplification 
The amplification used the half volume reactions that contained 3.75 µl Master Mix, 
1.25 µl Primer Set, 0.5 ng extracted DNA in 7.5 µl. The half volume reaction was 
optimised and validated by comparing the profiles of the positive control using the 
manufacturer’s guidelines (full volume) and the half volume. This was done in three 
replicates.  
Once the half volume reaction was validated, the 500 samples were amplified in 
batches (90 samples/batch). The amplification reactions were monitored using positive 
and negative controls (Table 2.2). A Veriti thermal cycler (AB) was utilized to carry out 
the PCR as following: [95 °C (60 s)] / [94 °C (10 s) 59 °C (90 s)] 29 cycles / [60 °C (10 min)]. 
Table 2.2. The components of amplification tubes of the GlobalFiler™ PCR kit. The table shows the 













Positive control 3.75  1.25  0.5 2.5  12.5  
Negative control 3.75  1.25  0 7.5  12.5  





2.3.2 DNA separation, detection and analysis  
An ABI 3500 DNA Genetic Analyser with an 8-capillary array (AB, USA) was employed 
for separation and detection following the manufacturer’s guidelines, except that POP-
6™ polymer and a 50 cm capillary array (AB) were used. In addition, the run time, in the 
Data Collection Software v3 (AB), was increased to 3800 s due to the use of the 50 cm 
capillary array (Alsafiah et al. 2017).  
Samples were prepared for injection by adding 0.5 µl of PCR amplicons to 9.5 µl of 
Liz-Formamide mixture. The Liz-Formamide mixture contained 9.25 µl Hi-Di™ 
Formamide and 0.25 µl Size Standard 600 LIZ™ v2 (AB) per sample. As recommended by 
the manufacturer, one well of an allelic ladder, which contained 9.5 µl Liz-Formamide 
mixture and 0.5 µl allelic ladder, was included every three injections (Alsafiah et al. 
2017).  
Following the published nomenclatures and the guidelines of the International 
Society for Forensic Genetics (ISFG) (Schneider 2007), alleles from the 21 STRs were 
identified using the allelic ladder and GeneMapper™ ID-X Software v1.2 (AB) (Alsafiah et 
al. 2017). 
2.4 Characterisation of six unusual alleles at SE33 and D1S1656 STR loci. 
2.4.1 Sequencing the SE33 alleles 
Samples that exhibited alleles of interest were amplified in 25 μl volume reactions. It 
contained 12.5 μl of 2X ReddyMix PCR Master Mix (AB), 1.25 μl of a 10 μM concentration 
of each primer, and a total of 2 ng DNA (up to 15 μl). A primer pair (SE33-1 and SE33-2), 
as published in (Gill et al. 1994), was used for the amplification reactions: SE33-1 [5´-
AAT CTG GGC GAC AAG AGT GA-3´] and SE33-2 [5´-ACA TCT CCC CTA CCG CTA TA-3´]. 
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Samples were amplified using a Veriti™ Thermal Cycler (AB): [95 °C / 2 min] [(95 °C / 25 
s) (60 °C / 30 s) (72 °C / 40 s)] 30 cycles [72 °C / 5 min] (Alsafiah et al. 2018).  
A 20-cm-long 3% agarose gel was employed to separate target fragments (section 
2.8.2). The bands of interest were then sliced and placed into a 15 ml falcon tube for 
recovery and purification. PureLink™ Quick Gel Extraction Kit (AB) was used for the DNA 
recovery and purification following the manufacturer’s procedure. Based on the weight 
of each slice and the percentage of the used gel, the volume of gel solubilization buffer 
(L3) was determined (e.g. 400 mg weight of 3% agarose gel needed 2.4 ml of L3 buffer). 
Therefore, the volumes of L3 buffer added to the gel slices ranged from 1.3 – 3.1 ml. 
Samples were then incubated at 50 °C for 15 min or until the gel was completely 
dissolved. This was followed by adding an equal volume to the L3 buffer of isopropanol 
to each tube. For the purification stage, the quick gel extraction column inserted in 2 ml 
collection tube was used. The mixture from the above steps was placed into the column 
and was centrifuged at 14,000 rpm for a 1 min. Then, 500 µl of W1 wash buffer was 
added to the column and was centrifuged at 14,000 rpm for a 2 min. The purified DNA 
was eventually eluted by 50 µl E5 elution buffer that incubated at the room temperature 
for 1 min. Finally, the DNA was collected in 1.5 ml tubes by centrifuging the column at 
14,000 rpm for a 1 min. Collected DNA was placed at -20 °C for storage. 
DNA concentrations of the purified fragments were estimated using Qubit™ dsDNA 
HS Assay Kit and Qubit® Fluorometer 3.0 (AB) following the above procedure (Section 
2.2.4) 
DNA fragments were sequenced directly using BigDye™ Terminator v3.1 Cycle 
Sequencing Kit (AB) following an internally validated 10 μl reaction volume. For each 
DNA strand, the 10 μl sequencing reaction contained 0.75 μl of BigDye® Terminator v3.1 
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Ready Reaction Mix, 1.7 μl 5X Sequencing Buffer, 0.32 μl of 10 μM primer (forward or 
reverse), and 3-6 ng of DNA (extracted from the gel). A Veriti™ Thermal Cycler was used 
for sequencing reaction: [95 °C / 1 min] [(96 °C / 10 s) (50 °C / 5 s) (60 °C / 4 min)] 25 
cycles (Alsafiah et al. 2018). 
Post-sequencing purification was carried out by adding 2 μl Shrimp Alkaline 
Phosphatase (SAP) (AB) to 5 μl of sequencing products that was followed by an 
incubation at 37 °C for 60 min then at 65°C for 15 min as recommended by the 
manufacturer (Alsafiah et al. 2018). 
Purified products were prepared for separation by adding 5 μl Hi-Di™ Formamide 
(AB). An ABI 3500 DNA Genetic Analyser, POP-6™ polymer and 50 cm capillary array 
were employed for separation using the run modules StdSeq50_POP6 and the base 
calling protocol BDTv3.1_PA_Protocol-POP6. Sequencing raw data was then analysed by 
sequencing analysis software v5.4 (AB) (Alsafiah et al. 2018). 
2.4.2 Sequencing the D1S1656 alleles 
This part is described in Section 2.6.1. 
2.5 An evaluation of the SureID®23comp Human Identification kit. 
The SureID®23comp kit was evaluated for forensic applications as a supplementary 
STR kit. The minimum criteria for validation recommended by the European Network of 
Forensic Science Institutes (ENFSI) (ENFSI 2010) and by the scientific working group on 
DNA analysis Methods (SWGDAM) (SWGDAM 2016) were followed.  
2.5.1 Preparation ABI 3500 DNA Genetic Analyser. 
The preparation included spectral calibration and run optimisation due to the use of 
50 cm capillaries and POP-6™ polymer (AB). The spectral calibration mix was prepared 
58 
 
by adding 8 µl HGT 5-Dye Matrix Standard (Health Gene Technologies) to 200 µl of Hi-
Di™ Formamide (AB); 10 µl were dispensed to each well. In the data collection software 
(AB), the dye set of SureID®23comp was created based on the G5 template as 
recommended by manufacturer. Based on the manufacturer guidelines, the run time in 
the run module of HID36_POP4 should be 1,210 – 1,500 s when using a 36 cm capillary. 
In this study, the run time was increased to 3900 s due to the use of the 50 cm capillaries 
(Alsafiah et al. 2019a). 
2.5.2 DNA Samples 
Initial tests of the SureID®23comp kit, were carried out using the 2800M control DNA 
(Promega Corporation). The control DNA was also used for sensitivity and stochastic 
tests by preparing five serial dilutions of (500, 250, 125, 62, and 31) pg. In addition, 0.5 
ng of the control was amplified with the presence of different concentrations (50, 75, 
100, 120 and 150) ng/µl of common PCR inhibitors humic and tannic acids (Sigma-
Aldrich, USA), for stability tests (Alsafiah et al. 2019a).  
The study of precision, accuracy, peak balances, concordance and stutter peak ratios 
were carried out using the 500 samples from the population of Saudi Arabia. The 
sensitivity and the stability of the kit were further assessed using nine bone samples 
collected from a mass grave in Iraq. The bone samples were previously extracted using 
PrepFiler™ BTA Forensic DNA Extraction Kit (AB) and were quantified using Quantifiler™ 
Trio DNA Quantification Kit (AB). The concentrations of the small fragments of the 
Quantifiler™ Trio ranged from 0.0173 ng/µl to 0.3271 ng/µl and the Degradation Indexes 
(DI) were from 1.6758 to 57.666. These samples were previously profiled using one or 




Table 2.3. Bone samples used in the evaluation tests of the SureID® 23 comp kit. Nine bone samples, 
collected from a mass grave in Iraq, were extracted using PrepFiler™ BTA Forensic DNA Extraction Kit (AB), 
and were quantified using Quantifiler™ Trio DNA Quantification Kit (AB). This table shows Quantifiler™ Trio 
small fragment concentrations (ng/µl) and degradation indexes (DI) of the samples (Alsafiah et al. 2019a). 
 
2.5.3 DNA amplification 
The Initial tests of the SureID®23comp used two reaction volumes that were 
optimised by the manufacturer. A 25 µl volume that contained 12.5 µl master mix, 6.25 
µl primer mix and up to 6.25 µl of DNA template; and a 10 µl volume that contained 5 µl 
master mix, 2.5 µl primer mix and up to 2.5 µl of DNA template. The range of 
recommended DNA quantity was 0.5 - 4 ng. To validate both volumes, two operators 
carried out the initial tests independently with 0.5 ng of control DNA in five replicates 
(20 tests in total) (Alsafiah et al. 2019a).  
Three DNA concentrations (0.5, 0.35, and 0.25) ng were used for the first 90 samples 
from Saudi population, to test the ideal concentration that can achieve the highest peak 
balances with the 10 µl volume. Then, the rest of samples were genotyped using the 10 
µl volume and 0.5 ng as the total DNA input per reaction (Alsafiah et al. 2019a). 
Sample # 














76 c 0.0173 57.666 
 
60% 66.60% 60.80% 
78 a 0.0194 16.166 
 
90% 95.20% 82.60% 
93 b 0.3271 2.7464 
 
100% N/A N/A 
76 e 0.093 2.2962 
 
100% N/A N/A 
81 a 0.0571 1.929 
 
100% 76.20% N/A 
97 b 0.0548 1.6758 
 
100% N/A N/A 
94 a 0.0685 2.4204 
 
100% N/A N/A 
25 a 0.0463 4.9784 
 
95% N/A N/A 
46 b 0.0412 3.1937 
 
100% N/A N/A 
N/A: sample was not profiled using the kit. 
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MicroAmp™ optical 96-well reaction plates and MicroAmp™ Optical adhesive films (AB), 
were used for amplification. The amplification contents were prepared by adding the 
2.5 µl of the DNA and DNase/RNase-free water, followed by aliquoting 7.5 µl the 
SureID®23comp mix (5 µl master mix and 2.5 µl primer mix). A Veriti thermal cycler (AB) 
was employed to carry out the amplification reactions as following [95 °C (5 min)] / [94 
°C (10 s) 61 °C (60 s) 70 °C (30 s)] 28-30 cycles / [60 °C (15 min)]. The 28-cycles protocol 
was used for the initial tests, stability tests and for the 500 samples. For sensitivity and 
stochastic study, the serial dilution samples were amplified in five replicates using both 
reaction volumes, each volume was tested with 28 and 30 PCR cycles. For the bone 
samples, the 25 µl volume and 30 PCR cycles were used (Alsafiah et al. 2019a).  
2.5.4 DNA separation, detection and analysis  
Samples were prepared for separation and detection by adding 1 µl of PCR products 
or of an allelic ladder (Health Gene Technologies) to 9 µl of Formamide/Size-500-Plus 
mix. This mix was prepared by 9 µl of Hi-Di™ Formamide (AB) and 0.25 µl Size-500-Plus 
(Health Gene Technologies), for each sample. An ABI 3500 DNA Genetic Analyser with 
50 cm capillaries and POP-6™ polymer (AB) was used for the separation and detection 
by applying 3900 s as the run time as validated in Section 2.5.1 (Alsafiah et al. 2019a).  
Alleles from the 23 markers were called using GeneMapper™ ID-X Software v1.2 (AB) 
with an allelic ladder mix supported by panels and bins provided by the manufacturer. 
For the sensitivity and stability tests, the minimum relative fluorescent units (RFU) was 
50 RFU for heterozygous genotypes and was 150 RFU for homozygous genotypes 
(Alsafiah et al. 2019a). 
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2.6 ForenSeq™ DNA Signature Prep kit. 
The kit was used in two parts of the project, sequencing the two allele variants of the 
D1S1656 locus (Chapter 4) and for generating ForenSeq™ data of the Saudi population 
(Chapter 6). For both parts the Verogen ForenSeq™ DNA Signature Prep kit (Verogen 
2018a) was used for the library preparation. 
2.6.1 Library preparation and sequencing for the D1S1656 variants. 
The library preparation of the two samples showed alleles 7 and 8 at the D1S1656 
was carried out using the Primer Mix B for the initial PCR (PCR1). The primer mix B 
targets additional 78 SNPs (56 aiSNPs and 22 piSNPs) to those markers included in Primer 
Mix A (27 autosomal STRs, 7 X, 24 Y haplotype markers and 94 iiSNPs) (Table 1.5). All 
other library preparation steps were carried out following the manufacturer’s guidelines 
(Verogen 2018a) (Alsafiah et al. 2018). 
The prepared libraries were then sequenced using a MiSeq FGx™ Instrument and a 
standard flow cell following the manufacturer’s guidelines (Verogen 2018c), in the 
Applications Laboratory (Illumina, Cambridge, United Kingdom) (Alsafiah et al. 2018).  
2.6.2 Library preparation and sequencing for the Saudi population data. 
For the population genetic study, 94 samples from the population of Saudi Arabia 
were sequenced using the Primer Mix A in the PCR1. All other library preparation steps 
were carried out following the manufacturer’s guidelines (Verogen 2018a), except that 
the volume of the pooled normalised libraries (PNL) that was added to the human 
sequencing control (HSC) mixture was increased from 7 µl to 12 µl as validated by 
Devesse et al. (2018). 
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The denatured normalised libraries (DNL) were then transferred to the reagent 
cartridge which was then loaded to a MiSeq FGx™ Instrument alongside with a standard 
flow cell, SBS solution (PR2) Bottle, and the waste Bottle following the manufacturer’s 
guidelines (Verogen 2018c). This part was carried out in Alec Jeffreys Forensic Genomics 
Unit, Department of Genetics and Genome Biology (University of Leicester, United 
Kingdom). 
2.6.3 Universal analysis software 
The run was created using the ForenSeq™ Universal Analysis (UAS) by entering the 
samples’ information including the indices combinations for each sample as described 
the manufacturer’s guide (Verogen 2018b). The UAS was also used to perform 
sequences analysis, allele call and to generate the samples’ report and the run Flanking 
Region Report. The default setting of the UAS uses, for the analytical and interpretation 
thresholds (AI and IT), 1.5% and 4.5% of the total number of reads of the most frequent 
sequences on a locus and applies minimum limits of 10 and 30 reads for the thresholds 
respectively. This study applied the default setting for the AT, IT and the stutter filter.  
2.6.4 Concordance study  
The data of 23 autosomal STRs gathered from the CE kits (Sections 2.3 and 2.5) 
common with ForenSeq™ data was compared using an Excel workbook and any 
differences were considered as a non-concordance. However, in few cases where a 
known heterozygote genotype (CE data) at the D22S1045, and the ForenSeq™ data 
showed only one allele with low coverage, the cases were considered as drop out not a 
discrepancy event due to the lower allele count ratios (ACR) feature of this locus. In 
addition, due to the lack of CE data for D4S2408, D6S1043, PentaE and PentaD STRs, 
they were not included in the concordance study. 
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2.6.5 Further analysis using the STRait Razor (SR) 
The FASTQ files of the samples that were generated from the MiSeq FGx™ instrument 
were loaded to STRait Razor (SR) v3.0 (Woerner et al. 2017). To recover as many as 
possible of sequences, the parameters of 0.20 for the heterozygote threshold and 2 for 
coverage threshold were used. Discordance events appeared in Section 2.6.2, were 
further investigated for possible allele drop-out, drop-in, or alleles imbalances. 
Additionally, allele calling generated from the SR was compared to those generated by 
the UAS to investigate any bioinformatical discordance.  
2.6.6 SE33 sequence-based data  
The SR (Woerner et al. 2017), was also used to recover the SE33 sequences from the 
FASTQ files generated by the MiSeq FGx after modifying the configuration file by adding 
the 5' and 3' anchors and motif sequence provided in (Borsuk et al. 2018). For the SE33 
sequences, all sequences with ≥ 10 reads (depth of coverage, DoC) were included and 
heterozygous sequences that showed ≥ 20% of ACR were considered as true sequences. 
Sequences that showed less than 20% ACR were then recovered manually (Alsafiah et 
al. 2019b).  
2.6.7 Novelty assessment 
The novelty assessment of an allele was started with the STRait Razor v3.0 by which 
alleles showed “Novel Sequence” were further assessed. The alleles were then searched 
for in the literature that included samples from the Middle East (Phillips et al. 2018a), 
from the Qatari population (Almohammed and Hadi 2019) and from Saudi Arabia 




For the SE33, the novelty of a motif pattern or of an allele sequence was assessed 
based on those motifs and sequences reported in (Borsuk et al. 2018) and in the 
GenBank database.  
2.7 Evaluation of DNA markers 
2.7.1 Forensic parameters 
The parameters included power of discrimination (PoD), power of exclusion (PoE), 
matching probability (MP), polymorphism information content (PIC), observed 
homozygosity (Ho) and typical paternity index (PI).  
For 38 autosomal STRs which were generated from Sections 2.3 and 2.5, the 
statistical parameters were calculated using PowerStat v 1.2 (Promega Promega 
Corporation). For DNA markers included in the ForenSeq™ DNA Signature Prep kit, 
GenAlEx 6.5 Excel software (Peakall and Smouse 2012), was used. 
2.7.2 Hardy-Weinberg equilibrium 
Convert software (Glaubitz 2004), was employed to convert an Excel sheet, which 
contains the data, to the input file (ARP files) for Arlequin Software. The expected 
heterozygosity (He) and the exact test for detecting deviation from the Hardy-Weinberg 
equilibrium (HWE) was carried out by Arlequin v3.5.2 Software (Excoffier et al. 2007), 
using values of 1,000,000 steps for the Markov chain and 100,000 for the 
dememorization steps.  
2.7.3 Linkage disequilibrium test  
Arlequin v3.5.2 Software (Excoffier et al. 2007), was also used to test linkage 
disequilibrium (LD) between syntenic loci (STR-STR, STR-SNP, and SNP-SNP). The data of 
the 500 samples were used to test LD between 12 syntenic pairs at the same arm 
resulted from combining GlobalFiler™ (Section 2.3) and SureID®23comp (Section 2.5) 
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kits. The data of the 87 samples sequenced by ForenSeq™ DNA Signature Prep kit 
(Section 2.6) were used to test LD between 166 syntenic loci at the same arm resulted 
from using ForenSeq™ alone. The LD test was carried out by applying the values of 1000 
in the permutations and of 2 in the Expectation-Maximisation (EM) algorithm.  
2.7.4 Population differentiation test, FST calculation, and inbreeding coefficient (FIS) 
Arlequin v3.5.2 Software was also used to perform a population differentiation exact 
test and to calculate the FST values.  
For GlobalFiler™ data (Section 2.3), fourteen populations were compared that 
included previous studies in the Saudi population reported by Sinha et al. (1999) (207 
samples), Osman et al. (2015) (190 samples) and by Khubrani et al. (2019a) (523 
samples). In addition, the comparison included Saudi individuals residing in Kuwait (Al-
Enizi et al. 2013) (250 samples) and in Dubai (Alshamali et al. 2005) (94 samples). Gulf 
Cooperation Council (GCC) populations were also included: Kuwait (Al-Enizi et al. 2013) 
(502 samples), United Arab Emirates (Jones et al. 2017) (477 samples), Qatar (Perez-
Miranda et al. 2006) (133 samples), Yemeni (101 samples) and Omani (79 samples) 
residing in Dubai (Alshamali et al. 2005). Egyptian (421 samples), Iraqi (146 samples), 
Iranian (287 samples), and Indian (415 samples) residing in Kuwait (Al-Enizi et al. 2013) 
were also included in the comparison. This part used the allele frequency data.  
For the SureID®23comp data (Section 2.5), four populations were included in the 
comparison that are European (321 samples), South Asian (315 samples), African (284 
samples) (Iyavoo et al. 2019), and Ningbo population (284 samples) (China, data 




The AMOVA test was also carried out using Arlequin v3.5.2 Software to estimate the 
average FIS for 21 loci included in GlobalFiler™ kit (Section 2.3), 17 loci included in 
SureID®23comp data (Section 2.5), and 122 loci included in ForenSeq™ data (Section 
2.6). 
2.7.5 RStudio platform and packages used in the project. 
RStudio platform (RStudio Team 2016) and DNA tools package (James and Curran 
2017), were used to identify the maximum number of matched loci and partial matches 
within the tested samples. The ggplot2 package (Wickham 2016) was also used for 
plotting figures. Finally, the cmdscale function (Ingwer and Patrick 2005) was used in R 
software to generate a multi-dimensional scale (MDS).  
2.8 Gel electrophoresis 
2.8.1 Assessment of extraction procedure and DNA yield 
Gel electrophoresis was employed to study the effect of each of the modifications 
during the optimisation of the extraction procedure and to give an initial assessment of 
the extracted DNA in all batches (Section 2.2.3). For both tests, a 1% agarose gel was 
used that was prepared by 0.5 g of agarose gel (AB) dissolved in 50 ml of Tris-Acetate 
with Ethylenediaminetetraacetic acid (EDTA) buffer (TAE) and 5 µl of a nucleic acid stain 
SafeView (NBS Biologicals, UK) or GelRed® (Biotium, USA).  A total of 5 μl of the extracted 
DNA and 2 μl of 100 bp DNA Ladder Plus (NBS-biologicals) were loaded into the gel and 
the electrophoresis was at 100 v for 20 min. 
2.8.2 Preparation of the 20-cm-long 3% agarose  
Gel electrophoresis was also employed for separation DNA fragments of the SE33 
alleles (Section 2.4.1). The 20-cm-long 3% agarose gel was prepared by adding 6 g of 
agarose gel (AB) to 220 mL of TAE buffer and 16 µl of GelRed® (Biotium). A total of 25 μl 
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of the PCR products of SE33 locus and 10 μl of 100 bp DNA Ladder Plus (NBS-biologicals) 
were loaded into the gel. Electrophoresis was at 120 v for 6 h (Alsafiah et al. 2018).  
2.9 An evaluation of 136 DNA markers for kinship testing 
The data of 42 aSTRs and 94 iiSNPs (136 markers) generated in Sections 2.3, 2.5 and 
2.6 were used in the simulation studies to evaluate the extent that they can improve the 
resolution of kinship testing in Saudi Arabia. An in-house Excel sheet was used to create 
a hypothetical pedigree based on the allele frequencies of the DNA markers obtained 
(Figure 2.2).  
 
Figure 2.2. A hypothetical pedigree created by an in-house Excel sheet. The hypothetical pedigree 
comprised of three generations and 13 members. Circles represent female members and squares 
represent male members. The profiles of the members were generated by the in-house Excel sheet based 
on the allele frequencies of the 136 loci. 
Familias3 software v3.2.7 (Kling et al. 2014) was used to test the parent-Child 
relationships of the hypothetical pedigree’s member to validate the members’ profiles, 
before starting the simulation study, using the blind search option. The software was 
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then used to do the simulation study using the allele frequency data of the 136 markers 
and the DNA profiles of the pedigree’s members after setting the mutation rates. 
2.9.1 Setting up the mutation rates in the Familias3 software  
For aSTRs, the sex-specific (Maternal/Paternal) mutation rates of 38/42 STRs were 
adopted from (Butler 2015, Lan et al. 2018, Jin et al. 2016) (no data were available for 
D3S1744, D4S2366, D19S253 and D21S2055) (Table 2.4). 
Table 2.4. Mutation rates for aSTRs that were reviewed from literatures. The mutation rates of 38 aSTRs 
were reviewed from (Butler 2015, Lan et al. 2018, Jin et al. 2016) and were used in the simulation study. No 
mutation rates were available for D3S1744, D4S2366, D19S253 and D21S2055.  
STRs 
Mutation rates  
STRs 
Mutation rates 
Maternal Paternal  Maternal Paternal 
D1S1656 (Butler 2015)  0 0.0025  TH01 (Butler 2015) 0.0001 0.0001 
D2S441 (Butler 2015) 0 0.0025  D11S2368 (Jin et al. 2016) 0.00047 0.00189 
D2S1338 (Butler 2015) 0.0002 0.001  D12S391 (Butler 2015) 0.0003 0.003 
TPOX (Butler 2015) 0 0.0001  vWA (Butler 2015) 0.0003 0.0017 
D3S1358 (Butler 2015) 0.0002 0.0013  D13S317 (Butler 2015) 0.0004 0.0014 
D3S1744 - -  D13S325 (Jin et al. 2016) 0 0.00095 
FGA (Butler 2015) 0.0005 0.0032  D14S1434 (Lan et al. 2018) 
 
0 0.00103 
D4S2366 - -  D15S659 (Jin et al. 2016) 0 0.00081 
D4S2408 (Lan et al. 2018) 0 0.00103  PentaE (Butler 2015) 0.0007 0.0013 
D5S818 (Butler 2015) 0.0003 0.0012  D16S539 (Butler 2015) 0.0003 0.0011 
D5S2800 (Lan et al. 2018) 
 
0 0  D17S1301 (Lan et al. 2018) 
 
0.00103 0.00206 
CSF1PO (Butler 2015) 0.0003 0.0015  D18S51 (Butler 2015) 0.0006 0.0022 
SE33 (Butler 2015) 0.003 0.0064  D18S1364 (Jin et al. 2016) 0 0.00141 
D6S474 (Lan et al. 2018) 
 
0 0  D19S433 (Butler 2015) 0.0005 0.0008 
D6S1043 (Butler 2015) 0.0003 0.0006  D19S253  -  - 
D7S820 (Butler 2015) 0.0001 0.0012  D20S482 (Lan et al. 2018) 
 
0.00103 0 
D7S3048 (Jin et al. 2016) 0.00095 0  D21S11 (Butler 2015) 0.0011 0.0015 
D8S1179 (Butler 2015) 0.0002 0.0016  D21S2055  -  - 
D8S1132 (Jin et al. 2016) 0.00095 0.00143  PentaD (Butler 2015) 0.0006 0.0009 
D9S1122 (Lan et al. 2018) 
 
0.00103 0  D22S1045 (Butler 2015) 0 0.0025 
D10S1248 (Butler 2015) 0 0.0025  D22GATA198B05 (Jin et al. 2016)  0 0.00144 
 
The mutation rates were applied for each locus in the rate box in the software (Figure 
2.3). In addition, due the lack of allele-specific mutation rates for every allele at a locus, 
the extended stepwise model was used by applying a fixed probability (one tenth less) 
for each ± unit difference (0.1 in the range box) (i. e. the mutation rates in Table 2.4 will 
be decreased by one tenth (0.1) for allele x ±1 repeat, 0.01  for allele x ±2….etc).  The 
mutation rate of 0.000001 was used for microvariants (e.g. allele x.1 > allele x.2) (rate 
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2). For iiSNPs, equal probability type was used by applying the mutation rate of 2.5E-8 
as reported in (Nachman and Crowell 2000) (Figure 2.3). All mutation settings were as 
recommended by Daniel Kling (kinship testing workshop in ISFG2019, Prague). 
 
Figure 2.3. Mutation rate settings in Familias3 software. For aSTRs, extended stepwise model was used 
by applying the mutation rate in Table 2.4 in the rate box, 0.1 in the range box, 0.000001 in the rate 2 box  
for microvariants alleles. For iiSNPs, equal probability was used by applying 2.5E-8 in the rate box. 
2.9.2 Simulation study 
The simulation was conducted using Familias3 software v3.2.7 (Kling et al. 2014) to 
test different combinations of DNA markers that make up the commercially available 
kits of Identifiler Plus (15 aSTRs), GlobalFiler (21 aSTRs), GlobalFiler and SureID (38 
aSTRs), Fusion 6C and SureID (40 aSTRs), and ForenSeq DNA Signature Prep kit (27 aSTRs 
and 94 iiSNPs). In addition, all loci (42 aSTRs and 94 iiSNPs) and the 94 iiSNPs alone were 
also tested. Although none of the samples were typed by Identifiler Plus or Fusion 6C, 
the data of all loci included in the kits have been obtained from Sections 2.3 and 2.6. 
Eight different scenarios were assumed to test potential five types of relationships, 
each of which was based on two hypotheses as shown in (Table 2.5). 
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In the simulation, members included in the simulation (genotyped) were simulated 
1000 times using the random seeds. When the simulation finished, different LR 
thresholds (1, 10, 100, 1,000, 10,000 and 100,000) were tested to find out the limits (the 
true positive (TP) and the false positive (FP)) of each LR threshold. 
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Table 2.5. The hypotheses 1 and 2 that were used in the simulation study. The simulation study was 
conducted using Familias3 software v3.2.7 (Kling et al. 2014). A total of 8 scenarios for five different 
relationships were tested. The table also shows members who were simulated (genotyped) in each run 
(orange colour).  
Tested relationship Hypothesis (1) Hypothesis (2) 
Parent-Child vs Unrelated 
(Mother not genotyped) 
 
Unrelated 












Half-Siblings vs Unrelated 
 
Unrelated 






Table 2.5. continued. 
 
In addition, the Familias3 software generates a data file (Simulation_LRs) that could 
be visualised by plotting in RStudio platform and produced two plots: LR distributions 
and exceedance probability (a figure that shows the improvement in probabilities at 
different LR thresholds). 
2.9.3 Estimating the genetic distance between syntenic pairs 
The genetic distances in cM of syntenic pairs resulted from combining the 136 
markers were estimated as described by Phillips et al. (2012). This needed to estimate 
the cumulative genetic map distance (cM) for each marker first.  
The cumulative genetic map distance for 41/42 aSTRs were already published and 
were reviewed from (Phillips 2017) (D16S539 was not available).   









An assumption: DNA profiles of members are not available 




For D16S539 and the 94 iiSNPs, the HapMap recombination map was retrieved from 
(ftp://ftp.ncbi.nlm.nih.gov/hapmap/recombination/2011-01_phaseII_B37/) that was 
used to approximate the cumulative genetic map distance for each marker. The 
rs925658351 SNP (Chr. 16:86386300, GRCh37) located at the 5′ flanking region 8 bp 
before the repeat region of D16S539 STR was used to approximate the cumulative 
genetic map distance of the D16S539 STR (repeat region starts from 86386308 to 
86386351, GRCh37) as recommended by Phillips, C. (personal communication). 
Then, the locations (bp) of the 95 SNPs (94 iiSNPs and the rs925658351 SNP for the 
D16S539 STR) were retrieved from the 1000 Genome Browser 
(https://www.internationalgenome.org/1000-genomes-browsers/) using the GRCh37 
coordinates. The SNP location (bp) was then used to find the closest map position to the 
SNP using the HapMap recombination map, by which the approximate cumulative 
genetic map distance (cM) could be estimated. Figure 2.4 shows how the genetic 
distance in cM was estimated for the rs560681 and rs10495407 SNPs (Chr. 1), as an 
example. 
2.9.4 Calculation of recombination fraction (RF) using Kosambi mapping function. 
Once the cumulative genetic map distance in cM was estimated for each marker, the 
distance between any two markers in cM was then calculated (subtraction the two 
values). The RF rate was then calculated by Kosambi mapping function using the Excel 





Figure 2.4. An example of how the genetic distance (cM) between syntenic pairs was calculated. This figure 




3 Chapter Three: An evaluation of 21 autosomal STRs for the population 
of Saudi Arabia using the Globalfiler™ PCR Amplification Kit. 
3.1 Overview of experiment 
This chapter presents the sample collection and preparation for downstream 
applications. In addition, the samples were genotyped using Globalfiler™ PCR 
amplification kit (AB) for 21 aSTRs included (D3S1358, vWA, D16S539, CSF1PO, TPOX, 
D8S1179, D21S11, D18S51, D2S441, D19S433, TH01, FGA, D22S1045, D5S818, D13S317, 
D7S820, SE33, D10S1248, D1S1656, D12S391 and D2S1338). The 21 aSTRs were then 
evaluated for forensic applications in the population of Saudi Arabia including 
assessment of HWE, population differentiation, and calculations of forensic statistical 
parameters.  
3.2 Aims of the study 
The initial aims of this chapter were to obtain ethical approval for the research and 
collect sufficient blood samples from unrelated representatives from the population of 
Saudi Arabia. This was followed by DNA extraction and quantification to prepare the 
samples for downstream applications.  
The second aim was to use the Globalfiler™ PCR amplification kit (AB) to genotype 21 
aSTRs to evaluate their performance in human identification applications in Saudi Arabia 
and compare it with the currently used kit (Identifiler® Plus). This include generating 
allele frequency data for the Saudi population that facilitates the estimation of match 
probabilities of DNA profiles in Saudi Arabia.   




3.3 Objectives  
1- To obtain ethical approval for the project from a recognised foundation in Saudi 
Arabia and from the Ethics Committee in UCLan before the sample’s collection. 
2- Collection around 500 blood samples from unrelated volunteers from the 
population of Saudi Arabia.  
3- Extract DNA from all samples using QIAamp DNA Mini Kit (Qiagen), after 
evaluating of modifications applied to the extraction protocol. 
4- Estimation of the concentration of the extracted DNA using Qubit® dsDNA HS Kit 
(Invitrogen). 
5- Validate the use of half volume reactions and of using 50 cm capillary with POP6 
before processing the 500 samples.  
6- Amplifying DNA extracts of the 500 samples using half volume reactions.  
7- Using the ABI 3500 DNA Genetic Analyser (AB) for separation and detection of 
PCR products. 
8- Analysing the raw data using GeneMapper™ ID-X Software v1.2 (AB) and 
transport the results using the export option. 
9- Evaluating the data for HWE, LD and other forensic statistical parameters. 
10- Carry out AMOVA analysis to estimate the inbreeding coefficient (FIS) and 
compare the results with previous studies in the population of Saudi Arabia. 
11- Carry out the population comparison tests to compare the data from this study 
to other published data for the Saudi population and neighbouring countries. 
3.4 Materials and Methods 




3.5 Results and discussion 
3.5.1 Ethical approval 
Initially, the sample collection was approved by the Security Forces Hospitals 
Programme (Saudi Arabia) (Appendix 3, Section 10.3.1). Following on from this, the 
UCLan Ethics Committee has granted an approval for the proposed application 
‘Forensically Relevant Polymorphisms (STRs/SNPs) in the population of Saudi Arabia’, 
and was given the reference number of STEMH 557. The approval was granted in 28th 
October 2016 for five years or to the end of the project (Appendix 3, Section 10.3.2). 
3.5.2 Sample collection 
A total of 500 blood samples was collected from unrelated individuals (116 Females 
and 384 Males) from the population of Saudi Arabia (Figure 3.1). Every donor confirmed 
that to the best of her/his knowledge and belief there were no relatives working or 
involved in a training programme at any of the six branches of the Security Forces 
Hospitals. The Security Forces Hospitals Programme are military hospitals established to 
serve military bases in those cities and staff or trainees are all Saudi citizens and are 
offspring of Saudi parents. This allowed more confidence regarding the origin of the 




Figure 3.1. An example of an FTA card used for sample collection. Each card contained the sample number 
and the donor sex (F/M). The same number was printed in the consent form. A series of 2 mm punches 
can be seen in the upper blood spot. 
Riyadh and Dammam had the highest number of participants, which may have been 
due the opportunity to give a presentation about the project to the staff; Tabuk had the 
lowest number. Table 3.1 shows the total number of samples that collected from each 
city. 
Table 3.1. The number of participants per each city. This table is showing samples numbers collected from 
each city where Riyadh and Dammam cities had the highest number of samples. 
City Riyadh Dammam Abha Makkah Al-Madinah Tabuk 
Samples No. 158 120 82 102 31 7 
 
Defining the “sufficient” number of samples can represent a population was 
addressed by Chakraborty (1992) who concluded that 100-150 may be adequate for 
statistical evaluation. However, the latest guidelines for the publication of genetic 
population data in the forensic science international (FSI): genetics defined 500 samples 
as the minimum required number for publication of autosomal markers detected 
through capillary electrophoresis (Gusmão et al. 2017), and thus this number was the 
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target number of collected samples. Although using blood samples on FTA cards is 
considered as an invasive procedure, it was practical as a method to collect material and 
has been demonstrated to preserve the DNA quality and quantity of samples for 16 
years (Rahikainen et al. 2016). 
3.5.3 DNA extraction 
Two modifications were applied to the manufacturer’s protocol (Qiagen 2016). The 
effect of these modification was assessed using 1% agarose gel with five samples before 
proceeding to extract the remaining 495 samples (Figure 3.2).  
 
Figure 3.2. Extracted DNA run on agarose gels (1%) (A, B, and C). A) Shows results of the 5 samples 
following manufacturer’s protocol. B) Shows results of the same samples after applying the 6 
hours/overnight incubation in the ATL buffer before starting the manufacturer’s protocol. C) Shows 
results of the 5 samples when using a volume of 100 µl of the AE buffer for the elution stage rather than 
150 µl, in addition to the first modification.  
Despite the time consumed in the extraction, DNA yield was increased by adopting 
the modifications. The first step of the original procedure was an incubation at 85 °C for 
10 min in the ATL buffer; however, this failed to release all the blood components from 
the FTA punches, which still showed staining. Although the DNA contents are in the 
white blood cell, this still an indication that the overall blood contents were not released 
form the paper. The FTA punches became whiter when they were incubated in the ATL 
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buffer for at least 6 hours at 56 °C, and this correlated with a higher yield of DNA (Figure 
3.2). Additionally, using 100 µl of AE buffer for elution was also correlated with a higher 
yield of DNA (Figure 3.2) which, theoretically, increases the concentration by one-third.  
Due to the number of samples that can be tested by the Qubit® dsDNA HS Kit (500 
samples/pack), the improvement in the DNA yield was not measured by the 
quantification kit.  
3.5.4 Quantification of the extracted DNA 
While pipetting and reaction time are critical when using the Qubit dsDNA HS Kit 
(Invitrogen 2019), the calibration sample was used to monitor the batches of assays. In 
addition, variations in the reaction time between the first tube and the last tube (53 
tubes/batch) was reduced by reversing the workflow of the assay. 
The calibration sample, which had a known concentration of 1.92 ng/µl, measured 
between 1.43 and 1.90 ng/µl in the ten extraction batches. This allowed more 
confidence in the concentrations estimates of the 500 samples. DNA extracts from the 
500 samples showed an average concentration of 1.5 ng/µl that ranged from 0.07 - 13.5 




Figure 3.3. The average concentration of each DNA samples extracted. The average of the samples 
concentrations was 1.5 ng/µl that ranged from 0.07 - 13.5 ng/µl. Each dot represents the average of the 
two reading/sample. 
3.5.5 Validation of half volume reaction and the 50 cm capillary with POP6. 
Prior to genotyping the 500 samples, the use of half volume reaction and the 50 cm 
capillary were validated. Three replicates of the positive control were amplified using 
the manufacturer’s guidelines and using half volume (6 reactions in total). Both reaction 
volumes showed a full profile from 0.5 ng DNA; however, the half volume was less 
balanced at TH01 and D2S1338 in all replicates (Figure 3.4). In addition, based on the 
user guide of the manufacturer (Applied Biosystems 2016), the kit uses 36 cm capillary 
and POP4 while 50 cm capillary and POP6 were used in this study. Increasing the run 
time to 3800 s allowed detection amplicons up to 480 bp that included the designated 
area for largest locus (SE33) that allowed the local Southern method to be used (Figure 
3.4).  
Based on the validation, the 500 samples were then successfully genotyped using the 
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Figure 3.4. Internal validation of half volume reaction and 50 cm capillary/ POP6. The figure shows one of the replicates of two Globalfiler™ profiles for the positive control using the 
manufacturer’s protocol (A) and the half volume reaction (B). Due to the use of 50 cm capillary, the run time was increased to 3800 s which was sufficient to cover the designated 
area of the largest locus SE33 that allowed the local Southern method to be used.   
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3.5.6 Allelic ladder variants 
After analysing the 500 samples, eight allelic ladder variants were detected at SE33: 
allele 7.3 (10 samples), allele 13.3 (two samples), allele 17.2 (one sample), allele 22 (8 
samples), allele 23 (3 samples), allele 28 (one sample), allele 33 (two samples) and allele 
34 (5 samples). All these have already been observed and had been reported (size-based 
and sequence-based alleles were reported) in STRBase (Ruitberg et al. 2001). Two 
variants were also detected at the D1S1656: allele 7 (one sample), allele 8 (one sample) 
where the size-based alleles were reported (no sequence data available) in STRBase 
(Ruitberg et al. 2001) (Figure 3.5) (Alsafiah et al. 2017).  
 
Figure 3.5. Allele variants of 7 and 8 at D1S1656. The figure shows allele 7 (A) and 8 (B) at the D1S1656 
locus and the allelic ladder (C). Allele 7 is located outside the designated area of the locus. Both alleles are 
not represented in the allelic ladder of the Globalfiler™ PCR amplification kit. The alleles were reported in 
STRBase (Ruitberg et al. 2001) but no sequence data was available (Alsafiah et al. 2017).  
Non-reported variants were also detected in SE33: allele 14.3 (one sample), allele 




Figure 3.6. Non-reported Allele variants at SE33. The figure shows alleles 14.3 (A), 20.3 (B), and 38 (C) at 
SE33 and the allelic ladder (D). The alleles have not been reported before in the STRBase (Ruitberg et al. 
2001) and are not represented in the allelic ladder of the Globalfiler™ PCR amplification kit (Alsafiah et al. 
2017). 
Interestingly, one sample showed three alleles (9, 12, OL) at D7S820, and showed 
homozygous allele (16) at SE33 (Figure 3.7 A). This suggests that the OL allele either 
belongs to D7S820 forming a triplet allele phenomenon, or is an unusual short allele 
belonging to SE33 forming a heterozygote genotype (OL, 16). To resolve this the D7S820 
was genotyped using the PowerPlex®21 System (Promega Corporation) following the 
manufacturer’s guidelines, and gave only two alleles (9, 12) (Figure 3.7 B). This 
demonstrated that the OL allele belonged to the SE33 locus and because of the adjacent 
locations of D7S820 and SE33 in the GlobalFiler® PCR amplification kit, the OL allele 




Figure 3.7. Two electropherograms (A & B) for the same sample using two different STR kits. (A) shows 
the genotype of D7S820 locus (9, 12, OL) using the GlobalFiler® PCR amplification kit. (B) shows the 
genotype of the same locus (9,12) using PowerPlex® 21 System. This confirmed that the OL allele belonged 
to SE33 and the OL allele appeared within the allelic window of D7S820 because of the adjacent locations 
of the D7S820 and SE33 in the GlobalFiler® PCR amplification kit (Alsafiah et al. 2017). 
Based on the sizes of the OL allele (296.85 bp) and allele 4.2 (306.55 bp) in the allelic 
ladder (Figure 3.8), the OL allele was designated as allele 2, which had not been reported 
in STRBase (Ruitberg et al. 2001). Therefore, the genotype of this sample at the SE33 
was designated (2, 16) rather than (16, 16). However, the stutter artefact of the OL allele 
(Figure 3.8) suggested that the allele has more than two repeats and a deletion in the 




Figure 3.8. The OL allele at the SE33 and the allelic ladder of the GlobalFiler® PCR amplification kit. The 
figure shows the size of the OL allele comparing to the allelic ladder. As it had been confirmed that the OL 
allele belonged to the SE33 locus, it was possible to calculate the repeat numbers based on the sizes of 
the OL allele and the nearest allele in the allelic ladder (4.2); the OL was called as allele 2 (size-based call). 
The black arrow points to stutter artefact of the OL allele (Alsafiah et al. 2017). 
Alleles outside the designated area of a locus or that are not represented by allelic 
ladder of a kit can be misinterpreted. More information about these alleles was 
gathered by sequencing that is addressed in Chapter 4. 
3.5.7 Population genetics 
Although the D18S51, D2S441, D22S1045, D7S820 and the SE33 have shown 
deviation from the Hardy–Weinberg equilibrium (HWE) (P value < 0.05), no significant 
deviation was detected after applying Bonferroni correction (P value < 0.002). The 
observed heterozygosity ranged from 0.660 in the TPOX to 0.914 in the SE33 (Table 3.2) 




Table 3.2. Results of expected heterozygosity calculation and of Hardy-Weinberg equilibrium exact test, 
conducted by Arlequin v3.5.2.1 software for the 21 STR loci. The P values after Bonferroni correction is 
significant if P < 0.002. The Bonferroni correction was performed by dividing 0.05 by the number of tested 
markers (the number of tests being performed), i.e. 0.05/21 STRs = 0.002. 
 The potential linkage of five syntenic pairs, three of which located in the same arm, 
was tested. The linkage disequilibrium (LD) test showed that all syntenic pairs has a P 
value > 0.05 (Table 3.3). Therefore, based on this population sample, the product rule 
can be used when calculating the frequencies of STR profiles with these 21 aSTRs. 
Table 3.3. Results of linkage disequilibrium tests of syntenic loci included the GlobalFiler® PCR amplification 
kit. The results showed that the tested samples did not show linkage disequilibrium (P value > 0.05). (p-q) 
indicates syntenic loci located in different arms. 
Chromosome Syntenic Pair LD test P value 
Chr.2 TPOX 0.97764 
 D2S441 
  Chr.2 (p-q) D2S1338 0.99164 
D2S441 
Chr.2 (p-q) TPOX 0.79338 
D2S1338 
Chr.5 D5S818 0.69008 
 CSF1PO 















D3S1358 1000 0.73800 0.76693 0.071 0.00018 1001000 
vWA 1000 0.74400 0.77924 0.286 0.00032 1001000 
D16S539 1000 0.76400 0.76466 0.320 0.00029 1001000 
CSF1PO 1000 0.70200 0.73067 0.239 0.00037 1001000 
TPOX 1000 0.66000 0.65855 0.144 0.00031 1001000 
D8S1179 1000 0.81200 0.83246 0.135 0.00029 1001000 
D21S11 1000 0.79400 0.82356 0.057 0.00012 1001000 
D18S51 1000 0.82400 0.87074 0.038 0.00016 1001000 
D2S441 1000 0.70400 0.76151 0.042 0.00018 1001000 
D19S433 1000 0.83600 0.87290 0.234 0.00036 1001000 
TH01 1000 0.72200 0.76965 0.089 0.00025 1001000 
FGA 1000 0.83400 0.86542 0.698 0.00018 1001000 
D22S1045 1000 0.67000 0.69240 0.006 0.00006 1001000 
D5S818 1000 0.73800 0.75465 0.989 0.00012 1001000 
D13S317 1000 0.73800 0.75901 0.922 0.00027 1001000 
D7S820 1000 0.76400 0.78855 0.011 0.00006 1001000 
SE33 1000 0.91400 0.95122 0.045 0.00010 1001000 
D10S1248 1000 0.71400 0.74877 0.747 0.00029 1001000 
D12S391 1000 0.84600 0.87630 0.058 0.00018 1001000 
D2S1338 1000 0.87400 0.88513 0.163 0.00027 1001000 
D1S1656 1000 0.82200 0.85961 0.068 0.00020 1001000 
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The 21 STRs have a combined match probability (CMP) of 1.42091E-26, a combined 
power of discrimination (PoD) of 0.999999999999999999999999986 and a combined 
power of exclusion of 0.999997405. Most of the 21 STRs (18/21) show ≥ 0.9 PoD: SE33 
was the most informative locus with 0.993 PoD and TPOX was the least informative locus 
with 0.84 PoD. Allele ranges varied from 6 alleles in TH01 to 44 alleles in SE33. Some 
alleles show very high frequencies in the Saudi population; for example, allele 8 in the 
TPOX and allele 15 in the D22S1045 displayed the highest frequencies of 0.520 and 0.463 




Table 3.4. Allele frequency data and forensic statistical parameters of 21 aSTRs included in GlobalFiler® PCR 
amplification kit for the population of Saudi Arabia. The parameters included: matching probability, power 
of discrimination, polymorphism information content, power of exclusion, observed homozygosity and 

























































6     0.007      0.317 
7    0.003 0.003      0.179 
8   0.028 0.013 0.520      0.098 
9   0.148 0.028 0.173 0.003   0.006  0.274 
9.3           0.117 
10   0.085 0.300 0.109 0.055  0.007 0.127  0.015 
10.2        0.001    
11   0.382 0.303 0.172 0.121  0.020 0.332 0.015  
11.3         0.068   
12   0.202 0.290 0.016 0.156  0.145 0.091 0.097  
12.2        0.001  0.005  
13 0.002 0.003 0.139 0.056  0.224  0.226 0.017 0.187  
13.2          0.047  
13.3         0.001   
14 0.063 0.035 0.011 0.007  0.181  0.132 0.313 0.194  
14.2          0.065  
15 0.249 0.122 0.005   0.203  0.120 0.041 0.129  
15.2        0.002  0.118  
16 0.284 0.296    0.046  0.111 0.004 0.082  
16.2        0.002  0.042  
17 0.272 0.267    0.010  0.087  0.005  
17.1      0.001      
17.2        0.002  0.014  
18 0.114 0.207      0.059    
18.2 0.001           
19 0.015 0.060      0.042    
20  0.008      0.022    
21  0.002      0.007    
22        0.007    
23        0.004    
24        0.003    
27       0.013     
28       0.135     
29       0.253     
30       0.259     
30.2       0.010     
31       0.053     
31.2       0.077     
32       0.005     
32.1       0.001     
32.2       0.128     
33       0.002     
33.2       0.050     
34       0.001     
34.2       0.003     
35       0.003     
35.2       0.001     
36       0.002     
37       0.002     
38       0.002     
Number of alleles 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 
Matching Probability 0.091 0.082 0.087 0.122 0.160 0.051 0.055 0.031 0.091 0.030 0.085 
Expressed as 1 in ... 10.988 12.169 11.471 8.190 6.237 19.785 18.019 32.027 10.983 33.069 11.754 
Power of Discrimination 0.909 0.918 0.913 0.878 0.840 0.949 0.945 0.969 0.909 0.970 0.915 
Polymorphic Information Content (PIC) 0.727 0.744 0.732 0.681 0.616 0.809 0.801 0.857 0.726 0.859 0.732 
Power of Exclusion 0.489 0.500 0.534 0.431 0.369 0.621 0.588 0.644 0.434 0.667 0.463 
Observed Homozygosity 0.262 0.256 0.236 0.298 0.340 0.188 0.206 0.176 0.296 0.164 0.278 
Observed Heterozygosity 0.738 0.744 0.764 0.702 0.660 0.812 0.794 0.824 0.704 0.836 0.722 
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Table 3.4. continued. 
 
Combined Match Probability (CMP) 1.42091E-26 
Combined Power of Exclusion (CPE) 0.999997405 





















































2      0.001     
6   0.001  0.001      
6.3      0.007     
7    0.002 0.010   0.001   
7.3     0.001 0.010     
8   0.016 0.112 0.183 0.001  0.001   
9   0.073 0.046 0.117 0.006 0.009    
9.3     0.003      
10  0.006 0.090 0.059 0.322   0.004   
11  0.120 0.298 0.220 0.204  0.007 0.052   
12  0.018 0.335 0.400 0.139 0.006 0.045 0.142   
13  0.003 0.177 0.114 0.018 0.015 0.144 0.100   
13.3      0.002     
14 0.001 0.063 0.007 0.047  0.060 0.371 0.104 0.005 0.005 
14.3      0.001  0.001   
15  0.463 0.003   0.038 0.285 0.161 0.021  
15.3        0.041   
16  0.268    0.059 0.090 0.209 0.009 0.072 
16.1 0.001          
16.3        0.061   
17  0.058   0.001 0.077 0.046 0.069 0.135 0.226 
17.1     0.001      
17.2      0.001     
17.3        0.029   
18 0.007 0.001    0.095 0.003 0.003 0.186 0.102 
18.3        0.015 0.006  
19 0.081     0.068   0.117 0.119 
19.1         0.001  
19.3        0.006 0.004  
20 0.091     0.028   0.102 0.217 
20.2      0.007     
20.3      0.001  0.001   
21 0.149     0.015   0.079 0.056 
21.2 0.002     0.034     
22 0.136     0.008   0.097 0.034 
22.2 0.005     0.010     
23 0.174     0.003   0.129 0.070 
23.2 0.002     0.034     
24 0.198        0.070 0.049 
24.2 0.001     0.037     
25 0.093        0.032 0.041 
25.2      0.023     
26 0.040        0.004 0.004 
26.2      0.049     
27 0.005        0.003 0.004 
27.2      0.057     
28 0.007     0.001    0.001 
28.2      0.043     
29 0.004          
29.2      0.031     
30 0.002          
30.2      0.053     
31.2      0.057     
32.2      0.032     
33      0.002     
33.1           
33.2      0.012     
34      0.005     
34.2      0.005     
35      0.001     
35.2      0.002     
36      0.002     
38      0.001     
48.2 0.001          
Number of alleles 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 
Matching Probability 0.033 0.138 0.098 0.087 0.076 0.007 0.098 0.030 0.026 0.035 
Expressed as 1 in ... 29.926 7.268 10.161 11.495 13.092 150.421 10.253 33.557 37.948 28.210 
Power of Discrimination 0.967 0.862 0.902 0.913 0.924 0.993 0.902 0.970 0.974 0.965 
Polymorphic Information Content (PIC) 0.850 0.648 0.715 0.728 0.757 0.948 0.711 0.863 0.873 0.844 
Power of Exclusion 0.664 0.383 0.489 0.489 0.534 0.824 0.450 0.687 0.743 0.640 
Observed Homozygosity 0.166 0.330 0.262 0.262 0.236 0.086 0.286 0.154 0.126 0.178 
Observed Heterozygosity 0.834 0.670 0.738 0.738 0.764 0.914 0.714 0.846 0.874 0.822 
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To assess the GlobalFiler™ kit for kinship testing, a typical paternity case (an alleged 
father, a child and a known mother) was assumed, and the combined typical paternity 
index (CPI) was used to calculate the paternity probabilities with different prior 
probabilities (Pr): 0.90, 0.50 and 0.10. The probabilities of paternity were 99.99999974% 
(Pr = 0.90), 99.99999765% (Pr = 0.50) and 99.99997886% (Pr = 0.10), which was 
expected, are much higher (   ̴300 fold) than those probabilities calculated when using 
the currently used kit in Saudi Arabia (Identifiler® Plus) (Table 3.5).  
Table 3.5. An assessment of the 21 loci included in the GlobalFiler™ kit for kinship testing. This table shows 
the paternity probabilities for a typical paternity case by using combined typical paternity index for different 
prior probabilities (Pr = 0.90, 0.50 and 0.10). The GlobalFiler™ kit showed much higher (  ̴300-fold) 
probabilities comparing to those probabilities calculated when using the currently used kit in Saudi Arabia 
(Identifiler® Plus).  
kit CPI 
Paternity probabilities (%) 
Pr = 0.90 Pr = 0.50 Pr = 0.10 
GlobalFiler™ 42,569,026.49 99.99999974 99.99999765 99.99997886 
Identifiler® Plus 126,843.32 99.9999124 99.99921163 99.99290514 
 
The data of the 500 samples were analysed by DNA tools package and R studio 
platform to define the maximum number of matched loci between any two DNA 
Globalfiler™ profiles. The result showed that, within the 500 samples, two sample pairs 
matched in 9/21 loci (42.8%), which was the maximum number of matched loci (Table 
3.6). On the other hand, one pair had partial match (i.e. one of the two alleles) in 19/21 




Table 3.6. The maximum matching loci within the 500 samples. In the 500 samples, only two pairs of samples showed full matching in 9 loci (i.e. both alleles); this was the maximum 
number of matched loci (shaded row). One pair showed partial matching (i.e. one of the two alleles) at 19 out of 22 loci (shaded column). This table was generated by the R studio using 
the package of DNA tools. 























 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
0 0 0 3 21 76 233 651 1433 2539 3793 4587 4467 3685 2483 1399 595 199 67 14 1 0 0 
1 0 0 7 58 174 644 1638 3300 5291 6768 7681 6841 5016 2947 1347 493 143 26 5 0 0  
2 0 3 13 52 226 709 1724 3206 4978 5967 5798 4590 2831 1401 619 165 40 4 1 0   
3 0 1 11 60 183 535 1144 2012 2710 2988 2487 1752 1023 426 132 28 3 0 0    
4 0 0 5 36 84 259 546 875 1012 907 761 437 190 81 20 3 1 1     
5 0 1 4 13 39 105 177 249 260 202 139 61 25 11 0 0 0      
6 0 0 0 5 19 38 52 53 45 31 12 9 6 0 0 0       
7 0 0 0 2 5 5 7 4 3 1 1 0 1 0 0        
8 0 0 0 0 0 0 1 1 0 0 1 0 0 0         
9 0 0 0 0 0 0 1 0 0 0 1 0 0          
10 0 0 0 0 0 0 0 0 0 0 0 0           
11 0 0 0 0 0 0 0 0 0 0 0            
12 0 0 0 0 0 0 0 0 0 0             
13 0 0 0 0 0 0 0 0 0              
14 0 0 0 0 0 0 0 0               
15 0 0 0 0 0 0 0                
16 0 0 0 0 0 0                 
17 0 0 0 0 0                  
18 0 0 0 0                   
19 0 0 0                    
20 0 0                     




3.5.8 Consanguinity in the population of Saudi Arabia.  
The level of consanguinity in the population of Saudi Arabia was found to be 56.8% -
54.3% (El-Hazmi et al. 1995, Wong and Anokute 1990), that is similar to those levels in 
neighbouring countries like UAE, Kuwait, Iraq, Jordan and Egypt, but is significantly 
higher than  Europeans, Eastern Asians, Americans  and Africans (El-Hazmi et al. 1995). 
This was supported by an inbreeding coefficient (FIS) value of 0.024 overall the 
population of Saudi Arabia (El-Hazmi et al. 1995). In addition, the most recent study in 
the population of Saudi Arabia (Khubrani et al. 2019a), which studied the same 21 aSTRs 
investigated here, found that 20/21 aSTRs (D10S1248 was the exception) showed 
deficiency of heterozygotes with 0.0476 inbreeding coefficient (FIS).  
The current data set also showed deficiency of heterozygotes in 20/21 aSTRs (Table 
3.2), but TPOX was the exception. The AMOVA analysis was carried out to estimate the 
inbreeding coefficient (FIS) that had an FIS value of 0.03560. Although higher FIS value 
could be an evidence of the presence of null alleles, none of the aSTRs showed 
significant deviation from HWE (Table 3.2). In addition, the results of this study are in 
line with previous studies conducted either by questionnaires (El-Hazmi et al. 1995, 
Wong and Anokute 1990) or by aSTRs analysis (Khubrani et al. 2019a) showing an 
evidence of consanguinity in the population of Saudi Arabia.  
3.5.9 Population comparison 
The comparison included previous studies in the population of Saudi Arabia (Sinha et 
al. 1999, Osman et al. 2015, Khubrani et al. 2019a), Saudi individuals residing in Kuwait 
and in Dubai (Al-Enizi et al. 2013, Alshamali et al. 2005). Populations from Gulf 
Cooperation Council (GCC) countries: Kuwait (Al-Enizi et al. 2013), United Arab Emirates 
(Jones et al. 2017), Qatar (Perez-Miranda et al. 2006), Yemeni and Omani populations 
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residing in Dubai (Alshamali et al. 2005) were included. Other populations such as 
Egyptian, Iraqi, Iranian, and Indian residing in Kuwait (Al-Enizi et al. 2013) were also 
included in the comparison. 
After the Bonferroni correction, the population differentiation exact test showed that 
the data of the Saudi populations previously reported in Al-Enizi et al. (2013), Sinha et 
al. (1999), and Khubrani et al. 2019a were consistent with the data reported in this 
study, i.e. no significant pairwise differences were observed. However, the data of the 
Saudi population in Dubai (Alshamali et al. 2005) showed significant difference in the 
TH01 locus (P value = 0), which was due in part to the notable differences in alleles 
frequencies at this locus. For example, allele 7 frequency was 0.179 in the current study 
while it had 0.08 frequency in (Alshamali et al. 2005), which is over 2-fold higher. This 
inconsistency may be due to the small number of Saudi participants (94 samples) in this 
study leading to an exaggerated sampling effect. There were also significant differences 
with the data from the Riyadh province (Osman et al. 2015) at three loci (vWA, CSF1PO 
and TH01). Despite the relatively small sample size (190 samples), alleles 5.3, 7.3, and 
8.3 at TH01 locus were observed which have not been observed in the current study or 
in previous studies of the Saudi population. In addition, this study found that 9 out of 15 
loci had significant deviation from HWE (P value < 0.05), which was attributed to the 
prevalence of consanguinity in Saudi Arabia (Alsafiah et al. 2017). The general 
percentage of consanguinity in the Riyadh province is 60%,which is higher than the 
average rate of Saudi Arabia (56%), and is even higher (74.3%) in rural areas (El-Mouzan 
et al. 2007).  
As expected, the differentiation between the data obtained in this study and the data 
from the Yemeni, Omani (Alshamali et al. 2005), Kuwaiti, Egyptian, Iraqi, Iranian, Indian 
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(Al-Enizi et al. 2013), UAE (Jones et al. 2017) and Qatari populations (Perez-Miranda et 
al. 2006) varies, with a general trend of more significant differences being detected as 
the populations become more geographically separated. For example, there was no 
significant difference observed between the Saudi and the Kuwaiti population whereas 
there were significant differences between the Indian and the Saudi populations in 13 
out of the 15 loci compared (Table 3.7) (Alsafiah et al. 2017). 
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Table 3.7. Population differentiation exact test results using the Arlequin v3.5.2.1 software. Shaded cells indicate significant differences (P value ˂ 0.002). The Bonferroni correction was 
performed by dividing 0.05 by the number of tested markers (the number of tests being performed), i.e. 0.05/21 STRs = 0.002. N/A values indicate data that was not collected during 




(Khubrani et al. 2019a) 
Saudi 
(Sinha et al. 1999) 
Saudi in Dubai  
(Alshamali et al. 2005) 
Saudi in Kuwait  
(Al-Enizi et al. 2013) 
Saudi in Riyadh  
(Osman et al. 2015) 
Yemeni 
(Alshamali et al. 2005) 
Omani 
 (Alshamali et al. 2005) 
Kuwaiti  
(Al-Enizi et al. 2013) 
D3S1358 0.34860+0.0344 N/A 0.62163+-0.0142    0.48355+-0.0259    0.01642+-0.0029 0.46105+-0.0151    0.31956+-0.0158    0.84557+-0.0236    
vWA 0.28936+0.0309 0.06000+-0.0139 0.28266+-0.0087 0.09801+-0.0084 0.00000+-0.0000 0.00000+-0.0000 0.24164+-0.0177 0.00726+-0.0025 
D16S539 0.00923+0.0031 N/A 0.11894+-0.0071 0.85052+-0.0092 0.04244+-0.0082 0.67981+-0.0203 0.71855+-0.0121 0.41396+-0.0463 
CSF1PO 0.00250+0.0007 0.12223+-0.0158 0.41111+-0.0230 0.06154+-0.0133 0.00000+-0.0000 0.16060+-0.0191 0.22793+-0.0161 0.00665+-0.0027 
TPOX 0.40218+0.0362 0.35619+-0.0230 0.85978+-0.0078 0.86633+-0.0152 0.13245+-0.0108 0.00000+-0.0000 0.00319+-0.0008 0.11572+-0.0128 
D8S1179 0.09649+0.0125 N/A 0.71537+-0.0125 0.39880+-0.0247 0.04653+-0.0080 0.00262+-0.0009 0.86144+-0.0146 0.07594+-0.0155 
D21S11 0.48562+0.0339 N/A 0.72354+-0.0157 0.27445+-0.0249 0.05186+-0.0076 0.78571+-0.0137 0.01399+-0.0037 0.56529+-0.0407 
D18S51 0.58406+0.0417 N/A 0.15631+-0.0200 0.59097+-0.0318 0.00706+-0.0020 0.87926+-0.0063 0.14291+-0.0134 0.44209+-0.0443 
D2S441 0.59406+0.0353 N/A N/A N/A N/A N/A N/A N/A 
D19S433 0.73678+0.0157 N/A N/A 0.31263+-0.0260 0.03886+-0.0086 N/A N/A 0.06922+-0.0113 
TH01 0.35251+0.0353 0.45546+-0.0215 0.00000+-0.0000 0.32640+-0.0147 0.00000+-0.0000 0.47472+-0.0154 0.00000+-0.0000 0.34986+-0.0297 
FGA 0.41584+0.0643 N/A 0.39644+-0.0267 0.03796+-0.0101 0.00978+-0.0081 0.07879+-0.0125 0.03816+-0.0048 0.03756+-0.0131 
D22S1045 0.25156+0.0359 N/A N/A N/A N/A N/A N/A N/A 
D5S818 0.13395+0.0220 N/A 0.51783+-0.0184 0.95086+-0.0067 0.01434+-0.0036 0.08981+-0.0078 0.29418+-0.0204 0.46785+-0.0448 
D13S317 0.04443+0.0154 N/A 0.07185+-0.0094 0.0023+-0.0002 0.07141+-0.0114 0.25500+-0.0134 0.05452+-0.0124 0.01935+-0.0068 
D7S820 0.26756+0.0400 N/A 0.66590+-0.0194 0.03002+-0.0102 0.38965+-0.0290 0.82962+-0.0165 0.15146+-0.0175 0.05470+-0.0142 
SE33 0.05082+0.0151 N/A N/A N/A N/A N/A N/A N/A 
D10S1248 0.30853+0.0232 N/A N/A N/A N/A N/A N/A N/A 
D12S391 0.27017+-0.0212 N/A N/A N/A N/A N/A N/A N/A 
D2S1338 0.13381+0.0159 N/A N/A 0.62703+-0.0337 0.17545+-0.0157 N/A N/A 0.23134+-0.0254 
D1S1656 0.49862+0.0347 N/A N/A N/A N/A N/A N/A N/A 
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(Al-Enizi et al. 2013) 
Iraqi  
(Al-Enizi et al. 2013) 
Iranian  
(Al-Enizi et al. 2013) 
India  
(Al-Enizi et al. 2013) 
Qatari  
(Perez-Miranda et al. 2006) 
UAE  
(Jones et al. 2017) 
D3S1358 0.16526+-0.0403    0.28366+-0.0173    0.04000+-0.0101    0.00001+-0.0000    0.04233+-0.0056    0.64109+-0.0372    
vWA 0.00000+-0.0000 0.00032+-0.0001 0.00149+-0.0005 0.00000+-0.0000 0.00172+-0.0006 0.05355+-0.0127 
D16S539 0.14551+-0.0246 0.00401+-0.0027 0.10082+-0.0119 0.00000+-0.0000 0.00531+-0.0021 0.22141+-0.0340 
CSF1PO 0.35504+-0.0323 0.09136+-0.0403 0.02183+-0.0049 0.00000+-0.0000 0.90715+-0.0106 0.64778+-0.0198 
TPOX 0.01078+-0.0051 0.00000+-0.0000 0.00000+-0.0000 0.00000+-0.0000 0.07145+-0.0096 0.00018+-0.0002 
D8S1179 0.00080+-0.0003 0.00000+-0.0000 0.00000+-0.0000 0.00000+-0.0000 0.13486+-0.0201 0.03907+-0.0150 
D21S11 0.10283+-0.0249 0.00257+-0.0023 0.01676+-0.0071 0.00000+-0.0000 0.54356+-0.0284 0.02580+-0.0092 
D18S51 0.00000+-0.0000 0.00081+-0.0004 0.00015+-0.0001 0.00000+-0.0000 0.60425+-0.0411 0.12998+-0.0171 
D2S441 N/A N/A N/A N/A N/A 0.00009+-0.0001 
D19S433 0.00000+-0.0000 0.00000+-0.0000 0.00728+-0.0034 0.00000+-0.0000 0.00000+-0.0000 0.01495+-0.0072 
TH01 0.00000+-0.0000 0.82111+-0.0244 0.02256+-0.0061 0.00742+-0.0036 0.10273+-0.0103 0.18154+-0.0524 
FGA 0.00001+-0.0000 0.04025+-0.0145 0.03340+-0.0086 0.08558+-0.0260 0.12379+-0.0225 0.21628+-0.0254 
D22S1045 N/A N/A N/A N/A N/A 0.01316+-0.0047 
D5S818 0.01659+-0.0046 0.25700+-0.0248 0.20914+-0.0159 0.00005+-0.0001 0.00000+-0.0000 0.01271+-0.0041 
D13S317 0.00000+-0.0000 0.00000+-0.0000 0.00258+-0.0016 0.00000+-0.0000 0.00012+-0.0001 0.07272+-0.0193 
D7S820 0.00114+-0.0012 0.11864+-0.0510 0.00015+-0.0002 0.00000+-0.000 0.93375+-0.0081 0.01476+-0.0079 
SE33 N/A N/A N/A N/A N/A 0.00000+-0.0000 
D10S1248 N/A N/A N/A N/A N/A 0.05404+-0.0122 
D12S391 N/A N/A N/A N/A N/A 0.04029+-0.0100 
D2S1338 0.00000+-0.0000 N/A 0.00000+-0.0000 0.00000+-0.0000 0.11449+-0.0135 0.00000+-0.0000 




The FST values of the 13 STRs, which are common with the previous studies (Perez-
Miranda et al. 2006, Jones et al. 2017, Al-Enizi et al. 2013, Alshamali et al. 2005, Osman 
et al. 2015, Khubrani et al. 2019a), was also calculated. The cmdscale function was used 
in R studio software to generate a multi-dimensional scale (MDS) for the average of FST 
values (Figure 3.9).  
 
Figure 3.9. A multi-dimensional scale (MDS) for the average FST values of 13 common loci. Fourteen 
populations were included in the comparison: Saudi Arabian (this study), Saudi Arabian (Khubrani et al. 
2019a), Saudi Arabian population in Riyadh (Osman et al. 2015), Saudi Arabian in Dubai (Alshamali et al. 
2005), Saudi Arabian in Kuwait (Al-Enizi et al. 2013), Qatari (Perez-Miranda et al. 2006), UAE population 
(Jones et al. 2017), Kuwaiti (Al-Enizi et al. 2013), Omani-Dubai (Alshamali et al. 2005), Yemeni-Dubai 
(Alshamali et al. 2005), Iraqi-Kuwait (Al-Enizi et al. 2013), Egyptians-Kuwait (Al-Enizi et al. 2013), Iranian-
Kuwait (Al-Enizi et al. 2013), and Indian-Kuwait (Al-Enizi et al. 2013). Note: the data of Saudi population in 
(Sinha et al. 1999) was not included in the FST test due to the limited number of common loci  included in 
the study (four loci). SA: Saudi Arabian and UAE: United Arab Emirates. The cmdscale function was used 
in R software to generate a multi-dimensional scale (MDS). 
As presented in the MDS plot, the results showed low differentiation between this 
study and the data of Saudi Arabia (Khubrani et al. 2019a), Qatari (Perez-Miranda et al. 
2006), Saudi in Kuwait (Al-Enizi et al. 2013) and Kuwaiti (Al-Enizi et al. 2013). The greatest 




which was included in the comparison as a control. In addition, the MDS plot confirms 
the exact test results for the Saudi population in Dubai and from the Riyadh city showing 
less similarity to the data generated from this study or from other studies in Saudi 
population (Khubrani et al. 2019a, Al-Enizi et al. 2013). 
3.6 Conclusion 
An ethical approval was granted for the project and 500 samples from unrelated 
volunteers (as far as could be ascertained) in Saudi Arabia were collected. High quality 
DNA was obtained from the samples after evaluating two modifications applied to the 
manufacturer’s DNA extraction protocol.  The quantities of the extracted DNA were as 
expected from blood samples and adequate for downstream applications. 
The 500 samples were genotyped using the Globalfiler™ PCR amplification kit. This 
was accomplished after validation of the half PCR volume and of using 50 cm 
capillary/POP6. Although, the half volume achieved full profile with 0.5 ng DNA, the 
profile was less balanced than the manufacturer’s protocol. The data of the 21 aSTRs 
were obtained and were evaluated for human identification applications in Saudi Arabia. 
Three of the additional STR loci (SE33, D12S391, and D1S1656) in this kit are more 
informative than any locus in the currently used kit (Identifiler® Plus). The kit provided 
a much higher discrimination power, by which CMP improved from 2.23E-18 to 1.42E-
26 and the combined typical paternity index increased by 300-fold demonstrating the 
usefulness of adapting this kit in the forensic genetic laboratories of Saudi Arabia.  
The data set examined here showed evidence of consanguinity in the population of 
Saudi Arabia that is supporting other studies either those conducted either by 




Allele frequencies generated from this study can be used to estimate the profile 
frequencies in Saudi Arabia (Alsafiah et al. 2017). 
The Saudi allele frequency data of the 21 aSTRs was used to measure the similarity 
with neighbouring populations. A general trend of more significant differences being 





4 Chapter Four: Characterisation of STR allele variants detected in Saudi 
population. 
4.1 Overview of experiment 
Six allele variants were detected in the population of Saudi Arabia when the 500 
samples were genotyped using the Globalfiler™ PCR amplification kit (AB) (Chapter 3).  
Four SE33 allele variants of 2 (Figure 3.8), 14.3, 20.3 and 38 (Figure 3.6) had not been 
reported in STRBase (STRBase 2017b) and two alleles 7 and 8, at D1S1656 (Figure 3.5), 
were reported in STRBase (STRBase 2017a), but no sequence data was available. Both 
STRs are within the three most informative loci for the population of Saudi Arabia 
(Alsafiah et al. 2018).  
SE33 is the most polymorphic well-characterised STR that is commonly used in 
forensic genetics (Wiegand et al. 1993). The landscape of this locus is divided to three 
regions: repeat region, “local flanks”, and extended flanks (Borsuk et al. 2018). The 
sequence structure of the repeat region is based on tetra-nucleotides repeats of 
[(CTTT)n] (forward strand) and the complexity of the structure increases as alleles 
become larger (Moller and Brinkmann 1994, Rolf et al. 1997) (Table 4.1 A). A recent 
study has classified the SE33 repeat motifs to 34 types (A0, A1, A2…. to D3) based on the 
structure of the repeat and the local flank regions, eleven of which were observed >1% 
of the tested populations (Borsuk et al. 2018) (Table 4.2) (Alsafiah et al. 2018). 
The D1S1656 has a compound repeat structure of [(TAGA)n (TAGG)] followed by 
[(TG)₅] in the 3´-local flank (Table 4.1 B). This locus was added to the European Standard 
Set (ESS) in 2006 (Gill et al. 2006) and to the Combined DNA Index System (CODIS) in 




Based on the sequence-based nomenclature guidelines of the International Society 
for Forensic Genetics (ISFG), the local flank regions showed in Table 4.1 A and B, are not 
counted in allele calling system (Parson et al. 2016). 
Table 4.1. Sequence structure of the SE33 and D1S1656 loci. (A) Shows the sequence structure of an SE33 
allele that comprised of the 5´-local flank (15 bp), repeat region, and 3´-local flank (24 bp). (B) A typical 
sequence structure of a D1S1656 allele is shown. The sequence structure of reference alleles (SE33, allele 
26.2 GenBank: V00481.1) and (D1S1656, allele 15.3 GenBank: G07820.1) are given for illustration. Based on 
the published guidelines of the International Society for Forensic Genetics (ISFG) (Parson et al. 2016), the 
local flank regions showed in A and B (greyed out sequences) are not counted in allele calling system (Alsafiah 
et al. 2018). 
Table 4.2. Classification of the SE33 motifs. The table shows the eleven motif patterns that had >1% 
frequency in the tested populations. Most sequence-based alleles show A0 and A1 patterns (Borsuk et al. 
2018). 
Allele range Motif ID Motif 
7 to 23 A0 CT [CTTT]3 C [CTTT]n CT [CTTT]3 CT [CTTT]2 
19.2 to 33.2 A1 CT [CTTT]2 CCTT C [CTTT]n TT [CTTT]n CT [CTTT]3 CT [CTTT]2 
15 to 23 A2 CT [CTTT]2 CCTT C [CTTT]n CT [CTTT]3 CT [CTTT]2 
22.2 to 30.2 A3 CT [CTTT]2 CCTT C [CTTT]n CT [CTTT]n CT [CTTT]3 CT [CTTT]2 
21.2 to 31.2 A4 CT [CTTT]2 [CCTT]2 C [CTTT]n TT [CTTT]n CT [CTTT]3 CT [CTTT]2 
16 to 23 A5 CT [CTTT]3 CCTT C [CTTT]n CT [CTTT]3 CT [CTTT]2 
10.2 to 15.2 A6 CT [CTTT]3 C[CTTT]n [CTTT]3 CT [CTTT]2 
30 to 36 A7 CT [CTTT]2 CCTT C [CTTT]n TT [CTTT]n TT [CTTT]n CT [CTTT]3 CT [CTTT]2 
27.2 to 34.2 A8 CT [CTTT]2 CCTT C [CTTT]n TT [CTTT]n CT [CTTT]3 CT CTTT 
15 to 20 A9 CT [CTTT]3 CCCTT [CTTT]n CT [CTTT]3 CT [CTTT]2 
26.2 to 32.2 B0 CT [CTTT]2 [CCTT]2 C [CTTT]n CT [CTTT]3 CT [CTTT]2 
  
A. SE33 locus 
Reference allele 
5´-local flank  
(15 bp) 
Repeat region 






CT CTTT CTTT 
CCTT C 
CTTT CTTT CTTT CTTT CTTT CTTT CTTT 
CTTT CTTT CTTT CTTT CTTT CTTT CTTT 
CTTT CTTT TT CTTT CTTT CTTT CTTT CTTT 
CTTT CTTT CTTT CTTT CTTT 
CT CTTT CTTT CTTT 
CT CTTT CTTT 
  
B. D1S1656 locus 






TAGA TAGA TAGA TAGA TGA TAGA TAGA TAGA TAGA 
TAGA TAGA TAGA TAGA TAGA TAGA TAGG 
TGTGTGTGTG 




Although SE33 is included in the primer mixes of the ForenSeq™ DNA Signature Prep 
(Verogen) (Novroski et al. 2016), it is not reported by the ForenSeq™ UAS (Verogen). 
This may be due to the high dropout rate that was observed when analysing the 
ForenSeq™ data using an independent software (Borsuk et al. 2018). The highly 
repetitive sequence of the extended flanking regions makes the size of amplicons large, 
which reduces the read quality (Gettings et al. 2015). In addition, thymine and cytosine 
represent more than 80% of the forward strand of the SE33 amplicons that makes 
sequencing more challenging (Borsuk et al. 2018). In contrast, the D1S1656 is already 
included and is reported in Precision ID GlobalFiler MPS Panel (AB) and in the ForenSeq™ 
DNA Signature Prep (Verogen) (Alsafiah et al. 2018), for example (Guo et al. 2017, Wang 
et al. 2017).  
During a training course “Illumina Forensic Genomics Workshop, 14th – 15th 
November 2017 (Cambridge, UK), each participant could bring two samples to be 
sequenced and analysed using the Verogen system. Therefore, this chapter describes 
the characterisation of the D1S1656 variants using ForenSeq™ DNA Signature Prep 
(Verogen) and the characterisation the SE33 variants using the conventional Sanger 
sequencing.   
4.2 Aims of the study 
The aim of this chapter is to characterise the allele variants detected in the population 
of Saudi Arabia when the 500 samples were genotyped using the Globalfiler™ PCR 
amplification kit (AB), to allow more information about their sequence structure. This 
include a confirmation of that a deletion in the flanking region was the reason for the 




stutter artefact. Finally, reporting the sequence data of the alleles to be added to the 
STRBase database. 
4.3 Objectives 
1- Sequencing D1S1656 allele variants using the ForenSeq™ DNA Signature Prep kit 
and MiSeq FGxTM System, which was followed by an analysis using the ForenSeq™ 
UAS (Verogen). 
2- Sequencing the SE33 allele variants using the BigDyeTM Terminator v3.1 Cycle 
Sequencing Kit (AB). This included PCR amplification for the SE33 STR using a 
published primer set, loading the samples in agarose gel for the physical 
separation of the target band and Sanger sequencing.  
3- Report the sequence structure of the six variants to STRBase. 
4.4 Materials and Methods 
The lab work in this chapter comprised of two different sequencing systems. 
Sequencing D1S1656 allele variants using the NGS part is described in Section 2.6 and 
the sequencing SE33 allele variants is described in Sections 2.4.1 and 2.8.2  
4.5 Results and discussion 
4.5.1 SE33 variants 
The SE33 locus was successfully amplified from samples that exhibited the alleles 2, 
14.3, 20.3 and 38. The physical separation of the alleles was successfully achieved when 
using the 20-cm-long agarose gel (Figure 4.1). DNA recovery from the targeted bands 
using PureLink™ Quick Gel Extraction Kit (AB) yielded adequate concentrations (0.25 to 





Based on size-based system, allele 2 could be due to a complete loss of the repeat 
region or due to sequence deletion within the flanking regions. However, the presence 
of a stutter artefact, which is associated with the repetitive regions, suggested sequence 
deletion in the flanking regions (Figure 3.8). Sequence data revealed that the allele 2 had 
B1 motif pattern and, as expected, consisted of 17 repeats in the repeat region with a 
60 bp deletion (GRCh38, 6:88277290-88277349) in the extended 3´-flank (Table 4.3) 
(Alsafiah et al. 2018). This deletion was previously observed with alleles 14 and 16 





Figure 4.1. A 20-cm-long 3% agarose gel for the novel SE33 alleles; from the left side, alleles 20.3, 14.3, 
38, 2 and a 100 bp ladder. It shows the separation of alleles 20.3 and 29.2 (35 bp) that could not be 
achieved with a shorter (10 cm) gel. 
 
Figure 4.2. An example of the quality of sequencing results. This figure shows an electropherogram for 




Table 4.3. Sequence data for the forward strand of 4 previously uncharacterized SE33 alleles: 2, 14.3, 20.3, and 38. The 5´uncounted sequence (15 bp) and 3´uncounted sequence (24 
bp) of the local flank region; and the extended 3´-flank are shown. The amplicons sizes of the GlobalFiler kit and of primer pair (SE33-1 and SE33-2) used in this study are shown. It also 
shows allele names based on their sizes, based on the sequence data, and the motif pattern based on the classification of Borsuk et al., (2018). Allele 2 had B1 motif and showed 17 
repeats on the repeat region, but a 60 bp deletion in the extended 3´-flank led to the observation of the allele 2 based on the size. Allele 14.3 had 18.1 repeats on the repeat region, and 
the 14.3 size-based allele resulted from a 14 bp deletion in the extended 3´-flank. In addition, the motif pattern of this allele is novel (has not been reported in the classification of Borsuk 
et al. (2018).The Allele 20.3 had D1 motif and showed a TTT within the repeat region. Allele 38 contained two hexanucleotide repeats (A7 motif) within the repeat region. ⁽ᵃ⁾ Represents 
































































































CTTTTT CTTT CTTTTT C [TTCC]₃ TTT [CT]₆ [CTTT]₃ CTAA 













































2 296.85 193 17 B1 1 2 0 1 17 0 0 0 0 0 0 1 3 1 0 2 
CTTTTT CTTT CTTTTT C TTC <60 bp del> [CTTT] ₂ TGAC 
GGAG TT 
14.3 348.21 244 18.1 Novel 1 2 0 1 3 1 0 0 15 0 0 1 3 0 1 2 
<14 bp del> TT C [TTCC]₃ TTT [CT]₆ [CTTT]₃ CTAA [CT]₂ 
CTTT GTCT [CTTT]₄ TGAC GGAG TT 
20.3 372.46 268 20.3 D1 1 2 1 1 9 0 1 0 11 0 0 1 3 1 0 2 
CTTTTT CTTT CTTTTT C [TTCC]₃ TTT [CT]₆ [CTTT]₃ CTAA 
[CT]₂ CTTT GTCT [CTTT]₄ TGAC GGAG TT 
38 441.70 337 38 A7 1 2 1 1 9 0 0 1 12 1 14 1 3 1 0 2 
CTTTTT CTTT CTTTTT C [TTCC]₃ TTT [CT]₆ [CTTT]₃ CTAA 





Allele 14.3 had a novel motif pattern of CT CTTT2 C CTTTn C CTTTn CT CTTT3 TT CTTT2 
(italic bases are within the local flanks, underlined base is C>T variant), which have not 
reported in the classification of Borsuk et al. (2018). Although the allele had 18.1 repeats 
in the counted region, a 14 bp deletion (GRCh38, 6:88277269-88277283) in the 
extended 3´-flank led to the observation of allele 14.3, based on size (Table 4.3). In 
addition, the T variant at location 6:88277260 (GRCh38) in the 3´-local flank represents 
rs1045867314 SNP (C:  > 99%, T: < 1%) (Auton et al. 2015) (Table 4.3) (Alsafiah et al. 
2018).  
Allele 20.3 had D1 motif pattern (Borsuk et al. 2018), and showed three T nucleotides 
within the repeat sequence that could have occurred due to a C deletion in a single 
repeat or due to an insertion of three T nucleotides (Table 4.3) (Alsafiah et al. 2018).  
Allele 38 showed a A7 motif pattern that exhibits two hexanucleotide repeats within 
the repeat region (Table 4.3) (Alsafiah et al. 2018). 
4.5.2 D1S1656 variants 
Samples that showed alleles 7 and 8 at the D1S1656 were successfully sequenced 
using the ForenSeq DNA Signature Prep Kit (Primer Mix B) and the MiSeq FGx Forensic 
System. Both samples showed 100% concordance at 21 autosomal STRs and DYS391 loci 
overlapped with the GlobalFiler® PCR amplification kit (Alsafiah et al. 2018).  
Allele 7 showed a typical sequence structure of TAGA₆ TAGG₁ TG5 (Figure 4.3 A). 
However, allele 8 showed TAGA₈ TG5 sequence where the TAGG repeat was absent 
(Figure 4.3 B) (Alsafiah et al. 2018). This absence was previously reported in (Kline et al. 
2011, Gettings et al. 2016), which could be interpreted by the presence of an A variant 







7 TAGA TAGA TAGA TAGA TAGA TAGA TAGG TGTGTGTGTG 
14 TAGA TAGA TAGA TAGA TAGA TAGA TAGA TAGA TAGA TAGA TAGA TAGA TAGA TAGG TGTGTGTGTG 
8 TAGA TAGA TAGA TAGA TAGA TAGA TAGA TAGA TGTGTGTGTG 
13 TAGA TAGA TAGA TAGA TAGA TAGA TAGA TAGA TAGA TAGA TAGA TAGA TAGA TGTGTGTGTG 
Figure 4.3. Sequencing data of the reverse strand of the alleles 7 and 8 at the D1S1656 locus. This data 
was generated using ForenSeq™ DNA Signature Prep (Primer Mix B) and MiSeq FGx System (Verogen). (A) 
Shows the sequence data of allele 7; (B) Shows the sequence data of allele 8. Due to the presence of the 
A variant of rs78443572 SNP (TAGG, G: 73%, A: 27%) in the alleles 8 and 13, these alleles ended with TAGA 
rather than TAGG (Alsafiah et al. 2018). 
As the two samples were sequenced using Primer Mix B that includes 56 aiSNPs and 
22 piSNPs, the ForenSeq™ UAS estimated biogeographical ancestry and predicted two 
phenotypic features (hair and eye colours). The software uses the principal component 
analysis (PCA) to estimate the biogeographical ancestry. Any sample can be classified to 
three main populations European, East Asian, and African and when a sample does not 
fit with any of the three populations, it will be assigned as ad-Mixed Americans (Verogen 
2018b). In addition, the software uses the HIrisPlex model (Walsh et al. 2014) 






Both samples were within the ad-Mixed Americans classification, one of which 
showed more similarity to the European main population (Figure 4.4). The software 
calculates the estimation based on the main populations of the Phase I of the 1000 
Genomes project (Verogen 2018b), and may be when subpopulation groups are added 
in the future phases, the estimation will be more specific.  
 
 
Figure 4.4. An estimation of the biogeographical ancestry. The figure shows the result of the biogeographical 
ancestry estimation of the two samples using the piSNPs and aiSNPs included in the Primer Mix B of the 
ForenSeq™ DNA Signature Prep kit. Both samples were classified as ad-Mixed Americans, one of which was 
more like the European main population. 
The samples showed a higher probability of having brown or black hair, which are 
more likely in the population of Saudi Arabia than red hair. The eye colour was also 
predicted and both samples showed very high percentage of 94% and 100% that the 






































Table 4.4. The results of hair and eye colour prediction. Both samples showed high probabilities of having 
brown eyes and brown or black hair. These features are more likely in the population of Saudi Arabia. 
Sample 1  Sample 2  
Hair Colour Results    Hair Colour Results   
Brown 0.45  Brown 0.29 
Red 0.00  Red 0.00 
Black 0.46  Black 0.71 
Blond 0.09  Blond 0.01 
         
Eye Colour Results    Eye Colour Results   
Intermediate 0.05  Intermediate 0.00 
Brown 0.94  Brown 1.00 
Blue 0.01  Blue 0.00 
     
 
4.6 Conclusion 
Six allele variants, at SE33 (four) and D1S1656 (two), were detected in the population 
of Saudi Arabia when the 500 samples were genotyped using the Globalfiler™ PCR 
amplification kit (AB). The D1S1656 allele variants were sequenced using the ForenSeq™ 
DNA Signature Prep kit and MiSeq FGxTM System and analysed by the ForenSeq™ UAS, 
while the SE33 allele variants were sequenced using the conventional sequencing assay 
(Sanger sequencing).  
This study has provided sequence data for six previously uncharacterized alleles at 
SE33 and D1S1656 loci. The SE33 alleles 2, 20.3 and 38 had B1, D1 and A7 motif pattern 
respectively, while allele 14.3 had a novel motif pattern. In addition, based on the 
sequence-based nomenclature guidelines of the ISFG, the alleles 2 and 14.3 at the SE33 
should be called 17 and 18.1 respectively. The study confirmed the assumption that 
allele 2 at the SE33 was due to deletion in a flanking region (Alsafiah et al. 2018). The 
observation of alleles outside the designated windows of an allelic ladder may lead to 
misinterpretation of this allele that was resolved by analysing the sequence structure 




 The sequence data of all alleles were reported to STRBase and are now included in 






5 Chapter Five: An evaluation of 17 non-CODIS STRs for the population 
of Saudi Arabia using the SureID® 23comp Human Identification Kit. 
5.1 Overview of experiment 
The extended number of STR markers required for the CODIS and for the ESS (Gill et 
al. 2006, Hares 2015), has led to the development of GlobalFilerTM PCR Amplification Kit, 
VeriFilerTM Plus PCR Amplification Kit (AB), PowerPlex® Fusion 6C system (Promega 
Corporation) and Investigator® 24plex (Qiagen) (Table 1.1). The information obtained 
from these kits will be sufficient in most kinship cases; however, it is still possible to have 
inconclusive results in complex cases (Goodwin et al. 2004). Kinship testing can be 
further complicated when the level of consanguinity in the target population is relatively 
high (Phillips et al. 2012), or when the family pedigree is deficient (Poetsch et al. 2013), 
(Alsafiah et al. 2019a).  
As mentioned in Section 1.5.2, It has been demonstrated that additional STRs can 
increase the power of genetic testing in determining the true relation between parent-
child, sibling or half sibling (O’Connor et al. 2010). For example, Carboni et al. (2014) 
described four complex cases, including incest, which were inconclusive using 13-15 
STRs, but that could be resolved using 39-41 STRs. 
As most loci are shared between the commonly used kits, the maximum number of 
aSTRs that can be tested, when combining any two kits, is 24 STRs (e.g. VeriFilerTM Plus 
and PowerPlex® Fusion 6C), which necessitates the use of a supplementary STR kit when 
more loci need to be tested. A set of 25 supplementary STRs (26-plex including 
amelogenin) was suggested by the National Institute of Standards and Technology (NIST, 
USA) to increase the certainty in kinship testing (Hill et al. 2009) (Table 5.1); however, 




Table 5.1. Supplementary autosomal STRs included in 3 supplementary autosomal STR kits. The kits are 
Microreader™ 23sp ID (Li, J. et al. 2017) (Suzhou Microread Genetics), Goldeneye™ DNA ID 22NC (Fu et al. 
2018) (Goldeneye® Technology Ltd.), AGCU 21+1 (Zhu et al. 2015) (AGCU ScienTech Incorporation). These 
kits are only commercially available in China (Phillips 2017). The table also shows a set of 25 supplementary 





Goldeneye™ DNA ID 
22NC 
AGCU 21+1 26plex (NIST) 
1 
D1S1656     
F13B     
D1S1677     
D1S1627     
D1GATA113     
2 
D2S441     
D2S1360     
D2S1338     
D2S1776     
3 
D3S1744     
D3S3045     
D3S1358     
D3S4529     
D3S3053     
4 
D4S2366     
D4S2408     
D4S2364     
5 
D5S2800     
D5S2500     
6 
D6S474     
D6S477     
SE33 ᵇ     
F13A01     
D6S1017     
7 
D7S3048     
D7S1517     
8 
D8S1132     
D8S1115     
LPL     
9 
D9S1122     
D9S2157     
PentaC     
D9S925     
10 
D10S1248     
D10S2325     
D10S1435     
11 
D11S2368     
D11S4463     
12 
D12S391     
D12ATA63     
13 D13S325     
14 
D14S1434     
D14S608     
15 
D15S659     
FESFPS     
PentaE     
16 D16S539     
17 
D17S1301     
D17S1290     
D17S974     
18 
D18S1364     
D18S51     
D18S535     
D18S853     
19 
D19S253     
D19S433     
20 
D20S482     
D20S470     
D20S1082     
21 
D21S2055     
PentaD     
D21S1270     
22  
D22GATA198B05     





Although, other supplementary Kits: Microreader™ 23sp ID (Li, J. et al. 2017) (Suzhou 
Microread Genetics, China), Goldeneye™ DNA ID 22NC (Fu et al. 2018) (Goldeneye® 
Technology Ltd., China), AGCU 21+1 (Zhu et al. 2015) (AGCU ScienTech Incorporation, 
China) have been developed (Table 5.1) (Alsafiah et al. 2019a), but they are only 
commercially available in China (Phillips 2017).  
Massively parallel systems (MPS) allow simultaneous sequencing of multiple DNA 
markers. For example, Precision ID GlobalFilerTM NGS STR (Li, H. et al. 2017) (20 CODIS 
STRs and nine non-CODIS STRs) (AB), Promega PowerSeqTM Auto/Y system (Montano et 
al. 2018) (20 CODIS STRs, PentaD, PentaE, and 23 Y-STRs) (Promega Corporation), and 
ForenSeqTM DNA Signature Prep (Li, R. et al. 2019) (20 CODIS STRs, seven non-CODIS 
STRs, 24 Y-STRs, 7 X-STRs and 94 iiSNPs) (Verogen). These can be utilised to increase the 
power of kinship testing. However, the systems are expensive to establish and are not 
yet commonly used in many laboratories (Alsafiah et al. 2019a). 
SureID® 23 comp Human Identification kit (Health Gene Technologies, China), 
combines amelogenin and 22 autosomal STRs: D1S1656, D2S441, D10S1248, D12S391, 
D16S539 and 17 non-CODIS STRs (D3S1744, D4S2366, D5S2800, D6S474, D7S3048, 
D8S1132, D9S1122, D11S2368, D13S325, D14S1434, D15S659, D17S1301, D18S1346, 
D19S253, D20S482, D21S2055, and D22GATA198B05). Twelve of these STRs are not 
included in other available supplementary kits, such as Investigator® HDplex Kit (Qiagen 
2012a) and PowerPlex® CS7 System (Promega Corporation 2016) (Table 5.2). The kit is 




Table 5.2. STR Markers included in the SureID® 23comp kit. This table shows the locations (GRCh38) and repeat structures of the 22 STRs included in the SureID® 23comp kit. Five loci are 
common with the CODIS and the ESS. Twelve loci are not included in other available supplementary kits (Investigator® HDplex and PowerPlex® CS7). All information was adapted from 
(Qiagen 2012a, Promega Corporation 2016, Phillips et al. 2018b) (Alsafiah et al. 2019a).  
 SureID® 23 comp  Investigator® HDplex 
STRs (a and b) 
PowerPlex® CS7 
STRs Chr. STRs (a) Location (GRCh38) Repeat structure *  
1 D1S1656 ᵃ 230769616-230769683 CCTA [TCTA]n   F13B 
2 D2S441 ᵃ 68011947-68011994 [TCTA]n  D2S1360  
3 D3S1744 147374752-147374828 [ATAG]n atg [ATAG]n at [ATAG]n  D3S1744  
4 D4S2366 6483114-6483172 [GATA]n [GATT]n [GATA]n gac [GATA]n  D4S2366  
5 D5S2800  59403132-59403199 [GGTA]n [GACA]n [GATA]n [GATT]n  D5S2500   
6 D6S474 112557951-112558018 [AGAT]n [GATA]n  D6S474, SE33 ᵇ F13A01 
7 D7S3048 21227099-21227174 [TATC]n [TACC]n [CACC]n  D7S1517  
8 D8S1132 106316692-106316774 [TCTA]n tca [TCTA]n  D8S1132 LPL 
9 D9S1122 77073826-77073873 [TAGA]n   PentaC 
10 D10S1248 ᵃ 129294244-129294295 [GGAA]n  D10S2325  
11 D11S2368 19259601-19259684 [TATC]n [TGTC]n [TATC]n    
12 D12S391 ᵃ 12297020-12297095 [AGAT]n [AGAC]n AGAT  D12S391 ᵃ  
13 D13S325 42599304-42599382 [TCTA]n tca [TCTA]n    
14 D14S1434 94842054-94842105 [CTGT]n [CTAT]n    
15 D15S659 46081911-46081966 [TATC]n   FESFPS, PentaE 
16 D16S539 ᵃ 86352702-86352745 [GATA]n    
17 D17S1301 74684855-74684902 [AGAT]n    
18 D18S1364 65732998-65733056 [TAGA]n TACA [TAGA]n  D18S51 ᵃ  
19 D19S253 15617484-15617531 [ATCT]n    
20 D20S482 4525692-4525747 [AGAT]n    
21 D21S2055 39819508-39819649 [CTAT]n CTAA [CTAT]n (30N) [TATC]n  D21S2055 PentaD 
22 D22GATA198B05 17169811-17169882 CTCT [ATCT]n [ACCT]n    
ᵃ: CODIS and ESS locus    









The SureID 23 comp was used to generate population genetic data for three main 
populations European, South Asian and African (Iyavoo et al. 2019), but it is believed 
that the kit has not been validated as no publications currently exist, either 
independently or from the manufacturer. Therefore, the kit should be validated using 
the minimum criteria for validation recommended by the European Network of Forensic 
Science Institutes (ENFSI) and by the scientific working group on DNA analysis Methods 
(SWGDAM), in order to be used in forensic laboratories (Alsafiah et al. 2019a). The 
minimum criteria for validation of new kits for forensic applications includes 
repeatability, reproducibility, sensitivity stochastic effect, heterozygote peak balances, 
stutter/corresponding allele ratios, concordance with other kits for the same STRs, and 
performance when PCR inhibitors are present. The SWGDAM guideline demand testing 
the precision and accuracy of the kit. Although both guidelines include mixture studies, 
they were not carried out as the kit is specifically designed to be used in complex kinship 
testing.   
5.2 Aims of the study 
This study aimed to carry out an internal validation of the SureID®23 comp Human 
Identification kit following the minimum criteria for validation recommended by the 
ENFSI and by the SWGDAM (Section 1.4). This is to aid the forensic DNA laboratories and 
the manufacturer by highlighting the befits and the drawbacks of the kit.  
It also aimed to generate allele frequency data for the 17 non-CODIS loci using the 
500 samples to facilitate the estimation of match probabilities of DNA profiles in Saudi 





The kit will also be assessed for kinship testing as a supplementary STR kit in Chapter 
7. 
5.3 Objectives 
1- Preparing the ABI 3500 DNA Genetic Analyser that included: 
a. Undertake spectral calibration for the genetic analyser.  
b. Optimisation the use of 50 cm capillaries and POP-6™ polymer. 
c. Install the panels, bins and the analysis method to the GeneMapper™ ID-X 
Software v1.2 (AB). 
2- Genotyping the 500 samples. 
3- Analysing the raw data using the GeneMapper™ ID-X Software v1.2 (AB) and 
transporting the result using the export option. 
4- Internal validation of the SureID® 23 comp kit following the ENFSI and the 
SWGDAM minimum criteria that included: 
a. Confirmation of the identity of the D5 locus included in the kit (i.e. is it 
D5S2800 or D5S2500) by testing the 9947A control DNA. 
b. Repeatability and reproducibility 
c. Sensitivity and stochastic effect. 
d. An evaluation of the kit’s performance against common PCR inhibitors 
e. Further assessment of the kit’s performance using the bone samples.  
f. Heterozygote peak balances study. 
g. Stutter/corresponding allele ratios. 




i. Concordance study of five common loci (D1S1656, D2S441, D10S1248, 
D12S391, D16S539) with the Globalfiler™ PCR amplification kit (AB) 
(Chapter 3). 
5- Population genetic data for the 17 non-CODIS loci. 
6- Evaluating the data for HWE, and the forensic statistical parameters. 
7- Carry out the population comparison test to compare the data of the Saudi 
population with other published data. 
8- Submit the data of the 17 non-CODIS loci to STRidER for quality control (Bodner 
et al. 2016). 
5.4 Materials and Methods 
All experimental work and analysis were described in Sections 2.5 and 2.7. 
5.5 Results and discussion 
5.5.1 Preparation ABI 3500 DNA Genetic Analyser 
Before starting the validation study, the Genetic Analyser was successfully calibrated. 
The use of 50 cm capillaries and POP-6™ polymer was optimised by increasing the run 
time to 3900 s (36 cm capillaries and POP-4 uses 1,210 – 1,500 s). Increasing the run 
time to 3900 s allowed detection of amplicons up to 455 bp that included the designated 
area for all loci and at least two size markers that were larger than the largest allele 
allowing the local Southern method to be used. All alleles were successfully called after 





Figure 5.1. Allelic ladder of the SureID® 23comp kit. This figure shows the allelic ladder provided with the 
SureID® 23 comp kit. It represents 232 alleles that are supported by 53 additional bins for variant alleles 
(pink bins). It also shows the successful calibration and optimisation of the ABI 3500 DNA Genetic Analyser 
(Alsafiah et al. 2019a). 
5.5.2 D5 locus confirmation 
It is important to note that the D5 locus included in this kit was named as D5S2500 in 
the panels and in the supporting documents. Two different loci, which are 1643 bp apart 
and have different sequence structure, both had the D5S2500 name. One locus is a part 
of the Investigator® HDplex Kit (Qiagen) and the other one is a part of the AGCU 21-plex 
(AGCU ScienTech Incorporation). This duplication was detected when this locus showed 
different genotypes for the 9947A control DNA using both kits (15, 16 for the 
Investigator® HDplex and 14, 23 for the AGCU 21-plex) (Phillips et al. 2016). Therefore, 
the name of D5S2800 was proposed for the STR marker included in the AGCU 21-plex to 
be differentiated from the other one included in the Investigator® HDplex Kit (Phillips et 
al. 2016) (Alsafiah et al. 2019a).   
The Health Gene Technologies has confirmed that the D5 locus included in SureID® 




additionally confirmed by genotyping the 9947A control DNA included in the kit as a 
positive control that showed alleles 14, 23 (Figure 5.2). Based on this confirmation, the 
Health Gene Technologies has updated the name of the locus to D5S2800 in the panels 
and in the supporting documents (Alsafiah et al. 2019a). 
 
Figure 5.2. The genotype of the 9947A control DNA at the D5 locus included in the SureID® 23 comp kit. 
The locus had 14, 23, which is the genotype of D5S2800, confirming the correct name. The locus name is 
now updated by the manufacturer from D5S2500 (as shown in the locus name) to D5S2800. 
5.5.3 Repeatability and Reproducibility. 
In the initial tests of the SureID® 23comp, the two reaction volumes (25 and 10 µl) 
optimised by the manufacturer were validated by two independent operators.  A total 
of 0.5 ng of the 2800M control DNA was amplified in 20 replicates using both reaction 
volumes (5 replicates per reaction volume per operator). All replicates were successfully 
profiled and showed full profiles that were fully concordant demonstrating repeatability 
and reproducibility (Alsafiah et al. 2019a). 
5.5.4 Sensitivity stochastic effect. 
The five replicates of dilution series were profiled using the 25 µl and 10 µl volumes 
with 28 and 30 cycles. Full profiles were generated from the 125 pg samples when using 




with 30 PCR cycles only. For the 62 pg samples, the 25 µl and 10 µl volumes with 30 
cycles, allow detection of 90.24% and 95.12% of alleles, respectively. The remaining 
alleles were visible and could be detected with a reduced RFU threshold of 30. With 31 
pg, 85.3% of alleles were detected when using the 10 µl volume with 30 cycles, while 
allele dropout was observed with the 25 µl volume (28 and 30 cycles) and with the 10 µl 
volume (28 cycles) (Figure 5.3). The sensitivity results are comparable to other 
commonly used kits, for example, Identifiler Kit (Collins et al. 2004), Investigator HDplex 
Kit (Westen et al. 2012) and PowerPlex Fusion 6C System (Ensenberger et al. 2016) 
where the profile percentage ranged from 82% to 94% for the 62 pg and from 37% to 
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Figure 5.3. Sensitivity and stochastic tests for the SureID® 23comp kit. Serial dilutions (500, 250, 125, 62, and 31) pg were prepared from the 2800M control DNA (Promega 
Corporation). Each test was done in five replicates and the highest number of detected alleles are shown. Each cell represents an allele and merged cells represent homozygote loci 
in 2800M. Green cells identify detected alleles with ≥ 60% peak balance ratios. Yellow cells identify detected alleles with < 60% peak balance ratios. Red cells represent non-detected 




5.5.1 Performance against common PCR inhibitors 
The performance of the SureID® 23comp kit with different concentrations of two 
common PCR inhibitors was tested. Full profiles were generated in the presence of ≤ 
120 ng/µl of tannic acid and of ≤ 75 ng/µl of humic acid (Figure 5.4-5.5 and Figure 5.6-
5.7). Although these levels are similar to those reported for the SureID®PanGlobal 
system (Health Gene Technologies) (Liu et al. 2017), other commonly used kits are more 
robust in the presence of higher concentrations of inhibitors (Lin et al. 2017) (Figure 5.8) 





Figure 5.4. Testing of the SureID® 23comp kit with tannic acid. Three different concentrations of 100 ng/µl, 
120 ng/µl and 150 ng/µl were tested. This figure shows the results of the control sample (no inhibition) 
and of the 100 ng/µl (tannic acid) sample. Figure 5.5 shows the results of 120 and 150 ng/µl of tannic acid.  
Control sample (Tannic Acid test) 





Figure 5.5. Testing of the SureID® 23comp kit with tannic acid. Three different concentrations of 100 ng/µl, 
120 ng/µl and 150 ng/µl were tested. This figure shows the results of the 120 ng/µl (tannic acid) sample 
and of the 150 ng/µl (tannic acid) sample. Full profiles were achieved with ≤ 120 ng/µl of tannic acid. 
  
Tannic Acid 120 ng/µl 





Figure 5.6. Testing of SureID® 23comp kit with humic acid. Three different concentrations of 50 ng/µl, 75 
ng/µl and 100 ng/µl were tested. This figure shows the results of the control sample (no inhibition) and 
of the 50 ng/µl (humic acid) sample. Figure 5.7 shows the results of 75 and 100 ng/µl of humic acid. 
  
Control sample (Humic Acid test) 





Figure 5.7. Testing of SureID® 23comp kit with humic acid. Three different concentrations of 50 ng/µl, 75 
ng/µl and 100 ng/µl were tested. This figure shows the results of the 75 ng/µl (humic acid) sample and of 
the 100 ng/µl (humic acid) sample. Full profiles were achieved with ≤75 ng/µl of humic acid. 
  
Humic Acid 75 ng/µl 





Figure 5.8. SureID® 23comp kit performance with two common PCR inhibitors. Full profiles were 
generated in the presence of 75 ng/µl of humic Acid and 120 ng/µl of tannic acid. These figures are similar 
to those reported for the SureID®PanGlobal (Liu et al. 2017). However, the kit was not as robust with 
inhibitors as PowerPlex® Fusion 6C, GlobalFiler™, and Investigator® 24plex (Lin et al. 2017) (Figure from 
(Alsafiah et al. 2019a). 
5.5.2 Further performance assessment  
The performance of the SureID® 23comp was further evaluated using the nine bone 
samples. The bone samples were profiled using the 25 µl volume to increase the capacity 
of the DNA input, in the PCRs, to 6.25 µl. Seven samples, where the total DNA input 
ranged from 0.2575 ng to 2.0444 ng/reaction, showed similar percentage of detected 
alleles to other kits previously used (Table 5.3). However, in two samples, which had 
lower concentrations and higher degradation indexes (DIs) of 0.0173 ng/µl (DI: 57.7) and 
0.0194 ng/µl (DI: 16.2) (total DNA input 0.1081 ng and 0.1213 ng); the performance 
deteriorated, both in absolute terms, and in comparison to other kits. The capacity of 
DNA quantity in the other kits (15 µl) allowed 2.4-fold more DNA to be added to the 
































SureID®23comp performance with inhibitors 




Table 5.3. The results of the bone samples used in the validation tests of the SureID® 23 comp kit. Nine samples, collected from a mass grave in Iraq, were extracted using PrepFiler™ BTA 
Forensic DNA Extraction Kit (AB), and were quantified using Quantifiler™ Trio DNA Quantification Kit (AB). This table shows Quantifiler™ Trio small fragment concentrations (ng/µl), total 
DNA quantities added to the PCRs of SureID®23 kit and other kits. The percentages of detected alleles of autosomal STRs (aSTRs) when using different STR kits, are also shown. The two 









Total DNA added to PCRs: 
 
SureID®23 PCR (ng/6.25 µl) / other kits (ng/15 µl) 



















PowerPlex® Fusion 6C 
(23 aSTRs) 
76 c 0.0173 57.666 0.1081/0.2595 27.30% 60% 66.60% 60.80% 
78 a 0.0194 16.166 0.1213/0.2910 54.50% 90% 95.20% 82.60% 
93 b 0.3271 2.7464 2.0444/4.9065 100% 100% N/A N/A 
76 e 0.093 2.2962 0.5813/1.3950 100% 100% N/A N/A 
81 a 0.0571 1.929 0.3569/0.8565 100% 100% 76.20% N/A 
97 b 0.0548 1.6758 0.3425/0.8220 100% 100% N/A N/A 
94 a 0.0685 2.4204 0.4281/1.0275 100% 100% N/A N/A 
25 a 0.0463 4.9784 0.2894/0.6945 86.30% 95% N/A N/A 
46 b 0.0412 3.1937 0.2575/0.6180 100% 100% N/A N/A 
N/A: sample was not profiled using this kit. 
    




Overall, the sensitivity tests, when using the DNA control, demonstrated the 
robustness of generating full profiles even below the recommended DNA concentrations 
and showed similar sensitivity to other commonly used STR kits. However, this kit was 
less sensitive with the bone samples, which is most likely due to the limited capacity of 
DNA input compared to the other kits (Table 5.3 and Table 5.4). Although this kit was 
designed as a supplementary kit for forensic genetics laboratories, some cases may 
involve human remains, e.g. disaster victim identification (DVI). Therefore, increasing 
the concentration of the master and primer mixes (e.g. to 2X) would permit additional 
space for more DNA input especially for highly degraded samples (Alsafiah et al. 2019a). 
Table 5.4. PCRs contents for the SureID® 23comp, PowerPlex® 21. GlobalFiler™, PowerPlex® Fusion 6C. The 
table shows the contents of the 25 µl volume PCRs for four kits used to genotype the bone samples. The 
SureID® 23comp has less space (6.25 µl) for DNA input compared to the other three kits (15 µl). Increasing 





Master Mix Primer Mix Maximum DNA input 
SureID® 23comp 25 µl 12.5 µl 6.25 µl 6.25 µl 
PowerPlex® 21 25 µl 5 µl 5 µl 15 µl 
GlobalFiler™ 25 µl 7.5 µl 2.5 µl 15 µl 
PowerPlex® Fusion 6C 25 µl 5 µl 5 µl 15 µl 
 
5.5.3 Heterozygote peak balances. 
Peak balances study started with measuring of the optimal DNA quantity for the 10 
µl reaction volume. The first 90 samples of the 500 samples were tested using three 
different DNA quantities (0.5 ,0.35, and 0.25) ng. With all template amounts, the 
minimum peak balance ratios were > 68%, which meets the criteria set out in the ENFSI 
guidelines (> 60%). The DNA input of 0.5 ng achieved the most balanced heterozygous 
peaks, with an average of 88.31% (Table 5.5), which are similar to ratios observed when 




D21S2055 showed the lowest degree of balance at all template concentrations, with 
ratios of 73.11% at 0.5 ng, 79.75% at 0.35 ng, and 68.12% at 0.25 ng (Table 5.5) (Alsafiah 
et al. 2019a).  
Table 5.5. Peak balance ratios study for the SureID® 23comp kit. The table shows the averages of peak 
balance ratios calculated for the amelogenin (AMEL) and 22 STRs included in the SureID® 23comp kit. A total 
of 90/500 samples were used to study balance ratios. The 10 µl reaction volume was evaluated using three 
DNA quantities 0.5, 0.35, and 0.25 ng. The 0.5 ng showed the highest peak ratios average. The D21S2055 
showed the lowest ratio at all DNA quantities (shaded row) (Alsafiah et al. 2019a). 
Marker 
Average peak balance ratios (%) of the 10 µl reaction volume 
0.5 ng 0.35 ng 0.25 ng 
AMEL 94.29 83.90 81.83 
D18S1364 90.90 86.11 83.90 
D1S1656 86.62 87.43 85.21 
D13S325 91.35 81.69 84.15 
D5S2800 85.95 88.85 80.28 
D9S1122 90.65 85.88 84.80 
D4S2366 91.42 86.94 85.15 
D3S1744 90.08 87.97 87.23 
D12S391 85.38 83.09 78.35 
D11S2368 91.57 84.19 83.81 
D21S2055 73.11 79.75 68.12 
D20S482 94.02 91.62 87.02 
D8S1132 88.96 82.64 84.44 
D7S3048 85.98 86.05 80.80 
D2S441 90.83 84.08 87.61 
D19S253 82.62 87.44 79.48 
D10S1248 90.53 84.86 85.27 
D17S1301 92.58 90.00 87.64 
D22GATA198B05 86.48 85.54 80.41 
D16S539 87.54 85.94 87.94 
D6S474 85.07 87.73 84.22 
D14S1434 88.41 87.93 85.99 
D15S659 86.74 85.12 82.72 
All markers’ average (%) 88.31 85.86 83.32 
 
The remaining 410 samples were successfully profiled using the 10 µl volume and 0.5 
ng of DNA input. Overall, the intra-locus balances were 81.8 % (D21S2055) - 96.9 % 
(D16S539), the intra-dye balances 71.9 % (TAMRA) – 82.6 % (JOE), and the inter-dye 
balances >43 % (Alsafiah et al. 2019a). These figures are consistent with the 
recommended standard of PCR performance that are >70% for intra-locus balance, 50% 
for intra-dye balance, and >30% for inter-dye balance (Liu et al. 2017).  
The peak imbalances of the D21S2055 became less than 50% when the size difference 




balances further decreased to < 45% when the size difference became > 50 nt (> 12 
repeats). For example, an average of 43.5% for the genotypes (16.1, 34) (two samples), 
and 31.8% for the genotype (16.1, 36) (one sample) (Figure 5.9). This locus is the longest 
marker in this kit (332 bp to 420 bp) and has the highest number of possible alleles (23 





Figure 5.9. Peak balance ratios study for the D21S2055 locus. This figure shows a study of the correlation between the size difference between heterozygous alleles and the peak 
balance ratio for the D21S2055 locus using data of 500 samples. The peak ratios of all genotypes that have the same size difference (nt) (e.g. the genotypes 13, 17; 14, 18; and 15, 
19 have the same size difference of 4 nt) were averaged and are represented by the black dots. The blue line shows the smoothed mean of the peak ratios. Heterozygote alleles with 




5.5.4 Stutter/corresponding allele ratios. 
Stutter artefacts are common to all PCR-based STR analysis and the most common 
type of stutter is a peak with one repeat smaller than the true allele (Krenke et al. 2005). 
In this study, the average of the stutter peak ratios was 9.18% and the average range 
was from 3.8% for D2S441 to 16.15% for D12S391 (Figure 5.10).  In addition, allele 
variants of x.1, x.2 and x.3 had lower stutter ratios than alleles x-1, x-2 and x-3, 
respectively. These figures were as expected that showed the correlation between the 
size of an allele and the complexity of a locus with the stutter ratios and were below the 
stutter filter provided by the manufacturer (Alsafiah et al. 2019a).  
5.5.5 Precision and accuracy. 
For the precision study, the data of 22,975 alleles (23,000 alleles from 500 samples 
excluding 25 alleles with a single observation) were used to calculate the standard 
deviation (s.d.) of the fragment sizes of each allele at a locus. Overall, the maximum s.d. 
was 0.1048 nucleotide (nt) observed in allele 21 at D7S3048 and the minimum was 
0.0071 nt observed in allele 22 at D3S1744 (Figure 5.11) (Alsafiah et al. 2019a).  
To measure the accuracy of the kit, the average sizes of each allele in the data of the 
500 samples and in 21 allelic ladders was compared to the actual size values of the 
corresponding allele (actual sizes provided by the manufacturer). All alleles fell within 
the range of ±0.41 nt, where allele 17 at D6S474 (0.4096 nt) and allele 26 at D7S3048 (-
0.4084 nt) recorded the highest difference compared to the actual sizes (Figure 5.12) 






Figure 5.10. Stutter ratios study for the SureID 23comp Kit. The figure shows the average of - 4 stutter ratios for STRs included in the SureID 23comp kit. Each box represents the 
stutter ratios of an STR. The x-axis represents alleles and the y-axis represents the stutter ratios. The line was drawn based on the average ratios of observed stutters. Alleles of x.1, 





Figure 5.11. Precision study of the SureID 23comp Kit. The figure shows standard deviation (s.d) values of the fragment sizes of 22,981 alleles generated from 500 samples tested by 
the SureID 23comp. The highest s.d. was observed in allele 21 at D7S3048 (0.1048 nt) (Alsafiah et al. 2019a). In the box plots, the lower whisker represents 25% of the lowest data, 
the upper whisker represents 25% of the highest data. The rectangle shows that 75% of the data are below the upper line, 25% of the data are below the lower line, and the centre 





Figure 5.12. Accuracy study of the SureID 23comp Kit. The average of the size values of each allele in the data of the 500 samples and in 21 allelic ladders were compared to the 
actual sizes of the corresponding allele (actual sizes provided by the manufacturer). The size differences per nucleotides were calculated and are represented by the coloured dots. 





The precision and the accuracy tests demonstrated the capability of detecting 
heterozygous alleles that differ by a single nucleotide and demonstrated that it is 
unlikely for any allele to be sized out of the designated window (±0.5 nt). The SureID® 
23comp was reliably able to detect genotypes where the difference between the alleles 
was a single nucleotide, for example 11.3, 12 at D2S441, 15.3, 16 and 16.3, 17 at 
D1S1656 (100% concordant with GlobalFilerTM genotypes) (Alsafiah et al. 2019a). 
5.5.6 Concordance study 
The concordance study was also carried out by comparing data of the 500 samples 
obtained from this study and that generated using the GlobalFiler™ kit (Chapter 3) 
(Alsafiah et al. 2017). The five common loci (D1S1656, D2S441, D10S1248, D12S391 and 
D16S539) showed 100% concordance. In addition, alleles generated from the bone 
samples using the SureID® 23comp kit at the common loci were concordant with alleles 
generated using the other kits. In addition, the amelogenin showed concordant 
genotypes to that generated by the GlobalFiler™ kit (Alsafiah et al. 2019a).  
5.5.7 Allelic ladder and rare alleles. 
This kit provides an allelic ladder representing 232 alleles that are supported by 53 
additional bins for variant alleles (Figure 5.1). After analysing the 500 samples, 34 alleles 
in 15 loci were not represented by the allelic ladder; three of which had been observed 
≥ 40 times (Table 5.6). In addition, ten of these alleles were situated outside the 
designated window of their loci: alleles 7 and 8 at D1S1656, 26.3 and 27.3 at D13S325, 
allele 16 at D4S2366, allele 12 at D3S1744, allele 30 at D7S3048, allele 10 at D6S474 and 
alleles 6 and 7 at D15S659 (Figure 5.13). The allele 7 at D1S1656 was situated under the 
designated area of D18S1364 locus (Figure 5.13 a). Although this allele could belonged 




belongs to D1S1656 (Alsafiah et al. 2018) (Chapter 4). It is not necessary for an allelic 
ladder to represent all rare alleles; however, alleles outside the designated window of a 
locus may be misinterpreted especially when adjacent loci are homozygous.  Examining 
data of 256 samples collected from the population of Ningbo, China (data provided by 
the Health Gene Technologies) (Table 5.6), most alleles present in the Saudi Arabian 
population but not present in the allelic ladder were absent in the Ningbo population 
(Alsafiah et al. 2019a). 
Table 5.6. Alleles not represented by the allelic ladder of SureID® 23comp kit detected in the population of 
Saudi Arabia; 34 alleles were detected at 15 STRs. It shows also the frequency of these alleles in Ningbo 
population (data provided by the Health Gene Technologies). The frequencies of detected alleles ranged 
from 0.001 (one observation) to 0.066 (66 observations). Shaded rows indicate alleles observed ≥ 40 times 
(Alsafiah et al. 2019a). 
STRs Allele frequency  STRs Allele frequency 
  Saudi Ningbo    Saudi Ningbo 
D18S1364 11 0.001 0.002  D13S325 26.3 0.002 0 
D1S1656 7 0.001 0   27.3 0.001 0 
 8 0.001 0  D8S1132 13.1 0.001 0 
 10 0.004 0.001   15 0.003 0 
 14.3 0.002 0  D7S3048 30 0.001 0 
 15.3 0.040 0  D2S441 8.3 0.001 0 
 16.3 0.061 0.007   9 0.005 0 
 18 0.003 0.011   11.3 0.066 0 
 19.3 0.006 0.003   13.3 0.001 0 
 20.3 0.001 0.002  D19S253 6 0.004 0 
D9S1122 7 0.001 0   16 0.001 0 
D4S2366 16 0.002 0  D22GATA198B05 11.2 0.001 0 
D3S1744 12 0.001 0   12 0.004 0 
D12S391 18.3 0.005 0  D6S474 10 0.001 0 
 19.1 0.001 0  D14S1434 16 0.004 0.004 
 19.3 0.004 0  D15S659 6 0.001 0 







Figure 5.13. Alleles outside the windows of the allelic ladder of the SureID® 23comp kit. This figure shows ten alleles observed in the population of Saudi Arabia that are not 
represented and were situated outside the designated widow of their loci. a) Alleles 7 and 8 at D1S1656. B) Alleles 26.3 and 27.3 at D13S325. c) Allele 30 at D7S3048. d) Allele 16 at 




5.5.8 Population study and excess of homozygosity.  
In Chapter 3, the 21 aSTRs included in the GlobalFiler™ kit have shown excess of 
homozygosity in 20/21 aSTRs (TPOX was the exception) with an inbreeding coefficient 
of 0.03560, but none of the loci showed significant deviation from HWE. Here, 14/17 
non-CODIS loci showed fewer than expected heterozygotes (D9S1122, D4S2366 and 
D8S1132 were the exception). In addition, D20S482 was the only locus that showed 
significant deviation (P value = 0) (Table 5.7). This also revealed some level of 
consanguinity in the population of Saudi Arabia which was supported by an inbreeding 
coefficient (FIS) of 0.02977.  
Table 5.7. Results of the expected heterozygosity calculation and of Hardy-Weinberg equilibrium exact test, 
conducted by Arlequin v3.5.2.1 Software for the 17 non-CODIS loci included in the SureID® 23comp kit. The 
P values is significant if < 0.05. The five common loci with the GlobalFiler™ kit were not included in this table 
as they had the same results in Table 3.2.  










D18S1364 1000 0.816 0.84136 0.56136 0.00041 1001000 
D13S325 1000 0.766 0.79728 0.39205 0.00043 1001000 
D5S2500 1000 0.726 0.77991 0.11518 0.00028 1001000 
D9S1122 1000 0.724 0.71099 0.05367 0.00021 1001000 
D4S2366 1000 0.818 0.7953 0.25306 0.00036 1001000 
D3S1744 1000 0.754 0.80825 0.23985 0.0003 1001000 
D11S2368 1000 0.77 0.80282 0.16433 0.00025 1001000 
D21S2055 1000 0.888 0.91181 0.16668 0.00024 1001000 
D20S482 1000 0.628 0.6915 0 0 1001000 
D8S1132 1000 0.87 0.85408 0.21807 0.00028 1001000 
D7S3048 1000 0.848 0.88177 0.48789 0.0003 1001000 
D19S253 1000 0.774 0.77516 0.88958 0.00022 1001000 
D17S1301 1000 0.662 0.67583 0.18288 0.00038 1001000 
D22GATA198B05 1000 0.806 0.84142 0.33665 0.00044 1001000 
D6S474 1000 0.726 0.75407 0.11216 0.00029 1001000 
D14S1434 1000 0.698 0.69978 0.13021 0.0003 1001000 
D15S659 1000 0.802 0.83976 0.34694 0.00048 1001000 
 
However, it is not clear whether the D20S482’s deviation was due to the 




Examining SNP variants with > 1% frequency at the flanking regions (100 bp each side) 
of the locus using the 1000 Genome browser (Auton et al. 2015), two SNPs in the 5´ 
flanking region: rs151133985 (all populations C: 99%, G: 1%; Africans C: 98%, G: 2%) and 
rs77560248 (all populations C: 94%, T: 6%; Europeans and South Asians C: 91%, T: 9%); 
and one SNP at 3´ flanking region: rs551422781 (Africans G: 99%, A: 1%), were found. 
These SNPs may cause null alleles if any of them was at a critical annealing region of the 
primer pair.  However, none of the three populations European, South Asian and African 
that were studied using the same kit has shown deviation from HWE at this locus (Iyavoo 
et al. 2019). Sequencing homozygotes samples or using a different kit to genotype the 
locus may reveal more information. Therefore, based on our results for the population 
of Saudi Arabia, D20S482 cannot be included in the product rule to calculate the 
probability of a DNA profile. 
Assuming no deviation from HWE, the CMP for the 22 STRs was 7.2 E-27, the CPE was 
0.999999037259, and the CPD was 0.9999999999999999999999999928. The non-
CODIS loci alone had 1.2 E-20 CMP, 0.9999747848 CPE and 
0.999999999999999999988164 CPD (Table 5.8). D21S2055 was the most informative 
locus, with a MP of 0.016, and D17S1301 was the least informative locus, with a MP of 
0.162. Heterozygosity ranged from 0.624 (D20S482) to 0.89 (D21S2055). The number of 
observed alleles per locus varied from 7 alleles in D17S1301 to 20 alleles in D21S2055. 
Three alleles, allele 14 in D20S482, allele 12 in D17S1301 and allele 12 in D9S1122; 
showed very high frequencies of 0.477, 0.449 and 0.405 respectively (Table 5.8). The 
frequency of the theoretical most common SureID® DNA profile, generated based on the 
frequencies of the 22 STRs (and assuming heterozygosity), was 3E-21 that equates to 1 
in 3.3E20. The CMP of the 22 STRs is ten times higher than CMP calculated when using 




SureID®23comp kit includes the four most informative loci that have been studied for 
the population of Saudi Arabia (D21S2055, D12S391, D7S3048, and D1S1656) (Alsafiah 
et al. 2019a). 
Table 5.8. Allele frequency of the 17 non-CODIS loci. The table shows the allele frequency and statistical 
parameters for the 17 non-CODIS included in the SureID® 23comp kit. Allele frequencies for D1S1656, 
D2S441, D10S1248, D12S391 and D16S539 are not shown as they are presented in Table 3.4. 
allele D18S1364 D13S325 D5S2800 D9S1122 D4S2366 D3S1744 D11S2368 D21S2055 
7    0.001     
9    0.008 0.299    
10    0.054 0.107    
11 0.001   0.237 0.172    
12 0.045   0.405 0.243 0.001   
13 0.247  0.021 0.256 0.106 0.008   
14 0.142  0.238 0.031 0.066 0.117 0.001  
15 0.185  0.003 0.007 0.005 0.079 0.002  
16 0.126 0.004 0.001 0.001 0.002 0.133 0.016  
16.1        0.082 
17 0.043 0.012 0.239   0.34 0.048  
17.1        0.013 
18 0.143 0.045 0.28   0.167 0.143  
18.1        0.013 
19 0.062 0.167 0.006   0.096 0.241  
19.1        0.108 
20 0.006 0.308 0.025   0.045 0.266  
20.1        0.01 
21  0.231    0.012 0.206  
22  0.141 0.003   0.002 0.059  
23  0.071 0.165    0.016 0.001 
24  0.017 0.019    0.002 0.026 
25  0.001      0.131 
26        0.121 
26.3  0.002       
27        0.014 
27.3  0.001       
28        0.012 
29        0.056 
30        0.032 
31        0.041 
32        0.102 
33        0.124 
34        0.07 
35        0.034 
36        0.008 
37        0.002 
Total Alleles 1000 1000 1000 1000 1000 1000 1000 1000 
Matching Probability 0.046 0.070 0.079 0.141 0.076 0.060 0.068 0.016 
Expressed as 1 in ... 21.868 14.346 12.579 7.093 13.176 16.611 14.685 61.516 
Power of Discrimination 0.954 0.930 0.921 0.859 0.924 0.940 0.932 0.984 
Polymorphic Information 
Content 
0.821 0.768 0.744 0.661 0.765 0.785 0.773 0.904 
Power of Exclusion 0.629 0.538 0.470 0.466 0.637 0.517 0.541 0.775 





Table 5.8. continued. 
allele D20S482 D8S1132 D7S3048 D19S253 D17S1301 
D22GAT
A198B05 
D6S474 D14S1434 D15S659 
6    0.004     0.001 
7    0.222     0.003 
8    0.018      
9 0.01   0.009 0.001   0.001 0.006 
10 0.004   0.018 0.042  0.001 0.29 0.037 
11 0.007   0.147 0.292   0.036 0.222 
11.2      0.001    
12 0.039   0.353 0.449 0.004  0.018 0.163 
13 0.222   0.16 0.188  0.002 0.261 0.059 
13.1  0.001        
14 0.477   0.061 0.023 0.01 0.345 0.384 0.037 
15 0.186 0.003  0.007 0.005 0.011 0.244 0.006 0.207 
16 0.052 0.016 0.003 0.001  0.131 0.214 0.004 0.18 
17 0.003 0.138 0.068   0.188 0.143  0.061 
18  0.211 0.091   0.099 0.039  0.021 
19  0.2 0.061   0.244 0.012  0.003 
20  0.124 0.075   0.153    
21  0.105 0.106   0.11    
22  0.106 0.086   0.044    
23  0.069 0.186   0.005    
24  0.023 0.181       
25  0.004 0.098       
26   0.037       
27   0.006       
28   0.001       
30   0.001       
Total Alleles 1000 1000 1000 1000 1000 1000 1000 1000 1000 
Matching Probability 0.143 0.041 0.027 0.083 0.162 0.045 0.102 0.148 0.046 
Expressed as 1 in 6.992 24.424 36.464 12.068 6.156 22.385 9.800 6.748 21.686 
Power of Discrimination 0.857 0.959 0.973 0.917 0.838 0.955 0.898 0.852 0.954 
Polymorphic Information 
Content 
0.641 0.836 0.869 0.743 0.619 0.821 0.713 0.641 0.818 
Power of Exclusion 0.321 0.735 0.695 0.552 0.372 0.610 0.466 0.422 0.610 
Typical Paternity Index 1.330 3.846 3.333 2.212 1.479 2.577 1.812 1.645 2.577 
  22 STRs  17 None- CODIS STRs 
Combined Match Probability (CMP) 7.2E-27  1.2E-20E-20 
Combined Power of Exclusion (CPE) 0.999999037259  0.9999747848 






The data of the 22 loci of the SureID® 23comp was uploaded to the R studio to find 
out the maximum number of matched loci between any two DNA profiles using the DNA 
Tools package. In the 500 samples, the maximum number of loci matching between any 
two samples was 9 out of 22 loci (40% of the 22 loci), which was observed in two sample 
pairs. One pair of sequences showed partial matching (i.e. one of the two alleles) at 20 
out of 22 loci.  This illustrates the power of the additional loci for human identification 
and kinship testing (Table 5.9) (Alsafiah et al. 2019a). 
To assess the SureID®23comp for kinship testing, a typical paternity case (an alleged 
father, a child and a known mother) was assumed, and the combined typical paternity 
index (CPI) of 93,835,307.21 was used to calculate the paternity probabilities with 
different prior probabilities (Pr): 0.90, 0.50 and 0.10. Assuming that all loci are within 
HWE, the probabilities of paternity were 99.99999988% (Pr = 0.90), 99.99999893% (Pr 
= 0.50) and 99.99999041% (Pr = 0.10), which are higher than those probabilities 
calculated when using the GlobalFiler™ kit and the currently used kit in Saudi Arabia 
(Table 3.5)(Alsafiah et al. 2019a). 
The ForenSeqTM DNA Signature Prep (Verogen), when combining the 94 SNPs and the 
27 STRs, has shown much higher CMP of 10E-67 to 10E-69 (length-based STRs calls) and 
of 10E-71 to 10E-74 (sequence-based STRs calls), where the CMP of the 94 SNPs alone 
were (10E-38 to 10E-35) (Churchill et al. 2017). In addition, using MPS systems in kinship 
testing could help in tracking mismatches between tested individuals that have occurred 
due to mutation in the binding sites of primers (Li, R. et al. 2019). However, this requires 
additional technology to be implement and is currently not available in many countries 





Table 5.9. The maximum of matched loci per any sample pair within the 500 samples. In the 500 samples, only two pairs of samples showed full matching in 9 loci (i.e. both alleles). 
This was the maximum number of matched loci (shaded row). One pair of sequences showed partial matching (i.e. one of the two alleles) at 20 out of 22 loci (shaded column). This 
table was generated by the R studio using the package of DNA tools (Alsafiah et al. 2019a). 























 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
0 0 0 2 11 29 114 320 730 1395 2219 3194 3689 3493 2820 2032 1065 494 194 57 19 1 0 0 
1 0 0 0 19 90 309 768 1816 3296 5036 6509 6769 6069 4408 2663 1264 448 133 24 5 0 0  
2 0 1 2 26 114 389 1060 2212 3588 5336 6016 5716 4473 2852 1450 565 189 39 7 0 0   
3 0 0 4 22 98 333 792 1660 2456 3269 3452 2811 1927 1019 469 158 35 8 2 0    
4 0 0 3 18 68 179 409 757 1081 1299 1183 899 517 268 76 20 4 0 0     
5 0 0 0 12 20 83 179 272 348 364 278 194 124 26 7 0 1 0      
6 0 0 1 6 8 26 53 63 89 85 49 25 9 0 1 0 0       
7 0 0 1 0 1 8 11 17 24 15 6 1 1 1 0 0        
8 0 0 0 1 1 3 2 1 2 0 0 0 0 0 0         
9 0 0 0 0 0 0 0 0 1 0 0 1 0 0          
10 0 0 0 0 0 0 0 0 0 0 0 0 0           
11 0 0 0 0 0 0 0 0 0 0 0 0  
 
         
12 0 0 0 0 0 0 0 0 0 0 0  
13 0 0 0 0 0 0 0 0 0 0   
14 0 0 0 0 0 0 0 0 0    
15 0 0 0 0 0 0 0 0     
16 0 0 0 0 0 0 0      
17 0 0 0 0 0 0       
18 0 0 0 0 0                  
19 0 0 0 0                   
20 0 0 0                    
21 0 0                     






5.5.9 Population comparison 
Recently, the kit was used to generate population genetic data for three main 
populations European, South Asian and African (Iyavoo et al. 2019). The data of the 
three populations, and the Ningbo population (China, data provided by the Health Gene 
Technologies) were compared to the data generated by this study. Arlequin v 3.5.2 was 
used to estimate the distance between all populations by calculating the FST values and 
to carry out the population differentiation exact test. 
The FST values showed that the European and South Asian populations were more 
similar to Saudi population than the African and Ningbo populations (Figure 5.14). 
 
Figure 5.14. Multi-dimensional scaling for the average FST values. Five populations were included in the 
comparison and each number represent a population, Saudi Arabia (this study), European (Iyavoo et al. 
2019), African (Iyavoo et al. 2019), South Asian (Iyavoo et al. 2019) and Ningbo population (data provided 
by the Health Gene Technologies). The European and South Asian populations were more similar to Saudi 
population than the African and Ningbo populations. The cmdscale function was used in R software to 




The P values of the exact test showed concordant result with the FST value estimates. 
The European population (Figure 5.14) had the lowest number of STRs with significant 
difference 15/22 loci (P value < 0.05) and South Asian population (Figure 5.14) had 16/22 
loci. The African (Figure 5.14) and Ningbo population (Figure 5.14) had more loci with 
significant difference of 21/22 and 18/22 respectively.  
Table 5.10. Population differentiation exact test results using the Arlequin v3.5.2 Software. Shaded data 
indicates significant differences (P value ˂ 0.05). European and South Asian populations showed lower 
number of STRs with significant difference.  
 D18S1364 D1S1656 D13S325 D5S2800 D9S1122 
European 0.00000+-0.0000 0.00000+-0.0000 0.00015+-0.0001 0.00000+-0.0000 0.01569+-0.0034 
African 0.00000+-0.0000 0.00000+-0.0000 0.00689+-0.0029 0.00000+-0.0000 0.00000+-0.0000 
South Asian 0.03643+-0.0041 0.00000+-0.0000 0.02873+-0.0121 0.00002+-0.0000 0.15175+-0.0248 
Ningbo 0.00000+-0.0000 0.00000+-0.0000 0.60367+-0.0282 0.00000+-0.0000 0.00000+-0.0000 
      
 D4S2366 D3S1744 D12S391 D11S2368 D21S2055 
European 0.00000+-0.0000 0.51861+-0.0200 0.00000+-0.0000 0.19631+-0.0167 0.00000+-0.0000 
African 0.00000+-0.0000 0.00059+-0.0004 0.00000+-0.0000 0.00000+-0.0000 0.00000+-0.0000 
South Asian 0.00184+-0.0008 0.00195+-0.0009 0.00000+-0.0000 0.20596+-0.0118 0.00000+-0.0000 
Ningbo 0.00000+-0.0000 0.21489+-0.0195 0.00000+-0.0000 0.00000+-0.0000 0.00000+-0.0000 
      
 D20S482 D8S1132 D7S3048 D2S441 D19S253 
European 0.61243+-0.0130 0.35328+-0.0362 0.01699+-0.0085 0.00018+-0.0002 0.10409+-0.0086 
African 0.11142+-0.0199 0.00000+-0.0000 0.00000+-0.0000 0.00000+-0.0000 0.00000+-0.0000 
South Asian 0.83443+-0.0185 0.00889+-0.0018 0.00000+-0.0000 0.00000+-0.0000 0.53261+-0.0272 
Ningbo 0.00201+-0.0008 0.08212+-0.0123 0.00000+-0.0000 0.00000+-0.0000 0.00111+-0.0003 
      
 D10S1248 D17S1301 D22GATA198B05 D16S539 D6S474 
European 0.00000+-0.0000 0.11679+-0.0122 0.00002+-0.0000 0.00452+-0.0012 0.00000+-0.0000 
African 0.00000+-0.0000 0.00000+-0.0000 0.00196+-0.0005 0.02100+-0.0044 0.00000+-0.0000 
South Asian 0.00000+-0.0000 0.00164+-0.0008 0.00000+-0.0000 0.07688+-0.0085 0.00000+-0.0000 
Ningbo 0.00000+-0.0000 0.00000+-0.0000 0.00000+-0.0000 0.00000+-0.0000 0.00000+-0.0000 
 
     
 D14S1434 D15S659  
European 0.00025+-0.0001 0.07551+-0.0113  
African 0.00001+-0.0000 0.00000+-0.0000  
South Asian 0.00000+-0.0000 0.09918+-0.0144  






5.5.10 STRidER quality control 
The data of the 17 non-CODIS STRs was sent to STRidER (Bodner et al. 2016) for 
quality control check. The data was approved and was given a dataset reference number 
of STR000178 (Appendix 4). 
5.6 Conclusion 
The SureID® 23comp was validated following the minimum criteria for validation 
recommended by the ENFSI and the SWGDAM for forensic applications as a 
supplementary kit with an exception of mixture studies that were not carried out as the 
kit is specifically designed to be used in complex kinship testing. The kit is reproducible, 
precise, accurate and reliable for forensic application as a supplementary kit and for 
databasing. The validation included a clarification of the correct identity of the D5 locus 
which is D5S2800 not D5S2500 that is now updated in the panels and supporting 
documents of the kit (Alsafiah et al. 2019a). The sensitivity tests demonstrated the 
capability of generating a full profile below the recommended DNA input but showed 
that the kit was less sensitive compared to other commonly used kits with degraded 
samples, which was at least in part because of the lower volume of template that can 
be added. Therefore, the kit can benefit from increasing the concentration of the 
reaction mix allowing more space for DNA input to 15 µl rather than 6.25 µl (Alsafiah et 
al. 2019a). In addition, including additional alleles and allele variations in the available 
spaces of the allelic ladder will allow specific allele designation and will minimise the 
need to re-run undesignated alleles (Alsafiah et al. 2019a).  
The kit was evaluated for the population of Saudi Arabia and showed that the 22 STRs 
provided a CMP of 7.4E−27; the 17 non-CODIS loci alone provided 1.2 E-20 CMP. When 




Apart of SE33, the kit includes the four most informative loci that have been studied for 
the population of Saudi Arabia (D21S2055, D12S391, D7S3048, and D1S1656), two of 
which are included in the GlobalFiler kit. The kit achieved a CPI of 93,835,307.21 that is 
two times higher the CPI recorded for the GlobalFiler™ kit and allowed higher paternity 
probability of 99.99999893% (Pr = 0.5) (Alsafiah et al. 2019a). The study provides allele 
frequency data for additional 17 STRs that can be used to estimate the profile 
frequencies in Saudi Arabia. 
Four populations were included in the population comparison by which the European 
and South Asian populations were, as expected, more similar to the Saudi population 
than the African and Ningbo populations. 
Overall, this study evaluates the utility of the SureID® 23comp as a supplementary kit 
for kinship testing and determined that the kit met the criteria commonly used in 
forensic genetics laboratories.  The kit allows the analysis of 17 non-CODIS loci and 
increases likelihood ratios, and thereby has the potential to increase the level of 




6 Chapter Six: Population Genetic Data For 122 DNA Markers for The 
Saudi Arabian Population Using the ForenSeq™ DNA Signature Prep 
Kit. 
6.1 Overview of experiment  
Massively Parallel Sequencing (MPS) systems are now being adopted in many forensic 
laboratories generating detailed sequence data for different types of markers 
simultaneously. The ForenSeq™ DNA Signature Prep Kit allows sequencing >150 (Primer 
Mix A) or >230 markers (Primer Mix B) where users can decide which primer mix will be 
used (Table 1.5) (Alsafiah et al. 2019b). Libraries can be sequenced on the MiSeq FGx 
instrument and the data analysed using ForenSeqTM Universal Analysis Software (UAS). 
The system had been under extensive evaluation to measure reliability, reproducibility, 
sensitivity, mixture discrimination capability and to investigate concordance with CE 
systems (Xavier and Parson 2017, Almalki et al. 2017, Devesse et al. 2018, Köcher et al. 
2018). In addition, the system provides higher degree of recovery from degraded 
samples (Almohammed et al. 2017), and improves the resolution in relationship testing 
(Ma et al. 2016, Li, R. et al. 2019) more than the CE systems do.  
The system was employed to solve the first court Dutch case where the CE system 
used concluded inconclusive DNA evidence. In addition, the Institut National de Police 
Scientifique (INPS, France) has implemented the system for casework in 2017 and 
started to feed the national databased in 2018. In April 2019, the SWGDAM extended 
the guidelines to cover the interpretation of STR data generated by MPS systems 
(SWGDAM 2019). As a result, Verogen’s MPS system is now approved by the FPI and the 
company has initiated a collaboration with Cellmark laboratories to establish an MPS 




Although MPS systems are well established for medical research in Saudi Arabia 
through the Saudi Human Genome Project (SHGP) launched in 2013 (Abedalthagafi 
2019) and released about 109 publications up to date 
(https://genomics.saudigenomeprogram.org/en), the systems have not been used for 
forensic applications.  
So far, little data has been published about the Middle East region (136 samples) 
(Phillips et al. 2018a), one study was about the population of Saudi Arabia (89 samples) 
(Khubrani et al. 2019b), and one study about the Qatari population (150 samples) 
(Almohammed and Hadi 2019). Despite that the Saudi population has been studied 
using this kit (Khubrani et al. 2019b), STRs like D12S391, D2S1338 and D21S11 have 
shown higher number sequence-based variants for the same sized-based allele that 
necessitates sequencing more samples to generate better allele frequencies estimates 
(Gettings et al. 2016, Gelardi et al. 2014). In addition, sequence-based data for SE33, 
which is included in the kit but not reported by the ForenSeqTM UAS, has not been 
studied (Alsafiah et al. 2019b). 
6.2 Aims of the study 
The main aim of this part is to generate sized-based Saudi population data for four 
additional STRs (PentaE, PentaD, D6S1043, and D4S2408), which is not provided by STR 
kits used in previous chapters (Chapters 3 and 5), and for 94 identity informative SNPs 
(iiSNPs) (Table 6.1). The second aim was to generate and sequence‐based data for 
autosomal DNA markers combined in the ForenSeq™ DNA Signature Prep Kit including 
the SE33 locus. Both types of data will be statistically evaluated for forensic applications 




disequilibrium (LD) and other forensic parameters. Lineage makers included in the kit (7 
X-STRs and 24 Y-STRs) were not part of the project and were not analysed. 
Finally, reporting any novel allele sequences and novel variants in the flanking region 
that were observed in the Saudi population. 
Table 6.1. Identity informative SNPs included in the ForenSeq™ DNA signature prep kit. The table shows the 












rs10495407 109 1  rs917118 109 7 rs1528460 115 15 
rs1294331 85 1  rs10092491 116 8 rs1821380 118 15 
rs1413212 64 1  rs2056277 104 8 rs8037429 63 15 
rs1490413 98 1  rs4606077 151 8 rs1382387 89 16 
rs560681 90 1  rs763869 85 8 rs2342747 104 16 
rs891700 115 1  rs1015250 117 9 rs430046 119 16 
rs1109037 118 2  rs10776839 103 9 rs729172 104 16 
rs12997453 100 2  rs1360288 119 9 rs740910 113 17 
rs876724 119 2  rs1463729 99 9 rs8078417 143 17 
rs907100 115 2  rs7041158 115 9 rs938283 98 17 
rs993934 120 2  rs3780962 94 10 rs9905977 170 17 
rs1355366 119 3  rs735155 170 10 rs1024116 98 18 
rs1357617 120 3  rs740598 120 10 rs1493232 75 18 
rs2399332 157 3  rs826472 153 10 rs1736442 153 18 
rs4364205 98 3  rs964681 105 10 rs9951171 119 18 
rs6444724 120 3  rs10488710 118 11 rs576261 76 19 
rs1979255 102 4  rs1498553 111 11 rs719366 170 19 
rs2046361 120 4  rs2076848 118 11 rs1005533 158 20 
rs279844 167 4  rs901398 90 11 rs1031825 126 20 
rs6811238 120 4  rs10773760 99 12 rs1523537 117 20 
rs13182883 169 5  rs2107612 103 12 rs445251 119 20 
rs159606 104 5  rs2111980 94 12 rs221956 97 21 
rs251934 97 5  rs2269355 65 12 rs2830795 114 21 
rs338882 157 5  rs2920816 157 12 rs2831700 79 21 
rs717302 110 5  rs1058083 76 13 rs722098 101 21 
rs13218440 170 6  rs1335873 109 13 rs914165 156 21 
rs1336071 120 6  rs1886510 116 13 rs1028528 78 22 
rs214955 120 6  rs354439 170 13 rs2040411 68 22 
rs727811 115 6  rs1454361 118 14 rs733164 120 22 
rs321198 165 7  rs4530059 170 14 rs987640 120 22 
rs6955448 120 7  rs722290 101 14    
rs737681 120 7  rs873196 114 14    
 
6.3 Objectives 
9- Prepare the samples for the library preparation stage by bringing the 
concentrations to 0.2 ng/µl. 
10- Library preparation using the ForenSeq™ DNA Signature Prep Kit following the 




normalised library (PNL) that was increased to 12 µl as used in (Devesse et al. 
2018). 
11- Sequencing the libraries using a MiSeq FGx™ instrument following the 
manufacturer’s protocol (Verogen 2018c). 
12- Use the ForenSeqTM UAS following the manufacturer’s default setting (Verogen 
2018b) for the data analysis and for generating the samples’ reports and the 
Flanking Region Report. 
13- Additional analysis using the STRait Razor v3.0 (SR) (Woerner et al. 2017) for 
bioinformatical concordance, flanking region variants not highlighted by the 
ForenSeq™ UAS, and for SE33 sequence-based data. 
14- Study the sequence variants generated by this study and compare them with 
previously reported variants in the Middle East region (Phillips et al. 2018a), in 
the Saudi Arabian population (Khubrani et al. 2019b) and in the Qatari population 
(Almohammed and Hadi 2019). This is for reporting any specific population 
variants and to assess the novelty of any sequence-based allele. 
15- A statistical evaluation for the size-based, sequence-based data (repeat region 
sequences and repeat + flanking regions) for the population of Saud Arabia. 
6.4 Materials and Methods 
This chapter focused on aSTRs (Table 1.5) and iiSNPs (Table 6.1) included in the 
ForenSeq™ DNA Signature Prep Kit. As SE33 data can be obtained from the FASTAQ files 
using the STRait Razor (SR), the SE33 data was analysed too. However, the results of the 
SE33 analysis will be in a separate sub-heading (Section 6.5.7). Materials and methods 





 A total of 94 male samples from the population of Saudi Arabia were diluted to the 
appropriate concentrations. A positive and negative controls were also added (96 
samples in total), and libraries were prepared for the pooling step. Libraries were then 
pooled, denatured, transferred to the reagent cartridge, and were sequenced on the 
MiSeq FGx instrument.  
6.5.1 Run metrics, sequencing results, and depth of coverage (DoC) 
The run metric indicators showed 958 K/mm² cluster density, 91.98% of clusters 
passed the Illumina chastity filter, 0.188% for phasing, and 0.097% for pre-phasing. 
These figures are within the recommended values that are 400–1650 K/mm², ≥ 80%, ≤ 
0.25%, and ≤ 0.15% respectively (Verogen 2018b). In addition, quality metric of the run 
showed that all indicators (read 1, read 2, index 1 and index 2) passed the quality filter 
(Figure 6.1).  
 
Figure 6.1.Run metric indicators of the sequencing results. The indicators of the sequencing showed that 




The 96 samples were sequenced, and 121 autosomal DNA markers were analysed 
using the ForenSeq™ UAS. The positive control showed a full profile for the 121 loci 
analysed and the negative control sample performed as expected. Seven out of the 94 
samples were eliminated after the primary analysis due to poor coverage, while the rest 
(87 samples) were further analysed.  
This study was able to achieve full profiles in 76/87 samples using the default setting 
of analytical threshold (AT) and interpretation threshold (IT). Table 6.2 summaries the 
11 samples that showed incomplete profiles. 
Table 6.2. Samples with partial DNA profiles for the 27 aSTRs and the 94 iiSNPs. Shaded cells represent 
sequences below the default thresholds. All samples presented here had lower average reads count 
comparing to other sample. This has led to allele drop out in PentaE, rs1357617, rs2920816, and rs1736442. 
The D22S1045 was previously genotyped in Chapter 3 and all samples presented in the table had 
heterozygous genotypes. Due to the lower coverage of samples presented here and the lower allele count 
ratio (ACR) feature of D22S1045, the absence of the second allele in samples 4,7 and 10 was considered as 
alleles drop out not discordance.  
sample 
PentaE D22S1045 rs1357617 rs2920816 rs1736442 
Allele 1 Allele 2 Allele 1 Allele 2 Allele 1 Allele 2 Allele 1 Allele 2 Allele 1 Allele 2 
1           
2           
3           
4           
5           
6           
7           
8           
9           
10           
11           
 
The average of total number of reads for autosomal markers analysed in this study 
was 72,166 per sample. The average reads count for aSTRs ranged from 2936 for the 
TH01 to 173 reads for the D5S818 (Figure 6.2) and for iiSNPs it ranged from 1320 for 






Figure 6.2. Depth of coverage for 27 aSTRs analysed in this study. The average reads count was 673 for all aSTRs that ranged from 173 reads for D5S818 to 2936 reads for TH01. In 
the box plots, the lower whisker represents 25% of the lowest data, the upper whisker represents 25% of the highest data. The rectangle shows that 75% of the data are below the 





Figure 6.3. Depth of coverage for 94 iiSNPs analysed in this study. The average was 120 reads for all iiSNPs that ranged from 36 for rs1736442 to 1320 reads for rs1109037. In the 
box plots, the lower whisker represents 25% of the lowest data, the upper whisker represents 25% of the highest data. The rectangle shows that 75% of the data are below the 




Allele count ratio (ACR) is an alternative description of heterozygous balance in CE 
systems. All aSTRs showed >60% ACR where the D17S1301 showed 92.5% as the highest 
ACR average, D22S1045 had the least ACR average of 65.5% and the rest of aSTRs were 
from 73.7% to 90.7% ACR (Figure 6.4). Remarkably, four heterozygous samples at 
D22S1045 showed lower ACR (2.78% to 13.90%), two of which had higher stutter ratios 
of the smaller allele than the ACRs of the true alleles (Table 6.3).  
 Table 6.3. The four samples that showed lower ACRs at D22S1045. The table shows the CE data, ForeSeq 
data (including the true alleles, coverage and the ACRs) and the n-4 stutter of allele 1 (including coverage of 
the -4 stutter and stutter ratios). The four samples showed relatively lower ACRs, two of which (shaded rows) 
had stutter ratios of the n-4 stutter of allele 1 greater than the ACR of the second true allele (allele 2). 
CE data  ForenSeq data  n-4 Stutter of Allele 1 
Allele 1 Allele 2  Allele 1 Coverage 1 Allele 2 Coverage 2 ACR  Coverage  Stutter Ratio 
11 15  11 1149 15 32 2.78%  39 3.40% 
11 16  11 1330 16 40 3%  50 3.80% 
11 16  11 3486 16 486 13.90%  116 3.30% 
11 16  11 2838 16 312 10.90%  94 3.30% 
 
The average ACR of all iiSNPs were >60% with an exception of the rs6955448 SNPs 





















The stutter ratios for the 27 aSTRs were assessed that ranged from 0.6% for allele 6 
in TPOX to 31.4% for allele 30 in FGA (Figure 6.6). In addition, allele variations of x.1, x.2 
and x.3 showed less stutter ratios, as expected, comparing to the ratios of x-1, x-2, and 
x-3 alleles respectively. 
6.5.2 Sequence variations 
All sequence-based data are presented in Appendix 5 using the default output of the 
UAS software. A total of 638 sequence-based alleles (396 from the aSTRs and 242 alleles 
from the iiSNPs) were observed in this study (Appendix 5). This represents an average 
increase of 53.4% in the number of observed alleles for the aSTRs and 28.7% for iiSNPs.  
Nineteen aSTRs presented greater number of observed alleles, 13 of which had more 
alleles based on the repeat region sequences and 8 of which had more alleles based on 
the flanking region sequences (two aSTRs had variants in both regions) (Figure 6.7). 
Examining the repeat region variations, the D2S1338 locus showed 181.8% the highest 
percentage of increase in the number of observed alleles (31 sequences and had 11 
alleles based on the size) and the D12S391 locus showed the greatest number of 
observed alleles of 43 sequences (168.75% increase). Allele 23 at D12S391 reported the 
highest number of observed sequences (seven variants) (Appendix 5). By including the 
flanking regions, D21S11, D7S820, D2S441, D16S539, D20S482, D5S818, D13S317 and 
PentaD showed more alleles (Figure 6.7). D7S820 had 100% more alleles due to the 
presence of two SNP variants, rs7789995-T (GRCh38-Chr7:84160204) in 10/14 
sequences and rs16887642-T (GRCh38-Chr7:84160286) in 3/14 sequences (one allele 





Figure 6.6. Averages of stutter ratios for the 27 aSTRs. Each STR is represented by a plot and the x-axis represents alleles and the y-axis represent stutter ratios. Stutter ratios ranged 





Figure 6.7. The number of observed alleles by sequencing. Nineteen aSTRs presented a greater number of observed alleles, 13 of which had more alleles based on the repeat region 
sequences (green), 8 aSTRs had more alleles based on the flanking region sequences (red) (two aSTRs had variants in both regions), and 8 aSTRs did not show difference in the 




For the iiSNPs, 37/94 had more allele sequences per locus where rs1109037, 
rs8078417 and rs876724 had the greatest number of observed sequences of 7, 5 and 5 
sequence variants respectively (Appendix 5). Some iiSNPs had additional variants at the 
flanking regions covered in the Flanking Region Report; however, they showed no 
additional alleles or showed a smaller number of alleles comparing to other iiSNPs with 
the same number of variants per amplicon. This was due to association between the 
target iiSNPs and variants in the flanking region (allele of one SNP perfectly predicts an 
allele of another SNP).  Perfect associations were observed between rs6955448-T with 
rs6950322-A, between rs6955448-C with rs6950322-G; between rs430046- C with 
rs409820-C and rs430044-C, between rs430046-T with rs409820-A and rs430044-T, 
leading to the observation of only two alleles in both target iiSNPs (target SNP is 
underlined) (Table 6.4). Another associations between rs4606077-T with rs1869434-G, 
between rs4606077-C with rs1869434-A; between rs445251-G with rs369438-G, and 
between rs445251-C with rs369438-A, resulting in a smaller number of observed alleles 
comparing to other iiSNPs with the same number of variants per amplicons (target SNP 
is underlined) (Table 6.4).  
Table 6.4. Perfect association between the target iiSNPs and variants in the flanking region. This table shows 
association that was noticed between the target iiSNPs and variants in the flanking region. Black colour 
indicates the target iiSNPs and the blue colour indicates variants within the flanking region. SNPs that 
showed perfect association are underlined. 
Target iiSNP Microhaplotype iiSNP and Variant Reference SNP 
rs6955448 A G A T rs6950322_rs140855431_rs143117431_rs6955448 
G G A C rs6950322_rs140855431_rs143117431_rs6955448 
rs430046 C C C rs409820_rs430044_rs430046 
A T T rs409820_rs430044_rs430046 
rs4606077 T T G rs4606077_rs58774517_rs1869434 
T T G rs4606077_rs58774517_rs1869434 
T T G C rs4606077_rs58774517_rs1869434_rs975955864 
C C A rs4606077_rs58774517_rs1869434 
rs445251 C T G G rs117702247_rs535095356_rs445251_rs369438 
C T C A rs117702247_rs535095356_rs445251_rs369438 




Fourteen variants at the flanking regions of two aSTRs (PentaD, D21S11) and of 12 
iiSNPs rs1109037 (two variants), rs1979255, rs917118, rs4606077, rs1015250, 
rs735155, rs1335873, rs8078417, rs1523537, rs914165 and rs733164, were reported by 
the UAS but were not highlighted (Table 7.5). These variants were reported by the SR as 
“Novel Sequences”, eleven of which already have rs identifiers in the dbSNP database, 






Table 6.5. Variants at the flanking region of two aSTRs and of 11 iiSNPs. The table shows 14 variants identified in this study which were reported by the UAS but were not highlighted in 
blue. The table presents the marker’s name, allele call (CE), rs identifiers if exist, GRCh37 location reported by the UAS, number of observation (Obs. #), and the comprehensive 
nomenclature as recommended by the ISFG (Parson et al. 2016). It also indicates if a variant was previously observed in the Saudi population (Khubrani et al. 2019b) or not. Variants in 
black are the target iiSNPs, in blue variants that were highlighted by the UAS and in red variants that were reported by the UAS in the Flanking Region Report but were not highlighted in 
blue (see Table 1.6). N/A: no rs identifier were found for the correspondence variant at the dbSNP database. None of these variants was observed in the data of the Qatari population 





r Targeted Marker  Variants in the flanking region not highlighted by the UAS Observation in Saudi 
population (Khubrani 
et al. 2019b) Name Allele 
 
rs identifier GRCh37 location Obs. # Comprehensive nomenclature as recommended by the ISFG 
aS
TR
 PentaD 8  rs927345580 Chr21:45056053 1 PentaD [CE 8]-GRCh38-Chr21-43636100-43636278 (AAAGA)8 rs927345580-C G>C (Not observed) 
D21S11 32.2 
 
N/A Chr21: 20554428 1 
D21S11 [CE 32.2]-GRCh38-Chr21-19181939-19182111 (TCTA)5 (TCTG)6 (TCTA)3 TA (TCTA)3 TCA (TCTA)2 TCCA TA 
(TCTA)12 TA TCTA 19182110-C 








N/A Chr.2:10085752 1 rs1109037 [CE G]-GRCh38-Chr2:9945582-9945659 rs1109037-G; 9945623-G; rs183533496-C; rs1109038-G A>G (Not observed) 
G 
 
rs999755320 Chr.2:10085721 2 rs1109037 [CE G]-GRCh38-Chr2:9945582-9945659 rs999755320-T; rs1109037-G; rs183533496-C; rs1109038-G C>T (observed) 
rs1979255 G 
 
rs190924736 Chr.4:190318065 1 rs1979255 [CE G]-GRCh38-Chr4:189396884-189396929 rs1979255-G; rs190924736-T C>T Not observed 
rs917118 T 
 
rs1431710768 Chr.7:4456981 1 rs917118 [CE T]-GRCh38-Chr7:4417342-4417409 rs917118-T; rs1431710768-C A>C (Not observed) 
rs4606077 T  rs975955864 Chr.8:144656787 1 rs4606077 [CE T]-GRCh38-Chr8:143574562-143574669 rs4606077-T; rs58774517-C; rs1869434-G; rs975955864-C G>C (Not observed) 
rs1015250 C 
 
rs1307278892 Chr.9:1823783 1 rs1015250 [CE C]-GRCh38-Chr9:1823726-1823793 rs6475200-G; rs1015250-C; rs1307278892-C, rs145984676-C G>C (observed) 
rs735155 A 
 
rs1003612513 Chr.10:3374201 1 
rs735155 [CE A]-GRCh38-Chr10:3331961-3332088 rs1003612513-A; rs79799511-G; rs735155-A; rs373487413-A; 
rs7905965-T 
G>A (Not observed) 
rs1335873 A 
 
rs1021428287 Chr.13:20901709 1 rs1335873 [CE A]-GRCh38-Chr13:20327551-20327614 rs1335873-A; rs1021428287-T G>T (Not observed) 
rs8078417 C 
 
N/A Chr.17:80461911 1 
rs8078417 [CE C]-GRCh38-Chr17:82503992-82504093 rs78650971-G; rs182919351-C; rs567092265-C; 
rs138630479-G; 82504035-T; rs559299986-G; rs8078417-C 
C>T (Not observed) 
rs1523537 C 
 
N/A Chr.20:51296113 1 rs1523537 [CE C]-GRCh38-Chr20:52679563-52679632 52679574-G; rs538906241-G; rs77195753-A; rs1523537-C T>G (Not observed) 
rs914165 A 
 
rs192267746 Chr.21:42415913 1 rs914165 [CE A]-GRCh38-Chr21:41043962-41044005 rs192267746-C; rs914165-A; rs755095-C G>C (Not observed) 




6.5.3 The impact of sequence variations on discrimination power and heterozygosity  
Using the size-based data, the PoD of the 19 aSTRs ranged from 84.9% for D9S1122 
to 98.3% for PentaE with an average of 92.7%, while it ranged from 88.1% for CSF1PO 
to 99.3% for D12S391 with an average of 95.9% using the sequence-based data. The 
number of aSTRs that had > 90% power of discrimination (PoD) was increased from 
17/27 to 21/27 with sequencing. The PoD improvement in the 19 aSTRs, with additional 
alleles observed by sequencing, ranged from 11.67% for D9S1122 (PoD from 84.9% to 
94.9%) to 0.004% for PentaD (PoD from 95.65377% to 95.65789 %). PentaE was the most 
informative locus with the CE data (98.3% PoD), but the sequence-based data showed 
that D12S391 (99.3% PoD) and D2S1338 (98.6% PoD) have become more informative 
(Figure 6.8). 
Using the size-based data, the PoD of the 37 iiSNPs ranged from 47.3% for rs740910 
to 62.5% for rs560681 with an average of 59.7%, while it ranged from 55.2% for 
rs1015250 to 86.6% for rs1109037 with an average of 66.7% using the sequence-based 
data (Figure 6.9). The improvement ranged from 51.9% for rs876724 (PoD from 52.5% 
to 79.9%) to 1.26% for rs733164 (PoD from 59.5% to 60.2%). 
Despite the increase in the observed alleles by sequencing in the 19 aSTRs, the 
heterozygosity was improved in 17 aSTRs. The heterozygosity was increased by 22.95% 
(from 70.1% to 86.2%) at D13S317 as the highest improvement, while no improvement 
was observed in D19S433 and PentaD. Twenty-seven iiSNPs showed an increased 
heterozygosity, three of which had >50% increase: rs876724 (75.8%), rs9905977 (67.7%) 














Linkage disequilibrium (LD) was tested for 292 pairs of syntenic markers (STR-STR, 
STR-SNP and SNP-SNP) and no linkage was detected within tested loci after Bonferroni 
correction (P value > 0.0001) (Appendix 5, Table 10.9). 
6.5.4 Evidence of consanguinity and HWE 
This study showed some level of consanguinity in our data set due the excess of 
homozygosity in 21/27 aSTRs (size-based data), 22/27 (repeat region sequence) and 
23/27 (repeat and flanking regions); 66/94 (CE data) and 68/94 (including the flanking 
region) for the iiSNPs. This manifestation of consanguinity was supported by the 
estimation of the in inbreeding coefficient (FIS) of 0.03924. However, none of the 
analysed markers showed significant deviation from HWE after Bonferroni correction (P 
value>0.0004) (Appendix 5, Table 10.5 and Table 10.8). 
6.5.5 Novel sequences 
The novelty assessment was initiated by the SR database, by which 33 alleles were 
labelled as novel sequences (Table 6.6). Twelve of the alleles were previously reported 
in Phillips et al. (2018a), Almohammed and Hadi (2019) and/or Khubrani et al. (2019) 
(2019b), where the majority (11/12) were mainly observed in the Middle Eastern data 
set (Phillips et al. 2018a), the Saudi population (Khubrani et al. 2019b), and/or Qatari 
population (Almohammed and Hadi 2019). The novelty of the rest of alleles (21 alleles) 
were further assessed using the GenBank database, by which 8/21 alleles were reported 
in the GenBank database (Table 6.6). Therefore, this study reported 13 novel sequences, 





 Table 6.6. Novel alleles observed in the population of Saudi Arabia. The table show 33 novel alleles assessed based on the SR database. Shaded alleles are novel and have not been 
observed in  (Phillips et al. 2018a, Khubrani et al. 2019b, Almohammed and Hadi 2019) or in the GenBank. The reason of the novelty types is also shown: repeat sequence (RS) and 
flanking region sequence (FS).  
 
Nomenclature Type Obs. # 
Observations  
Qatari population Phillips et al. (2018) Saudi population GenBank 
D2S441 [CE 9]-GRCh38-Chr2-68011918-68012017 (TCTA)9 RS 1 - ME/EUR/AFR/EA Observed MH167314 
D2S441 [CE 9]-GRCh38-Chr2-68011918-68012017 (TCTA)9 68011922-A (rs74640515) FS 1 - - - MK570007 
D2S1338 [CE 14]-GRCh38-Chr2-218014856-218014964 (GGAA)8 (GGCA)6 RS 3 - - - MK569967 
D2S1338 [CE 20]-GRCh38-Chr2-218014856-218014964 (GGAA)6 GAAA (GGAA)5 (GGCA)8 RS 1 - - - - 
D2S1338 [CE 21]-GRCh38-Chr2-218014856-218014964 (GGAA)12 (GGCA)9 RS 1 - - - MH105157 
D2S1338 [CE 24]-GRCh38-Chr2-218014856-218014964 (GGAA)2 GGAC (GGAA)16 (GGCA)5 RS 1 - - - MK569981 
D3S1358 [CE 16]-GRCh38-Chr3-45540691-45540820 TCTA (TCTG)2 TCTC (TCTA)12 RS 1 - ME - - 
D3S1358 [CE 17]-GRCh38-Chr3-45540691-45540820 TCTA (TCTG)2 TCTC (TCTA)13 RS 1 Observed ME/SCA Observed MK990348
.1 D3S1358 [CE 18]-GRCh38-Chr3-45540691-45540820 TCTA (TCTG)2 TCTC (TCTA)14 RS 1 Observed - Observed MK990350
.1 D3S1358 [CE 18.2]-GRCh38-Chr3-45540691-45540820 TCTA (TCTG)3 TC (TCTA)14 RS 1 - - - MK990351 
CSF1PO [CE 12]-GRCh38-Chr5-150076318-150076389 ATCT ACCT (ATCT)10 RS 4 - ME Observed - 
D6S1043 [CE 12.3]-GRCh38-Chr6-91740160-91740292 (ATCT)8 ATC (ATCT)4 RS 1 - - - - 
D9S1122 [CE 7]-GRCh38-Chr9-77073809-77073880 (TAGA)7 RS 1 - - - - 
D10S1248 [CE 9]-GRCh38-Chr10 129294226-129294318 (GGAA)9 RS 2 Observed AFR/ME Observed MH167056
.1 vWA [CE 13]-GRCh38-Chr12-5983950-5984049 (TAGA)3 TGGA (TAGA)3 (CAGA)4 (TAGA)2 5983970-G (rs75219269) FS 1 - - - MK569942
.1 vWA [CE 17]-GRCh38-Chr12-5983950-5984049 (TAGA)11 (CAGA)5 TAGA RS 1 - SCA/AFR - MH167086 
D12S391 [CE 18]-GRCh38-Chr12-12296981-12297168 (AGAT)10 (AGAC)8 RS 1 - - - MH167121 
D12S391 [CE 19]-GRCh38-Chr12-12296981-12297168 (AGAT)9 (AGAC)9 AGAT RS 1 - ME - MK569923
.1 D12S391 [CE 23]-GRCh38-Chr12-12296981-12297168 (AGAT)16 (AGAC)6 AGAT RS 1 - - - - 
D12S391 [CE 23]-GRCh38-Chr12-12296981-12297168 (AGAT)15 (AGAC)7 AGAT RS 1 - ME - MK569936
.1 D12S391 [CE 26]-GRCh38-Chr12-12296981-12297168 (AGAT)17 (AGAC)8 AGAT RS 1 - - Observed MH167197
.1 D12S391 [CE 27]-GRCh38-Chr12-12296981-12297168 (AGAT)18 (AGAC)8 AGAT RS 1 - EA - MH167200
.1 PentaE [CE 14.4]-GRCh38-Chr15-96830996-96831114 (TCTTT)14 TCTT RS 1 - - - - 
PentaE [CE 16.4]-GRCh38-Chr15-96830996-96831114 (TCTTT)16 TCTT RS 3 - ME/SCA Observed - 
PentaE [CE 17]-GRCh38-Chr15-96830996-96831114 (TCTTT)6 TATTT (TCTTT)10 RS 1 - - - - 
PentaE [CE 18]-GRCh38-Chr15-96830996-96831114 (TATTT)2 (TCTTT)16 RS 1 - - - - 
D16S539 [CE 8]-GRCh38-Chr16-86352664-86352781 (GATA)8 86352761-C (rs11642858) FS 1 - - - MK570017 
D16S539 [CE 12]-GRCh38-Chr16-86352664-86352781 (GATA)12 86352749-C (rs906687856) FS 1 - - - - 
D19S433 [CE 14]-GRCh38-Chr19-29926205-29926352 (CCTT)13 CCTA CCT TTT CCTT 29926229-29926230 DEL (rs745607776) FS 1 - - - - 
D21S11 [CE 32]-GRCh38-Chr21-19181939-19182111 (TCTA)6 (TCTG)7 (TCTA)3 TA (TCTA)3 TCA (TCTA)2 TCCA TA (TCTA)11 RS 1 - - - - 
* D21S11 [CE 32.2]-GRCh38-Chr21-19181939-19182111 (TCTA)5 (TCTG)6 (TCTA)3 TA (TCTA)3 TCA (TCTA)2 TCCA TA (TCTA)12 TA TCTA 
19182110-C (no rs identifier) 
FS 1 - - - - 
D21S11 [CE 38]-GRCh38-Chr21-19181939-19182111 (TCTA)10 (TCTG)8 (TCTA)3 TA (TCTA)3 TCA (TCTA)2 TCCA TA (TCTA)12 RS 1 - - - - 
* PentaD [CE 8]-GRCh38-Chr21-43636100-43636278 (AAAGA)8 43636172-C (rs927345580) FS 1 - - - - 
ME: Middle East, SCA: South Central Asia, EA: East Asian, EUR: European, AFR: African       




6.5.6 Concordance study 
Apart of the drop out events presented in Table 6.2; all samples showed 100% 
chemistry concordance at the common 23 aSTRs. In addition, all samples showed 100% 
bioinformatical concordance between the UAS and the SR. Interestingly, one sample had 
size-based alleles of 12,14 at the D19S433 locus using the GlobalFiler™ kit and showed, 
in this study, the same alleles call when analysed by the UAS and the SR, but was labelled 
as a novel sequence by the SR. Examining the sequences, the allele 14 had [AAGG] AAA 
AGG [TAGG] [AAGG]13 in the repeat region, which is allele 14.2, suggesting a deletion of 
2 bp in the flanking region (Figure 6.10 A). The sequence revealed an uncommon 
deletion (rs745607776 AG DEL, reverse strand) at 3' end of the locus and the SR was not 
able to call the allele as 14.2 as the deletion is located within the 5' and the 3' anchors 







Figure 6.10. Allele of interest at D19S433. A) shows the genotype of the sample using the GlobalFiler™ kit, 
the sequencing results using the ForenSeqTM kit, and typical sequences of the alleles 14 and 14.2 
comparing to the allele of interest. B) shows the repeat region (blue) and the location of AG deletion 




6.5.7 Sequence‐Based Saudi Population Data for The SE33 Locus 
The SE33 sequences of the 87 samples were recovered using the FASTAQ files and 
SR, 83 of which were within the designated limits (≥ 10 reads and ≥ 20% ACR), and the 
remaining four samples were recovered manually due lower ACR (< 20%). The ACR of 
heterozygous sequences ranged from 6.5% to 99.4% and showed an average of 58.6%, 
the four manually typed samples had ACR of 6.5% for alleles 6.3, 31.2, 8.14% for alleles 
14,35.2, 12.17% for alleles 13.3,31.2, and 12.8% for alleles 17,34 (Alsafiah et al. 2019b).  
The total coverage of the SE33 locus in all samples was 53,956 reads and the average 
reads number of recovered sequences was 742 reads that ranged from 32 to 2196 reads 
for alleles 31.2 and 6.3 respectively (Alsafiah et al. 2019b).  
The number of observed sequence-based alleles was 130% more (69 alleles) 
comparing to 30 size-based alleles (Figure 6.11). Most sequence variants were observed 
in x.2 alleles where alleles 27.2 and 30.2 had the highest number of observed sequences 
(7 sequence variants/allele) (Figure 6.12) (Alsafiah et al. 2019b). 
 
Figure 6.11. The number of observed size and sequence-based SE33 alleles. 
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Figure 6.12. The number of SE33 sequence variants observed per allele.  
The SE33 motif patterns of the 69 sequences showed that 66 alleles were within the 
classification of Borsuk et al. (2018) and most of these alleles (53 alleles), as expected, 
had an A0 or A1 motif. Two new motif patterns were observed in three alleles that are 
shown in Table 6.7. Following on from the earlier study we suggested two new motif IDs 
(D4 & D5) (Alsafiah et al. 2019b). In addition, seven sequences, which fall within the 
motif classification, but have not been reported in the GenBank database before, were 







































































































Table 6.7. Motif patterns of the SE33 locus observed in the samples from the population of Saudi Arabia. A 
total of 66 allele sequences were within motif patterns classified by Borsuk et al. (2018), 53 of which, as 
expected, had the A0 and A1 motif patterns.  Two unreported motif patterns were observed in three alleles 
and were classified as D4 and D5 motif IDs. Rows in red indicates novel motifs observed in the Saudi 
population and shaded rows indicates novel alleles that were not reported before in the GenBank database 
(Alsafiah et al. 2019b).  
Alleles Motif Obs. ID  Novelty 
9-22 CT [CTTT]3 C [CTTT]n CT [CTTT]3 CT [CTTT]2 13 A0 Novel sequence (Allele 9) 
20.2-33.2 CT [CTTT]2 CCTT C [CTTT]n TT [CTTT]n CT [CTTT]3 CT [CTTT]2 40 A1 
Reported in (Borsuk et al. 
2018) 
30.2 CT [CTTT]2 CCTT C [CTTT]n CT [CTTT]n CT [CTTT]3 CT [CTTT]2 1 A3 
Reported in (Borsuk et al. 
2018) 
34 
CT [CTTT]2 CCTT C [CTTT]n TT [CTTT]n TT [CTTT]n CT [CTTT]3 CT 
[CTTT]2 
1 A7 Novel sequence 
35.2 CT [CTTT]2 CCTT C [CTTT]n TT [CTTT]n CT [CTTT]3 CT CTTT 1 A8 Novel sequence 
6.3 & 7.3 CT [CTTT]3 [CTTT]n CT [CTTT]3 CT [CTTT]2 2 C2 Novel sequence (Allele 7.3) 
13.3 CT [CTTT]3 C [CTTT]n C [CTTT]n [CTTT]3 CT [CTTT]2 1 B2 Novel sequence 
18 CT [CTTT]2 C [CTTT]n CT [CTTT]3 CT [CTTT]2 1 B1 
Reported in (Borsuk et al. 
2018) 
20.2 & 22.2 CT [CTTT]3 C [CTTT]n CT [CTTT]n CT [CTTT]3 CT [CTTT]2 2 B3 Novel sequence 
26.2 CT [CTTT]2 [CCTT]3 C [CTTT]n TT [CTTT]n CT [CTTT]3 CT [CTTT]2 1 B9 
Reported in (Borsuk et al. 
2018) 
28.2 CT [CTTT]2 [CCTT]2 C [CTTT]n TT [CTTT]n CT [CTTT]3 CT [CTTT]2 1 A4 
Reported in (Borsuk et al. 
2018) 
27.2 
CT [CTTT]2 CCTT C [CTTT]n CTGT [CTTT]n TT [CTTT]n CT [CTTT]3 CT 
[CTTT]2 
1 C4 Novel sequence 
27.2 CT [CTTT]2 CCTT C [CTTT]n TT [CTTT]n CT TTTT [CTTT]2 CT [CTTT]2 1 D4* Novel motif 
29.2 & 30.2 
CT [CTTT]2 CCTT C [CTTT]n CCTT [CTTT]n TT [CTTT]n CT [CTTT]3 CT 
[CTTT]2 
2 D5* Novel motif 
30.2 CT [CTTT]2 C [CTTT]n TT [CTTT]n CT [CTTT]3 CT [CTTT]2 1 B5 
Reported in (Borsuk et al. 
2018) 
*The D4 and D5 IDs were suggested to continue the work done by Borsuk et al. (2018). 
 
A single discordance was observed, where the sample had 19,31.2 in the sequence-
based data while it had 18,31.2 in the size-based data. The allele 19 had CT [CTTT]3 C 
[CTTT]19 CT [CTTT]3 CT [CTTT]2 (counted part of the repeat region is in bold) suggesting 
a deletion of four bp within the flanking region. Examination of the FASTQ file of the 
sample revealed the presence of rs369314007-DEL, a [TTTT] deletion at 
88277355_88277358 (GRCh38), when compared to the reference sequence of the locus. 
This was further investigated by Sanger sequencing and the deletion was confirmed 





Figure 6.13. Sanger sequencing results for the discordance event. (A) the reference sequence of 
nucleotides 88277350 – 88277381 (GRCh38) at the 3' flanking region of the SE33 locus. (B) the sequence 
of the sample showed the discordance event. It shows a TTTT deletion at 88277355_88277358 (GRCh38) 
that explains the discordance between sequence and CE data. 
The data showed that the heterozygosity was increased from 90.8% (79 heterozygous 
samples) to 91.9% (80 heterozygous samples), and both data were within the 
expectations of HWE (P value > 0.05) and the power of discrimination increased from 
99.3% to 99.7% (Alsafiah et al. 2019b). 
6.6 Discussion 
In this study, 122 autosomal markers included in the ForenSeq™ DNA Signature Prep 
Kit were analysed for the successfully sequenced samples (87 samples). All run 
indicators ensured that the average quality of the generated reads is within the optimal 
ranges (Verogen 2018b).  The reads elevation of the n-4 stutter of allele 1 compared to 
the second allele’s read (the true allele), at D22S1045, have been observed previously 
(e.g. (Gettings et al. 2018, Jäger et al. 2017)) and was also mentioned in the 
manufacturer’s reference guide (Verogen 2018a).  
The rs6955448 SNP showed an ACR of 40%, which was very low compared to other 




(Churchill et al. 2016, Guo et al. 2017, King et al. 2018)), and even in the developmental 
validation of the MiSeq FGx™ carried out by Illumina (Jäger et al. 2017). Guo et al. (2017) 
suggested that the rs6955464 (C: 68%/ T: 32%, Chr.7:4310397, GRCh37) located in the 
primer binding site (amplicon of rs6955448 starts at 4310285 and ends at 4310404, 
GRCh37 (Verogen 2018a)) could be the reason of this imbalance. King et al. (2018) used 
an in-house capture panel and found that the presence of the rs6955464-T variant 
showed reduced ACR (42%) in comparison to the rs6955464-C variant demonstrating a 
preferential amplification with the rs6955464-C variant. The stutter ratios for aSTRs 
estimated in this study were as expected showing the correlation between the allele 
sizes and the complexity of the repeat regions.  
The sequencing results showed that 46/121 loci had more observed alleles by 
sequencing allowing more differentiation between alleles with the same sizes (STRs) or 
between genotypes with the same iiSNPs. As expected from aSTRs with complex repeat 
structures like D12S391, D2S1338, D21S11, and D3S1358, they showed more than a two-
fold increase in the observed alleles, which improved the random match probabilities 
greatly from 0.0218 to 0.0066, 0.0370 to 0.0139, 0.0666 to 0.0211 and from 0.0910 to 
0.0235 respectively. Despite the significant increase on the number of observed alleles 
in those loci, this was not reflected in the heterozygosity, with a maximum of 10.1% gain 
for D21S11 that is obviously due the massive heterozygosity level of those loci even with 
the size-based data (>77%). D9S1122 had the greatest heterozygosity gain of 15.4% 
(from 75.8% to 89.6%) due to variants rs4281164-C (A: 58.3% C: 41.7%, Chr. 9: 
77073831, GRCh38) within the repeat region.  
Variants at the flanking region of aSTRs significantly increased the number of 




D13S317 (71.4%) reducing the match probabilities by two-fold or more. Notably, the 
flanking region variants at D13S317 and D5S818 allowed the highest percentage of 
heterozygosity gain with 18.6% (from 70.1% to 86.2%) and 17.5% (from 70.1 to 85%) 
respectively. Variants at the flanking region of the target iiSNPs are also reported. This 
led to that rs1109037 becoming more informative (0.133 MP) than the lowest 
discriminating aSTRs TPOX (0.151 MP) D17S1301 (0.148 MP) and displayed a higher level 
of heterozygosity (67.8%) than five aSTRs TPOX (66.66%), D4S2408 (66.66%), TH01 
(65.51%), D17S1301 (60.92%) and D22S1045 (60.97%). It is clear, at least in this study, 
that variants at the flanking region had significant impact on the heterozygosity, 
especially in iiSNPs.  
However, the UAS does not highlight all variants at the flanking region as it looks at 
specific positions for pre-defined variants that mostly were taken from (King et al. 2018) 
and from the dbSNP database. As the variants still reported in the Flanking Region 
Report, this study was able to identify 14 additional variants that were not highlighted 
in blue by the UAS (Table 6.5). King, J et al. (2018) studied four major populations African 
American, East Asian, US Caucasian, and Southwest US Hispanic which may explain why 
the 14 variants have not been pre-defined in the UAS as they may be restricted to 
geographical region. Ten/fourteen variants already have been assigned to rs identifiers 
in the dbSNP database, two of which (rs999755320-T at rs1109037 and  rs1307278892-
C at rs1015250) were observed in the previous study of population of Saudi Arabia 
(Khubrani et al. 2019b). The rest of reported variants 19182110-C at D21S11, 9945623-





Perfect associations between SNP variants at four pairs rs6955448- rs6950322 
(separated by 48 bp), rs430046-rs409820-rs430044 (separated by 17 and 6 bp 
respectively), rs4606077-rs1869434 (separated by 11 bp), and rs445251-rs369438 
(separated by 40 bp) (target SNP is underlined), were observed in this data set (Table 
6.4). All these associations were also observed in the previous study of the population 
of Saudi Arabia (Khubrani et al. 2019b), and is due to physical linkage. Although the 
variants are known to be closely linked (6 bp – 48 bp apart), other variants are also 
closely linked but no do not show perfect associations. This can be explained by the 
presence of recombinational hot spot between any two linked but not associated 
variants or by several mutational events through generations (Carothers and Wright 
1992). However, Khubrani et al.(2019b) reported another perfect association between 
rs279844-A with rs279845-T and between rs279844-T with rs279845-A (separated by 68 
bp) that was not observed in this study due the observation of the allele rs279844-T, 
rs279845-T (0.02299 frequency) (Appendix 5) (Table 6.8). 
Table 6.8. Perfect association between the target iiSNP and variant in the flanking region observed in 
Khubrani et al. (2019b) but not in this study. In Khubrani et al. (2019b), perfect association was observed 
between rs279844 and rs279845 but was not observed in this study due to the presence of the allele TT at 
rs279844_rs279845 (shaded). Black colour indicates the target iiSNPs and the blue colour indicates variants 
within the flanking region. SNPs that showed perfect association are underlined. 
Study Target iiSNP Microhaplotype iiSNP and Variant Reference SNP 
This study rs279844 TA rs279844_rs279845 
  TT rs279844_rs279845 
  AT rs279844_rs279845 
Khubrani et al.(2019b) rs279844 TA rs279844_rs279845 






This has raised a question whether these associations are also present in other 
populations. Therefore, all associations were further investigated in the data of five 
major populations (African, ad Mixed American, East Asian, European and South Asian) 
generated by the 1000 Genomes Project (Phase 3) using LDlink v3.7.2. 
(https://ldlink.nci.nih.gov) (Machiela and Chanock 2015). The four associations 
observed in this study and in (Khubrani et al. 2019b) (Table 6.4) were observed in the 
five populations too, with an R2 (a measure of association between alleles for two SNPs, 
where 0: variants are completely independent, 1: an allele of one SNP perfectly predicts 
an allele of another SNP) value of 0.9982 for rs6955448-rs6950322 pair, 1 for rs430046-
rs409820-rs430044 pair, 0.9796 for rs4606077-rs1869434 and of 1 for rs445251-
rs369438 pair (Machiela and Chanock 2015) (Table 6.9 A-F). Interestingly, the pair 
rs279844-rs279845 (previously reported in the population of Saudi Arabia (Khubrani et 
al. 2019b), but not observed in this study) (Table 6.8), showed lower R2 value of 0.7826 
due to the observation of the rs279844-T/rs279845-T microhaplotype in 300/5008 
samples, 284 of which are from the African population (Table 6.9 F and G). This suggests 
that the donor of the four samples that showed the TT microhaplotype (in this study) at 





Table 6.9. Associations between five SNP pairs observed in the Saudi population and in five major 
populations (African, Ad Mixed American, East Asian, European and South Asian) generated by the 1000 
Genomes Project (Phase 3) using LDlink v3.7.2. (Machiela and Chanock 2015). (A) is for pairs rs6955448- 
rs6950322, (B) rs430046-rs409820, (C) rs409820-rs430044, (D) rs430046-rs430044, (E) rs4606077-
rs1869434, (F) rs445251-rs369438, (G) rs279844-rs279845 (all populations) and (H) is for rs279844-rs279845 
(Africans). Each table shows the haplotypes frequencies across 5008 samples per all population (A-G)/African 
population (H), D' (an indicator of allelic segregation for two genetic variants. A D' value of 0 presents no 
linkage of alleles and a D' value of 1 indicates at least one expected haplotype combination is not observed), 
R2 value, Chi-sq. and p-value (High chi-square statistics and low p-values are evidence that haplotype counts 
deviate from expected values and suggest linkage disequilibrium may be present). Each table shows a 




rs6950322       
  A G Total Frequency Haplotypes Statistics 
rs6955448 C 1 3408 3409 0.681 C_G: 3408 (0.681) D': 0.9991 
 T 1598 1 1599 0.319 T_A: 1598 (0.319) R2: 0.9982 
 Total 1599 3409 5008  C_A: 1 (0.0) Chi-sq: 4998.802 
 Frequency 0.319 0.68
1 
  T_G: 1 (0.0) p-value: <0.0001 
 rs6955448(C) allele is correlated with rs6950322(G) allele    




rs430046        
  A C Total Frequency Haplotypes Statistics 
rs409820  C 4 3246 3250 0.649 C_C: 3246 (0.648) D': 1 
 T 1758 0 1758 0.351 T_A: 1758 (0.351) R2: 0.9965 
 Total 1762 3246 5008  C_A: 4 (0.001) Chi-sq: 4990.481 
 Frequency 0.352 0.64
8 
  T_C: 0 (0.0) p-value: <0.0001 
 rs430046(C) allele is correlated with rs409820(C) allele    




rs430044        
  C T Total Frequency Haplotypes Statistics 
rs409820 A 0 1762 1762 0.352 C_C: 3246 (0.648) D': 1 
 C 3246 0 3246 0.648 A_T: 1762 (0.352) R2: 1 
 Total 3246 1762 5008  A_C: 0 (0.0) Chi-sq: 5008 
 Frequency 0.648 0.35
2 
  C_T: 0 (0.0) p-value: <0.0001 
 rs409820(A) allele is correlated with rs430044(T) allele    




rs430044        
  C T Total Frequency Haplotypes Statistics 
rs430046 C 3246 4 3250 0.649 C_C: 3246 (0.648) D': 1 
 T 0 1758 1758 0.351 T_T: 1758 (0.351) R2: 0.9965 
 Total 3246 1762 5008  C_T: 4 (0.001) Chi-sq: 4990.481 
 Frequency 0.648 0.35
2 
  T_C: 0 (0.0) p-value: <0.0001 
 rs430046(C) allele is correlated with rs430044(C) allele    




rs1869434       
  A G Total Frequency Haplotypes Statistics 
rs4606077 C 3315 22 3337 0.666 C_A:  3315 (0.662) D': 0.9991 
 T 1 1670 1671 0.334 T_G: 1670 (0.333) R2:0.9796 
 Total 3316 1692 5008  C_G: 22 (0.004) Chi-sq: 4905.84 
 Frequency 0.662 0.33
8 
  T_A: 1 (0.0) p-value: <0.0001 
 rs4606077(C) allele is correlated with rs1869434(A) allele    





Table 6.9. continued. 
 
The previous studies in the Saudi population using GlobalFiler™ kit (Alsafiah et al. 
2017) (Chapter 3) and SureID® 23comp kit (Alsafiah et al. 2019a) (Chapter 5) showed 
excess of homozygosity in 20/21 (FIS = 0.03560) and in 14/17 (FIS =0.02977) respectively, 
which revealed some level of consanguinity in the population of Saudi Arabia.  D20S482 
was the only STR among 38 loci investigated, in those studies, that showed a significant 
deviation from HWE (P value= 0), which was not clear if this was due null alleles or 
because of the consanguinity. Although this study cannot eliminate null alleles theory as 
both kits (SureID® 23comp and ForeSeq) may use the same primer pairs (100% 
concordance), sequencing results showed the presence of rs77560248-T variant 
(Chr.20:4525680, GRCh38) at flanking region with 16.67% frequency that increased the 
heterozygosity by 44.4% improving the P value from 0.03 (size-based) to 0.1 (sequence-
based). Despite this improvement in the P value, both theories (null alleles and 




rs369438        
  C T Total Frequency Haplotypes Statistics 
rs445251 C 2927 0 2927 0.584 C_C: 2927 (0.584) D': 1 
 G 0 2081 2081 0.416 G_T: 2081 (0.416) R2: 1 
 Total 2927 2081 5008  C_T: 0 (0.0) Chi-sq: 5008 
 Frequency 0.584 0.41
6 
  G_C: 0 (0.0) p-value: <0.0001 
 rs445251(C) allele is correlated with rs369438(C) allele     




rs279845        
  A T Total Frequency Haplotypes Statistics 
rs279844 A 1 2680 2681 0.535 A_T: 2680 (0.535) D': 0.9991 
 T 2027 300 2327 0.465 T_A: 2027 (0.405) R2: 0.7826 
 Total 2028 2980 5008  T_T: 300 (0.06) Chi-sq: 3919.368 
 Frequency 0.405 0.59
5 
  A_A:1 (0.0) p-value: <0.0001 
 rs279844(A) allele is correlated with rs279845(T) allele     
 rs279844(T) allele is correlated with rs279845(A) allele     
H African rs279845        
  A T Total Frequency Haplotypes 
  
Statistics 
  rs279844 A 0 690 690 0.522 A_T: 690 (0.522) D': 1 
 T 348 284 632 0.478 T_A: 348 (0.263) R2: 0.3901 
 Total 348 974 1322  T_T: 284 (0.215) Chi-sq: 515.6841 
 Frequency 0.263 0.73
7 
  A_A: 0 (0.0) p-value: <0.0001 
 rs279844(A) allele is correlated with rs279845(T) allele     




In this study, the excess of homozygosity was also detected in the sequence-based 
data of 23/27 for aSTRs and 68/94 of iiSNPs, which was supported by 0.03924 value for 
inbreeding coefficient (FIS).  Khubrani et al. (2019b) reported similar figures where 23/27 
aSTRs and 63/91 had excess of homozygosity and the FIS was 0.04131.  
A total of 33 potentially novel alleles assessed based on the SR database were further 
investigated. Twelve alleles have been reported before in (Phillips et al. 2018a), 
(Almohammed and Hadi 2019) and/or (Khubrani et al. 2019b), eleven of which were 
observed in the Middle Eastern population, Qatari population and/or the Saudi 
population. Eight out the 33 alleles were only reported in the National Centre for 
Biotechnology Information (NCBI) by the STRSeq project (Gettings et al. 2017). This 
study reported 13 novel alleles where the novelty of 9 alleles was due to the repeat 
sequence (RS) and 4 alleles was due to the variant at the flanking sequence (FS) (Table 
6.6). it is believed that when more samples from the Saudi population or from 
neighbouring countries are sequenced, the novel alleles will be observed and reflect 
ascertainment bias in the database.  
Three additional non-CODIS loci D9S1122, D17S1301 and D20S482 were included in 
the concordance study, which were previously genotyped using the SureID® 23comp kit 
(Alsafiah et al. 2019a) (Chapter 5). In addition, the sequence data of three iiSNPs 
rs1736442, rs2920816 and rs719366, which were not covered in the previous 
publication (Khubrani et al. 2019b), are also included.  
The 27 aSTRs showed CMP of 6.26E-32 for the size-based data and 6.52E-37 for the 
sequence-based data that are comparable to combined CMPs estimated for Caucasians 
(6.28E-32 and 3.63E-36) and for Asians (6.37E-32 and 8.66E-36) (Novroski et al. 2016). 




sequencing providing higher CMP than what aSTRs provided. The 121 autosomal loci 
combined allowed 1.97E-68 and 3.65E-77 using the size-based data and by sequencing 
respectively. In Khubrani et al. (2019b), the aSTRs showed CMP of 2.62E-30 to 3.49E-34 
and the iiSNPs showed 9.97E-37 to 6.83E-40 CMP for size and sequence-based data 
respectively, which are relatively higher than figures generated from this study. 
Although this can be, in part, due to exclusion of three iiSNPs in that study, clearly the 
major impact came from aSTRs. The population of Saudi Arabia is highly structured 
(Khubrani, et al. 2018), and some parts can be distinguished from others even by using 
aSTRs (Khubrani et al. 2019a), and thus variations in the CMP within different data set 
can be expected in the population of Saudi Arabia. 
The SE33 locus showed the lowest ACR of all aSTRs analysed. Among the 87 samples, 
the four manually recovered samples had the largest size difference between the long 
and short allele that ranged from 99 bp to 68 bp demonstrating the ACR correlation with 
the size difference of the heterozygous allele pair. This correlation was observed when 
1036 U.S. population samples were sequenced that was attributed to a decline in the 
reads number of the second allele (Borsuk et al. 2018).  
A single discordance was observed between the GlobalFiler™ kit data (Chapter 3) and 
data generated from this study at SE33.  Sanger sequencing confirmed the presence of 
the rs369314007 deletion, which was found to be associated with the A0 motif (Borsuk 
et al. 2018), which is the motif pattern of allele 19 (Alsafiah et al. 2019b). 
The data showed that the SE33 heterozygosity was increased from 90.8% (79 
heterozygous samples) to 91.9% (80 heterozygous samples), and both data were within 
the expectations of HWE (P value > 0.05). As expected, SE33 still the most informative 




that was improved to 99.7% by sequencing. This can further improve the CMP obtained 
from the ForenSeq™ DNA Signature Prep Kit to 5.02E-71 and 1.01E-79. Although, the 
figures emphasize the value of using SE33 in forensic applications especially with 
mixture analysis and in paternity testing, it was difficult to be confident in sequence-
based data for SE33 without CE data support due to variation in reads depth and ACR 
values (Borsuk et al. 2018).  
6.7 Conclusion 
In this chapter, 87 samples from the population of Saudi Arabia were successfully 
sequenced using ForenSeq™ DNA Signature Prep Kit with a MiSeq FGx™ instrument and 
data of 122 autosomal markers (28 aSTRs and 94 iiSNPs) were analysed. It was shown 
that the 122 autosomal markers presented more discrimination power and 
heterozygosity by sequencing. Using the kit allowed obtaining the CE data of four aSTRs 
(PentaE, PentaD, D6S1043, and D13S317) and the sequence-based data of 28 autosomal 
markers including the most polymorphic well-characterised STR (SE33). In addition, the 
data of 94 iiSNPs for 87 samples were obtained in one sequencing run that could not be 
achieved using other SNP genotyping methods like TaqMan® Real-Time PCR assay or 
SNaPshot assay.  
The sequence-based data allowed CMP of 6.52E-37 for the 27 aSTRs, 5.6E-41 for the 
94 iiSNPs, and of 3.65E-77 for the 121 autosomal loci combined. The CMP obtained from 
the ForenSeq™ DNA Signature Prep Kit increased to 1.01E-79 when including the SE33 
taking in account possible allele drop out. Associations between the target iiSNPs and 
variants at the flanking region were observed in the Saudi population, which were also 
observed in different populations. These associations have limited or reduced the 




within the target autosomal markers allowing the maximum benefit of combining the 
122 markers. 
This study reported 13 novel sequences and 14 variants at the flanking region that 
were not highlighted in blue in the Flanking Region Reports, which can be added to the 
pre-defined list of variants at the target iiSNPs. The novel sequences and variants may 
be observed when samples from the Middle East or more samples from the Saudi 
population are sequenced.  
As MPS systems are being established in Saudi Arabia, sequencing more samples is 
needed to establish a representative sequence-based databased for both aSTRs and 
iiSNPs. Although the total number of sequenced samples from the Saudi population is 
176 samples, the highly structured nature of the Saudi population necessitates the 





7 Chapter Seven: Evaluation Study of 136 DNA Markers for Kinship 
Applications in Saudi Arabia. 
7.1 Overview of experiment 
The data of DNA markers (42 aSTRs and 94 iiSNPs) obtained from Chapters 3,5 and 6 
were further assessed for kinship testing in Saudi Arabia. The assessment was carried 
out to measure the impact on the extra markers could have on the resolution of kinship 
testing in Saudi Arabia. Different combinations of autosomal markers included in 
Identifiler Plus (15 aSTRs), GlobalFiler (21 aSTRs), GlobalFiler and SureID23 (38 aSTRs), 
Fusion 6C and SureID23 (40 aSTRs), ForenSeq DNA Signature Prep kit (27 aSTRs and 94 
iiSNPs (121 loci)), all markers (42 aSTRs and 94 iiSNPs (136 loci)) and 94 iiSNPs alone, 
were used in this study to test five types of relationships (eight different scenarios in 
total) (Table 2.5).  
Testing additional markers increases the number of loci situated on the same 
chromosome (syntenic loci) and raises concerns regarding their independence (Tillmar 
and Phillips 2017, O’Connor and Tillmar 2012). Syntenic loci are regarded as 
independent (unlinked) if they are 50 centimorgans (cM) or more apart (at which point 
the probability of recombination between them is 0.5) (Lobo and Shaw 2008). As 
recombination rates vary along chromosomes, using the physical distance (bp) may 
underestimate or overestimate the genetic distance between syntenic loci (Westen et 
al. 2012). Therefore, family studies have been undertaken to estimate the 
recombination fraction (RF) between syntenic loci (Westen et al. 2012, Liu et al. 2014, 
Budowle et al. 2011, Wu et al. 2014). However, family studies are expensive and, 
sometimes, may not be informative enough due to the need of a large number of 




Phillips et al. 2012). An alternative approach employed by Phillips et al. (2012) used the 
high-density multi-point SNP data of HapMap to approximate the genetic distance 
between syntenic loci to estimate the RFs, which showed RF values similar to those 
generated using the family studies (Alsafiah et al. 2019a). 
Three potential types of syntenic pairs resulted from using the 42 aSTRs and 94 
iiSNPs: STR-STR, STR-SNP and SNP-SNP pairs, that can impact the LR estimation in kinship 
testing.   
7.2 Aims of the study 
This chapter aimed to evaluate that to what extent DNA markers, characterised in 
previous chapters, can improve the confidence in kinship testing in Saudi Arabia. The 
evaluation included seven different combinations of markers combined in Identifiler 
Plus (currently used kit in Saudi Arabia), GlobalFiler, GlobalFiler and SureID 23, Fusion 
6C and SureID 23, ForenSeq DNA Signature Prep kit, 94 iiSNPs alone and all markers. 
Based on the simulation study, this part will feed into guidelines for the Supreme Council 
of Magistracy in Saudi Arabia in defining the LR threshold that can be used for kinship 
testing, and  for the genetic laboratories in Saudi Arabia regarding the number/type of 
markers that would allow sufficient differentiation between tested hypotheses. 
It also aimed to estimate the genetic distance between syntenic markers located on 
the same arm (p-p and q-q) using the high-density multi-point SNP data of HapMap as 
described by Phillips et al. (2012) and to calculate the RF using the Kosambi function. 
Based on the estimated RFs, the study highlighted those syntenic pairs that would have 





1- Creating a hypothetical pedigree using an in-house Excel software that contains 
all relationships to be tested. 
2- Prepare the input files for the Familias3 software v3.2.7 for each simulation test. 
As each simulation contained a certain number of markers, a total of 14 files were 
prepared, 7 of which contained the allele frequencies and 7 contained the profiles 
of the hypothetical members of the pedigree. 
3- Setting up the mutation rate for each marker in the Familias3 software. 
4- Confirm the parent-child relationship within the members of the hypothetical 
pedigree using the blind search in Familias3 software. 
5- Carry out the simulation tests for the five relationships 1000 times using the seven 
sets of markers. 
6-  Define the LR limits for each simulation tests. 
7- Study the impact of the number of markers and the number of relatives included 
in the simulation study on the LR estimates. 
8- Using the cumulative genetic map distances (cM) of 41 aSTR published in (Phillips 
2017) and the approximated cumulative genetic map distances (cM) for D16S539 
and 94 iiSNPs to calculate RFs for syntenic pairs as described by Phillips et al. 
(2012). 
9- Highlight syntenic pairs that can potentially impact the LR estimation.  
7.4 Materials and Methods 




7.5 Results and discussion 
7.5.1 Confirmation of the parent-child relationship of the pedigree’s members. 
A hypothetical pedigree consisted of three generations with 13 members including 
all tested relationships was created using an in-house Excel software (Figure 7.1). To 
confirm that all members had appropriate genotypes for the 136 loci, the parent-child 
relationships between the pedigree’s members (A&B with D&F; D&E with N, O, J and I; 
D&C with H; F&G with L) were tested using the blind search in Familias3 software. All 
parent-child relationships were confirmed demonstrating the correct genotypes 






Figure 7.1. A hypothetical pedigree created by an in-house Excel sheet. The hypothetical pedigree 
comprised of three generations and 13 members. Circles represent female members and squares 
represent male members (This figure is a copy of Figure 2.2). 
 
Figure 7.2. A confirmation of the parent-child relationship assumed between the pedigree’s members. 
The figure shows a screen shot from the Familias3 software for the results of the blind search (parent-





7.5.2 Simulation results 
To evaluate the differentiation power between related and unrelated individuals that 
can be achieved when using more DNA markers, five types of relationships: parent-
child/unrelated (mother not available (duo pedigree)), full-siblings/unrelated (3 
scenarios), half-siblings/unrelated, first-cousins/unrelated (2 scenarios) and grand-
parent or grand-child/unrelated, were simulated using allele frequency data generated 
from Chapters 3, 5, and 6 and the hypothetical pedigree. In addition, seven different 
combinations of DNA markers included in different commercially available kits: 
Identifiler Plus (15 aSTRs), GlobalFiler (21 aSTRs), GlobalFiler and SureID23 (38 aSTRs), 
Fusion 6C and SureID23 (40 aSTRs), ForenSeq DNA Signature Prep (27 aSTRs and 94 
iiSNPs (121 loci)), all loci (42 aSTRs and 94 iiSNPs (136 loci)) and 94 iiSNPs, were used. 
For the rest of this study, the number of the markers are used rather than the name of 
the kits. 
For each relationship tested, Familias3 software (Kling et al. 2014) calculated the 
Likelihood ratio (LR) for the two hypotheses, which are shown in (Table 2.5), by dividing 
the probability of hypothesis 1 by the probability of hypothesis 2. The LR will have a 
value of >1 (log10 of 1 = 0) if the probability of hypothesis 1 higher than the probability 
of hypothesis 2 (related as claimed in hypothesis 1) and will have a value of <1 if the 
probability of hypothesis 2 higher than the probability of hypothesis 1 (unrelated). In all 
relationships tested in this study, hypothesis 1 is the correct relationship between tested 
members. 
Each relationship was simulated 1000 times for each marker set and six LR limits 
(thresholds) (from 1, 10 … to 100,000) were applied to measure the true positive (TP) 




when using LR threshold of 1, represents the percentage of related simulations that 
appeared as related (they are related and LR >1), while the FP represents the percentage 
of unrelated simulations that appeared as related (they are unrelated, but LR>1).  False 
negative (FN) represents the percentage of related simulations that appeared as 
unrelated (they are related, but LR < 1), which can be calculated by 100% – TP% (Figure 
7.3). The software generates a data file for each simulation run that can be visualised by 
plotting in the RStudio platform (RStudio Team 2016).  
Typically, when more loci are added, the LRs for related individuals are increased 
(more shifting to the right) and the LRs for unrelated individuals are decreased (more 
shifting to the left) in comparison to fewer markers. This shifting reduces the 
overlapping area (uncertainty area) between the LRs of related and unrelated and thus 






Figure 7.3. The impact of adding more DNA markers to the simulation tests on the LR. The figure shows 
how testing more DNA markers improves the LR and thus reduces uncertainty. The blue line represents 
LR distribution for related simulations, the red line represents LR distribution for unrelated simulations, 
the light blue area represents the true positive (TP), the light red area represents the true negative (TN), 
the yellow area represents the false positive (FP), and the green area represents false negative (FN). The 
marker sets A, B and C are examples of different marker sets where the number of markers in set A lower 
than in set B, which is lower than in set C. The green and yellow areas are the uncertainty areas. When 
more markers are used (e.g. set B) LR distribution of related moves to the right (LR increased) and LR 
distribution of unrelated moves left (LR decreased). The uncertainty areas are decreased when more 







Parents (mother and father)-child/unrelated relationship (trio pedigree) was not 
included in the simulation study as 15 loci were found to be enough to differentiate 
between parents-child and unrelated with 100% TP and 0% FP up to a LR threshold of 
100,000 (Figure 7.4). In addition, previous work demonstrated that even the 13 CODIS 
STRs were able to differentiate between parent-child and unrelated with 0% FP and FN 
at a LR threshold of 1 (O’Connor et al. 2010).  
 
Figure 7.4. LR distributions of the simulation study for parents-child relationship (trio pedigree) using 15 
aSTRs included in the Identifiler kit, which was plotted based on data generated by Familias3 software. 
The green histogram represents LR distributions for the true positive simulations (parents-child 
relationship), the orange histogram represents the LR distributions of true negative simulations 
(unrelated). The 15 aSTRs showed 100% TP and 0% FP up to the 100,000 LR threshold. 
However, more loci may be needed when a meiotic mutation is observed (Jia et al. 
2015), a mother less pedigree (duo pedigree) (Poetsch et al. 2013, González-Andrade et 
al. 2009), or when the alleged fathers/mothers are close relatives (Dogan et al. 2015, 
Canturk et al. 2016).  
For the rest of relationships, the assessments started with studying the impact of 
additional markers on the LRs. The simulation results showed that the LRs, as expected, 
improved (increased in related simulations and decreased in unrelated simulations) 




loci added. However, the level of improvement varied and was impacted by the type of 
relationship tested and by the number of relatives included in the simulation (Figure 7.5 
and Figure 7.6) (Table 7.1). For example, the LR medians for parent-child relationship 
(duo pedigree) ranged from 24564.25 (15 aSTRs) to 1.05665E+20 (136 loci) while they 
ranged from 1.086125 (15 aSTRs) to 2.31342 (136 loci) for first-cousins/unrelated 
(Scenario 1). When more relatives were included in the simulation, the LRs medians of 
full-siblings, for example, were significantly improved from 7.373645 (Scenario 1, two 
siblings were tested) to 344.3885 (Scenario 2, three siblings were tested) and to 43126.8 
(Scenario 3, four siblings were tested) using the 15 aSTRs (Figure 7.5 and Figure 7.6) 
(Table 7.1).  Table 7.1 summarises the improvements in LR medians of related/unrelated 





Figure 7.5. LR improvements (increment) for different relationships using the seven marker sets for related simulations. The figure shows LR improvements when more loci used and 
shows the impact of type of the relationship simulated and impact of including relatives in the simulation tests, on the LRs. In the box plots, the lower whisker represents 25% of the 
lowest data, the upper whisker represents 25% of the highest data. The rectangle shows that 75% of the data are below the upper line, 25% of the data are below the lower line, 





Figure 7.6. LR improvements (decrease) for different relationships using the seven marker sets for unrelated simulations. The figure shows LR improvements when more loci were 
used and shows the impact of type of the relationship simulated and impact of including relatives in the simulation tests, on the LRs. Higher impact of the 94 iiSNPs on parent-child 
relationship (when used alone or when they were included in the 121 or the 136 loci) can be seen in the bottom right (will be discussed at the end of this study). In the box plots, 
the lower whisker represents 25% of the lowest data, the upper whisker represents 25% of the highest data. The rectangle shows that 75% of the data are below the upper line, 25% 




Table 7.1. LR medians for eight scenarios simulated using seven different markers sets for related and 
unrelated simulations. The table shows the improvement on LRs when more markers were used for the 
tested relationships. It also shows the case pedigrees (hypothesis 1) as in (Table 2.5) where orange colour 
represents simulated members (i.e. genotyped members) and crossed member were assumed as not 
available for testing. As expected, LRs improved when more loci were added. The improvement varied and 
was impacted by the type relationship tested and by the number of relatives included in the simulation. 








15 aSTRs 2.46E+04 1.23E-09 
21 aSTRs 4.70E+06 1.62E-15 
38 aSTRs 3.86E+11 1.12E-26 
40 aSTRs 3.39E+12 1.27E-29 
121 loci 1.54E+15 7.31E-92 
136 loci 1.06E+20 5.94E-104 
94 iiSNPs 4.36E+06 4.37E-70 
Full-Siblings/ Unrelated  
(Scenario 1) 
 
15 aSTRs 7.37 1.49E-01 
21 aSTRs 3.01E+01 5.29E-02 
38 aSTRs 2.91E+02 6.65E-03 
40 aSTRs 5.30E+02 3.85E-03 
121 loci 2.02E+03 8.69E-04 
136 loci 3.15E+04 1.27E-04 
94 iiSNPs 2.02E+01 4.14E-02 
Full-Siblings/ Unrelated  
(Scenario 2) 
 
15 aSTRs 3.44E+02 3.11E-03 
21 aSTRs 7.96E+03 6.85E-05 
38 aSTRs 9.68E+06 5.96E-08 
40 aSTRs 2.67E+07 1.30E-08 
121 loci 5.44E+08 4.09E-09 
136 loci 7.73E+11 2.55E-12 
94 iiSNPs 3.12E+03 3.08E-04 
Full-Siblings/ Unrelated  
(Scenario 3) 
 
15 aSTRs 4.31E+04 1.38E-05 
21 aSTRs 4.03E+07 6.02E-09 
38 aSTRs 8.66E+12 2.50E-14 
40 aSTRs 1.00E+14 7.90E-16 
121 loci 2.32E+16 4.23E-16 
136 loci 4.02E+22 1.64E-22 




15 aSTRs 1.09 8.16E-01 
21 aSTRs 1.22 7.52E-01 
38 aSTRs 1.63 5.64E-01 
40 aSTRs 1.67 5.67E-01 
121 loci 1.67 5.87E-01 
136 loci 2.31 4.27E-01 




15 aSTRs 5.72E+01 2.14E-02 
21 aSTRs 7.78E+02 3.04E-03 
38 aSTRs 1.31E+05 2.66E-05 
40 aSTRs 2.37E+05 1.58E-05 
121 loci 3.58E+06 9.73E-07 
136 loci 7.47E+08 1.22E-08 
94 iiSNPs 3.93E+02 1.33E-03 
Half-Siblings/Unrelated 
 
15 aSTRs 7.02 1.42E-01 
21 aSTRs 2.82E+01 4.70E-02 
38 aSTRs 4.31E+02 5.12E-03 
40 aSTRs 5.55E+02 4.42E-03 
121 loci 1.73E+03 9.67E-04 
136 loci 3.22E+04 1.14E-04 
94 iiSNPs 1.78E+01 3.77E-02 
Grand-Parent or Child/ Unrelated 
 
15 aSTRs 8.06 1.36E-01 
21 aSTRs 2.57E+01 4.88E-02 
38 aSTRs 3.56E+02 5.29E-03 
40 aSTRs 7.72E+02 4.04E-03 
121 loci 2.36E+03 1.15E-03 
136 loci 3.83E+04 9.67E-05 





The data files generated by Familias3 software for each relationship using each 
marker set were used to generate two plots: LR distribution and exceedance probability 
(a figure that shows the improvement in probabilities at different LR thresholds). To 
compare between the marker sets, the LR distribution plots for each relationship were 
integrated in one plot and are presented (Figures 8.7, 8.9, 8.11, 8.13, 8.15, 8.17, 8.19 
and 8.21). In addition, another type of figures that shows the percentages of TP and FP 
estimated for each relationship using each marker set at different LR thresholds (Figures 
8.8, 8.10, 8.12, 8.14, 8.16, 8.18, 8.20 and 8.22) are also presented. The combined 
exceedance probability figures (8 Figures) are presented in Section 10.6.1 (Appendix 6). 






Figure 7.7. LR distributions of the simulation study for parent-child relationship (duo pedigree) using different marker combinations. The figure also shows the case pedigree 





Figure 7.8. The TP and FP at different LR thresholds generated from the simulation study for parent-child relationship (duo pedigree) using different marker combinations. Each 
marker set is represented by a unique colour. True positive (TP) and false positive (FP). 
TP FP TP FP TP FP TP FP TP FP TP FP
1 10 100 1000 10000 100000
Identifiler Plus (15 aSTRs) 99.60% 0.30% 98.40% 0.00% 95.00% 0.00% 82.50% 0.00% 60.60% 0.00% 31.20% 0.00%
GlobalFiler (21 aSTRs) 100.00% 0.00% 99.50% 0.00% 99.00% 0.00% 97.50% 0.00% 92.30% 0.00% 83.10% 0.00%
GlobalFiler and SureID (38 aSTRs) 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 99.70% 0.00%
Fusion 6C and SureID (40 aSTRs) 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 100.00% 0.00%
ForenSeq (121 a-loci) 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 100.00% 0.00%
All loci (136 a-loci) 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 100.00% 0.00%














































Figure 7.9. LR distributions of the simulation study for full-siblings/unrelated (Scenario 1) using different marker combinations. The figure also shows the case pedigree (hypothesis 





Figure 7.10. The TP and FP at different LR limits generated from the simulation study for full-siblings/unrelated (Scenario 1) using different marker combinations. Each marker set 
represented by a unique colour. True positive (TP) and false positive (FP).   
TP FP TP FP TP FP TP FP TP FP TP FP
1 10 100 1000 10000 100000
Identifiler Plus (15 aSTRs) 85.10% 15.00% 44.30% 1.60% 14.50% 0.10% 3.60% 0.00% 0.90% 0.00% 0.10% 0.00%
GlobalFiler (21 aSTRs) 88.80% 9.50% 63.40% 0.80% 33.70% 0.00% 10.80% 0.00% 2.70% 0.00% 0.30% 0.00%
GlobalFiler and SureID (38 aSTRs) 93.90% 5.70% 82.00% 1.20% 61.10% 0.00% 36.50% 0.00% 19.20% 0.00% 7.60% 0.00%
Fusion 6C and SureID (40 aSTRs) 95.70% 5.20% 85.80% 0.50% 68.30% 0.10% 42.60% 0.00% 24.50% 0.00% 10.90% 0.00%
ForenSeq (121 a-loci) 97.30% 2.20% 90.90% 0.50% 76.40% 0.20% 56.80% 0.00% 36.20% 0.00% 19.60% 0.00%
All loci (136 a-loci) 99.10% 2.10% 95.80% 0.10% 89.00% 0.00% 77.60% 0.00% 59.10% 0.00% 40.30% 0.00%













































Figure 7.11. LR distributions of the simulation study for full-siblings/unrelated (Scenario 2) using different marker combinations. The figure also shows the case pedigree (hypothesis 





Figure 7.12. The TP and FP at different LR limits generated from the simulation study for full-siblings/unrelated (Scenario 2) using different marker combinations. Each marker set 
represented by a unique colour. True positive (TP) and false positive (FP).   
TP FP TP FP TP FP TP FP TP FP TP FP
1 10 100 1000 10000 100000
Identifiler Plus (15 aSTRs) 96.20% 3.50% 83.40% 0.80% 63.20% 0.20% 39.40% 0.00% 18.40% 0.00% 8.10% 0.00%
GlobalFiler (21 aSTRs) 98.60% 2.00% 93.70% 0.30% 84.50% 0.10% 68.10% 0.00% 47.70% 0.00% 29.00% 0.00%
GlobalFiler and SureID (38 aSTRs) 100.00% 0.30% 99.30% 0.10% 98.10% 0.00% 94.10% 0.00% 87.00% 0.00% 78.40% 0.00%
Fusion 6C and SureID (40 aSTRs) 99.40% 0.20% 98.60% 0.10% 97.50% 0.00% 95.30% 0.00% 91.10% 0.00% 83.30% 0.00%
ForenSeq (121 a-loci) 99.90% 0.00% 99.70% 0.00% 98.50% 0.00% 97.50% 0.00% 94.50% 0.00% 90.20% 0.00%
All loci (136 a-loci) 100.00% 0.00% 99.90% 0.00% 99.80% 0.00% 99.20% 0.00% 98.50% 0.00% 97.30% 0.00%














































Figure 7.13. LR distributions of the simulation study for full-siblings/unrelated (Scenario 3) using different marker combinations. The figure also shows the case pedigree (hypothesis 






Figure 7.14. The TP and FP at different LR limits generated from the simulation study for full-siblings/unrelated (Scenario 3) using different marker combinations. Each marker set 
represented by a unique colour. True positive (TP) and false positive (FP).
TP FP TP FP TP FP TP FP TP FP TP FP
1 10 100 1000 10000 100000
Identifiler Plus (15 aSTRs) 98.70% 1.10% 96.30% 0.30% 91.00% 0.00% 77.50% 0.00% 62.10% 0.00% 43.30% 0.00%
GlobalFiler (21 aSTRs) 99.70% 0.10% 99.30% 0.00% 98.50% 0.00% 96.00% 0.00% 90.80% 0.00% 82.20% 0.00%
GlobalFiler and SureID (38 aSTRs) 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 99.90% 0.00% 99.80% 0.00% 99.40% 0.00%
Fusion 6C and SureID (40 aSTRs) 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 99.90% 0.00% 99.80% 0.00% 99.30% 0.00%
ForenSeq (121 a-loci) 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 99.90% 0.00% 99.90% 0.00% 99.50% 0.00%
All loci (136 a-loci) 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 100.00% 0.00% 99.90% 0.00%















































Figure 7.15. LR distributions of the simulation study for first-cousin/unrelated (Scenario 1) using different marker combinations. The figure also shows the case pedigree (hypothesis 





Figure 7.16. The TP and FP at different LR limits generated from the simulation study for first-cousin/unrelated (Scenario 1) using different marker combinations. Each marker set 
represented by a unique colour. True positive (TP) and false positive (FP). 
 
TP FP TP FP TP FP TP FP TP FP TP FP
1 10 100 1000 10000 100000
Identifiler Plus (15 aSTRs) 57.80% 34.20% 1.50% 0.10% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
GlobalFiler (21 aSTRs) 60.20% 34.50% 3.00% 0.30% 0.10% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
GlobalFiler and SureID (38 aSTRs) 64.60% 27.30% 9.30% 0.70% 0.50% 0.00% 0.10% 0.00% 0.00% 0.00% 0.00% 0.00%
Fusion 6C and SureID (40 aSTRs) 67.50% 27.40% 10.10% 0.30% 1.20% 0.00% 0.10% 0.00% 0.00% 0.00% 0.00% 0.00%
ForenSeq (121 a-loci) 68.80% 26.90% 10.70% 1.10% 1.20% 0.10% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
All loci (136 a-loci) 71.60% 22.60% 19.90% 0.80% 2.30% 0.00% 0.20% 0.00% 0.00% 0.00% 0.00% 0.00%












































Figure 7.17. LR distributions of the simulation study for first-cousin/unrelated (Scenario 2) using different marker combinations. The figure also shows the case pedigree (hypothesis 





Figure 7.18. The TP and FP at different LR limits generated from the simulation study for first-cousin/unrelated (Scenario 2) using different marker combinations. Each marker set 
represented by a unique colour. True positive (TP) and false positive (FP). 
TP FP TP FP TP FP TP FP TP FP TP FP
1 10 100 1000 10000 100000
Identifiler Plus (15 aSTRs) 92.20% 9.10% 72.80% 2.30% 43.20% 0.00% 20.30% 0.00% 7.20% 0.00% 3.50% 0.00%
GlobalFiler (21 aSTRs) 96.60% 3.70% 88.10% 0.90% 70.20% 0.10% 48.40% 0.10% 26.80% 0.00% 12.60% 0.00%
GlobalFiler and SureID (38 aSTRs) 98.80% 1.10% 97.00% 0.20% 91.40% 0.10% 81.10% 0.00% 67.90% 0.00% 51.40% 0.00%
Fusion 6C and SureID (40 aSTRs) 99.10% 0.60% 96.90% 0.30% 93.30% 0.00% 84.80% 0.00% 73.30% 0.00% 56.00% 0.00%
ForenSeq (121 a-loci) 99.40% 0.20% 98.30% 0.00% 95.70% 0.00% 92.60% 0.00% 83.30% 0.00% 71.10% 0.00%
All loci (136 a-loci) 99.80% 0.00% 99.70% 0.00% 99.10% 0.00% 97.70% 0.00% 95.10% 0.00% 90.80% 0.00%














































Figure 7.19. LR distributions of the simulation study for half-siblings/unrelated using different marker combinations. The figure also shows the case pedigree (hypothesis 1) as in 





Figure 7.20. The TP and FP at different LR limits generated from the simulation study for half-siblings/unrelated different marker combinations. Each marker set represented by a 
unique colour. True positive (TP) and false positive (FP). 
TP FP TP FP TP FP TP FP TP FP TP FP
1 10 100 1000 10000 100000
Identifiler Plus (15 aSTRs) 81.30% 15.70% 44.10% 1.20% 12.80% 0.00% 2.50% 0.00% 0.70% 0.00% 0.10% 0.00%
GlobalFiler (21 aSTRs) 88.70% 9.70% 63.70% 1.00% 32.70% 0.10% 12.70% 0.00% 3.70% 0.00% 1.20% 0.00%
GlobalFiler and SureID (38 aSTRs) 95.70% 5.10% 83.40% 1.00% 65.50% 0.00% 41.10% 0.00% 23.20% 0.00% 8.50% 0.00%
Fusion 6C and SureID (40 aSTRs) 95.50% 4.90% 84.90% 0.80% 66.60% 0.00% 43.50% 0.00% 23.60% 0.00% 10.90% 0.00%
ForenSeq (121 a-loci) 97.00% 3.00% 89.60% 0.50% 74.90% 0.00% 55.10% 0.00% 34.80% 0.00% 16.90% 0.00%
All loci (136 a-loci) 98.40% 1.40% 95.50% 0.00% 87.70% 0.00% 76.20% 0.00% 59.00% 0.00% 41.50% 0.00%



































Figure 7.21. LR distributions of the simulation study for grand-parent or child/unrelated using different marker combinations. The figure also shows the case pedigree (hypothesis 1) 





Figure 7.22. The TP and FP at different LR limits generated from the simulation study for grand-parent or child/unrelated using different marker combinations. Each marker set 
represented by a unique colour. True positive (TP) and false positive (FP). 
TP FP TP FP TP FP TP FP TP FP TP FP
1 10 100 1000 10000 100000
Identifiler Plus (15 aSTRs) 81.60% 13.10% 46.00% 1.10% 14.30% 0.10% 3.30% 0.00% 0.50% 0.00% 0.20% 0.00%
GlobalFiler (21 aSTRs) 86.90% 10.40% 62.80% 1.70% 33.10% 0.10% 10.60% 0.00% 2.80% 0.00% 1.00% 0.00%
GlobalFiler and SureID (38 aSTRs) 94.50% 4.10% 83.30% 0.70% 63.50% 0.10% 39.40% 0.00% 19.60% 0.00% 7.70% 0.00%
Fusion 6C and SureID (40 aSTRs) 95.90% 4.80% 86.40% 1.50% 67.70% 0.20% 46.40% 0.00% 25.30% 0.00% 9.90% 0.00%
ForenSeq (121 a-loci) 97.70% 3.80% 91.50% 0.20% 76.60% 0.00% 56.50% 0.00% 37.00% 0.00% 19.80% 0.00%
All loci (136 a-loci) 99.10% 0.90% 96.00% 0.10% 87.80% 0.00% 76.60% 0.00% 61.10% 0.00% 43.20% 0.00%







































In the parent-child relationship, where it was assumed that the genotype of the 
mother was not available, all sets had, at LR of 1, 100% TP and 0% FP except the 15 aSTRs 
that showed 99.6% TP with 0.3% FP (Figure 7.7 and Figure 7.8). This supports that using 
15 aSTRs is not enough for duo pedigrees due to the probability of false inclusion or false 
exclusion (Poetsch et al. 2013). Although, the 21 aSTRs were able to reduce the false 
inclusion and exclusion to 0%, some cases where putative fathers are relatives e.g. 
(Goodwin et al. 2004), may need more loci to be included as the LR distributions for 
related (parent-child) and unrelated are nearly overlapping (Figure 7.7). In such cases, 
38 or 40 aSTRs will be robust to differentiate between parent-child and unrelated even 
at LR of 10,000 with 100% TP and 0% FP (Figure 7.8).  
The relationship of full-siblings/unrelated was also tested using three different 
scenarios that included simulation of only two siblings (Scenario 1) (Figure 7.9 and Figure 
7.10), simulation of three siblings (Scenario 2) (Figure 7.11 and Figure 7.12), and 
simulation of four siblings (Scenario 3) (Figure 7.13 and Figure 7.14) (Table 7.1). 
Significant improvements in the TP and FP at all LR thresholds were observed when the 
third (Scenario 2) and the fourth (Scenario 3) siblings were included. For example, the 
136 loci had TP percentage of 40.3% (Scenario 1), 97.30% (Scenario 2) and of 99.9% 
(Scenario 3) at LR threshold of 100,000.  At the same LR level, the TP was also improved, 
when using 94 iiSNPs, from 0% (Scenario 1) to 21.5% (Scenario 2) and to 70.6% (Scenario 
3). In addition, at LR of 1, the FP was reduced from 15% (15 loci) and from 10.7% (94 
iiSNPs) (Scenario 1) to 3.5% and 2.3% (Scenario 2) and to 1.1% and 0.6% (Scenario 3), 
respectively. 
First-cousin/unrelated relationship (Scenario 1) recorded the lowest percentage of 




the 136 loci the TP was 71.6%, which means 28.4% of related simulations appeared as 
unrelated (FN), and the FP was 22.6% (LR 1). Moreover, the 15 aSTRs and 94 iiSNPs had 
57.8% and 62.2% TP (34.2% and 39.3% FP) at LR of 1 respectively, but both had 0% TP 
when using LR ≥ 100 (Figure 7.15 and Figure 7.16). However, the differentiation was 
significantly improved when a grand-parent’s genotypes were available and included in 
the simulation (Scenario 2). For example, at LR 1, the 136 loci had 99.8% TP with 0% FP 
and the performance of the 15 aSTRs and the 94 iiSNPs was improved to 92.2% (9.1% 
FP) and 96.5% (2.5% FP) respectively (Figure 7.17 and Figure 7.18). 
The relatively poor discrimination when testing full-siblings and first-cousins 
compared to parent-child relationship came from the fact both relationships have lower 
probability of sharing alleles than in parent-child relationship. In parent-child 
relationship, there are 100% probability that a child shares half of the father’s alleles 
and half of the mother’s alleles. The shared alleles are termed as identical by descent 
(IBD) as they have come from the parents’ ancestors. In full-siblings relationship; 
however, there is 25% probability of not having an IBD allele, 50% probability of having 
one IBD allele and 25% probability of having two IBD alleles (Figure 1.8).  This is more 
difficult in first-cousin relationship as there is 75% probability of not having an IBD allele 
and 25% probability of having one IBD allele (Figure 1.8).  
Despite the relatively poor discrimination when testing full-siblings and first-cousin, 
significant improvement can be obtained when more relatives were included. The 
probability of having IBD alleles is increased when more relatives are included and thus 
the TP and FP will be improved.  It has been reported previously that adding more 





Half siblings could be differentiated from unrelated using 136 loci that showed 99.4% 
TP and only 1.1% FP at LR of 1. Interestingly, both 121 and 136 loci recorded 0% of FP at 
LR of 100 with 82.4% and 91.4% TP of the simulations respectively, while the 15 aSTRs 
had only 5.1% TP (Figure 7.19 and Figure 7.20). The grand-parent or child (Figure 7.21 
and Figure 7.22) had similar discrimination power to that observed in half siblings. This 
may be due to that both relationships have the same probabilities of having IBD alleles 
(50% probability of not having IBD allele and 50% probability of having one shared 
allele), that has led to similar improvements in the LRs (Table 7.1). 
7.5.3 Performance of the marker sets 
Although the 94 iiSNPs have shown higher CMP of 1.24E-37 (Chapter 6) compared to 
that can be obtained by the 21 aSTRs (1.42E-26, Chapter 3), their performance in kinship 
testing was similar over all relationships (Table 7.1) and (Figure 7.5 and Figure 7.6). This 
was due the fact binary markers have much lower performance than the multi-allelic 
markers (STRs).  In parent-child/unrelated; however, more significant impact was 
noticed when using the 94 iiSNPs set (alone or when included to the 121 and 136 loci) 
in the LRs of unrelated compared to related simulations. This can be explained by the 
lower mutation rate of SNPs comparing to STRs and the impact was less when related 
was simulated since mutations were not present in related simulations (Daniel Kling, 
personal communication). In addition, this was only observed with parent-child 
relationship due the expected shared component of DNA between parents and offspring 
(100% probability of sharing one IBD allele at any locus). 
As expected, the performance of the 40 aSTRs (Fusion 6C and SureID 23) was slightly 
higher than the 38 aSTRs (GlobalFiler and SureID 23) due to the additional two STRs 




other forensic application (human identification) as two rapidly mutating (RM) Y-STRs 
(DYS576 and DYS570) are also included in the kit. 
The 121 autosomal loci included in the ForenSeq™ DNA Signature Prep Kit (Primer 
Mix A) showed the highest discrimination power could be obtained from one kit, which 
was due to the number of typed markers and the inclusion of 94 iiSNPs. In addition, 
using the kit would improve the resolution of kinship testing by including sequence 
variants that can be observed in STRs (Ma et al. 2016) and in the flanking region of iiSNPs 
(King et al. 2018). Moreover, the kit includes 24 Y-STRs and 7 X-STRs that have been 
useful in many cases (e.g. (Junge et al. 2006) and (Li et al. 2012) respectively). 
7.5.4 Potential linkage effect of closely located markers  
It is worth knowing that all simulation tests carried out in this study were under the 
assumption of no linkage between all markers used. However, using more markers has 
raised concerns regarding including them in the product rule as independent markers, 
e.g. (Tillmar and Phillips 2017, O’Connor and Tillmar 2012). To address the impact of 
linkage in the LR estimation, family studies have been carried out to estimate RF 
between four syntenic pairs residing on the same chromosome arm: vWA-D12S391, 
D5S818-CSF1PO, TPOX-D2S441 and D21S11-PentaD typed when using any of the 
commonly used STR kits (Liu et al. 2014, Westen et al. 2012, Budowle et al. 2011, 
O’Connor and Tillmar 2012). RF values were 0.17 (Westen et al. 2012), 0.13 (Liu et al. 
2014), 0.089 (O’Connor and Tillmar 2012) and 0.11 (Budowle et al. 2011) for vWA-
D12S391; 0.197 (Buckleton and Triggs 2006) for D5S818-CSF1PO; 0.53 (Westen et al. 
2012) for TPOX-D2S441 and 0.316 (Buckleton and Triggs 2006) D21S11-PentaD. The 
high-density multi-point SNP data of HapMap was also used to approximate the genetic 




for D5S818-CSF1PO, 0.36 for D21S11-PentaD, and of 0.47 for TPOX-D2S441 (Phillips et 
al. 2012); these values are similar to those generated using family studies (Alsafiah et al. 
2019a).  
When using additional markers available in supplementary kits (e.g. SureID 23) in 
conjunction with commonly used kits, or when using MPS kits that include a large 
number of markers, the number of syntenic loci will be increased. Although excluding 
the less informative locus from the probability estimation (Budowle et al. 2011) is an 
option, this may lead to an overestimation or to an underestimation of the strength of 
an evidence (Gill et al. 2012).  
Gill et al. (2012) has addressed the impact of using the closely located vWA-D12S391 
and concluded that, for most pedigrees, syntenic loci with RF value of    ̴0.12 has almost 
zero effect in any population as long as no linkage disequilibrium is detected. For some 
pedigrees, where at least one individual has a heterozygote genotype in both syntenic 
loci and is involved in at least two transmissions of genetic components, linkage can 
have a significant effect in the product rule calculation in kinship testing (i. e. incest 
cases) (Alsafiah et al. 2019a).  
FamLink software v.1.16 (Kling et al. 2012) allows the calculation of case specific LRs 
taking in account linkage between syntenic pairs. In addition, it can perform simulations 
to study the impact of ignoring the linkage on the LRs calculation for each linked pair. To 
use the software, the RFs between potentially linked pairs should be estimated and used 
in the FamLink setting.  
Therefore, LD test was carried out for all syntenic loci included in this study using the 
data of the 500 samples (38 aSTRs) from Chapters 3 and 5 and the data of 87 samples 




high-density multi-point SNP data of HapMap as described by Phillips et al. (2012) after 
estimating the cumulative genetic map distances for each locus. 
The cumulative genetic map distances (cM) of 41/42 aSTR were already published in 
(Phillips 2017), while the cumulative genetic map distances (cM) of D16S539 and 94 
iiSNPs were estimated using the HapMap data as described by Phillips et al. (2012). The 
cumulative genetic map distance (cM) of D16S539 was not estimated in (Phillips 2017) 
as there was not any other STR located in chromosome 16 in that study. However, in 
this study, there are four iiSNPs located in chromosome 16 (rs729172, rs2342747, 
rs430046 and rs1382387) that necessitates estimating the cumulative genetic map 
distances of D16S539. 
The cumulative genetic map distances (cM) of 95 SNPs (94 iiSNPs and rs925658351 
SNP for D16S539) were estimated and are shown in Section 10.6.2 (Appendix 6). This 
was followed by calculating the RFs of all syntenic loci using the Excel tool provided by 
Phillips et al. (2012) as shown in Figure 2.4. 
Three tables are presented for the results of LD test and for RFs estimations. Table 
7.2 shows the results of syntenic pairs at the same arm resulted from using SureID 23 kit 
in conjunction with GlobalFiler or with Fusion 6C kits (12 or 14 STR-STR pairs 
respectively). Table 7.3 shows the results of syntenic pairs at the same arm (166 STR-
STR, STR-SNP and SNP-SNP pairs) resulted when using the ForenSeq DNA Signature Prep 
kit alone (with an assumption that SE33 was typed as in Chapter 6). Table 7.4 shows the 
results of additional 50 syntenic pairs at the same arm (STR-STR and STR-SNP pairs) 
resulted when using the 136 loci included in all kits (GlobalFiler, SureID 23 and ForenSeq 




Table 7.2. The results of the LD test for 14 syntenic STR-STR pairs (at the same arm) resulted from using SureID 23 kit in conjunction with GlobalFiler (12 syntenic pairs, P value = 0.004) 
or with Fusion 6C (14 syntenic pairs, P value = 0.0035) and their RF values. The RFs were calculated using Kosambi mapping function using genetic map distance in cM estimated using 
cumulative genetic map distance in cM which were reviewed from (Phillips 2017). None of the syntenic pairs showed LD after Bonferroni correction. The Bonferroni correction was 
performed by dividing 0.05 by the number of tested pairs (the number of tests being performed), i.e. 0.05/12 STRs = 0.004 and 0.05/14 = 0.0035. Shaded rows show all syntenic pairs 
with RFs < 0.12. Cautions should be considered when including D18S51-D18S1364 and PentaD-D21S2055 pairs in the calculation of LRs due to low RFs. The pair vWA-D12S391 will not 
have significant impact for most pedigrees as RF is   ̴ 0.12 (Gill et al. 2012). 
No. 
Location Syntenic pair 
LD test p value 
Cumulative genetic map distance in cM 
Genetic map distance in cM RFs from Kosambi mapping function 
Chr. Arm Locus 1 Locus 2 Locus 1 Locus 2 
1 Chr.2 p-p TPOX D2S441 0.97764 1.6661 90.47903 88.81293 0.472145669 
2 Chr.5 q-q D5S2800 D5S818 0.15198 70.3208 126.67284 56.35204 0.405002025 
3 Chr.5 q-q D5S2800 CSF1PO 0.85646 70.3208 154.43395 84.11315 0.466577301 
4 Chr.5 q-q D5S818 CSF1PO 0.69008 126.67284 154.43395 27.76111 0.252211952 
5 Chr.6 q-q SE33 D6S474 0.99963 95.44921 118.66248 23.21327 0.216777122 
6 Chr.8 q-q D8S1132 D8S1179 0.23577 119.96228 136.44313 16.48085 0.159088296 
7 Chr.11 p-p TH01 D11S2368 0.20421 4.48933 32.88891 28.39958 0.256941387 
8 Chr.12 p-p vWA D12S391 0.89307 15.63031 27.57129 11.94098 0.117190251 
9 Chr.13 q-q D13S325 D13S317 0.97422 44.90825 79.83074 34.92249 0.301691441 
10 Chr.18 q-q D18S51 D18S1364 0.04312 84.639759 91.21746 6.577701 0.065400163 
11 Chr.21 q-q D21S11 D21S2055 1 14.64555 49.46478 34.81923 0.301033962 
12 Chr.22 q-q D22S1045 D22GATA198B05 0.98893 46.21362 7.39585 38.81777 0.325304911 
13 Chr.15 q-q PentaE D15S659 0.99899* 124.05054 49.51748 74.53306 0.451723167 
14 Chr.21 q-q PentaD D21S2055 0.96176* 59.37591 49.46478 9.91113 0.097833282 
* the LD test was carried out using the data of 500 samples from Chapter 3 and 5, except pairs No. 13 and 14 where LD test was carried out using the data of PentaE and PentaD from the 87 samples in Chapter 6 as they are 





Table 7.3. The results of the LD test for 166 syntenic (STR-STR, STR-SNP and SNP-SNP) pairs (at the same arm) resulted from using ForenSeq DNA Signature Prep kit alone and the RF 
values. The RFs were calculated using Kosambi mapping function using genetic map distance in cM estimated using high-density multi-point SNP data of HapMap as described by Phillips 
et al. (2012). The cumulative genetic map distance in cM of 27 aSTRs were reviewed from (Phillips 2017) and of the 94 iiSNPs were estimated as described by Phillips et al. (2012) 
(Appendix 6, Section 10.6.2). None of the syntenic pairs showed LD after Bonferroni correction (P value = 0.0003). The Bonferroni correction was performed by dividing 0.05 by the 
number of tested pairs (the number of tests being performed), i.e. 0.05/166 pairs = 0.0003. Shaded rows present pairs with RFs < 0.12 (43 pairs). This table assumed that SE33 was typed 





LD P value 
Cumulative genetic map distance in cM 
Genetic map distance in cM RFs from Kosambi mapping function 
Chr. Arm Locus 1 Locus 2 Locus 1 Locus 2 
1 Chr.1 q-q STR-SNP D1S1656 rs560681 0.92158 244.2349 173.5187 70.71623 0.444204471 
2 Chr.1 q-q STR-SNP D1S1656 rs1294331 0.0004 244.2349 252.6893 8.454454 0.083747908 
3 Chr.1 q-q SNP-SNP rs560681 rs1294331 0.20475 173.5187 252.6893 79.17068 0.459566663 
4 Chr.1 q-q STR-SNP D1S1656 rs10495407 0.98907 244.2349 264.5096 20.27471 0.192320103 
5 Chr.1 q-q SNP-SNP rs560681 rs10495407 0.95563 173.5187 264.5096 90.99094 0.474410174 
6 Chr.1 q-q SNP-SNP rs1294331 rs10495407 0.60182 252.6893 264.5096 11.82026 0.116048705 
7 Chr.1 q-q STR-SNP D1S1656 rs891700 0.84749 244.2349 266.7565 22.52162 0.211127162 
8 Chr.1 q-q SNP-SNP rs560681 rs891700 0.34016 173.5187 266.7565 93.23784 0.476558202 
9 Chr.1 q-q SNP-SNP rs1294331 rs891700 0.11079 252.6893 266.7565 14.06716 0.137073921 
10 Chr.1 q-q SNP-SNP rs10495407 rs891700 0.37552 264.5096 266.7565 2.246905 0.022453937 
11 Chr.1 q-q STR-SNP D1S1656 rs1413212 0.26974 244.2349 275.1116 30.87668 0.274704236 
12 Chr.1 q-q SNP-SNP rs560681 rs1413212 0.66458 173.5187 275.1116 101.5929 0.4831053 
13 Chr.1 q-q SNP-SNP rs1294331 rs1413212 0.93969 252.6893 275.1116 22.42223 0.210309797 
14 Chr.1 q-q SNP-SNP rs10495407 rs1413212 0.4255 264.5096 275.1116 10.60197 0.104458858 
15 Chr.1 q-q SNP-SNP rs891700 rs1413212 0.92589 266.7565 275.1116 8.355065 0.082781581 
16 Chr.2 p-p STR-STR TPOX D2S441 0.92419 1.6661 90.47903 88.81293 0.472145669 
17 Chr.2 p-p STR-SNP TPOX rs876724 0.54976 1.6661 0.054278 1.611822 0.016112639 
18 Chr.2 p-p STR-SNP D2S441 rs876724 0.94563 90.47903 0.054278 90.42475 0.473839353 
19 Chr.2 p-p STR-SNP TPOX rs1109037 0.66548 1.6661 25.84589 24.17979 0.224559402 
20 Chr.2 p-p STR-SNP D2S441 rs1109037 0.97426 90.47903 25.84589 64.63314 0.429911158 
21 Chr.2 p-p SNP-SNP rs876724 rs1109037 0.4241 0.054278 25.84589 25.79162 0.237238494 
22 Chr.2 q-q STR-SNP D2S1338 rs993934 0.99215 223.4832 143.1388 80.34436 0.461349352 
23 Chr.2 q-q STR-SNP D2S1338 rs12997453 0.96577 223.4832 196.6693 26.81395 0.245083072 
24 Chr.2 q-q SNP-SNP rs993934 rs12997453 0.53139 143.1388 196.6693 53.53041 0.394845118 
25 Chr.2 q-q STR-SNP D2S1338 rs907100 0.17878 223.4832 261.3676 37.88436 0.319856327 
26 Chr.2 q-q SNP-SNP rs993934 rs907100 0.29721 143.1388 261.3676 118.2287 0.491243368 
27 Chr.2 q-q SNP-SNP rs12997453 rs907100 0.2164 196.6693 261.3676 64.69831 0.43008088 





Table 7.3. continued. 
29 Chr.3 p-p STR-SNP D3S1358 rs4364205 0.01625 67.1789 56.4601 10.7188 0.10557559 
30 Chr.3 p-p SNP-SNP rs1357617 rs4364205 0.21329 1.267142 56.4601 55.19296 0.400940491 
31 Chr.3 q-q SNP-SNP rs2399332 rs1355366 0.0964 120.1666 209.7995 89.63285 0.473020138 
32 Chr.3 q-q SNP-SNP rs2399332 rs6444724 0.14662 120.1666 214.0278 93.86121 0.477122283 
33 Chr.3 q-q SNP-SNP rs1355366 rs6444724 0.35106 209.7995 214.0278 4.22836 0.042183089 
34 Chr.4 p-p STR-SNP D4S2408 rs2046361 0.0473 49.54939 26.4958 23.05359 0.215478653 
35 Chr.4 p-p STR-SNP D4S2408 rs279844 0.88737 49.54939 68.75248 19.20309 0.183114834 
36 Chr.4 p-p SNP-SNP rs2046361 rs279844 0.99515 26.4958 68.75248 42.25668 0.34425927 
37 Chr.4 q-q STR-SNP FGA rs6811238 0.82269 156.8129 174.3913 17.57833 0.168882112 
38 Chr.4 q-q STR-SNP FGA rs1979255 0.98527 156.8129 213.0553 56.24236 0.404624171 
39 Chr.4 q-q SNP-SNP rs6811238 rs1979255 0.55961 174.3913 213.0553 38.66403 0.324416484 
40 Chr.5 q-q STR-STR D5S818 CSF1PO 0.61363 126.6728 154.434 27.76111 0.252211952 
41 Chr.5 p-p SNP-SNP rs717302 rs159606 0.70771 6.711702 33.52614 26.81443 0.245086742 
42 Chr.5 q-q STR-SNP D5S818 rs1318288
3 
0.29308 126.6728 139.7681 13.09522 0.128037968 
43 Chr.5 q-q STR-SNP CSF1PO rs1318288
3 
0.95781 154.434 139.7681 14.66589 0.142592815 
44 Chr.5 q-q STR-SNP D5S818 rs251934 0.63361 126.6728 191.9862 65.3134 0.431664031 
45 Chr.5 q-q STR-SNP CSF1PO rs251934 0.51731 154.434 191.9862 37.55229 0.317886224 
46 Chr.5 q-q SNP-SNP rs1318288
3 
rs251934 0.21562 139.7681 191.9862 52.21818 0.389802681 
47 Chr.5 q-q STR-SNP D5S818 rs338882 0.56016 126.6728 199.6403 72.96742 0.448762987 
48 Chr.5 q-q STR-SNP CSF1PO rs338882 0.36063 154.434 199.6403 45.20631 0.359150533 
49 Chr.5 q-q SNP-SNP rs1318288
3 
rs338882 0.40301 139.7681 199.6403 59.8722 0.416436656 
50 Chr.5 q-q SNP-SNP rs251934 rs338882 0.68537 191.9862 199.6403 7.654021 0.07594789 
51 Chr.6 q-q STR-SNP D6S1043 rs1336071 0.03743 99.86628 100.6511 0.784821 0.007847566 
52 Chr.6 q-q STR-SNP D6S1043 rs214955 0.51 99.86628 159.8483 59.98204 0.416772515 
53 Chr.6 q-q SNP-SNP rs1336071 rs214955 0.2689 100.6511 159.8483 59.19722 0.414345667 
54 Chr.6 q-q STR-SNP D6S1043 rs727811 0.94169 99.86628 180.0571 80.19079 0.461120464 
55 Chr.6 q-q SNP-SNP rs1336071 rs727811 0.76128 100.6511 180.0571 79.40597 0.459930248 
56 Chr.6 q-q SNP-SNP rs214955 rs727811 0.376 159.8483 180.0571 20.20875 0.191757788 
57 Chr.6 q-q STR-STR D6S1043 SE33 1 99.86628 95.44921 4.41707 0.044056152 
58 Chr.6 q-q SNP-STR rs1336071 SE33 0.87309 100.6511 95.44921 5.201891 0.051832037 
59 Chr.6 q-q SNP-STR rs214955 SE33 0.99894 159.8483 95.44921 64.39911 0.429298586 
60 Chr.6 q-q SNP-STR rs727811 SE33 0.98595 180.0571 95.44921 84.60786 0.467210713 
61 Chr.7 p-p SNP-SNP rs6955448 rs917118 0.5883 6.912354 7.494464 0.58211 0.005820837 
62 Chr.7 q-q STR-SNP D7S820 rs321198 0.61806 100.2012 145.3779 45.17667 0.359007011 
63 Chr.7 q-q STR-SNP D7S820 rs737681 0.37979 100.2012 181.9196 81.71839 0.463340543 
64 Chr.7 q-q SNP-SNP rs321198 rs737681 0.98621 145.3779 181.9196 36.54172 0.311787756 
65 Chr.8 p-p SNP-SNP rs763869 rs1009249
1 
0.94969 1.957165 56.01666 54.0595 0.396819976 
66 Chr.8 q-q STR-SNP D8S1179 rs2056277 0.06427 136.4431 156.441 19.9979 0.189956504 
67 Chr.8 q-q STR-SNP D8S1179 rs4606077 0.73678 136.4431 166.5671 30.12392 0.269405425 
68 Chr.8 q-q SNP-SNP rs2056277 rs4606077 0.37239 156.441 166.5671 10.12603 0.09989821 





Table 7.3. continued. 
70 Chr.9 q-q STR-SNP D9S1122 rs1463729 0.78652 81.15767 136.0526 54.89488 0.39987129 
71 Chr.9 q-q STR-SNP D9S1122 rs1360288 0.58519 81.15767 137.9145 56.75681 0.406384914 
72 Chr.9 q-q SNP-SNP rs1463729 rs1360288 0.13896 136.0526 137.9145 1.861931 0.018610708 
73 Chr.9 q-q STR-SNP D9S1122 rs10776839 0.35676 81.15767 155.8453 74.68764 0.452006465 
74 Chr.9 q-q SNP-SNP rs1463729 rs10776839 0.7046 136.0526 155.8453 19.79276 0.188198434 
75 Chr.9 q-q SNP-SNP rs1360288 rs10776839 0.95171 137.9145 155.8453 17.93083 0.171997414 
76 Chr.10 p-p SNP-SNP rs826472 rs735155 0.9813 3.568912 6.796451 3.227539 0.032230636 
77 Chr.10 p-p SNP-SNP rs826472 rs3780962 0.82519 3.568912 38.18664 34.61773 0.299746241 
78 Chr.10 p-p SNP-SNP rs735155 rs3780962 0.008 6.796451 38.18664 31.39019 0.278269047 
79 Chr.10 q-q STR-SNP D10S1248 rs740598 0.61305 169.8992 143.7301 26.16903 0.240152437 
80 Chr.10 q-q STR-SNP D10S1248 rs964681 0.24918 169.8992 175.6694 5.770234 0.057447533 
81 Chr.10 q-q SNP-SNP rs740598 rs964681 0.85486 143.7301 175.6694 31.93926 0.282035914 
82 Chr.11 p-p STR-SNP TH01 rs1498553 0.44699 4.48933 11.57216 7.082833 0.070358341 
83 Chr.11 p-p STR-SNP TH01 rs901398 0.40305 4.48933 20.23465 15.74532 0.152446978 
84 Chr.11 p-p SNP-SNP rs1498553 rs901398 0.43619 11.57216 20.23465 8.662483 0.085768417 
85 Chr.11 q-q SNP-SNP rs10488710 rs2076848 0.19635 119.9957 157.8437 37.84798 0.319641288 
86 Chr.12 p-p STR-STR vWA D12S391 1 15.63031 27.57129 11.94098 0.117190251 
87 Chr.12 p-p STR-SNP vWA rs2107612 0.092 15.63031 2.139891 13.49042 0.131723262 
88 Chr.12 p-p STR-SNP D12S391 rs2107612 0.11141 27.57129 2.139891 25.4314 0.234437749 
89 Chr.12 p-p STR-SNP vWA rs2269355 0.34054 15.63031 17.7073 2.076994 0.020758002 
90 Chr.12 p-p STR-SNP D12S391 rs2269355 0.01118 27.57129 17.7073 9.863986 0.097379808 
91 Chr.12 p-p SNP-SNP rs2107612 rs2269355 0.09493 2.139891 17.7073 15.56741 0.150831581 
92 Chr.12 q-q SNP-SNP rs2920816 rs2111980 0.4073 56.2715 124.5179 68.24635 0.438765443 
93 Chr.12 q-q SNP-SNP rs2920816 rs10773760 0.01395 56.2715 168.4425 112.171 0.488869132 
94 Chr.12 q-q SNP-SNP rs2111980 rs10773760 0.53318 124.5179 168.4425 43.92465 0.352831761 
95 Chr.13 q-q STR-SNP D13S317 rs1335873 0.1836 79.83074 2.118193 77.71255 0.45724208 
96 Chr.13 q-q STR-SNP D13S317 rs1886510 0.44997 79.83074 4.798954 75.03179 0.452631533 
97 Chr.13 q-q SNP-SNP rs1335873 rs1886510 0.67946 2.118193 4.798954 2.680761 0.026781953 
98 Chr.13 q-q STR-SNP D13S317 rs1058083 0.20642 79.83074 94.11131 14.28057 0.139045264 
99 Chr.13 q-q SNP-SNP rs1335873 rs1058083 0.8001 2.118193 94.11131 91.99312 0.475390962 
100 Chr.13 q-q SNP-SNP rs1886510 rs1058083 0.98344 4.798954 94.11131 89.31235 0.472681542 
101 Chr.13 q-q STR-SNP D13S317 rs354439 0.05434 79.83074 107.2948 27.46404 0.249990473 
102 Chr.13 q-q SNP-SNP rs1335873 rs354439 0.4077 2.118193 107.2948 105.1766 0.485328429 
103 Chr.13 q-q SNP-SNP rs1886510 rs354439 0.18306 4.798954 107.2948 102.4958 0.483694821 
104 Chr.13 q-q SNP-SNP rs1058083 rs354439 0.85193 94.11131 107.2948 13.18347 0.128862206 
105 Chr.14 q-q SNP-SNP rs1454361 rs722290 0.40185 17.19934 47.50283 30.30349 0.270677336 
106 Chr.14 q-q SNP-SNP rs1454361 rs873196 0.8474 17.19934 104.0042 86.80488 0.469886201 
107 Chr.14 q-q SNP-SNP rs722290 rs873196 0.17717 47.50283 104.0042 56.50139 0.405514378 
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109 Chr.14 q-q SNP-SNP rs722290 rs4530059 0.16601 47.50283 114.5175 67.01463 0.435871244 
110 Chr.14 q-q SNP-SNP rs873196 rs4530059 0.29418 104.0042 114.5175 10.51324 0.103609962 
111 Chr.15 q-q STR-SNP PentaE rs1821380 0.90582 124.0505 53.23968 70.81086 0.444403566 
112 Chr.15 q-q STR-SNP PentaE rs8037429 0.05451 124.0505 64.45011 59.60043 0.415600384 
113 Chr.15 q-q SNP-SNP rs1821380 rs8037429 0.15606 53.23968 64.45011 11.21043 0.110262881 
114 Chr.15 q-q STR-SNP PentaE rs1528460 0.01971 124.0505 66.37152 57.67902 0.409468346 
115 Chr.15 q-q SNP-SNP rs1821380 rs1528460 0.62987 53.23968 66.37152 13.13185 0.128380147 
116 Chr.15 q-q SNP-SNP rs8037429 rs1528460 0.72056 64.45011 66.37152 1.921413 0.019204678 
117 Chr.16 p-p SNP-SNP rs729172 rs2342747 0.45601 11.31258 11.86134 0.548754 0.00548732 
118 Chr.16 q-q STR-SNP D16S539 rs430046 0.93666 125.5782 97.20913 28.3691 0.256717036 
119 Chr.16 q-q STR-SNP D16S539 rs1382387 0.48523 125.5782 103.7257 21.85252 0.205598289 
120 Chr.16 q-q SNP-SNP rs430046 rs1382387 0.61647 97.20913 103.7257 6.516582 0.064799334 
121 Chr.17 p-p SNP-SNP rs9905977 rs740910 0.09089 8.279761 13.40866 5.128894 0.051109803 
122 Chr.17 q-q STR-SNP D17S1301 rs938283 0.05557 113.1115 120.3081 7.196665 0.071473761 
123 Chr.17 q-q STR-SNP D17S1301 rs8078417 0.31548 113.1115 127.7513 14.6399 0.142354018 
124 Chr.17 q-q SNP-SNP rs938283 rs8078417 0.58137 120.3081 127.7513 7.443234 0.073887346 
125 Chr.18 p-p SNP-SNP rs1493232 rs9951171 0.42172 3.666872 28.53392 24.86705 0.230011673 
126 Chr.18 q-q STR-SNP D18S51 rs1736442 0.2397 84.63976 74.55715 10.08261 0.09948127 
127 Chr.18 q-q STR-SNP D18S51 rs1024116 0.0422 84.63976 112.7889 28.14917 0.255093811 
128 Chr.18 q-q SNP-SNP rs1736442 rs1024116 0.6107 74.55715 112.7889 38.23177 0.321899622 
129 Chr.19 q-q STR-SNP D19S433 rs719366 0.43138 51.72618 49.40652 2.319663 0.023180002 
130 Chr.19 q-q STR-SNP D19S433 rs576261 0.41759 51.72618 63.83692 12.11074 0.118793304 
131 Chr.19 q-q SNP-SNP rs719366 rs576261 0.93067 49.40652 63.83692 14.4304 0.140426575 
132 Chr.20 p-p STR-SNP D20S482* rs1031825 0.82481 13.25549 12.79543 0.460058 0.00460045 
133 Chr.20 p-p STR-SNP D20S482* rs445251 0.97978 13.25549 35.36648 22.11099 0.207741353 
134 Chr.20 p-p SNP-SNP rs1031825 rs445251 0.53286 12.79543 35.36648 22.57105 0.211533151 
135 Chr.20 q-q SNP-SNP rs1005533 rs1523537 0.49579 58.01538 77.58417 19.56879 0.186272852 
136 Chr.21 q-q STR-STR D21S11 PentaD 1 14.64555 59.37591 44.73036 0.356830933 
137 Chr.21 q-q STR-SNP D21S11 rs722098 0.28111 14.64555 4.539526 10.10602 0.099706169 
138 Chr.21 q-q STR-SNP PentaD rs722098 0.16683 59.37591 4.539526 54.83638 0.399660259 
139 Chr.21 q-q STR-SNP D21S11 rs2830795 0.99158 14.64555 27.34826 12.70271 0.124362925 
140 Chr.21 q-q STR-SNP PentaD rs2830795 0.33265 59.37591 27.34826 32.02765 0.28263799 
141 Chr.21 q-q SNP-SNP rs722098 rs2830795 0.16096 4.539526 27.34826 22.80873 0.213480666 
142 Chr.21 q-q STR-SNP D21S11 rs2831700 0.78972 14.64555 29.39708 14.75153 0.143379188 
143 Chr.21 q-q STR-SNP PentaD rs2831700 0.57032 59.37591 29.39708 29.97883 0.268374108 
144 Chr.21 q-q SNP-SNP rs722098 rs2831700 0.99355 4.539526 29.39708 24.85755 0.229936842 
145 Chr.21 q-q SNP-SNP rs2830795 rs2831700 0.17265 27.34826 29.39708 2.048821 0.020476751 
146 Chr.21 q-q STR-SNP D21S11 rs914165 0.99605 14.64555 50.55435 35.9088 0.30788909 





Table 7.3. continued. 
148 Chr.21 q-q SNP-SNP rs722098 rs914165 0.49236 4.539526 50.55435 46.01482 0.363018811 
149 Chr.21 q-q SNP-SNP rs2830795 rs914165 0.1051 27.34826 50.55435 23.20609 0.216718806 
150 Chr.21 q-q SNP-SNP rs2831700 rs914165 0.26508 29.39708 50.55435 21.15727 0.199788458 
151 Chr.21 q-q STR-SNP D21S11 rs221956 0.40982 14.64555 54.76922 40.12367 0.332708611 
152 Chr.21 q-q STR-SNP PentaD rs221956 0.13376 59.37591 54.76922 4.606694 0.045937032 
153 Chr.21 q-q SNP-SNP rs722098 rs221956 0.14699 4.539526 54.76922 50.22969 0.381758347 
154 Chr.21 q-q SNP-SNP rs2830795 rs221956 0.0073 27.34826 54.76922 27.42096 0.249667226 
155 Chr.21 q-q SNP-SNP rs2831700 rs221956 0.94269 29.39708 54.76922 25.37214 0.233975149 
156 Chr.21 q-q SNP-SNP rs914165 rs221956 0.80822 50.55435 54.76922 4.214868 0.042049126 
157 Chr.22 q-q STR-SNP D22S1045 rs733164 0.6213 46.21362 31.36631 14.84731 0.14425778 
158 Chr.22 q-q STR-SNP D22S1045 rs987640 0.93037 46.21362 37.65417 8.559449 0.084768042 
159 Chr.22 q-q SNP-SNP rs733164 rs987640 0.90829 31.36631 37.65417 6.287865 0.06254926 
160 Chr.22 q-q STR-SNP D22S1045 rs2040411 0.52838 46.21362 62.88724 16.67362 0.160818685 
161 Chr.22 q-q SNP-SNP rs733164 rs2040411 0.62269 31.36631 62.88724 31.52093 0.2791702 
162 Chr.22 q-q SNP-SNP rs987640 rs2040411 0.08637 37.65417 62.88724 25.23307 0.232887568 
163 Chr.22 q-q STR-SNP D22S1045 rs1028528 0.35004 46.21362 64.13652 17.9229 0.171927565 
164 Chr.22 q-q SNP-SNP rs733164 rs1028528 0.73114 31.36631 64.13652 32.77022 0.287648446 
165 Chr.22 q-q SNP-SNP rs987640 rs1028528 0.95043 37.65417 64.13652 26.48235 0.24255562 
166 Chr.22 q-q SNP-SNP rs2040411 rs1028528 0.20921 62.88724 64.13652 1.249286 0.012490261 





Table 7.4. The results of the LD test for additional 50 syntenic (STR-STR and STR-SNP) pairs (at the same arm) resulted from combining GlobalFiler, SureID23 and ForenSeq DNA Signature 
Prep kits. The cumulative genetic map distance in cM of 12 STRs were reviewed from (Phillips 2017) and of D16S539 with the 94 iiSNPs were estimated as described by Phillips et al. 
(2012) (Appendix 6, Section 10.6.2). The RFs were calculated by Kosambi mapping function using genetic map distance in cM that was estimated using high-density multi-point SNP data 
of HapMap as described by Phillips et al. (2012). None of the syntenic pairs showed LD after Bonferroni correction (P value = 0.00023). The Bonferroni correction was performed by 
dividing 0.05 by the number of tested pairs (the number of tests being performed), i.e. 0.05/216 pairs (166 pairs from Table 7.3 and 50 from this table) = 0.00023. Shaded rows present 





LD P value 
Cumulative genetic map distance in cM 
Genetic map distance in cM RFs from Kosambi mapping function 
Chr. Arm Locus 1 Locus 2 Locus 1 Locus 2 
1 Chr. 3 q-q STR-SNP D3S1744 rs2399332 0.90477 157.2413 120.1666 37.07471 0.315023543 
2 Chr. 3 q-q STR-SNP D3S1744 rs1355366 0.34413 157.2413 209.7995 52.55814 0.391129009 
3 Chr. 3 q-q STR-SNP D3S1744 rs6444724 0.10599 157.2413 214.0278 56.7865 0.406485625 
4 Chr. 4 p-p STR-SNP D4S2366 rs2046361 0.71089 12.9467 26.4958 13.5491 0.132269204 
5 Chr. 4 p-p STR-STR D4S2366 D4S2408 0.41066 12.9467 49.54939 36.60269 0.312160118 
6 Chr. 4 p-p STR-SNP D4S2366 rs279844 0.36692 12.9467 68.75248 55.80578 0.403106769 
7 Chr. 5 q-q STR-STR D5S2800 D5S818 0.15198 70.3208 126.6728 56.35204 0.405002025 
8 Chr. 5 q-q STR-SNP D5S2800 rs13182883 0.80499 70.3208 139.7681 69.44726 0.441469306 
9 Chr. 5 q-q STR-STR D5S2800 CSF1PO 0.85646 70.3208 154.434 84.11315 0.466577301 
10 Chr. 5 q-q STR-SNP D5S2800 rs251934 0.12807 70.3208 191.9862 121.6654 0.492359464 
11 Chr. 5 q-q STR-SNP D5S2800 rs338882 0.71809 70.3208 199.6403 129.3195 0.494363158 
12 Chr. 6 q-q STR-STR D6S474 D6S1043 0.94319 118.6625 99.86628 18.7962 0.179581236 
13 Chr. 6 q-q STR-SNP D6S474 rs1336071 0.28042 118.6625 100.6511 18.01138 0.172707239 
14 Chr. 6 q-q STR-SNP D6S474 rs214955 0.49762 118.6625 159.8483 41.18584 0.338543909 
15 Chr. 6 q-q STR-SNP D6S474 rs727811 0.24364 118.6625 180.0571 61.39459 0.420983376 
16 Chr. 6 q-q STR-STR D6S474 SE33 0.99963 118.6625 95.44921 23.21327 0.216777122 
17 Chr.7 p-p STR-SNP D7S3048 rs6955448 0.6802 36.14071 6.912354 29.22836 0.26298849 
18 Chr.7 p-p STR-SNP D7S3048 rs917118 0.98508 36.14071 7.494464 28.64625 0.258752057 
19 Chr.8 q-q STR-STR D8S1132 D8S1179 0.23577 119.9623 136.4431 16.48085 0.159088296 
20 Chr.8 q-q STR-SNP D8S1132 rs2056277 0.17658 119.9623 156.441 36.47875 0.311402629 
21 Chr.8 q-q STR-SNP D8S1132 rs4606077 0.98885 119.9623 166.5671 46.60477 0.365784691 
22 Chr. 11 p-p STR-STR D11S2368 TH01 0.20421 32.88891 4.48933 28.39958 0.256941387 
23 Chr. 11 p-p STR-SNP D11S2368 rs1498553 0.01869 32.88891 11.57216 21.31675 0.201126911 






Table 7.4. continued. 
25 Chr.13 q-q STR-SNP D13S325 rs1335873 0.62987 44.90825 2.118193 42.79006 0.347043992 
26 Chr.13 q-q STR-SNP D13S325 rs1886510 0.96891 44.90825 4.798954 40.1093 0.332628523 
27 Chr.13 q-q STR-STR D13S325 D13S317 0.97422 44.90825 79.83074 34.92249 0.301691441 
28 Chr.13 q-q STR-SNP D13S325 rs1058083 0.57451 44.90825 94.11131 49.20306 0.377409289 
29 Chr.13 q-q STR-SNP D13S325 rs354439 0.25147 44.90825 107.2948 62.38653 0.423823012 
30 Chr.14 q-q STR-SNP D14S1434 rs1454361 0.30728 20.49462 17.19934 3.295282 0.032905192 
31 Chr.14 q-q STR-SNP D14S1434 rs722290 0.18768 20.49462 47.50283 27.00821 0.24655614 
32 Chr.14 q-q STR-SNP D14S1434 rs873196 0.46521 20.49462 104.0042 83.5096 0.465788531 
33 Chr.14 q-q STR-SNP D14S1434 rs4530059 0.56093 20.49462 114.5175 94.02284 0.477266361 
34 Chr.15 q-q STR-SNP D15S659 rs1821380 0.09532 49.51748 53.23968 3.722197 0.037153362 
35 Chr.15 q-q STR-SNP D15S659 rs8037429 0.50019 49.51748 64.45011 14.93263 0.145039546 
36 Chr.15 q-q STR-SNP D15S659 rs1528460 0.71734 49.51748 66.37152 16.85404 0.16243442 
37 Chr.15 q-q STR-STR D15S659 PentaE 0.99899 49.51748 124.0505 74.53306 0.451723167 
38 Chr. 18 q-q STR-SNP D18S1364 rs1736442 0.43181 91.21746 74.55715 16.66031 0.160699335 
39 Chr. 18 q-q STR-SNP D18S1364 rs1024116 0.4926 91.21746 112.7889 21.57147 0.203257577 
40 Chr.21 q-q STR-SNP D21S2055 rs722098 0.20135 49.46478 4.539526 44.92525 0.357784594 
41 Chr.21 q-q STR-STR D21S2055 D21S11 1 49.46478 14.64555 34.81923 0.301033962 
42 Chr.21 q-q STR-SNP D21S2055 rs2830795 0.71641 49.46478 27.34826 22.11652 0.20778713 
43 Chr.21 q-q STR-SNP D21S2055 rs2831700 0.96164 49.46478 29.39708 20.0677 0.19055345 
44 Chr.21 q-q STR-SNP D21S2055 rs914165 0.97298 49.46478 50.55435 1.089568 0.010893956 
45 Chr.21 q-q STR-SNP D21S2055 rs221956 0.31349 49.46478 54.76922 5.304436 0.05284625 
46 Chr.22 q-q STR-SNP D22GATA198B05 rs733164 0.90886 7.39585 31.36631 23.97046 0.222885135 
47 Chr.22 q-q STR-SNP D22GATA198B05 rs987640 0.87136 7.39585 37.65417 30.25832 0.270357836 
48 Chr.22 q-q STR-STR D22GATA198B05 D22S1045 0.98893 7.39585 46.21362 38.81777 0.325304911 
49 Chr.22 q-q STR-SNP D22GATA198B05 rs2040411 0.49551 7.39585 62.88724 55.49139 0.402000746 






None of the pairs showed LD allowing insignificant impact when using those pairs 
with RF values   ̴ 0.12 for most pedigrees (Gill et al. 2012). In addition, the RFs of the 220 
syntenic pairs were estimated and showed that 49 pair had RF values < 0.12, four of 
which are STR-STR pairs, 22 STR-SNP pairs and 23 SNP-SNP pairs (Table 7.2, Table 7.3 
and Table 7.4). Three out of the 49 pairs: vWA-D12S391 (0.117190251), D19S433-
rs576261 (0.118793304) and rs1294331-rs10495407 (0.116048705) will have 
insignificant effect for most pedigrees as they had almost 0.12 RFs, while the rest (46 
pairs) are expected to have a considerable effect on the LRs calculation. The effect within 
the 46 pairs will be varied, which was found to be influenced by the type of the pair (e.g. 
STR-STR or STR-SNP) and by the distance between the pairs (closer pairs have larger 
impact) (Tillmar and Phillips 2017). The effect STR-STR pairs was found to be the largest 
on LRs than STR-SNP pairs, which shows larger effect than SNP-SNP pairs, due to the 
increased level of heterozygosity of STRs (Tillmar and Phillips 2017). Therefore, it is 
expected to have significant impact from D6S1043-SE33 (RF= 0.044056152) D18S51-
D18S1364 (RF= 0.065400163) and PentaD-D21S2055 (RF= 0.097833282) pairs more than 
other pairs due to the type of the pairs (STR-STR) and the close distance.  
In real cases, the RF values estimated in this study can be used in FamLink software 
v.1.16 (Kling et al. 2012) to calculate LRs for two assumptions: ignoring linkage LR 
(unlinked) and considering linkage LR (linked). However, this version is limited in the 
number of pairs that can be run (i.e. the LR can be calculated and simulation can only be 
done for only one pair (2 markers) each run) (Kling et al. 2012). A new version v.2.1 





Despite that this study was carried out under the assumption that no linkage between 
tested markers, a precise impact of linkage applicable for all possible scenarios cannot 
be achieved as it highly influenced by the case scenario itself (case-specific impact) 
(Tillmar and Phillips 2017). Here, the case scenario includes the type of relationship, the 
available members for testing, and the DNA profile of tested members, where the LRs 
are influenced by the amount of shared DNA (IBD) components between tested 
individuals that cannot be predictable. 
7.5.5 Defining thresholds for kinship testing in Saudi Arabia 
Although the Supreme Council of Magistracy of Saudi Arabia is the responsible 
authority of defining and enacting a specific LR threshold for kinship testing, this study 
can be used as a guide as it has defined the TP and FP that can be achieved at different 
thresholds for each relationship using different marker sets. Balance between the 
sensitivity (TP) and specificity (true negative (TN) must be taken into consideration when 
defining the LR threshold (O’Connor et al. 2010) and uncertainty should be expected in 
some cases. It is also possible to use the grey zone approach (Giroti et al. 2007) rather 
than using a specific LR threshold, where an upper and a lower LR limits (LR rang) are 
defined as a grey zone for each type of relationship and LRs fall within this zone cannot 
eliminate uncertainty. 
7.5.6 Defining the number of tested markers for each relationship 
This study can also be used as a guide for genetic laboratories in Saudi Arabia 
regarding the number/type of markers that would allow sufficient differentiation 
between tested hypotheses. This study suggests 21 aSTRs (e.g. that included in the 
GlobalFiler kit) as a minimum number of markers for parent-child testing either trio or 




TP up to LR threshold of 100,000 with 0% FP respectively. However, when the alleged 
fathers/mothers are relatives or when a mismatch was suspected to be a mutation, 
supplementary STR kits (e.g. SureID 23 kit) can be used to improve the certainty of the 
test. In more complex cases (e.g. when two or three mismatches were suspected), using 
ForenSeq DNA Signature Prep kit would allow much better resolution due to the 
inclusion of 94 iiSNPs and the lineage markers.  
For the relationships of full-siblings, half-siblings and grand parent/child, using 
autosomal markers included the ForenSeq DNA Signature Prep kit alone would allow ≥ 
97% TP and ≤ 3.8% FP at LR of 1, where lineage markers included in the kit can also 
improve these figures.  
For more complex relationships like first-cousin, where even the 136 autosomal 
markers would allow the lowest TP and the highest FP comparing to other relationships, 
including as many as possible of relatives in the test would significantly improve the 
certainty. This has been shown when a grand-parent was added to the simulation that 
improved the TP to 99.4% and the FP to 0.2% (LR 1). 
7.6  Conclusion 
The performance of 136 autosomal DNA markers in kinship testing was assessed 
using seven different combinations of markers included in Identifiler Plus (currently used 
kit in Saudi Arabia), GlobalFiler, GlobalFiler and SureID 23, Fusion 6C and SureID 23, 
ForenSeq DNA Signature Prep kit (27 aSTRs and 94 iiSNPs), all markers (42 aSTRs and 94 
iiSNPs (136 loci)) and 94 iiSNPs alone. Five types of relationships parent-child (duo 
pedigree), full-siblings (3 scenarios), half-siblings, first-cousins (2 scenarios) and grand-





The impact of testing additional markers was evaluated for all relationships tested 
that was found highly influenced by the relationship types. In addition, including more 
relatives had significant impact that was more than using more loci. It has shown that 
using 21 aSTRs as a minimum number of markers for parent-child relationship would 
provide confidence in most cases, but more supplementary aSTRs markers may be 
needed in some cases. The ForenSeq DNA Signature Prep kit showed the highest 
percentage of confidence due to number and the type of makers included in the system. 
Potential TP and FP for each type of relationship using different marker sets can be 
used as a guide for the Supreme Council of Magistracy in Saudi Arabia in defining the LR 
threshold or a grey zone area for kinship testing in Saudi Arabia, and as a guide for the 
genetic laboratories in Saudi Arabia regarding the number/type of markers that would 
allow sufficient differentiation between tested hypotheses. 
The genetic location of 95 markers in cM were estimated (41 markers were already 
published) using on the high-density multi-point SNP data of HapMap and RFs between 
syntenic markers located on the same arm were calculated using Kosambi function. The 
study highlighted 46 closely located syntenic pairs (3 STR-STR pairs, 21 STR-SNP pairs 
and 22 SNP-SNP) that would have significant impact (RFs < 12) on the LR estimation 
when using the 136 markers. The RFs values estimated here can be used to calculate the 
case specific LRs and to measure the case-specific impact of linkage. 
With the increasing number of DNA markers that can be typed simultaneously, the 
need for a software that can calculate case-specific LR and includes the linkage effect 





8 Chapter Eight: General Conclusion 
The aims of the project were to evaluate a total of 42 aSTRs and 94 iiSNPs, which 
were generated using three commercially available kits, for kinship testing using 
samples from the population of Saudi Arabia. Five-hundred samples from unrelated 
individuals from the population of Saudi Arabia were collected after obtaining the 
ethical approvals from the SFHP (Saudi Arabia) and from UCLan Ethics Committee 
(STEMH 557).  
Two typing systems (CE and MPS) were used in the project. GlobalFiler™ kit (AB) and 
SureID®23comp (Health Gene Technologies) were used to obtain the data of 38 aSTRs 
using the 500 samples. ForenSeq™ DNA Signature Prep Kit (Verogen) was used to obtain 
size and sequence-based data for 122 autosomal markers using 87 samples. The project 
allowed, in total, obtaining size-based data for 136 autosomal markers (42 aSTRs and 94 
iiSNPs) and sequence-based data for 122 autosomal markers (28 aSTRs including SE33 
and 94 iiSNPs). 
The three kits were evaluated for the population of Saudi Arabia. For the GlobalFiler 
kit, as expected, the data of the 21 aSTRs included in the kit showed much higher CMP 
(1.42E-26) (Alsafiah et al. 2017) than the currently used kit in Saudi Arabia 2.23E-18 
(Identifiler plus kit). In addition, using the kit would improve the combined typical 
paternity index by 300-fold demonstrating the usefulness of adapting this kit in the 
forensic genetic laboratories of Saudi Arabia.  
SureID®23comp kit is a supplementary STR kit that includes 22 aSTRs, 17 of which are 
non-CODIS STRs, developed for complex kinship testing. In this project, the kit has been 
evaluated following the minimum criteria for validation recommended by the ENFSI and 




commonly used in forensic genetics laboratories allowing the analysis of 17 non-CODIS 
loci that increases the number of aSTRs, when used in conjunction with any of 
commercially available kits, to 38-40 aSTRs. This would improve the resolution in kinship 
testing and thereby has the potential to increase the level of confidence in conclusions 
in kinship tests. The kit can benefit from some developments that were suggested by 
the evaluation study including adding as many common alleles found outside Chinese 
population were not included in the allelic ladder and increasing the concentration of 
the chemistry to allow more space for the DNA template. The data of the 17 non-CODIS 
STRs were approved by STRidER and were given a dataset reference number of 
STR000178. 
ForenSeq™ DNA Signature Prep Kit was also used to sequence 87 samples on a MiSeq 
FGx instrument and the data were analysed using ForenSeqTM Universal Analysis 
Software (UAS) and STRait Razor v3.0 (SR). The system provided CMP of 1.97E-68 and 
3.65E-77 for the size and sequence-based data respectively, where 1.24E-37 (size-based 
data) and 5.6E-41 (sequence-based data) were provided from the iiSNPs alone. Using 
the system allowed the data of additional four aSTRs (PentaE, PentaD, D6S1043, and 
D4S2408), which is not provided by CE-based kits used in the project, and of 94 iiSNPs. 
Analysing the data generated by the system and using SR also provided sequence‐based 
Saudi population data for the most polymorphic well-characterised STR (SE33). 
During the evaluation of the GlobalFiler kit, six allele variants were detected in the 
population of Saudi Arabia at the SE33 and D1S1656 that have not been characterised 
before. The SE33 variants were sequenced using Sanger sequencing while the D1S1656 
variants were sequenced using the Verogen system. The sequence data of the six alleles 




ForenSeq™ DNA Signature Prep Kit was used, 13 novel sequences and 14 variants at the 
flanking region, which were not highlighted in the Flanking Region Report, were 
reported. The sequence‐based data of the SE33 loci provided two novel motif patterns 
(D4 & D5) and seven novel sequences (Alsafiah et al. 2019b).  
8.1 Human identification application in Saudi Arabia 
Although one of the project aims was to evaluate the GlobalFiler kit, the project 
provided the data of 42 aSTRs that enabled expanding the evaluation to additional three 
commercially available CE-aSTR kits like PowerPlex Fusion 6C (Promega), VeriFiler Plus 
(AB) and Investigator 24plex (Qiagen) (Table 1.1).  
As expected, PowerPlex Fusion 6C system showed the lowest CMP (1.03E-29) can be 
obtained from the kits that also includes two rapidly mutating STRs DYS570 and DYS576 
that are useful for human identification application (Table 8.1). However, the other 
three kits (GlobalFiler (AB), VeriFiler Plus (AB) and Investigator 24plex (Qiagen)) benefit 
from including the Y-indel especially in determining male minor contribution in sexual 
assault cases. In addition, VeriFiler Plus (9.26E-29) and Investigator 24plex (1.41E-26) 
have an advantage of the presence of an internal quality control marker that enables 
differentiation between degraded samples and samples with inhibitors and thus allows 
more information about the sample’s quality to decide further processing or not. 
Therefore, adopting either VeriFilerTM Plus (AB) or PowerPlex Fusion 6C system 
(Promega Corporation) as a standard analysis kit is highly encouraged for the Saudi 
laboratories which will provide much lower CMP using the same infrastructure and with 
almost the same cost. The flexibility of the Laboratory Information Management 




Table 8.1. The order of 42 aSTRs studied in this project based on their MP. The table also shoes the CMP that 
can be obtained when using any of the latest four developed CE-based aSTR kits. 
order aSTRs Matching Probability (MP) 
1 SE33 0.007 
2 D21S2055 0.016 
3 PentaE 0.017 
4 D12S391 0.026 
5 D7S3048 0.027 
6 D1S1656 0.030 
7 D19S433 0.030 
8 D18S51 0.031 
9 FGA 0.033 
10 D2S1338 0.035 
11 D8S1132 0.041 
12 PentaD 0.043 
13 D22GATA198B05 0.045 
14 D18S1364 0.046 
15 D15S659 0.046 
16 D8S1179 0.051 
17 D21S11 0.055 
18 D3S1744 0.060 
19 D6S1043 0.063 
20 D11S2368 0.068 
21 D13S325 0.070 
22 D4S2366 0.076 
23 D7S820 0.076 
24 D5S2800 0.079 
25 vWA 0.082 
26 D19S253 0.083 
27 TH01 0.085 
28 D16S539 0.087 
29 D13S317 0.087 
30 D3S1358 0.091 
31 D2S441 0.091 
32 D10S1248 0.098 
33 D5S818 0.098 
34 D6S474 0.102 
35 D4S2408 0.112 
36 CSF1PO 0.122 
37 D22S1045 0.138 
38 D9S1122 0.141 
39 D20S482 0.143 
40 D14S1434 0.148 
41 TPOX 0.160 
42 D17S1301 0.162 
GlobalFiler 1.41E-26 
Fusion 6C system 1.03E-29 
VeriFiler Plus 9.26E-29 
Investigator 24plex 1.41E-26 
 
Allele frequencies of the aSTRs provided by the project can be used in estimating DNA 
profiles frequencies when using any of the commercially available kits. In addition, all 
autosomal markers were evaluated for forensic statistical parameters that can guide 
decision makers, in the forensic genetic laboratories, in creating population-specific 




informative loci taking in account having the majority of loci shared with CODIS, ESS, and 
UK panel to allow sharing information between countries. 
8.2 Kinship testing in Saudi Arabia 
The data of 136 autosomal markers were also evaluated for kinship testing. The 
evaluation was carried out for seven different marker combinations that included in 
Identifiler Plus (15 aSTRs), GlobalFiler (21 aSTRs), GlobalFiler and SureID23 (38 aSTRs), 
Fusion 6C and SureID23 (40 aSTRs), ForenSeq DNA Signature Prep kit (27 aSTRs and 94 
iiSNPs (121 loci), all markers (42 aSTRs and 94 iiSNPs (136 loci)) and 94 iiSNPs alone. Five 
types of relationships: parent-child (duo pedigree), full-siblings, half-siblings, first-
cousins and grand-parent or grand-child, were simulated and the TP and FP were 
estimated at different LRs. Additional scenarios were included in the simulation study of 
full-siblings (3 scenarios) and first-cousin (2 scenarios) relationships to study the impact 
of testing more relatives for the same relationship. 
The results supported previous work and showed that using 15 aSTRs will give 
sufficient confidence in most parents-child relationship cases (trio pedigrees). However, 
as recommended in the previous section (Section 8.1), if any of latest four developed 
CE-based aSTR kits (21-23 aSTRs) was adopted in Saudi Arabia as a standard kit, this 
would allow sufficient confidence for both types of pedigrees (trio and duo) in most 
cases. Supplementary STR kit may be used in more complex cases (e.g. when the alleged 
fathers or mothers are close relatives or when the 21-23 aSTRs showed inconclusive 
evidence). The SureID®23comp kit allows 38 or 40 aSTRs in conjunction with GlobalFiler 
or Fusion 6C respectively, providing 100% TP and 0% with LR thresholds up to 100,000 




However, when two or three mismatches were suspected to be mutations or when 
testing distant relationships (e.g. full-siblings, half-siblings and grand parent/child or 
first-cousins), using ForenSeq DNA Signature Prep kit would allow much better 
resolution, due to the number (152 markers) of and the type (aSTRs, iiSNPs and linage 
markers) of included markers, than CE systems analyse. In addition, this study supports 
previous work concluded that including more relatives to the test would significantly 
increase the resolution of kinship testing more than testing more DNA markers.  
The study can be used by the Supreme Council of Magistracy of Saudi Arabia to define 
a specific threshold or a grey zone for kinship testing and by the genetic laboratories in 
Saudi Arabia to define the appropriate number of tested markers. 
Using additional markers would increase the number markers located in the same 
chromosome (syntenic markers) and thus potential linkage should be considered in 
kinship testing. The RFs of a total of 220 syntenic pairs located at the same arm were 
estimated using the high-density multi-point SNP data of HapMap. As no LD was 
detected with the data set of the Saudi population, syntenic pairs with of    ̴0.12 will have 
almost zero effect for most pedigrees. Thus, the project has highlighted 46 syntenic pairs 
(3 STR-STR, 21 STR-SNP and 22 SNP-SNP) that would have significant impact on LR 
estimation due to lower RFs (< 0.12). The case-specific impact of linkage should be 
included in the estimation of LRs by using the RFs values estimated in this project.  With 
the increasing number of DNA markers that can be typed simultaneously, the need to a 
software that can calculate case-specific LR and includes the linkage effect for all linked 




8.3 Evidence of consanguinity in the population of Saudi Arabia 
Previous studies, in the population of Saudi Arabia, which were conducted by either 
questionnaires (Wong and Anokute 1990, El-Hazmi et al. 1995) or by genetic analysis of 
forensically relevant markers (Khubrani et al. 2019b, Khubrani et al. 2019a), have 
demonstrated an increasing level of consanguinity.  
In this project, lack of heterozygosity was observed in the size-based data of the 
majority of loci tested (20/21 loci in the GlobalFiler kit, 14/17 of the non- CODIS loci in 
the SureID23 kit, and 87/121 loci ForenSeq DNA Signature Prep kit(size-based data). In 
addition, the sequence-based data generated of the 122 markers (including the SE33 
data) generated using ForenSeq DNA Signature Prep kit showed lack of heterozygosity 
in 92/122 loci. This was evidential by an increasing level of the inbreeding coefficient 
(FIS) of 0.03560 (GlobalFiler kit), 0.02977 (SureID23 kit) and of 0.03924 (ForenSeq DNA 
Signature Prep kit).  
Higher FIS was also observed in the Middle Eastern samples included in the Human 
Genome Diversity Panel (HGDP-CEPH) that showed an averages of 0.041 (Bedouin) 
0.032 (Druze) 0.014 (Mozabite) and 0.020 (Palestinian) (Leutenegger et al. 2011). These 
levels (including the Saudi data set examined here) are higher than other populations 
included in the HGDP-CEPH like Africans (7 populations with an average of 0.0032), 
Europeans (5 populations with an average of 0.003), East Asians (17 populations with an 
average of 0.0032) and Oceanians (2 populations with an average of 0.0025) 
(Leutenegger et al. 2011).  
The data of the 21 aSTRs (GlobalFiler kit) showed an FIS of 0.03560 that was increased 
to 0.03924 when more loci were tested (ForenSeq DNA Signature Prep kit). The higher 




of STR panel used in Saudi Arabia especially when relative are expected to be involved. 
In addition, less certainty would be expected in kinship testing comparing to other 
population with lower level of consanguinity. 
8.4 Future work 
As the hypothetical pedigree generated by the in-house Excel sheet does not reflect 
the type of samples that could be seen in real casework (FIS of the 13 members was -
0.06343 that represents an excess of heterozygosity). It would be interesting to study 
the impact of higher inbreeding coefficient in real cases. Another option is by studying 
one of the large families in Saudi Arabia that are known to have a high level of 
consanguinity. 
Sequencing more samples from the population of Saudi Arabia using MPS systems 
would allow establishing a representative sequence-based databased for both aSTRs 
and iiSNPs. It would be interesting to use the systems to study ancestry informative SNPs 
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10 Chapter Ten: Appendixes 
10.1 Appendix 1 
10.1.1 Scenarios specific equations that used for calculating the RI. 
Table 10.1. Scenarios specific equations that used for calculating the RI. The table shows the equations that 
are used in calculating RI based on the genotypes of the tested individuals. The numerator (X) represents 
the probability of that the alleged father has passed the common allele with the disputed child. The 
denominator (Y) represent the probability of that random male from the same population is the source of 
shared allele. The RI equations are the result of numerator (X)/denominator (Y). The last five rows, show 
specific scenarios’ equations that used for calculating the RI when the mother’s genotype is not available 
(Stephenson 2010).  
Genotypes 
Numerator (X) Denominator (Y) RI (X/Y) Mother Child Alleged 
father 
AA AA AA 1 pA 1/ pA 
AA AA AB 1/2 pA 1/2 pA 
AA AA BC 0 pA 0 
AB AA AA 1/2 pA/2 1/ pA 
AB AA AB 1/4 pA/2 1/2 pA 
AB AA AC 1/4 pA/2 1/2 pA 
AB AA BC 0 pA/2 0 
AA AB AB 1/4 pB/2 1/2 pB 
AA AB BB 1 pB 1/ pB 
AA AB BC 1/2 pB 1/2 pB 
AA AB CD 0 PA 0 
AB AB AA 1/2 (pA+pB)/2 1/(pA+pB) 
AB AB AB 1/2 (pA+pB)/2 1/(pA+pB) 
AB AB BC 1/4 (pA+pB)/2 1/[2(pA+pB)] 
AB AB AC 1/4 (pA+pB)/2 1/[2(pA+pB)] 
AB AC AC 1/2 pC 1/2 pC 
AB AC CD 1/4 pC/2 1/ 2pC 
AB AC BC 1/4 pC/2 1/2pC 
AB BC CC 1/2 pC/2 1/ pC 
AB BB AB 1/4 pB/2 1/ 2pB 
AB BC BC 1/2 pC 1/2pC 
AB BC CD 1/4 pC/2 1/ 2pC 
AB AB CD 0 (pA+pB)/2 0 
AC AB BB 1/2 pB/2 1/ pB 
AC AB BD 1/4 pB/2 1/ 2pB 
AC AB BC 1/4 pB/2 1/ 2pB 
AC AB CD 0 pB/2 0 
n/a AA AA 1 pA 1/pA 
n/a AA AB 1 2pA 1/2pA 
n/a AB AB (pA+pB) 4pApB (pA+pB)/4pApB) 
n/a AB BB 1 2pB 1/2pB 
n/a AB BC 1 4pB 1/4pB 
A, B, C and D: the possible alleles of the tested individuals. 
pA, pB and pC: the frequency of the alleles A, B and C respectively. 





10.1.2 Scenarios specific equations that used for calculating the RI when the child is 
missing 
Table 10.2. Scenarios specific equations that used for calculating the RI when the child is missing, and the 
genotypes of the parent are is available (AABB 2010b) 
Genotypes 
Numerator (X) Denominator (Y) RI (X/Y) 
Mother Alleged child Father 
AA AA AB 1 2pA2 1/2pA2 
AA AB AB 1 4pApB 1/4pApB 
AA AB BC 1 4pApB 1/4pApB 
AB AA AB 1 4pA2 1/4pA2 
AB AA AC 1 4pA2 1/4pA2 
BC AB AB 1 8pApB 1/8pApB 
BC AB AC 1 8pApB 1/8pApB 
BD AB AC 1 8pApB 1/8pApB 
AA AA AA 1 pA2 1/pA2 
AB AA AA 1 2pA2 1/2pA2 
BB AB AA 1 2pApB 1/2pApB 
BC AB AA 1 4pApB 1/4pApB 
AB AB AC 1 8pApB 1/8pApB 
AB AB AA 1 4pApB 1/4pApB 
AB AB AB 1 4pApB 1/4pApB 
A, B, C and D: the possible alleles of the tested individuals. 
pA and pB: the frequency of the alleles A and B respectively. 






10.1.3 Scenarios specific equations that used for calculating the SI and HSI. 
Table 10.3. Scenarios specific equations that used for calculating the Sibling Index (SI) and the Half-Sibling 




Half-Sibling Index  
(HSI) Sibling / half sibling  
Alleged  
Sibling/half sibling 
AB AB (1+pA+pB+2pApB)/8pApB (pA+pB+4pApB)/8pApB 
AA AA (1+pA) 2/(2pA) 2 (1+pA)/2pA 
AA AB (1+pA)/4pA (1+2pA)/4pA 
AB AC (1+2pA)/8pA (1+4pA)/8pA 
AB CD 0.25 0.5 
A, B, C and D: the possible alleles of the tested individuals. 






10.1.4  Including the mutation event into the RI-LR 
First, by directly substituting the LR with the mutation rate of the locus. For example, 
the mutation rate of the CSF1PO is 0.002021 (AABB 2008), and when a mutation event 
is expected, the LR will be 0.002021 for this locus.  
Second, by dividing the mutation rate of the locus by the power of exclusion of the 
same locus (Butler 2015), by which two hypotheses are considered: X (the alleged father 
is the true father and a mutation has occurred and has inherited to the child), which is 
equal to the mutation rate (µ), and Y (the alleged father is not the true father and the 
allele has inherited from unrelated man) which is equal to the power of exclusion (PE). 
Using the above example: 
LR = X/Y = µ of CSF1PO / (PE) 
LR = 0.002021 / 0.431 (the PE of the locus for the Saudi population (Alsafiah et al. 2017). 
LR = 0.00469. 
However, the first way does not compare the two probabilities of the typical 
hypotheses, and the second one does not include the inheritance probability from the 
parent to the child (Allen 2013).  
Third, compares two hypotheses, take in account the inheritance probability and uses 
allele-specific mutation rate (Figure 10.1)(Gjertson et al. 2007). Although the AABB has 
provides allele-specific mutation (paternal and maternal) rates for 15 STRs (AABB 2008), 
the data does not include the rest of commonly used STRs (e.g. D1S1656, D2S441, 







Figure 10.1. Incorporating the allele-specific mutation rates in the calculation of the RI-LR. This Figure 
explains the third way of incorporating the allele-specific mutation rates in the calculation of the RI-LR. 
The allele-specific mutation (paternal and maternal) rates for are provided in (AABB 2008). µ 𝐵→𝐸: is the 
mutation rate of allele B to allele E, µ 𝐴 →𝐸: is the mutation rate of allele A to allele E, and 𝑝𝐸: the 
frequency of the allele E (An original figure). 
Fourth, a more appropriate way for the STR markers (Gjertson et al. 2007), was 
suggested by Brenner (2018), which assumes a fixed probability for each type of 
mutation (0.5 for a single step increase/decrease, 0.05 for two steps increase/ decrease, 
0.005 for three steps increase/ decrease…. etc), includes the average mutation rate of 






Figure 10.2. Incorporating the mutation event into the calculation of the RI-LR. This figure describes a way 
of including the mutation event into the calculation of the RI-LR using a fixed probability for each type of 





10.1.5  Including the prior probability (Pr) to the posterior probability (Po). 
The Pr and the genetic evidence are included in the calculation of the posterior 
probability (Po) (i. e. relationship probability) as follows: Po = (CRI X Pr) / (CRI X Pr + (1-
Pr)).  
10.1.6 RMNE calculation. 
The RMNE (random man not excluded) can also be calculated using the frequency of 
the shared allele between the alleged father and the child. In other words, what the 
portion of the population that could have the shared allele. Assuming allele A is the 
shared allele and p is the frequency of the allele A, the genotypes (homozygous and 
heterozygous) that could have the allele A can be calculated by using the HW-equation 
(p2 + 2pq = RMNE, where q = 1 - p). Subsequently, the power of exclusion (PE) can be 







Figure 10.3. An example of calculating the PI, paternity probability, RMNE and PE. This figure shows a 
typical parentage case and shows how the strength of evidence can be estimated. In this example, the 
specific equation was adopted from Table 10.1  based on the genotypes of the tested individuals and the 
frequencies of the D1S1656 alleles were adopted from (Alsafiah et al. 2017). By only one locus, the PI 
shows that there is 1/9.6 chance random unrelated man from the same population is the biological father. 
The paternity probability shows that 90.6% (posterior probability) is the chance that the AF is the source 
of the shared allele comparing to 50% (prior probability). Based on the RMNE, the PE is 80.3% that means 









Figure 10.4. An example of calculating the PI, paternity probability, RMNE and PE in a mother-less case. 
This figure shows a typical parentage mother-less case and shows how the strength of evidence can be 
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10.5 Appendix 5 





Size Based Data Repeat Region Sequence Data Repeat and flanking regions 








10 0.00575 [TAGA]10 0.00575 TAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATGTGTGTGTGTTTAATTGTATGTATATATATTTGGTTCCCTAGTGATTCTATTTCTCTGAA 0.00575 
11 0.05747 [TAGA]11  0.05747 TAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATGTGTGTGTGTTTAATTGTATGTATATATATTTGGTTCCCTAGTGATTCTATTTCTCTGAA 0.05747 
12 0.12644 
[TAGA]11 TAGG  0.08046 TAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATGTGTGTGTGTTTAATTGTATGTATATATATTTGGTTCCCTAGTGATTCTATTTCTCTGAA 0.08046 
[TAGA]12  0.04598 TAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATGTGTGTGTGTTTAATTGTATGTATATATATTTGGTTCCCTAGTGATTCTATTTCTCTGAA 0.04598 
13 0.05747 
[TAGA]12 TAGG  0.02299 TAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGGTGTGTGTGTGTTTAATTGTATGTATATATATTTGGTTCCCTAGTGATTCTATTTCTCTGAA 0.02299 
[TAGA]13  0.03448 TAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATGTGTGTGTGTTTAATTGTATGTATATATATTTGGTTCCCTAGTGATTCTATTTCTCTGAA 0.03448 
14 0.11494 [TAGA]13 TAGG  0.11494 TAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGGTGTGTGTGTGTTTAATTGTATGTATATATATTTGGTTCCCTAGTGATTCTATTTCTCTGAA 0.11494 
14.3 0.00575 [TAGA]4 TGA [TAGA]9 TAGG  0.00575 TAGATAGATAGATAGATGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGGTGTGTGTGTGTTTAATTGTATGTATATATATTTGGTTCCCTAGTGATTCTATTTCTCTGAA 0.00575 
15 0.15517 
[TAGA]14 TAGG  0.12069 TAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGGTGTGTGTGTGTTTAATTGTATGTATATATATTTGGTTCCCTAGTGATTCTATTTCTCTGAA 0.12069 
[TAGA]15  0.02299 TAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATGTGTGTGTGTTTAATTGTATGTATATATATTTGGTTCCCTAGTGATTCTATTTCTCTGAA 0.02299 
[TAGA]14 TAAG  0.01149 TAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAAGTGTGTGTGTGTTTAATTGTATGTATATATATTTGGTTCCCTAGTGATTCTATTTCTCTGAA 0.01149 
15.3 0.06897 
















































6 0.01724 [AATG]6  0.01724 AATGAATGAATGAATGAATGAATGTTTGG 0.01724 
7 0.01149 [AATG]7  0.01149 AATGAATGAATGAATGAATGAATGAATGTTTGG 0.01149 
8 0.51724 [AATG]8  0.51724 AATGAATGAATGAATGAATGAATGAATGAATGTTTGG 0.51724 
9 0.18391 [AATG]9  0.18391 AATGAATGAATGAATGAATGAATGAATGAATGAATGTTTGG 0.18391 
10 0.12069 [AATG]10  0.12069 AATGAATGAATGAATGAATGAATGAATGAATGAATGAATGTTTGG 0.12069 
11 0.13793 [AATG]11  0.13793 AATGAATGAATGAATGAATGAATGAATGAATGAATGAATGAATGTTTGG 0.13793 
12 0.01149 [AATG]12  0.01149 AATGAATGAATGAATGAATGAATGAATGAATGAATGAATGAATGAATGTTTGG 0.01149 
 
 











[TCTA]10  0.07471 CCAGGAACTGTGGCTCATCTATGAAAACTTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATATCATAACACCACAGCCACTTA 0.07471 
[TCTA]8 TCTG TCTA  0.01724 CCAGGAACTGTGGCTCATCTATGAAAACTTCTATCTATCTATCTATCTATCTATCTATCTATCTGTCTATATCATAACACCACAGCCACTTA 0.01724 
11 0.36782 [TCTA]11  0.36782 
CCAGGAACTGTGGCTCATCTATGAAAACTTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATATCATAACACCACAGCCACTTA 0.33908 
CCAGAAACTGTGGCTCATCTATGAAAACTTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATATCATAACACCACAGCCACTTA 0.02874 
11.3 0.06322 [TCTA]4 TC A [TCTA]7  0.06322 CCAGGAACTGTGGCTCATCTATGAAAACTTCTATCTATCTATCTATCATCTATCTATCTATCTATCTATCTATCTATATCATAACACCACAGCCACTTA 0.06322 
12 0.06897 [TCTA]12  0.06897 CCAGGAACTGTGGCTCATCTATGAAAACTTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATATCATAACACCACAGCCACTTA 0.06897 
13 0.02299 
[TCTA]13  0.00575 CCAGGAACTGTGGCTCATCTATGAAAACTTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATATCATAACACCACAGCCACTTA 0.00575 
[TCTA]10 TTTA [TCTA]2  0.01724 CCAGGAACTGTGGCTCATCTATGAAAACTTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTTATCTATCTATATCATAACACCACAGCCACTTA 0.01724 
14 0.33908 [TCTA]11 TTTA [TCTA]2  0.33908 CCAGGAACTGTGGCTCATCTATGAAAACTTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTTATCTATCTATATCATAACACCACAGCCACTTA 0.33908 
15 0.02874 [TCTA]12 TTTA [TCTA]2  0.02874 CCAGGAACTGTGGCTCATCTATGAAAACTTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTTATCTATCTATATCATAACACCACAGCCACTTA 0.02874 









174 14 0.01724 [TGCC]6 [TTCC]8 0.01724 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.01724 
16 0.05172 [TGCC]6 [TTCC]10 0.05172 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.05172 
17 0.21264 [TGCC]6 [TTCC]11 0.21264 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.21264 
18 0.09195 
[TGCC]7 [TTCC]11 0.03448 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.03448 
[TGCC]6 [TTCC]12 0.05747 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.05747 
19 0.14944 
[TGCC]7 [TTCC]12 0.08621 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.08621 
[TGCC]6 [TTCC]13 0.04598 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.04598 
[TGCC]6 [TTCC]10 GTCC [TTCC]2 0.00575 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCGTCCTTCCTTCCCTC 0.00575 
[TGCC]8 [TTCC]11 0.00575 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.00575 
[TGCC]5 [TTCC]14  0.00575 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.00575 
20 0.22989 
[TGCC]7 [TTCC]10 GTCC [TTCC]2   0.1092 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCGTCCTTCCTTCCCTC 0.1092 
[TGCC]6 [TTCC]14  0.01149 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.01149 
[TGCC]7 [TTCC]13  0.08621 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.08621 
[TGCC]4 [TTCC]16  0.00575 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.00575 
[TGCC]8 [TTCC]12  0.01149 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.01149 
[TGCC]8 [TTCC]5 TTTC [TTCC]6 0.00575 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTTCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.00575 
21 0.07472 
[TGCC]7 [TTCC]11 GTCC [TTCC]2  0.02874 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCGTCCTTCCTTCCCTC 0.02874 
[TGCC]7 [TTCC]14 0.04023 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.04023 
[TGCC]9 [TTCC]12 0.00575 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.00575 
22 0.02874 
[TGCC]6 [TTCC]13 GTCC [TTCC]2  0.00575 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCGTCCTTCCTTCCCTC 0.00575 
[TGCC]9 [TTCC]13 0.01149 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.01149 
[TGCC]7 [TTCC]12 GTCC [TTCC]2 0.00575 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCGTCCTTCCTTCCCTC 0.00575 
[TGCC]7 [TTCC]15  0.00575 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCCTC 0.00575 
23 0.05172 [TGCC]7 [TTCC]13 GTCC [TTCC]2 0.05172 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCGTCCTTCCTTCCCTC 0.05172 
24 0.02874 
[TGCC]8 [TTCC]13 GTCC [TTCC]2 0.00575 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCGTCCTTCCTTCCCTC 0.00575 
[TGCC]7 [TTCC]14 GTCC [TTCC]2 0.01149 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCGTCCTTCCTTCCCTC 0.01149 
[TGCC]5 [TTCC]16 GTCC [TTCC]2 0.00575 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCGTCCTTCCTTCCCTC 0.00575 
[TGCC]6 [TTCC]15 GTCC [TTCC]2 0.00575 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCGTCCTTCCTTCCCTC 0.00575 
25 0.06322 
[TGCC]8 [TTCC]14 GTCC [TTCC]2 0.00575 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCGTCCTTCCTTCCCTC 0.00575 
[TGCC]7 [TTCC]15 GTCC [TTCC]2 0.05172 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCGTCCTTCCTTCCCTC 0.05172 
[TGCC]6 [TTCC]16 GTCC [TTCC]2 0.00575 AAATGGCTTGGCCTTGCCTGCCTGCCTGCCTGCCTGCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCGTCCTTCCTTCCCTC 0.00575 
  












TCTA [TCTG]2 [TCTA]11  0.06322 TTTGGGGGCATCTCTTATACTCATGAAATCAACAGAGGCTTGCATGTATCTATCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATGAGACAGGGTCTTGCTC 0.06322 
TCTA [TCTG]2 [TCTA]11  0.06322 TTTGGGGGCATCTCTTATACTCATGAAATCAACAGAGGCTTGCATGTATCTATCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATGAGACAGGGTCTTGCTC 0.06322 
15 0.25287 












































































8 0.3908 [ATCT]8  0.3908 CTATGCATCTATCTATCTATCTATCTATCTATCTATCTAATGGTTA 0.3908 
9 0.13218 [ATCT]9 0.13218 CTATGCATCTATCTATCTATCTATCTATCTATCTATCTATCTAATGGTTA 0.13218 
10 0.21264 [ATCT]10 0.21264 CTATGCATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTAATGGTTA 0.21264 
11 0.21839 [ATCT]11 0.21839 CTATGCATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTAATGGTTA 0.21839 
12 0.04023 [ATCT]12 0.04023 CTATGCATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTAATGGTTA 0.04023 
13 0.00575 [ATCT]13 0.00575 CTATGCATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTAATGGTTA 0.00575 
  












[TTTC]3 TTTT TTCT [CTTT]11 CTCC 
[TTCC]2  
0.04598 GCATATTTACAAGCTAGTTTCTTTCTTTCTTTTTTCTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCCTTCCTTCCTTTCTTCCTTTCTTTTTTGCTGG 0.04598 
20 0.13218 
[TTTC]3 TTTT TTCT [CTTT]12 CTCC 
[TTCC]2  
0.13218 GCATATTTACAAGCTAGTTTCTTTCTTTCTTTTTTCTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCCTTCCTTCCTTTCTTCCTTTCTTTTTTGCTGG 0.13218 
21 0.10345 
[TTTC]3 TTTT TTCT [CTTT]13 CTCC 
[TTCC]2  
0.10345 GCATATTTACAAGCTAGTTTCTTTCTTTCTTTTTTCTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCCTTCCTTCCTTTCTTCCTTTCTTTTTTGCTGG 0.10345 
21.2 0.01149 
[TTTC]3 TTTT TT [CTTT]14 CTCC 
[TTCC]2  
0.01149 GCATATTTACAAGCTAGTTTCTTTCTTTCTTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCCTTCCTTCCTTTCTTCCTTTCTTTTTTGCTGG 0.01149 
22 0.18391 
[TTTC]3 TTTT TTCT [CTTT]14 CTCC 
[TTCC]2  
0.18391 GCATATTTACAAGCTAGTTTCTTTCTTTCTTTTTTCTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCCTTCCTTCCTTTCTTCCTTTCTTTTTTGCTGG 0.18391 
22.2 0.00575 
[TTTC]3 TTTT TT [CTTT]15 CTCC 
[TTCC]2  
0.00575 GCATATTTACAAGCTAGTTTCTTTCTTTCTTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCCTTCCTTCCTTTCTTCCTTTCTTTTTTGCTGG 0.00575 
23 0.16667 
[TTTC]3 TTTT TTCT [CTTT]15 CTCC 
[TTCC]2  
0.16092 GCATATTTACAAGCTAGTTTCTTTCTTTCTTTTTTCTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCCTTCCTTCCTTTCTTCCTTTCTTTTTTGCTGG 0.16092 
[TTTC]3 TTTT TTCT [CTTT]13 GTTT 
CTTT CTCC [TTCC]2  
0.00575 GCATATTTACAAGCTAGTTTCTTTCTTTCTTTTTTCTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTGTTTCTTTCTCCTTCCTTCCTTTCTTCCTTTCTTTTTTGCTGG 0.00575 
23.2 0.00575 





















[TTTC]3 TTTT TTCT [CTTT]12 CCTT 












[TTTC]3 TTTT TTCT [CTTT]13 CCTT 












[TTTC]3 TTTT TTCT [CTTT]14 CCTT 






[TTTC]3 TTTT TTCT [CTTT]16 CCTT 


















8 0.03448 [AGAT]8 0.03448 ATTTTGAAGATAGATAGATAGATAGATAGATAGATAGATAGATGTATAAATA 0.03448 
9 0.07471 [AGAT]9 0.07471 ATTTTGAAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATGTATAAATA 0.07471 
10 0.08046 [AGAT]10  0.08046 
ATTTTGAAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATGTATAAATA 0.01724 
ATTTTGAAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGGTATAAATA 0.06322 
11 0.2931 [AGAT]11  0.2931 
ATTTTGAAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGGTATAAATA 0.24138 
ATTTTGAAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATGTATAAATA 0.05172 
12 0.34482 [AGAT]12  0.34482 
ATTTTGAAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATGTATAAATA 0.13218 
ATTTTGAAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGGTATAAATA 0.21264 
13 0.15518 [AGAT]13  0.15518 
ATTTTGAAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGGTATAAATA 0.1092 
ATTTTGAAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATGTATAAATA 0.04598 













8 0.01149 [AGAT]8  0.01149 AAGATAGATAGATTAGATAGATAGATAGATAGATAGATAGATAGATAGGAAG 0.01149 
9 0.02874 [AGAT]9 0.02874 AAGATAGATAGATTAGATAGATAGATAGATAGATAGATAGATAGATAGATAGGAAG 0.02874 
10 0.32184 [AGAT]10  0.32184 AAGATAGATAGATTAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGGAAG 0.32184 
11 0.28736 [AGAT]11  0.28736 AAGATAGATAGATTAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGGAAG 0.28736 
12 0.29885 
[AGAT]12  0.27586 AAGATAGATAGATTAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGGAAG 0.27586 
[AGAT]10 AGGT AGAT 0.02299 AAGATAGATAGATTAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGGTAGATAGGAAG 0.02299 
13 0.04598 [AGAT]13  0.04598 AAGATAGATAGATTAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGGAAG 0.04598 
14 0.00575 [AGAT]14  0.00575 AAGATAGATAGATTAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGGAAG 0.00575 











































































7 0.00575  [GATA]7  0.00575 ATAGTTTAGAACGAACTAACGATAGATAGATAGATAGATAGATAGATAGACAGATTGATAGTTTTTTTTTATCTCACTAAATA 0.00575 
8 0.24713  [GATA]8  0.24713 
ATAGTTTAGAACGAACTAACGATAGATAGATAGATAGATAGATAGATAGATAGACAGATTGATAGTTTTTTTTTATCTCACTAAATA 0.17816 
ATAGTTTAGAATGAACTAACGATAGATAGATAGATAGATAGATAGATAGATAGACAGATTGATAGTTTTTTTTTATCTCACTAAATA 0.06897 
9 0.0862  [GATA]9  0.0862 
ATAGTTTAGAACGAACTAACGATAGATAGATAGATAGATAGATAGATAGATAGATAGACAGATTGATAGTTTTTTTTTATCTCACTAAATA 0.07471 
ATAGTTTAGAATGAACTAACGATAGATAGATAGATAGATAGATAGATAGATAGATAGACAGATTGATAGTTTTTTTTTATCTCACTAAATA 0.01149 




11 0.18391  [GATA]11  0.18391 
ATAGTTTAGAACGAACTAACGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGACAGATTGATAGTTTTTTTTAATCTCACTAAATA 0.01724 
ATAGTTTAGAACGAACTAACGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGACAGATTGATAGTTTTTTTTTATCTCACTAAATA 0.16667 
12 0.13793  [GATA]12  0.13793 
ATAGTTTAGAACGAACTAACGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGACAGATTGATAGTTTTTTTTAATCTCACTAAATA 0.01724 
ATAGTTTAGAACGAACTAACGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGACAGATTGATAGTTTTTTTTTATCTCACTAAATA 0.12069 
















9 0.00575  [TCTA]9  0.00575 TCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.00575 
10 0.04598  [TCTA]10  0.04598 TCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.04598 
11 0.12644  [TCTA]11  0.12644 TCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.12644 
12 0.17242 
 [TCTA]12  0.14943 TCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.14943 
 [TCTA]2 TCTG [TCTA]9  0.01724 TCTATCTATCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.01724 
 TCTA TCTG [TCTA]10  0.00575 TCTATCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.00575 
13 0.22414 
 TCTA TCTG [TCTA]11  0.16667 TCTATCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.16667 
 [TCTA]13  0.05747 TCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.05747 
14 0.18966 
 [TCTA]2 TCTG [TCTA]11  0.04598 TCTATCTATCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.04598 
 TCTA TCTG [TCTA]12  0.14368 TCTATCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.14368 
15 0.16667 
 TCTA TCTG [TCTA]13  0.02874 TCTATCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.02874 
 [TCTA]2 TCTG [TCTA]12  0.13218 TCTATCTATCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.13218 
 [TCTA]2 [TCTG]2 [TCTA]11  0.00575 TCTATCTATCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.00575 
16 0.05173 
 TCTA TCTG [TCTA]14  0.00575 TCTATCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.00575 
 [TCTA]2 TCTG [TCTA]13  0.04598 TCTATCTATCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.04598 
17 0.01724 
 [TCTA]2 TCTG [TCTA]14  0.01149 TCTATCTATCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATTCCC 0.01149 







7 0.00575  [TAGA]7 0.00575 AGATAACTGTAGATAGGTAGATAGATAGATAGATAGATAGATAGATATTAAT 0.00575 
10 0.04023  [TAGA]10  0.04023 AGATAACTGTAGATAGGTAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATATTAAT 0.04023 
11 0.21265 
 TAGA TCGA [TAGA]9  0.02874 AGATAACTGTAGATAGGTAGATCGATAGATAGATAGATAGATAGATAGATAGATAGATAGATATTAAT 0.02874 
 [TAGA]11  0.18391 AGATAACTGTAGATAGGTAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATATTAAT 0.18391 
12 0.43678 
 [TAGA]12  0.21264 AGATAACTGTAGATAGGTAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATATTAAT 0.21264 
 TAGA TCGA [TAGA]10  0.22414 AGATAACTGTAGATAGGTAGATCGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATATTAAT 0.22414 
13 0.27012 
 [TAGA]13  0.12069 AGATAACTGTAGATAGGTAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATATTAAT 0.12069 
 TAGA TCGA [TAGA]11  0.14943 AGATAACTGTAGATAGGTAGATCGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATATTAAT 0.14943 
14 0.02299 
 [TAGA]14  0.00575 AGATAACTGTAGATAGGTAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATATTAAT 0.00575 
 TAGA TCGA [TAGA]12  0.01724 AGATAACTGTAGATAGGTAGATCGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATATTAAT 0.01724 
15 0.01149  [TAGA]15  0.01149 AGATAACTGTAGATAGGTAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATATTAAT 0.01149 











174 9 0.01149  [GGAA]9 0.01149 TTGAACAAATGAGTGAGTGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAATGAAGACAATACAACCAGAGTT 0.01149 
11 0.01724  [GGAA]11  0.01724 TTGAACAAATGAGTGAGTGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAATGAAGACAATACAACCAGAGTT 0.01724 
12 0.05172  [GGAA]12  0.05172 TTGAACAAATGAGTGAGTGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAATGAAGACAATACAACCAGAGTT 0.05172 
13 0.1092  [GGAA]13  0.1092 TTGAACAAATGAGTGAGTGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAATGAAGACAATACAACCAGAGTT 0.1092 
14 0.44253  [GGAA]14  0.44253 TTGAACAAATGAGTGAGTGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAATGAAGACAATACAACCAGAGTT 0.44253 
15 0.25287  [GGAA]15  0.25287 TTGAACAAATGAGTGAGTGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAATGAAGACAATACAACCAGAGTT 0.25287 
16 0.08046  [GGAA]16  0.08046 TTGAACAAATGAGTGAGTGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAATGAAGACAATACAACCAGAGTT 0.08046 
17 0.03448  [GGAA]17  0.03448 TTGAACAAATGAGTGAGTGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAGGAAATGAAGACAATACAACCAGAGTT 0.03448 
 
 




174 6 0.32759  [AATG]6  0.32759 TGCAGGTCACAGGGAACACAGACTCCATGGTGAATGAATGAATGAATGAATGAATGAGGGAAATAAGG 0.32759 
7 0.14943  [AATG]7  0.14943 TGCAGGTCACAGGGAACACAGACTCCATGGTGAATGAATGAATGAATGAATGAATGAATGAGGGAAATAAGG 0.14943 
8 0.10345  [AATG]8  0.10345 TGCAGGTCACAGGGAACACAGACTCCATGGTGAATGAATGAATGAATGAATGAATGAATGAATGAGGGAAATAAGG 0.10345 
9 0.27586  [AATG]9  0.27586 TGCAGGTCACAGGGAACACAGACTCCATGGTGAATGAATGAATGAATGAATGAATGAATGAATGAATGAGGGAAATAAGG 0.27586 
9.3 0.13218  [AATG]6  ATG [AATG]3  0.13218 TGCAGGTCACAGGGAACACAGACTCCATGGTGAATGAATGAATGAATGAATGAATGATGAATGAATGAATGAGGGAAATAAGG 0.13218 
10 0.01149  [AATG]10  0.01149 TGCAGGTCACAGGGAACACAGACTCCATGGTGAATGAATGAATGAATGAATGAATGAATGAATGAATGAATGAGGGAAATAAGG 0.01149 
 
 






[TCTA]2 [TCTG]4 [TCTA]3 TCCA  
[TCTA]3  
0.00575 ATTGATCTATCTATCTGTCTGTCTGTCTGTCTATCTATCTATCCATCTATCTATCTATCCATCCATCCATCCATCCTATGTATT 0.00575 
14 0.06321 
TCTA  [TCTG]4 [TCTA]9  0.01149 ATTGATCTATCTGTCTGTCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCCATCTATCCATCCATCCTATGTATT 0.01149 
TCTA TCTG TCTA [TCTG]4 [TCTA]3 
TCCA  [TCTA]3  
0.05172 ATTGATCTATCTGTCTATCTGTCTGTCTGTCTGTCTATCTATCTATCCATCTATCTATCTATCCATCCATCCATCCATCCTATGTATT 0.05172 
15 0.10345 
TCTA  [TCTG]4 [TCTA]10 0.06322 ATTGATCTATCTGTCTGTCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCCATCTATCCATCCATCCTATGTATT 0.06322 
TCTA  [TCTG]3 [TCTA]11 0.04023 ATTGATCTATCTGTCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCCATCTATCCATCCATCCTATGTATT 0.04023 
16 0.28735 
TCTA  [TCTG]4 [TCTA]11 0.25287 ATTGATCTATCTGTCTGTCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCCATCTATCCATCCATCCTATGTATT 0.25287 
TCTA  [TCTG]3 [TCTA]12  0.03448 ATTGATCTATCTGTCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCCATCTATCCATCCATCCTATGTATT 0.03448 
17 0.26437 
TCTA  [TCTG]4 [TCTA]12 0.23563 ATTGATCTATCTGTCTGTCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCCATCTATCCATCCATCCTATGTATT 0.23563 
TCTA  [TCTG]3 [TCTA]13 0.02299 ATTGATCTATCTGTCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCCATCTATCCATCCATCCTATGTATT 0.02299 
TCTA  [TCTG]5 [TCTA]11  0.00575 ATTGATCTATCTGTCTGTCTGTCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCCATCTATCCATCCATCCTATGTATT 0.00575 
18 0.20115 
TCTA  [TCTG]4 [TCTA]13  0.1954 ATTGATCTATCTGTCTGTCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCCATCTATCCATCCATCCTATGTATT 0.1954 
TCTA  [TCTG]5 [TCTA]12 0.00575 ATTGATCTATCTGTCTGTCTGTCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCCATCTATCCATCCATCCTATGTATT 0.00575 
19 0.06322 TCTA  [TCTG]4 [TCTA]14 0.06322 ATTGATCTATCTGTCTGTCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCCATCTATCCATCCATCCTATGTATT 0.06322 
20 0.0115 
TCTA  [TCTG]4 [TCTA]15 0.00575 ATTGATCTATCTGTCTGTCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCCATCTATCCATCCATCCTATGTATT 0.00575 
TCTA  [TCTG]6 [TCTA]13 0.00575 ATTGATCTATCTGTCTGTCTGTCTGTCTGTCTGTCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCCATCTATCCATCCATCCTATGTATT 0.00575 
  

















































































































































































































174 8 0.10345  [TATC]8  0.10345 TCTGACCCATCTAACGCCTATCTGTATTTACAAATACATTATCTATCTATCTATCTATCTATCTATCTATCAATCAATCATCTATCTATCTTTCTGTCTGTCTTTTTGGG 0.10345 
9 0.04023  [TATC]9  0.04023 TCTGACCCATCTAACGCCTATCTGTATTTACAAATACATTATCTATCTATCTATCTATCTATCTATCTATCTATCAATCAATCATCTATCTATCTTTCTGTCTGTCTTTTTGGG 0.04023 
10 0.04598  [TATC]10  0.04598 
TCTGACCCATCTAACGCCTATCTGTATTTACAAATACATTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCAATCATCTATCTATCTTTCTGTCTGTCTTTTTGGG 0.02874 
TCTGACCCATCTAACGCCTATCTGTATTTACAAATACATTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCAATCAATCATCTATCTATCTTTCTGTCTGTCTTTTTGGG 0.01724 
11 0.22988  [TATC]11  0.22988 
TCTGACCCATCTAACGCCTATCTGTATTTACAAATACATTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCAATCATCTATCTATCTTTCTGTCTGTCTTTTTGGG 0.11494 
TCTGACCCATCTAACGCCTATCTGTATTTACAAATACATTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCAATCAATCATCTATCTATCTTTCTGTCTGTCTTTTTGGG 0.11494 
12 0.41954  [TATC]12  0.41954 
TCTGACCCATCTAACGCCTATCTGTATTTACAAATACATTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCAATCATCTATCTATCTTTCTGTCTGTCTTTTTGGG 0.2069 
TCTGACCCATCTAACGCCTATCTGTATTTACAAATACATTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCAATCAATCATCTATCTATCTTTCTGTCTGTCTTTTTGGG 0.21264 



























5 0.02907  [AAAGA]5  0.02907 AAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.02907 
7 0.00581  [AAAGA]7  0.00581 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.00581 
8 0.0814  [AAAGA]8  0.0814 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.0814 
9 0.03488  [AAAGA]9  0.03488 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.03488 
10 0.05233  [AAAGA]10  0.05233 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.05233 
11 0.12791  [AAAGA]11  0.12791 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.12791 
12 0.19186  [AAAGA]12  0.19186 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.19186 
13 0.10465  [AAAGA]13  0.10465 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.10465 
14 0.06395  [AAAGA]14  0.06395 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.06395 
14.4 0.00581  AAGA [AAAGA]14 0.00581 AAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.00581 
15 0.05233 
 [AAAGA]14 AAATA 0.00581 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATAAAATTGTAAGGAGTTTTCT 0.00581 
 [AAAGA]15  0.04651 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.04651 
16 0.05233  [AAAGA]16  0.05233 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.05233 
16.4 0.01744  AAGA [AAAGA]16  0.01744 AAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.01744 
17 0.05233 
 [AAAGA]17  0.04651 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.04651 
 [AAAGA]10 AAATA [AAAGA]6 0.00581 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.00581 
18 0.0407 
 [AAAGA]18  0.03488 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.03488 
 [AAAGA]16  [AAATA]2 0.00581 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATAAAATAAAATTGTAAGGAGTTTTCT 0.00581 
19 0.05233  [AAAGA]19  0.05233 AAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAAGAAAATTGTAAGGAGTTTTCT 0.05233 





















8 0.03449 [GATA]8  0.03449 
TCCTCTTCCCTAGATCAATACAGACAGACAGACAGGTGGATAGATAGATAGATAGATAGATAGATAGATATCATTGAAAGACAAAACAGAGATGGATGATAGATAC 0.02874 
TCCTCTTCCCTAGATCAATACAGACAGACAGACAGGTGGATAGATAGATAGATAGATAGATAGATAGATATCATTGAAAGACAAACCAGAGATGGATGATAGATAC 0.00575 
9 0.14368 [GATA]9 0.14368 
TCCTCTTCCCTAGATCAATACAGACAGACAGACAGGTGGATAGATAGATAGATAGATAGATAGATAGATAGATATCATTGAAAGACAAACCAGAGATGGATGATAGATAC 0.0977 
TCCTCTTCCCTAGATCAATACAGACAGACAGACAGGTGGATAGATAGATAGATAGATAGATAGATAGATAGATATCATTGAAAGACAAAACAGAGATGGATGATAGATAC 0.04598 
10 0.07471 [GATA]10  0.07471 
TCCTCTTCCCTAGATCAATACAGACAGACAGACAGGTGGATAGATAGATAGATAGATAGATAGATAGATAGATAGATATCATTGAAAGACAAACCAGAGATGGATGATAGATAC 0.05172 
TCCTCTTCCCTAGATCAATACAGACAGACAGACAGGTGGATAGATAGATAGATAGATAGATAGATAGATAGATAGATATCATTGAAAGACAAAACAGAGATGGATGATAGATAC 0.02299 
11 0.36782 [GATA]11  0.36782 
TCCTCTTCCCTAGATCAATACAGACAGACAGACAGGTGGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATATCATTGAAAGACAAAACAGAGATGGATGATAGATAC 0.34483 
TCCTCTTCCCTAGATCAATACAGACAGACAGACAGGTGGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATATCATTGAAAGACAAACCAGAGATGGATGATAGATAC 0.02299 




























10 0.04598 [AGAT]10  0.04598 ATATGTGTGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATCCATCATAGGAATTTT 0.04598 
11 0.28736 [AGAT]11 0.28736 ATATGTGTGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATCCATCATAGGAATTTT 0.28736 
12 0.44253 [AGAT]12 0.44253 ATATGTGTGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATCCATCATAGGAATTTT 0.44253 
13 0.17241 [AGAT]13 0.17241 ATATGTGTGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATCCATCATAGGAATTTT 0.17241 
14 0.03448 [AGAT]14 0.03448 ATATGTGTGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATCCATCATAGGAATTTT 0.03448 
15 0.01724 [AGAT]15 0.01724 ATATGTGTGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATCCATCATAGGAATTTT 0.01724 










174 10 0.01149 [AGAA]10  0.01149 GTCTCAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAAAGAGAGAGGAAAGAAAGAGAAAAAGAAAAGAAATAGTAGCAACTGTTATTGTAAGA 0.01149 
11 0.02299 [AGAA]11 0.02299 GTCTCAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAAAGAGAGAGGAAAGAAAGAGAAAAAGAAAAGAAATAGTAGCAACTGTTATTGTAAGA 0.02299 
12 0.12644 [AGAA]12 0.12644 GTCTCAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAAAGAGAGAGGAAAGAAAGAGAAAAAGAAAAGAAATAGTAGCAACTGTTATTGTAAGA 0.12644 
13 0.24713 [AGAA]13 0.24713 GTCTCAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAGAAAAAGAGAGAGGAAAGAAAGAGAAAAAGAAAAGAAATAGTAGCAACTGTTATTGTAAGA 0.24713 




















































































































9 0.01724  [AGAT]9  0.01724 AGACACCGAACCAATAAGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGATTTATTATAGGAATTGATT 0.01724 
10 0.00575  [AGAT]10  0.00575 AGACACCGAACCAATAAGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGATTTATTATAGGAATTGATT 0.00575 
11 0.00575  [AGAT]11  0.00575 AGACACCGAACCAATAAGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGATTTATTATAGGAATTGATT 0.00575 
12 0.07471  [AGAT]12  0.07471 AGACACCGAACCAATAAGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGATTTATTATAGGAATTGATT 0.07471 
13 0.1954  [AGAT]13  0.1954 
AGACACCGAACCAATAAGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGATTTATTATAGGAATTGATT 0.14368 
AGACACTGAACCAATAAGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGATTTATTATAGGAATTGATT 0.05172 
14 0.41954  [AGAT]14 0.41954 
AGACACTGAACCAATAAGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGATTTATTATAGGAATTGATT 0.08046 
AGACACCGAACCAATAAGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGATTTATTATAGGAATTGATT 0.33908 
15 0.19541  [AGAT]15  0.19541 
AGACACCGAACCAATAAGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGATTTATTATAGGAATTGATT 0.16667 
AGACACTGAACCAATAAGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGATTTATTATAGGAATTGATT 0.02874 
16 0.08046  [AGAT]16  0.08046 
AGACACCGAACCAATAAGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGATTTATTATAGGAATTGATT 0.07471 
AGACACTGAACCAATAAGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGATTTATTATAGGAATTGATT 0.00575 
17 0.00575  [AGAT]17  0.00575 AGACACCGAACCAATAAGAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGAGATTTATTATAGGAATTGATT 0.00575 












 [TCTA]4 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 






 [TCTA]4 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 





 [TCTA]4 [TCTG]7 [TCTA]3   TA [TCTA]3  TCA 





 [TCTA]6 [TCTG]5 [TCTA]3   TA [TCTA]3  TCA 






 [TCTA]6 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 





 [TCTA]4 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 





 [TCTA]5 [TCTG]5 [TCTA]3   TA [TCTA]3  TCA 





 [TCTA]5 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 





 [TCTA]6 [TCTG]5 [TCTA]3   TA [TCTA]3  TCA 






 [TCTA]6 [TCTG]5 [TCTA]3   TA [TCTA]3  TCA 





 [TCTA]5 [TCTG]6 [TCTA]3   TA [TCTA]2  TCA 





 [TCTA]4 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 





 [TCTA]5 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 






 [TCTA]5 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 






 [TCTA]6 [TCTG]5 [TCTA]3   TA [TCTA]3  TCA 





 [TCTA]5 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 





 [TCTA]4 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 





 [TCTA]6 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 





 [TCTA]7 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 






 [TCTA]5 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 





 [TCTA]5 [TCTG]5 [TCTA]3   TA [TCTA]3  TCA 






 [TCTA]6 [TCTG]7 [TCTA]3   TA [TCTA]3  TCA 






 [TCTA]5 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 









 [TCTA]5 [TCTG]6 [TCTA]3   TA [TCTA]3  TCA 






 [TCTA]10 [TCTG]8 [TCTA]3 TA [TCTA]3  











































































































Table 10.5. HWE test for aSTRs for the data generated from Chapter 6. None of the analysed markers showed significant deviation from HWE after Bonferroni correction (P value>0.0004). The 
Bonferroni correction was performed by dividing 0.05 by the number of tested markers (the number of tests being performed), i.e. 0.05/121 loci = 0.0004. 
STRs 
Size-based data  Repeat region   repeat and flanking regions 
Ho He HW P-value  Ho He HW P-value  Ho He HW P-value 
D1S1656 0.8046 0.87855 0.19358  0.82759 0.90439 0.1428  0.82759 0.90439 0.1428 
TPOX 0.66667 0.66833 0.30143  0.66667 0.66833 0.30143  0.66667 0.66833 0.30143 
D2S441 0.66667 0.73523 0.14683  0.67816 0.73802 0.17308  0.71264 0.75769 0.23924 
D2S1338 0.77011 0.85921 0.0077  0.85057 0.91489 0.23498  0.85057 0.91489 0.23498 
D3S1358 0.7931 0.77244 0.03995  0.87356 0.89044 0.49752  0.87356 0.89044 0.49752 
D4S2408 0.66667 0.73949 0.49684  0.66667 0.73949 0.49684  0.66667 0.73949 0.49684 
FGA 0.90805 0.86885 0.94851  0.91954 0.87124 0.9274  0.91954 0.87124 0.9274 
D5S818 0.70115 0.76194 0.49358  0.70115 0.76194 0.49358  0.85057 0.85602 0.37169 
CSF1PO 0.65517 0.7256 0.24374  0.67816 0.73836 0.19969  0.67816 0.73836 0.1997 
D6S1043 0.73563 0.81131 0.56902  0.73563 0.81131 0.56902  0.73563 0.81131 0.56902 
D7S820 0.75862 0.77922 0.45703  0.75862 0.77922 0.45703  0.83908 0.85569 0.96444 
D8S1179 0.82759 0.84001 0.63187  0.88506 0.88984 0.67975  0.88506 0.88984 0.67975 
D9S1122 0.75862 0.69271 0.84892  0.89655 0.83569 0.85082  0.89655 0.83569 0.85082 
D10S1248 0.70115 0.72168 0.65711  0.70115 0.72168 0.65711  0.70115 0.72168 0.65711 
TH01 0.65517 0.77038 0.18778  0.65517 0.77038 0.18778  0.65517 0.77038 0.18778 
vWA 0.77011 0.79277 0.69823  0.82759 0.83284 0.08192  0.82759 0.83284 0.08192 
D12S391 0.87356 0.89602 0.34996  0.94253 0.94412 0.35894  0.94253 0.94412 0.35894 
D13S317 0.70115 0.7438 0.76506  0.70115 0.7438 0.76506  0.86207 0.86838 0.78149 
PentaE 0.7907 0.91201 0.00217  0.80233 0.9135 0.00828  0.80233 0.9135 0.00828 
D16S539 0.70115 0.76912 0.11584  0.70115 0.76912 0.11584  0.73563 0.80101 0.21452 
D17S1301 0.6092 0.69225 0.00988  0.6092 0.69225 0.00988  0.6092 0.69225 0.00988 
D18S51 0.85057 0.86679 0.4085  0.85057 0.86679 0.4085  0.85057 0.86679 0.4085 
D19S433 0.88506 0.86008 0.33301  0.88506 0.86287 0.33811  0.88506 0.86287 0.33811 
D20S482 0.74713 0.73942 0.03667  0.74713 0.73942 0.03667  0.8046 0.81975 0.09326 
D21S11 0.81609 0.80466 0.52645  0.90805 0.89476 0.5972  0.90805 0.89542 0.62249 
PentaD 0.8046 0.84891 0.16973  0.8046 0.84891 0.16973  0.8046 0.84898 0.2107 













Repeat Region Sequence Data Flanking Regions Sequences Mtif 
ID 
Novelty 





6.3 0.006 CTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.0060 C2  
7.3 0.011 CTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.011 No variant 0.0110 C2 
Novel 
Allele 
9 0.006 CTCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.0060 A0 
Novel 
Allele 
12 0.006 CTCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.0060 A0  
13 0.023 CTCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.023 No variant 0.0230 A0  
13.3 0.006 CTCTTTCTTTCTTTCCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.0060 B2 
Novel 
Allele 
14 0.086 CTCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.086 No variant 0.0860 A0  
15 0.034 CTCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.034 No variant 0.0340 A0  
16 0.04 CTCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.04 No variant 0.0400 A0  
17 0.069 CTCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.069 No variant 0.0690 A0  
18 0.0980 
CTCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.092 No variant 0.0920 A0  
CTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.0060 B1  
19 0.075 CTCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.075 
No variant 0.0690 A0  
rs369314007 0.0060 A0  
20 0.034 CTCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.034 No variant 0.0340 A0  
20.2 0.024 
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.0060 A1  
CTCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.0060 B3 
Novel 
Allele 
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.0060 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.0060 A1  
21 0.011 CTCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.011 No variant 0.0110 A0  
21.2 0.029 
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.023 No variant 0.023 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.006 A1  
22 0.017 CTCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.017 No variant 0.017 A0  
22.2 0.018 
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.006 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.006 A1  
CTCTTTCTTTCTTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.006 B3 
Novel 
Allele 
23.2 0.029 CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.029 No variant 0.029 A1  
24.2 0.023 
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.011 No variant 0.011 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.006 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.006 A1  
26.2 0.04 
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.017 No variant 0.017 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.011 No variant 0.011 A1  
CTCTTTCTTTCCTTCCTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.006 B9  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.006 A1  
27.2 0.052 
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.011 No variant 0.011 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.011 No variant 0.011 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.006 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTGTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.006 C4 
Novel 
Allele 
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.006 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTTCTTT 0.006 No variant 0.006 A1  












0.017 No variant 0.017 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTT
CTTT 
0.023 No variant 0.023 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTT
CTTT 
0.006 No variant 0.006 A1  
CTCTTTCTTTCCTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTCTTT
CTTT 




0.011 No variant 0.011 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCCTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCT
CTTTCTTT 





0.006 No variant 0.006 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCT
CTTTCTTT 




0.006 No variant 0.006 B5  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCT
TTCTCTTTCTTT 
0.017 No variant 0.017 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCT
TTCTCTTTCTTT 
0.006 No variant 0.006 A3  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCT
TTCTCTTTCTTT 
0.006 No variant 0.006 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCCTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCT
TTCTCTTTCTTT 





0.017 No variant 0.017 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCTTTCT
TTCTCTTTCTTT 




0.006 No variant 0.006 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCT
TTCTTTCTCTTTCTTT 
0.006 No variant 0.006 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCT
TTCTTTCTCTTTCTTT 
0.011 No variant 0.011 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCT
TTCTTTCTCTTTCTTT 
0.011 No variant 0.011 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTTTCT
TTCTTTCTCTTTCTTT 




0.017 No variant 0.017 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCT
TTCTTTCTTTCTCTTTCTTT 
0.006 No variant 0.006 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCT
TTCTTTCTTTCTCTTTCTTT 




0.006 No variant 0.006 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTT
CTCTTTCTTTCTTTCTCTTTCTTT 
0.006 No variant 0.006 A1  
CTCTTTCTTTCCTTCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTT
CTCTTTCTTTCTTTCTCTTTCTTT 










0.006 No variant 0.006 A8 
Novel 
Allele 















Microhaplotype   ͨ 
Microhaplotype/SNPs 
Frequency 
iiSNP & Variant Reference SNP ᵃ  iSNP & Variant GRCh37 Position ᵇ Sequence ᵈ Strand 
rs1490413 174 













          
rs560681 174 
A 0.50575 
ACA 0.48276 rs560681_rs186550433_rs60615385 160786670_160786675_160786688 TCCATCTCTATTTACTCAGGTCACAGGACCTTGGGGCCTCCAAGAGTT Forward 
ACG 0.02299 rs560681_rs186550433_rs60615385 160786670_160786675_160786688 TCCATCTCTATTTACTCAGGTCACAGGGCCTTGGGGCCTCCAAGAGTT Forward 
G 0.49425 GCA 0.49425 rs560681_rs186550433_rs60615385 160786670_160786675_160786688 TCCATCTCTGTTTACTCAGGTCACAGGACCTTGGGGCCTCCAAGAGTT Forward 
          
rs1294331 174 
A 0.37356 A 0.37356 rs1294331 233448413 AGTATAGTTATGGATTTTTATTGAATTTTTG Reverse 
G 0.62644 G 0.62644 rs1294331 233448413 AGTGTAGTTATGGATTTTTATTGAATTTTTG Reverse 
          
rs10495407 174 













          
rs891700 174 








          
rs1413212 174 
G 0.73563 G 0.73563 rs1413212 242806797 GGTGGAGCATGGGGCATTTCA Reverse 









































          
rs1109037 174 
A 0.46551 



































          
rs993934 174 
T 0.53449 












          
rs12997453 174 













          
rs907100 174 




























          
rs4364205 174 








          
rs2399332 174 
A 0.35058 


























          
rs1355366 174 








          
rs6444724 174 








          
rs2046361 174 































          
rs6811238 174 








          
rs1979255 174 
G 0.33908 
G 0.33333 rs1979255 190318080 GATGAGCAAGAGTTCCAACGTTCCATGCCCTGACCAACACAAGCTA Reverse 
GT 0.00575 rs1979255_rs190924736 190318080_190318065 GATGAGCAAGAGTTCCAATGTTCCATGCCCTGACCAACACAAGCTA Reverse 
C 0.66092 C 0.66092 rs1979255 190318080 GATCAGCAAGAGTTCCAACGTTCCATGCCCTGACCAACACAAGCTA Reverse 
          
rs717302 174 








          
rs159606 174 
G 0.78736 G 0.78736 rs159606 17374898 GTTTCTCATCCTGTTATTATTTGTTTACGTCTGTCTCCTATATTTTATTCTCTC Forward 
A 0.21264 A 0.21264 rs159606 17374898 GTTTCTCATCCTGTTATTATTTGTTTACATCTGTCTCCTATATTTTATTCTCTC Forward 
          
rs13182883 174 










          
rs251934 174 

























          
rs13218440 174 










          
rs1336071 174 
G 0.4023 












          
rs214955 174 













          
rs727811 174 













          
rs6955448 174 














          
rs917118 174 































          
rs737681 174 








          
rs763869 174 
T 0.61494 T 0.61494 rs763869 1375610 TGTTTATATTATTTCTAACTCAATTGCATTACATT Reverse 
C 0.38506 C 0.38506 rs763869 1375610 TGTTTATATTATTTCTAACTCAACTGCATTACATT Reverse 
          
rs10092491 174 








          
rs2056277 174 
C 0.74138 












          
rs4606077 174 
T 0.37357 


















































          
rs7041158 174 








          
rs1463729 174 
A 0.54597 












          
rs1360288 174 








          
rs10776839 174 













          
rs826472 174 
























































          
rs3780962 174 
C 0.55172 C 0.55172 rs3780962 17193346 CTGTCCTCACGGGTGAAAGCTGATATCTTGACCTTGTTCATC Reverse 
T 0.44828 T 0.44828 rs3780962 17193346 CTGTCCTTACGGGTGAAAGCTGATATCTTGACCTTGTTCATC Reverse 
          
rs740598 174 








          
rs964681 174 








          
rs1498553 174 








          
rs901398 174 
T 0.6954 T 0.6954 rs901398 11096221 GTGCAAACTAGCTGAATATCAGCCCTGTTGATAGCTAACATTAGT Forward 
C 0.3046 C 0.3046 rs901398 11096221 GTGCAAACTAGCTGAATATCAGCCCCGTTGATAGCTAACATTAGT Forward 
          
rs10488710 174 




























          
rs2107612 174 
A 0.63218 A 0.63218 rs2107612 888320 ACTAATTATGTGTTTTTTCTAAATCATATTGTCTACTTTTCTCCAAAACA Forward 
G 0.36782 G 0.36782 rs2107612 888320 ACTAATTATGTGTTTTTTCTAAATCATATTGTCTGCTTTTCTCCAAAACA Forward 
          
rs2269355 174 
C 0.59195 C 0.59195 rs2269355 6945914 TCCCGAGTTCTCTCCACAGTCCC Forward 
G 0.40805 G 0.40805 rs2269355 6945914 TCCCGAGTTCTCTGCACAGTCCC Forward 
          
rs2920816 166 
















          
rs2111980 174 
A 0.64368 
AG 0.63793 rs2111980_rs79578959 106328254_106328228 CCTTCAAGCTCCAGCCTGGTGCCTCCGCTCCGTGACTCACTGGCAAAGATCT Reverse 
AA 0.00575 rs2111980_rs79578959 106328254_106328228 CCTTCAAGCTCCAGCCTGGTGCCTCCGCTCCATGACTCACTGGCAAAGATCT Reverse 
G 0.35632 GG 0.35632 rs2111980_rs79578959 106328254_106328228 CCTTCGAGCTCCAGCCTGGTGCCTCCGCTCCGTGACTCACTGGCAAAGATCT Reverse 
          
rs10773760 174 








          
rs1335873 174 




























          
rs1058083 174 
G 0.5977 G 0.5977 rs1058083 100038233 TTTGCTCAGAGTATCCGGAGTTAGCCACTAGG Forward 
A 0.4023 A 0.4023 rs1058083 100038233 TTTGCTCAGAGTATCCAGAGTTAGCCACTAGG Forward 
          
rs354439 174 










          
rs1454361 174 








          
rs722290 174 








          
rs873196 174 








          
rs4530059 174 
A 0.41379 






























          
rs8037429 174 
T 0.40805 T 0.40805 rs8037429 53616909 GAGTTATGTAG Forward 
C 0.59195 C 0.59195 rs8037429 53616909 GAGTTACGTAG Forward 
          
rs1528460 174 








          
rs729172 174 
C 0.56897 C 0.56897 rs729172 5606197 AGCCTCATTAATATGACCAAGGCTCCTCTGCAGACCGAATGTATGTAACCG Reverse 
A 0.43103 A 0.43103 rs729172 5606197 AGCCTCATTAATATGACCAAGGCTCCTCTGCAGACAGAATGTATGTAACCG Reverse 
          
rs2342747 174 








          
rs430046 174 








          
rs1382387 174 
T 0.81034 TC 0.81034 rs1382387_rs551898660 80106361_80106359 GAAGGAGAAACACCTGAACTTTCAATTCCCTGCAGTGGGCAGATGC Reverse 
G 0.18966 GC 0.18966 rs1382387_rs551898660 80106361_80106359 GAAGGAGAAACACCTGAACTTTCAAGTCCCTGCAGTGGGCAGATGC Reverse 
 
  



























          
rs740910 174 













          
rs938283 174 





















































          
rs1493232 174 
A 0.75862 A 0.75862 rs1493232 1127986 TTTTGGGTGCTAGGCCACAAAATAAACA Forward 
C 0.24138 C 0.24138 rs1493232 1127986 TTTTGGGTGCTAGGCCCCAAAATAAACA Forward 
          
rs9951171 174 
G 0.67241 






























          
rs1024116 174 
A 0.61494 AG 0.61494 rs1024116_rs545003555 75432386_75432370 CATACACTTAATAAAGTATGCCTTTGTATTTACTTTTGCTCACTTCCCA Reverse 
G 0.38506 GG 0.38506 rs1024116_rs545003555 75432386_75432370 CATGCACTTAATAAAGTATGCCTTTGTATTTACTTTTGCTCACTTCCCA Reverse 
          
rs719366 174 
















          
rs576261 174 
A 0.62644 A 0.62644 rs576261 39559807 GTCACCAACCCTGGCCTCACAACTCTCTC Forward 
C 0.37356 C 0.37356 rs576261 39559807 GTCACCACCCCTGGCCTCACAACTCTCTC Forward 
          
rs1031825 174 








          
rs445251 174 






















          
rs1005533 174 







































          
rs722098 174 
A 0.75287 A 0.75287 rs722098 16685598 GAAATATCCTTGATAAGGATTTAAATTTTGGATGTGCTGAATATTTCTT Forward 
G 0.24713 G 0.24713 rs722098 16685598 GAAATATCCTTGGTAAGGATTTAAATTTTGGATGTGCTGAATATTTCTT Forward 
          
rs2830795 174 
A 0.72414 

















          
rs2831700 174 
A 0.46552 A 0.46552 rs2831700 29679687 ATTTGGCTAAACTATTGCCGGAGATAAGTTAGAA Forward 
G 0.53448 G 0.53448 rs2831700 29679687 ATTTGGCTAAACTATTGCCGGAGATGAGTTAGAA Forward 
          
rs914165 174 
A 0.51724 



























C 0.63793 CA 0.63793 rs221956_rs182328575 43606997_43607005 TTCCCTCCAGCTCTCCTCTCCCCTTTCTGAGCCCTCAGCAAACTGACTTTAG Forward 
T 0.36207 TA 0.36207 rs221956_rs182328575 43606997_43607005 TTCCCTCCAGCTCTCCTCTCCCCTTTCTGAGCCCTCAGCAAATTGACTTTAG Forward 
          
rs733164 174 
A 0.33908 












          
rs987640 174 













          
rs2040411 174 
A 0.62644 A 0.62644 rs2040411 47836412 AAGTGCATATTTCATGA Forward 
G 0.37356 G 0.37356 rs2040411 47836412 AAGTGCGTATTTCATGA Forward 
          
rs1028528 174 
A 0.63218 A 0.63218 rs1028528 48362290 CTTACTCGACATCACTGTGTGCAGATCCGCGGAGGT Forward 
G 0.36782 G 0.36782 rs1028528 48362290 CTTACTCGACATCGCTGTGTGCAGATCCGCGGAGGT Forward 
 





Table 10.8. HWE test for iiSNPs data generated from Chapter 6. None of the analysed markers showed 
significant deviation from HWE after Bonferroni correction (P value>0.0004). The Bonferroni correction was 
performed by dividing 0.05 by the number of tested markers (the number of tests being performed), i.e. 
0.05/121 loci = 0.0004. 
 CE data  Sequence data  
iiSNP  Ho He HW P-value  Ho He HW P-value 
rs1490413 0.48276 0.49751 0.83053  0.48276 0.50761 0.00827 
rs560681 0.54023 0.50289 0.52634  0.54023 0.52515 0.05416 
rs1294331 0.47126 0.47073 1  0.47126 0.47073 1 
rs10495407 0.35632 0.47073 0.03669  0.35632 0.47791 0.0142 
rs891700 0.48276 0.50229 0.83035  0.48276 0.50229 0.83035 
rs1413212 0.29885 0.3912 0.04966  0.29885 0.3912 0.04966 
rs876724 0.33333 0.3623 0.55123  0.58621 0.62893 0.68571 
rs1109037 0.50575 0.50123 1  0.67816 0.71444 0.64579 
rs993934 0.44828 0.5005 0.39166  0.45977 0.50661 0.39343 
rs12997453 0.26437 0.39658 0.00294  0.28736 0.42954 0.00061 
rs907100 0.52874 0.49963 0.66566  0.5977 0.60567 0.43775 
rs1357617 0.31395 0.31191 1  0.31395 0.31191 1 
rs4364205 0.43678 0.48369 0.3842  0.43678 0.48369 0.3842 
rs2399332 0.42529 0.45798 0.63671  0.49425 0.50854 0.51652 
rs1355366 0.48276 0.47359 1  0.48276 0.47359 1 
rs6444724 0.43678 0.47891 0.49917  0.43678 0.47891 0.49917 
rs2046361 0.28736 0.38569 0.02415  0.28736 0.38569 0.02415 
rs279844 0.33333 0.42608 0.04603  0.34483 0.43911 0.0971 
rs6811238 0.50575 0.48794 0.82585  0.50575 0.48794 0.82585 
rs1979255 0.48276 0.44701 0.48093  0.48276 0.45465 0.31 
rs717302 0.49425 0.49864 1  0.49425 0.49864 1 
rs159606 0.33333 0.33679 1  0.33333 0.33679 1 
rs13182883 0.51724 0.48588 0.65618  0.51724 0.48588 0.65618 
rs251934 0.43678 0.46136 0.64457  0.43678 0.46136 0.64457 
rs338882 0.51724 0.50183 0.83124  0.51724 0.50183 0.83124 
rs13218440 0.41379 0.47359 0.2609  0.41379 0.47359 0.2609 
rs1336071 0.43678 0.48369 0.37753  0.43678 0.50123 0.14435 
rs214955 0.42529 0.49332 0.27208  0.43678 0.49983 0.31959 
rs727811 0.45977 0.49166 0.66078  0.47126 0.49824 0.80479 
rs6955448 0.3908 0.4215 0.60739  0.3908 0.4215 0.60739 
rs917118 0.49425 0.46462 0.64398  0.50575 0.46874 0.32782 
rs321198 0.42529 0.41678 1  0.42529 0.41678 1 
rs737681 0.55172 0.50123 0.39249  0.55172 0.50123 0.39249 
rs763869 0.42529 0.47631 0.36764  0.42529 0.47631 0.36764 
rs10092491 0.4023 0.41678 0.7966  0.4023 0.41678 0.7966 
rs2056277 0.41379 0.3912 0.78198  0.49425 0.46475 0.86632 
rs4606077 0.54023 0.47073 0.17941  0.5977 0.53 0.37152 
rs1015250 0.34483 0.34337 1  0.35632 0.36124 0.25345 
rs7041158 0.42529 0.50183 0.19486  0.42529 0.50183 0.19486 
rs1463729 0.37931 0.49864 0.03223  0.4023 0.511 0.04016 
rs1360288 0.33333 0.43485 0.04501  0.33333 0.43485 0.04501 
rs10776839 0.47126 0.49625 0.66996  0.52874 0.59391 0.22383 
rs826472 0.33333 0.48136 0.00642  0.3908 0.5288 0.02871 
rs735155 0.41379 0.47891 0.26176  0.42529 0.49033 0.12284 
rs3780962 0.50575 0.49751 1  0.50575 0.49751 1 
rs740598 0.3908 0.50229 0.05308  0.3908 0.50229 0.05308 
rs964681 0.43678 0.43054 1  0.43678 0.43054 1 
rs1498553 0.44828 0.49625 0.38876  0.44828 0.49625 0.38876 
rs901398 0.33333 0.42608 0.04716  0.33333 0.42608 0.04716 
rs10488710 0.44828 0.5005 0.38993  0.44828 0.5005 0.38993 
rs2076848 0.47126 0.48588 0.82688  0.50575 0.55564 0.41465 
rs2107612 0.3908 0.46774 0.16255  0.3908 0.46774 0.16255 
rs2269355 0.47126 0.48588 0.82701  0.47126 0.48588 0.82701 
rs2920816 0.36145 0.48193 0.03786  0.40964 0.54034 0.013 
rs2111980 0.45977 0.46136 1  0.47126 0.46874 1 
rs10773760 0.29885 0.43054 0.00556  0.29885 0.43054 0.00556 







 Table 10.8. continued.   
 CE data 
data 
 Sequence data 
iiSNP  Ho He HW P-value  Ho He HW P-value 
rs1886510 0.44828 0.47631 0.65242  0.44828 0.47631 0.65242 
rs1058083 0.50575 0.48369 0.82408  0.50575 0.48369 0.82408 
rs354439 0.47126 0.5005 0.66668  0.47126 0.5005 0.66668 
rs1454361 0.56322 0.49332 0.19598  0.56322 0.49332 0.19598 
rs722290 0.51724 0.50262 0.83107  0.51724 0.50262 0.83107 
rs873196 0.26437 0.32323 0.09949  0.26437 0.32323 0.09949 
rs4530059 0.43678 0.48794 0.37569  0.43678 0.50601 0.12226 
rs1821380 0.43678 0.44701 1  0.43678 0.44701 1 
rs8037429 0.51724 0.48588 0.65706  0.51724 0.48588 0.65706 
rs1528460 0.47126 0.48136 1  0.47126 0.48136 1 
rs729172 0.51724 0.49332 0.66668  0.51724 0.49332 0.66668 
rs2342747 0.37931 0.39658 0.7848  0.37931 0.39658 0.7848 
rs430046 0.37931 0.48588 0.0465  0.37931 0.48588 0.0465 
rs1382387 0.31034 0.30915 1  0.31034 0.30915 1 
rs9905977 0.35632 0.39658 0.4141  0.5977 0.65238 0.33312 
rs740910 0.26437 0.30915 0.17705  0.41379 0.46316 0.12104 
rs938283 0.26437 0.34981 0.03127  0.26437 0.34981 0.03127 
rs8078417 0.42529 0.49332 0.27453  0.45977 0.5189 0.64078 
rs1493232 0.32184 0.36835 0.2475  0.32184 0.36835 0.2475 
rs9951171 0.35632 0.44309 0.08771  0.37931 0.46582 0.16165 
rs1736442 0.38272 0.5028 0.04468  0.38272 0.5028 0.04468 
rs1024116 0.44828 0.47631 0.65321  0.44828 0.47631 0.65321 
rs719366 0.21839 0.27938 0.05311  0.21839 0.27938 0.05311 
rs576261 0.51724 0.47073 0.49083  0.51724 0.47073 0.49083 
rs1031825 0.48276 0.48794 1  0.48276 0.48794 1 
rs445251 0.44828 0.48987 0.50983  0.44828 0.49465 0.49305 
rs1005533 0.50575 0.49751 1  0.50575 0.49751 1 
rs1523537 0.43678 0.47359 0.50004  0.44828 0.49884 0.48639 
rs722098 0.33333 0.37426 0.3836  0.33333 0.37426 0.3836 
rs2830795 0.36782 0.40183 0.42841  0.49425 0.53106 0.53606 
rs2831700 0.49425 0.5005 1  0.49425 0.5005 1 
rs914165 0.43678 0.50229 0.2832  0.48276 0.54634 0.0818 
rs221956 0.37931 0.46462 0.10579  0.37931 0.46462 0.10579 
rs733164 0.42529 0.4508 0.63726  0.42529 0.45465 0.75277 
rs987640 0.47126 0.5005 0.66845  0.51724 0.55923 0.5596 
rs2040411 0.47126 0.47073 1  0.47126 0.47073 1 




Table 10.9. LD test for 122 autosomal markers. A total of 292 pairs (STR-STR, STR-SNP and SNP-SNP) of 
syntenic markers (q-q, p-p, and p-q) were tested and no LD was detected after Bonferroni correction (P 
value> Bonferroni-corrected P value 0.0001). The Bonferroni correction was performed by dividing 0.05 
by the number of tested markers (the number of tests being performed), i.e. 0.05/292 pairs = 0.0001. 
Chr.1     
Locus 1 Chr Locus 2 Chr P value 
D1S1656 1 rs1490413 1 0.49812 
D1S1656 1 rs560681 1 0.92158 
rs1490413 1 rs560681 1 0.21847 
D1S1656 1 rs1294331 1 0.0004 
rs1490413 1 rs1294331 1 0.26927 
rs560681 1 rs1294331 1 0.20475 
D1S1656 1 rs10495407 1 0.98907 
rs1490413 1 rs10495407 1 0.2437 
rs560681 1 rs10495407 1 0.95563 
rs1294331 1 rs10495407 1 0.60182 
D1S1656 1 rs891700 1 0.84749 
rs1490413 1 rs891700 1 0.96219 
rs560681 1 rs891700 1 0.34016 
rs1294331 1 rs891700 1 0.11079 
rs10495407 1 rs891700 1 0.37552 
D1S1656 1 rs1413212 1 0.26974 
rs1490413 1 rs1413212 1 0.72779 
rs560681 1 rs1413212 1 0.66458 
rs1294331 1 rs1413212 1 0.93969 
rs10495407 1 rs1413212 1 0.4255 
rs891700 1 rs1413212 1 0.92589 
     
Chr.2     
Locus 1 Chr Locus 2 Chr P value 
TPOX 2 D2S441 2 0.92419 
TPOX 2 D2S1338 2 0.99902 
D2S441 2 D2S1338 2 1 
TPOX 2 rs876724 2 0.54976 
D2S441 2 rs876724 2 0.94563 
D2S1338 2 rs876724 2 0.95084 
TPOX 2 rs1109037 2 0.66548 
D2S441 2 rs1109037 2 0.97426 
D2S1338 2 rs1109037 2 1 
rs876724 2 rs1109037 2 0.4241 
TPOX 2 rs993934 2 0.78769 
D2S441 2 rs993934 2 0.15379 
D2S1338 2 rs993934 2 0.99215 
rs876724 2 rs993934 2 0.44642 
rs1109037 2 rs993934 2 0.61803 
TPOX 2 rs12997453 2 0.92084 
D2S441 2 rs12997453 2 0.42381 
D2S1338 2 rs12997453 2 0.96577 
rs876724 2 rs12997453 2 0.42313 
rs1109037 2 rs12997453 2 0.4308 
rs993934 2 rs12997453 2 0.53139 
TPOX 2 rs907100 2 0.32496 
D2S441 2 rs907100 2 0.84765 
D2S1338 2 rs907100 2 0.17878 
rs876724 2 rs907100 2 0.32775 
rs1109037 2 rs907100 2 0.09452 
rs993934 2 rs907100 2 0.29721 
rs12997453 2 rs907100 2 0.2164 
     
Chr.3     
Locus 1 Chr Locus 2 Chr P value 
D3S1358 3 rs1357617 3 0.69048 
D3S1358 3 rs4364205 3 0.01625 
rs1357617 3 rs4364205 3 0.21329 
D3S1358 3 rs2399332 3 0.99998 
rs1357617 3 rs2399332 3 0.203 
rs4364205 3 rs2399332 3 0.5772 
D3S1358 3 rs1355366 3 0.8982 
rs1357617 3 rs1355366 3 0.43829 
rs4364205 3 rs1355366 3 0.17517 
rs2399332 3 rs1355366 3 0.0964 
D3S1358 3 rs6444724 3 0.17982 
rs1357617 3 rs6444724 3 0.33372 
rs4364205 3 rs6444724 3 0.37217 
rs2399332 3 rs6444724 3 0.14662 





Table 10.9. continued.  
Chr.4     
Locus 1 Chr Locus 2 Chr P value 
D4S2408 4 FGA 4 0.97374 
D4S2408 4 rs2046361 4 0.0473 
FGA 4 rs2046361 4 0.58089 
D4S2408 4 rs279844 4 0.88737 
FGA 4 rs279844 4 0.58135 
rs2046361 4 rs279844 4 0.99515 
D4S2408 4 rs6811238 4 0.42173 
FGA 4 rs6811238 4 0.82269 
rs2046361 4 rs6811238 4 0.77136 
rs279844 4 rs6811238 4 0.39323 
D4S2408 4 rs1979255 4 0.86667 
FGA 4 rs1979255 4 0.98527 
rs2046361 4 rs1979255 4 0.47412 
rs279844 4 rs1979255 4 0.78028 
rs6811238 4 rs1979255 4 0.55961 
     
Chr.5     
Locus 1 Chr Locus 2 Chr P value 
D5S818 5 CSF1PO 5 0.61363 
D5S818 5 rs717302 5 0.47702 
CSF1PO 5 rs717302 5 0.77664 
D5S818 5 rs159606 5 0.50772 
CSF1PO 5 rs159606 5 0.92497 
rs717302 5 rs159606 5 0.70771 
D5S818 5 rs13182883 5 0.29308 
CSF1PO 5 rs13182883 5 0.95781 
rs717302 5 rs13182883 5 0.03423 
rs159606 5 rs13182883 5 0.06971 
D5S818 5 rs251934 5 0.63361 
CSF1PO 5 rs251934 5 0.51731 
rs717302 5 rs251934 5 0.42705 
rs159606 5 rs251934 5 0.53025 
rs13182883 5 rs251934 5 0.21562 
D5S818 5 rs338882 5 0.56016 
CSF1PO 5 rs338882 5 0.36063 
rs717302 5 rs338882 5 0.13621 
rs159606 5 rs338882 5 0.7189 
rs13182883 5 rs338882 5 0.40301 
rs251934 5 rs338882 5 0.68537 
     
Chr.6     
Locus 1 Chr Locus 2 Chr P value 
D6S1043 6 rs13218440 6 0.25599 
D6S1043 6 rs1336071 6 0.03743 
rs13218440 6 rs1336071 6 0.92278 
D6S1043 6 rs214955 6 0.51 
rs13218440 6 rs214955 6 0.72748 
rs1336071 6 rs214955 6 0.2689 
D6S1043 6 rs727811 6 0.94169 
rs13218440 6 rs727811 6 0.55577 
rs1336071 6 rs727811 6 0.76128 
rs214955 6 rs727811 6 0.376 
D6S1043 6 SE33 6 1 
rs13218440 6 SE33 6 0.03156 
rs1336071 6 SE33 6 0.87309 
rs214955 6 SE33 6 0.99894 
rs727811 6 SE33 6 0.98595 
     
Chr.7     
Locus 1 Chr Locus 2 Chr P value 
D7S820 7 rs6955448 7 0.27511 
D7S820 7 rs917118 7 0.33909 
rs6955448 7 rs917118 7 0.5883 
D7S820 7 rs321198 7 0.61806 
rs6955448 7 rs321198 7 0.88742 
rs917118 7 rs321198 7 0.70173 
D7S820 7 rs737681 7 0.37979 
rs6955448 7 rs737681 7 0.62853 
rs917118 7 rs737681 7 0.40061 
rs321198 7 rs737681 7 0.98621 
     
Chr.8     
Locus 1 Chr Locus 2 Chr P value 
D8S1179 8 rs763869 8 0.5584 
D8S1179 8 rs10092491 8 0.80943 
rs763869 8 rs10092491 8 0.94969 
D8S1179 8 rs2056277 8 0.06427 
rs763869 8 rs2056277 8 0.58136 
rs10092491 8 rs2056277 8 0.03819 
D8S1179 8 rs4606077 8 0.73678 
rs763869 8 rs4606077 8 0.05069 
rs10092491 8 rs4606077 8 0.54565 
rs2056277 8 rs4606077 8 0.37239 




Table 10.9. continued.  
Chr.9     
Locus 1 Chr Locus 2 Chr P value 
D9S1122 9 rs1015250 9 0.82415 
D9S1122 9 rs7041158 9 0.54512 
rs1015250 9 rs7041158 9 0.58814 
D9S1122 9 rs1463729 9 0.78652 
rs1015250 9 rs1463729 9 0.56888 
rs7041158 9 rs1463729 9 0.9958 
D9S1122 9 rs1360288 9 0.58519 
rs1015250 9 rs1360288 9 0.12583 
rs7041158 9 rs1360288 9 0.48289 
rs1463729 9 rs1360288 9 0.13896 
D9S1122 9 rs10776839 9 0.35676 
rs1015250 9 rs10776839 9 0.17131 
rs7041158 9 rs10776839 9 0.12548 
rs1463729 9 rs10776839 9 0.7046 
rs1360288 9 rs10776839 9 0.95171 
     
Chr.10     
Locus 1 Chr Locus 2 Chr P value 
D10S1248 10 rs826472 10 0.71276 
D10S1248 10 rs735155 10 0.81945 
rs826472 10 rs735155 10 0.9813 
D10S1248 10 rs3780962 10 0.84618 
rs826472 10 rs3780962 10 0.82519 
rs735155 10 rs3780962 10 0.008 
D10S1248 10 rs740598 10 0.61305 
rs826472 10 rs740598 10 0.07554 
rs735155 10 rs740598 10 0.59965 
rs3780962 10 rs740598 10 0.18169 
D10S1248 10 rs964681 10 0.24918 
rs826472 10 rs964681 10 0.11341 
rs735155 10 rs964681 10 0.64347 
rs3780962 10 rs964681 10 0.55506 
rs740598 10 rs964681 10 0.85486 
     
Chr.11     
Locus 1 Chr Locus 2 Chr P value 
TH01 11 rs1498553 11 0.44699 
TH01 11 rs901398 11 0.40305 
rs1498553 11 rs901398 11 0.43619 
TH01 11 rs10488710 11 0.06893 
rs1498553 11 rs10488710 11 0.7525 
rs901398 11 rs10488710 11 0.77747 
TH01 11 rs2076848 11 0.10053 
rs1498553 11 rs2076848 11 0.1509 
rs901398 11 rs2076848 11 0.33796 
rs10488710 11 rs2076848 11 0.19635 
     
Chr.12     
Locus 1 Chr Locus 2 Chr P value 
vWA 12 D12S391 12 1 
vWA 12 rs2107612 12 0.092 
D12S391 12 rs2107612 12 0.11141 
vWA 12 rs2269355 12 0.34054 
D12S391 12 rs2269355 12 0.01118 
rs2107612 12 rs2269355 12 0.09493 
vWA 12 rs2920816 12 0.75296 
D12S391 12 rs2920816 12 0.91764 
rs2107612 12 rs2920816 12 0.26062 
rs2269355 12 rs2920816 12 0.27157 
vWA 12 rs2111980 12 0.99755 
D12S391 12 rs2111980 12 0.99653 
rs2107612 12 rs2111980 12 0.24372 
rs2269355 12 rs2111980 12 0.32378 
rs2920816 12 rs2111980 12 0.4073 
vWA 12 rs10773760 12 0.45454 
D12S391 12 rs10773760 12 0.54357 
rs2107612 12 rs10773760 12 0.46767 
rs2269355 12 rs10773760 12 0.2639 
rs2920816 12 rs10773760 12 0.01395 
rs2111980 12 rs10773760 12 0.53318 
     
Chr.13     
Locus 1 Chr Locus 2 Chr P value 
D13S317 13 rs1335873 13 0.1836 
D13S317 13 rs1886510 13 0.44997 
rs1335873 13 rs1886510 13 0.67946 
D13S317 13 rs1058083 13 0.20642 
rs1335873 13 rs1058083 13 0.8001 
rs1886510 13 rs1058083 13 0.98344 
D13S317 13 rs354439 13 0.05434 
rs1335873 13 rs354439 13 0.4077 
rs1886510 13 rs354439 13 0.18306 
rs1058083 13 rs354439 13 0.85193 




Table 10.9. continued. 
Chr.14     
Locus 1 Chr Locus 2 Chr P value 
rs1454361 14 rs722290 14 0.40185 
rs1454361 14 rs873196 14 0.8474 
rs722290 14 rs873196 14 0.17717 
rs1454361 14 rs4530059 14 0.35381 
rs722290 14 rs4530059 14 0.16601 
rs873196 14 rs4530059 14 0.29418 
     
Chr.15     
Locus 1 Chr Locus 2 Chr P value 
PentaE 15 rs1821380 15 0.90582 
PentaE 15 rs8037429 15 0.05451 
rs1821380 15 rs8037429 15 0.15606 
PentaE 15 rs1528460 15 0.01971 
rs1821380 15 rs1528460 15 0.62987 
rs8037429 15 rs1528460 15 0.72056 
     
Chr.16     
Locus 1 Chr Locus 2 Chr P value 
D16S539 16 rs729172 16 0.66784 
D16S539 16 rs2342747 16 0.40729 
rs729172 16 rs2342747 16 0.45601 
D16S539 16 rs430046 16 0.93666 
rs729172 16 rs430046 16 0.96647 
rs2342747 16 rs430046 16 0.32501 
D16S539 16 rs1382387 16 0.48523 
rs729172 16 rs1382387 16 0.37103 
rs2342747 16 rs1382387 16 0.49138 
rs430046 16 rs1382387 16 0.61647 
     
Chr.17     
Locus 1 Chr Locus 2 Chr P value 
D17S1301 17 rs9905977 17 0.31891 
D17S1301 17 rs740910 17 0.76952 
rs9905977 17 rs740910 17 0.09089 
D17S1301 17 rs938283 17 0.05557 
rs9905977 17 rs938283 17 0.77258 
rs740910 17 rs938283 17 0.21571 
D17S1301 17 rs8078417 17 0.31548 
rs9905977 17 rs8078417 17 0.86012 
rs740910 17 rs8078417 17 0.93825 
rs938283 17 rs8078417 17 0.58137 
     
Chr.18     
Locus 1 Chr Locus 2 Chr P value 
D18S51 18 rs1493232 18 0.16849 
D18S51 18 rs9951171 18 0.85345 
rs1493232 18 rs9951171 18 0.42172 
D18S51 18 rs1736442 18 0.2397 
rs1493232 18 rs1736442 18 0.27082 
rs9951171 18 rs1736442 18 0.30702 
D18S51 18 rs1024116 18 0.0422 
rs1493232 18 rs1024116 18 0.69953 
rs9951171 18 rs1024116 18 0.22616 
rs1736442 18 rs1024116 18 0.6107 
     
Chr.19     
Locus 1 Chr Locus 2 Chr P value 
D19S433 19 rs719366 19 0.43138 
D19S433 19 rs576261 19 0.41759 
rs719366 19 rs576261 19 0.93067 
     
Chr.20     
Locus 1 Chr Locus 2 Chr P value 
D20S482 20 rs1031825 20 0.82481 
D20S482 20 rs445251 20 0.97978 
rs1031825 20 rs445251 20 0.53286 
D20S482 20 rs1005533 20 0.52687 
rs1031825 20 rs1005533 20 0.58398 
rs445251 20 rs1005533 20 0.20619 
D20S482 20 rs1523537 20 0.90156 
rs1031825 20 rs1523537 20 0.29564 
rs445251 20 rs1523537 20 0.60129 


























Chr.21     
Locus 1 Chr Locus 2 Chr P value 
D21S11 21 PentaD 21 1 
D21S11 21 rs722098 21 0.28111 
PentaD 21 rs722098 21 0.16683 
D21S11 21 rs2830795 21 0.99158 
PentaD 21 rs2830795 21 0.33265 
rs722098 21 rs2830795 21 0.16096 
D21S11 21 rs2831700 21 0.78972 
PentaD 21 rs2831700 21 0.57032 
rs722098 21 rs2831700 21 0.99355 
rs2830795 21 rs2831700 21 0.17265 
D21S11 21 rs914165 21 0.99605 
PentaD 21 rs914165 21 0.79375 
rs722098 21 rs914165 21 0.49236 
rs2830795 21 rs914165 21 0.1051 
rs2831700 21 rs914165 21 0.26508 
D21S11 21 rs221956 21 0.40982 
PentaD 21 rs221956 21 0.13376 
rs722098 21 rs221956 21 0.14699 
rs2830795 21 rs221956 21 0.0073 
rs2831700 21 rs221956 21 0.94269 
rs914165 21 rs221956 21 0.80822 
     
Chr.22     
Locus 1 Chr Locus 2 Chr P value 
D22S1045 22 rs733164 22 0.6213 
D22S1045 22 rs987640 22 0.93037 
rs733164 22 rs987640 22 0.90829 
D22S1045 22 rs2040411 22 0.52838 
rs733164 22 rs2040411 22 0.62269 
rs987640 22 rs2040411 22 0.08637 
D22S1045 22 rs1028528 22 0.35004 
rs733164 22 rs1028528 22 0.73114 
rs987640 22 rs1028528 22 0.95043 




10.6 Appendix 6 
10.6.1 Combined exceedance probability Figures 
 
Figure 10.5.Exceedance probability for Parent-child relationship when using seven different marker 
combinations.  
 
Figure 10.6. Exceedance probability for full-siblings (Scenario 1) relationship when using seven different 







Figure 10.7. Exceedance probability for full-siblings (Scenario 2) relationship when using seven different 
marker combinations.  
 
 
Figure 10.8. Exceedance probability for full-siblings (Scenario 3) relationship when using seven different 








Figure 10.9. Exceedance probability for first-cousin (Scenario 1) relationship when using seven different 
marker combinations.  
 
 
Figure 10.10. Exceedance probability for first-cousin (Scenario 2) relationship when using seven different 






Figure 10.11. Exceedance probability for grand parent/child relationship when using seven different 
marker combinations.  
 
 






10.6.2 Cumulative genetic map distances (cM) of 95 SNPs. 
Table 10.10. The cumulative genetic map distances of 95 SNPs estimated in this study. The 95 SNPs includes 
94 iiSNPs and (rs925658351) for D16S539 STR (shaded row). The cumulative genetic map distances were 
estimated as described by (Phillips et al. 2012). The SNP position (bp) on 1000 Genome Browser was used to 
find the approximate HAP MAP Position (bp) and then to give the cumulative genetic map distance 
estimation that were eventually used to calculate the RFs.  
Chr. SNP 
Position (bp) 
based on 1000 
Genome 
Browser 
HAP MAP data 
Approximate HAP 





Difference between the 
two potions 
chr1 rs1490413 4367323 4367389 59.435141 10.344332 66 
chr1 rs1294331 233448413 233448413 0.118928 252.689344 0 
chr1 rs891700 239881926 239881926 0.045405 266.756507 0 
chr1 rs1413212 242806797 242806797 2.302109 275.111572 0 
chr1 rs10495407 238439308 238439308 0.335417 264.509602 0 
chr1 rs560681 160786670 160787725 0.273362 173.518665 1055 
chr2 rs876724 114974 115035 0.139591 0.054278 61 
chr2 rs1109037 10085722 10085722 27.277036 25.845894 0 
chr2 rs993934 124109213 124109213 0.130837 143.138842 0 
chr2 rs907100 239563579 239563579 0.037258 261.36756 0 
chr2 rs12997453 182413259 182413259 0.506536 196.66925 0 
chr3 rs1357617 961782 961782 0.501977 1.267142 0 
chr3 rs4364205 32417644 32417644 0.735566 56.460103 0 
chr3 rs2399332 110301126 110301126 8.794905 120.166599 0 
chr3 rs1355366 190806108 190806108 1.004389 209.79945 0 
chr3 rs6444724 193207380 193207380 0.461293 214.02781 0 
chr4 rs2046361 10969059 10969059 0.478327 26.495803 0 
chr4 rs279844 46329655 46329655 0.093115 68.752478 0 
chr4 rs6811238 169663615 169663615 0.232386 174.391264 0 
chr4 rs1979255 190318080 190318080 0.141926 213.05529 0 
chr5 rs717302 2879395 2879395 0.608829 6.711702 0 
chr5 rs159606 17374898 17374898 3.172765 33.526135 0 
chr5 rs13182883 136633338 136633338 0.347841 139.768061 0 
chr5 rs251934 174778678 174778678 0.150587 191.98624 0 
chr5 rs338882 178690725 178690725 1.698655 199.640261 0 
chr6 rs13218440 12059954 12059954 0.167491 26.504673 0 
chr6 rs1336071 94537255 94537255 1.416482 100.651101 0 
chr6 rs214955 152697706 152697706 3.948237 159.848323 0 
chr6 rs727811 165045334 165045334 2.845524 180.057073 0 
chr7 rs6955448 4310365 4310365 1.246937 6.912354 0 
chr7 rs917118 4457003 4457003 0.257833 7.494464 0 
chr7 rs321198 137029838 137029838 0.456228 145.377873 0 
chr7 rs737681 155990813 155990813 3.482274 181.919589 0 
chr8 rs763869 1375610 1376074 0.261994 1.957165 464 
chr8 rs10092491 28411072 28411072 0.00252 56.016662 0 
chr8 rs2056277 139399116 139399116 2.752499 156.441029 0 
chr8 rs4606077 144656754 144656754 1.288918 166.567054 0 
chr9 rs1015250 1823774 1823774 0.783254 4.30155 0 
chr9 rs7041158 27985938 27985938 0.024507 53.005534 0 
chr9 rs1463729 126881448 126881448 1.545209 136.052552 0 
chr9 rs1360288 128968063 128968063 1.159908 137.914483 0 
chr9 rs10776839 137417308 137417308 0.548701 155.845308 0 







Table 10.10. continued. 
chr10 rs735155 3374178 3374178 0.159617 6.796451 0 
chr10 rs3780962 17193346 17193346 0.003591 38.18664 0 
chr10 rs740598 118506899 118507219 3.475211 143.730145 320 
chr10 rs964681 132698419 132698419 10.412997 175.669404 0 
chr11 rs1498553 5709028 5709028 0.669088 11.572163 0 
chr11 rs901398 11096221 11096221 1.199891 20.234646 0 
chr11 rs10488710 115207176 115207176 4.03968 119.995733 0 
chr11 rs2076848 134667546 134667546 4.646889 157.84371 0 
chr12 rs2107612 888320 888320 0.206495 2.139891 0 
chr12 rs2269355 6945914 6945914 3.626098 17.707304 0 
chr12 rs2920816 40863052 40863052 0.003186 56.271503 0 
chr12 rs2111980 106328254 106328254 6.280602 124.517852 0 
chr12 rs10773760 130761696 130761696 0.542549 168.442499 0 
chr13 rs1335873 20901724 20901724 0.179491 2.118193 0 
chr13 rs1886510 22374700 22374700 25.742717 4.798954 0 
chr13 rs1058083 100038233 100038233 0.350926 94.111308 0 
chr13 rs354439 106938411 106938411 0.880698 107.294777 0 
chr14 rs1454361 25850832 25850832 0.070597 17.199338 0 
chr14 rs722290 53216723 53216723 0.002611 47.502832 0 
chr14 rs873196 98845531 98845531 0.012235 104.004219 0 
chr14 rs4530059 104769149 104769149 1.968272 114.517458 0 
chr15 rs1821380 39313402 39313402 3.849343 53.239677 0 
chr15 rs8037429 53616909 53616909 0.533222 64.450111 0 




86386300 86386367 10.340142 125.578237 67 
chr16 rs729172 5606197 5606197 0.494381 11.312582 0 
chr16 rs2342747 5868700 5868700 1.253583 11.861336 0 
chr16 rs430046 78017051 78017051 0.925856 97.209133 0 
chr16 rs1382387 80106361 80106361 0.292771 103.725715 0 
chr17 rs9905977 2919393 2919393 9.110377 8.279761 0 
chr17 rs740910 5706623 5706623 0.273417 13.408655 0 
chr17 rs938283 77468498 77467821 11.920114 120.308115 677 
chr17 rs8078417 80461935 80461935 31.907279 127.751349 0 
chr18 rs1493232 1127986 1127986 0.079291 3.666872 0 
chr18 rs9951171 9749879 9749879 1.956372 28.533917 0 
chr18 rs1736442 55225777 55225777 0.321859 74.557154 0 
chr18 rs1024116 75432386 75432386 0.054529 112.788928 0 
chr19 rs719366 28463337 28463337 2.41979 49.406517 0 
chr19 rs576261 39559807 39559807 0.128519 63.836919 0 
chr20 rs1031825 4447483 4447483 1.041895 12.795432 0 
chr20 rs445251 15124933 15124933 0.001705 35.366478 0 
chr20 rs1005533 39487110 39487110 1.169482 58.015382 0 
chr20 rs1523537 51296162 51296162 0.565814 77.584173 0 
chr21 rs722098 16685598 16686158 1.932588 4.539526 560 
chr21 rs2830795 28608163 28608163 0.373499 27.348259 0 
chr21 rs2831700 29679687 29679687 0.099294 29.39708 0 
chr21 rs914165 42415929 42415929 1.71141 50.554348 0 
chr21 rs221956 43606997 43606997 0.900948 54.769216 0 
chr22 rs733164 27816784 27816784 2.701817 31.366306 0 
chr22 rs987640 33559508 33559508 2.465237 37.654171 0 
chr22 rs2040411 47836412 47836412 0.747932 62.887237 0 
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